0001109486 false --09-30 0001109486 2022-08-31 2022-08-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  August 31, 2022

 

 

 

ENDEXX CORPORATION

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Nevada   000-30233   30-0353162

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

38246 North Hazelwood Circle    
Cave Creek, Arizona   85331
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (480) 595-6900

 

(Former Name or Former Address, if Changed Since Last Report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
         

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Section 1 – Registrant’s Business and Operations

 

Item 1.01. Entry into a Material Definitive Agreement.

 

Hyla Acquisition and Related Transactions

 

Effective August 31, 2022, Endexx Corporation (“we”, “us”, or “our”) and EH Sub Inc., a Nevada corporation that is our wholly-owned subsidiary (our “Acquisition Sub”), closed the transactions (the “Hyla Transaction Closing Date”) contemplated by a Control Acquisition Agreement (the “Hyla Acquisition Agreement”) with HYLA UK Holdco Limited, a United Kingdom limited company (the “Seller”). Pursuant to the terms of the Hyla Acquisition Agreement, we, through our Acquisition Sub, purchased (the “Hyla Transaction”) 51% of the issued and outstanding capital stock of Hyla US Holdco Limited, a Delaware corporation (“Hyla”), a wholly-owned operating subsidiary of the Seller.

 

Hyla produces and sells organic, plant-based, all-natural, zero-nicotine vape products. Each HYLA device contains a natural guarana extract that is blended with proprietary botanical formulas. Hyla launched its products in October 2021 and its initial inventory (140,000 devices) was sold out the following month. Hyla’s products bear the Underwriters Laboratories global safety certification and are CE approved.

 

The Hyla Transaction was valued at $10 million and was paid through the issuance (i) of shares of our capital stock (20% of the value) and (ii) our promissory note (80% of the value). We issued to the Seller 4,878,049 shares of our newly constituted Series H Convertible Preferred Stock (the “Hyla Series H Preferred”). We valued those shares at an aggregate of two million dollars, which was based upon an as-converted-into-our Common Stock value of $0.041 per share. The per-share price was the closing price of our Common Stock, par value $0.0001 per share (our “Common Stock”), as reported by the OTC Markets Group Inc. (the “OTCM”), on August 19, 2022, the date on which certain of the initial set of Hyla Transaction-related draft documents were circulated for signature. We also issued to the Seller our Self-financing Promissory Note (our “Self-financing Note”) with a term of up to nine years. The initial principal balance of our Self-financing Note is $8 million and it bears interest at an annual simple interest rate of 3.15%, which is the Internal Revenue Service’s August 2022 Applicable Federal Rate for promissory notes with terms from three to nine years. We are obligated to make payments of principal and interest on a quarterly basis, in arrears (each, a “Quarterly Payment”). The amount of each of our Quarterly Payments is calculated pursuant to a formula set forth in the Self-financing Note, the components of which are derived from a matrix that consists of Hyla’s quarterly gross sales revenues and its gross sales margin. As a result of the Hyla Transaction, we will consolidate Hyla’s financial statements with ours in the periodic reports that we file with the Securities and Exchange Commission (the “SEC”).

 

Certificate of Designation of Rights, Privileges, Preferences, and Limitations of Series H Convertible Preferred Stock

 

To establish our Series H Preferred, we filed a Certificate of Designation of Rights, Privileges, Preferences, and Limitations of Series H Convertible Preferred Stock with the Secretary of State of the State of Nevada on August 25, 2022 (the “Series H CoD”). The Series H Preferred has a par value of $0.0001 per share and a stated value of $0.41 per share. Each share of Series H Preferred may be initially converted into 10 shares of our Common Stock, subject to adjustment due to merger, consolidation, exchange of shares, recapitalization, reorganization, or similar events, all as set forth in the Series H CoD. The holders of the Series H Preferred are entitled to receive dividends in an aggregate amount equal to the total amount of any dividends that we declare, pay, or set aside for the holders of shares of our Common Stock. The holders of Series H Preferred shall vote together as a single class, but otherwise have the same voting rights as the holders of shares of our Common Stock except that the holders of the Series H Preferred are entitled to an aggregate vote equivalent to one share in excess of the maximum potential vote of the aggregate of the other classes or series of our then-issued and outstanding equity voting shares on any occasion when the vote of the holders of our voting equity is held. Further, for so long as shares of Series H Preferred are outstanding, the holders of the majority of the Series H Preferred shall have the right to appoint two of our directors, while the other three directors will be appointed by the vote of a majority of our Common Stock and the Series H Preferred, the holders thereof exercising their variable basis voting rights. The Series H Preferred has a liquidation preference to our Common Stock equal to $0.41 per share.

 

Self-financing Note

 

Pursuant to the Hyla Acquisition Agreement, we issued to the Seller our Self-financing Note in the principal amount of $8 million, which accrues interest at the rate of 3.15% per annum. Upon an Event of Default (as such term is defined in the Self-financing Note), the interest rate will increase to 6.3% per annum until such Event of Default has been cured or the debt has been paid in full. The amount of principal and interest due to the Seller for each of our Quarterly Payments is calculated pursuant to a formula set forth in the Self-financing Note, the components of which are derived from a matrix that consists of Hyla’s quarterly gross sales revenues and its gross sales margin. Each Quarterly Payment shall, at the option of the Seller, be paid either in cash or through the issuance of shares of our Common Stock. The pricing of those shares will be determined by the volume weighted average price of our Common Stock as of the last business day of the relevant quarter. The Self-financing Note is subject to an “ownership limitation” such that the Seller cannot request that it be issued shares of our Common Stock as payment if such issuance would result in the Seller holding more than 4.99% of the then-issued and outstanding shares of our Common Stock (a “Conversion or Exercise Blocker”). We may pre-pay our Self-financing Note in whole or in part at any time without premium or penalty.

 

Intercompany Services Agreement

 

In connection with the Hyla Transaction, Hyla and we entered into an Intercompany Services Agreement (the “Hyla ISA”), pursuant to the provisions of which, we agreed to provide to Hyla certain human resources, marketing, information technology, and other administrative services that are necessary to support its business. We will invoice Hyla on a monthly basis for our performance of the services thereunder, and for which Hyla will pay us in accordance with the provisions of the HYLA ISA. The initial term of the Hyla ISA is nine years and it is subject to renewal for successive 12-month periods.

 

2
 

 

ISA-related Promissory Note

 

In connection with the Hyla ISA, Hyla issued to us its two-year Promissory Note in the principal amount of $1.5 million, which accrues interest at the rate of 10% per annum (“Hyla’s ISA Note”). Principal and interest payments thereunder are due and payable on a monthly basis. Upon an Event of Default (as such term is defined in Hyla’s ISA Note), the interest rate increases to 18% per annum until such Event of Default has been cured or the debt has been paid in full. The principal amount is due and payable on or before August 31, 2024.

 

Financing Related to the Hyla Acquisition and Endexx’s On-going Obligations

 

In connection with the financing that we required to effectuate the Hyla Transaction and for certain of our on-going obligations, pursuant to a Note Purchase Agreement (the “NPA”), we sold and issued two Convertible Promissory Notes (each, an “NPA Promissory Note”) in an aggregate principal amount of approximately $2.174 million for an aggregate purchase price of $2.0 million ($1.335 million to one of the NPA Investors and $655 thousand to the other NPA Investor) and granted two five-year Common Stock Purchase Warrants (each, an “NPA Warrant”) that are exercisable for the purchase of up to an aggregate of approximately 88.7 million shares (approximately 59.2 million shares to one of the NPA Investors and approximately 29.5 million shares to the other NPA Investor) of our Common Stock (collectively, the “NPA Warrant Stock”) to two of our Historic Investors (as such term is defined in “Reduction of Historic Promissory Obligations; Cancellation of Historic Warrants”, below; each of such Historic Investors, an “NPA Investor”). In addition, each NPA Investor and we also entered into a Registration Rights Agreement (the “NPA Registration Rights Agreement”), pursuant to the provisions of which we are obligated to register for resale the shares of our Common Stock that underly our NPA Promissory Notes and our NPA Warrants. To secure our obligations to each NPA Investor under our NPA Promissory Notes, we entered into a Security Agreement (the “NPA Security Agreement”) and an IP Security Agreement (the “NPA IP Security Agreement”), each in favor of each NPA Investor (collectively, the “NPA Security Agreements”).

 

The sale and issuance of the NPA Promissory Notes, the grant of the NPA Warrants, and the other transactions contemplated by the NPA were completely consummated on August 31, 2022 (the “NPA Closing Date”). The NPA also granted to each NPA Investor a one-year option to purchase up to an aggregate of 22.5 million shares of our Common Stock (20 million shares for one NPA Investor and 2.25 million shares for the other NPA Investor) at a per-share exercise price of $0.01 (collectively, the “NPA Options”). Exercise of the NPA Options is subject to the Conversion or Exercise Blocker.

 

Each NPA Promissory Note is due on the 12-month anniversary of the NPA Closing Date and is secured by all of our assets (including the equity of each of our partially and wholly-owned subsidiaries) pursuant to the provisions of the NPA Security Agreements. Initially, the NPA Promissory Notes are convertible into shares of our Common Stock (the “NPA Conversion Stock”) at an initial, fixed conversion price of $0.0245 per share, subject to adjustment due to merger, consolidation, exchange of shares, recapitalization, reorganization, or similar event as set forth in the NPA Promissory Notes (the “NPA Conversion Price”). The NPA Promissory Notes contain an adjustment provision that, subject to certain exceptions, reduces the conversion price if we issue shares of our Common Stock or common stock equivalents at a price lower than the then-current NPA Conversion Price for the NPA Promissory Notes. Upon the occurrence of any fundamental transaction, distributions, stock dividends, or other similar event, each NPA Investor will be entitled to participate in such an event on an “as-converted” basis, and the NPA Conversion Price will be ratably adjusted upon any stock split, stock distribution, or other similar event. Each NPA Promissory Note is subject to the Conversion or Exercise Blocker, such that the applicable NPA Investor cannot convert any portion of its NPA Promissory Note that would result in the NPA Investor and its affiliates exceeding the limits of the Conversion or Exercise Blocker following such conversion (excluding, for purposes of such determination, shares of our Common Stock that will be issuable upon conversion of that portion of the holder’s NPA Promissory Note or exercise of that portion of the holder’s NPA Warrant that had not then been converted or exercised, respectively). An NPA Promissory Note may not be converted until the six-month anniversary of the NPA Closing Date, except in the event of an uncured Event of Default (as such term is defined in the NPA Promissory Note). Each NPA Promissory Note accrues interest at an annual rate equal to 12% (the first 12 months of which constitute guaranteed interest) and is due and payable on its maturity date (or sooner if an NPA Investor converts an NPA Promissory Note or otherwise accelerates the maturity date, as provided for therein). Interest is payable in cash on the maturity date or, in shares of our Common Stock at the then-current NPA Conversion Price if the NPA Investor were to convert an NPA Promissory Note or otherwise accelerates the maturity date, as provided for therein.

 

We have the right, but not the obligation, to prepay, in full, but not in part, the outstanding principal and interest under each NPA Promissory Note prior to its maturity date. Exercise of our prepayment option requires us to pay to the then-holder of the applicable NPA Promissory Note an amount equal to the sum of (i) the then-outstanding principal amount plus (ii) the guaranteed interest and any other outstanding and accrued interest thereon, multiplied by 125%. We must provide five calendar days’ prior written notice to the then-holder of the applicable NPA Promissory Note of our intention to effectuate a prepayment.

 

We also granted to each of the NPA Investors an NPA Warrant for the purchase of up to an aggregate of approximately 88.7 million shares of NPA Warrant Stock. Each NPA Warrant has a five-year term, is immediately exercisable at an exercise price of $0.02695 per share (the “NPA Warrant Exercise Price”), subject to adjustment, and is exercisable by the then-holder on a “cashless” basis. Each NPA Warrant contains an adjustment provision that, subject to certain exceptions, reduces the NPA Warrant Exercise Price if we issue shares of our Common Stock or common stock equivalents at a price lower than the then-current NPA Warrant Exercise Price. Any stock splits, reverse stock splits, recapitalizations, mergers, combinations and asset sales, stock dividends, and similar events will result in an equitable adjustment of the NPA Warrant Exercise Price and, in certain circumstances, the number of shares of NPA Warrant Stock. Each NPA Warrant is subject to an “ownership limitation,” such that the applicable NPA Investor cannot exercise any portion of an NPA Warrant that would result in that NPA Investor and its affiliates holding more than the limits of the Conversion or Exercise Blocker upon such exercise (excluding, for purposes of such determination, shares of our Common Stock remaining issuable upon the exercise of its NPA Warrant or the conversion of its NPA Promissory Note).

 

Pursuant to the provisions of the NPA Registration Rights Agreement, we are obligated to file a Registration Statement with the SEC to register for resale the shares of Conversion Stock and the shares of NPA Warrant Stock not later than the four-month anniversary of the NPA Closing Date. Further, we agreed to use our best efforts to have the Registration Statement declared effective by the SEC within 90 days after we have filed it, but in no event later than 90 days after such filing, or by the 5th trading day following the date on which we are notified that the Registration Statement will not be reviewed by the SEC or is no longer subject to further review and comments. Pursuant to the provisions of the NPA Registration Rights Agreement, we are subject to payment of partial liquidated damages in an amount equal to 2.0% of the aggregate purchase price paid by the applicable NPA Investor pursuant to the NPA for the NPA Promissory Note and the NPA Warrant if we fail (i) to meet various specified filing and effectiveness dates in accordance with the schedule set forth therein or (ii) to keep the Registration Statement effective and usable by the NPA Investors in the manner set forth therein. The NPA Investors and we also agreed, among other things, to indemnify each NPA Investor from certain liabilities and to pay all fees and expenses that we may incur in connection with the registration of the shares of Conversion Stock and the shares of Warrant Stock held by each NPA Investor.

 

3
 

 

Reduction of Historic Promissory Obligations; Cancellation of Historic Warrants

 

Between February of 2019 and May of 2022, we borrowed approximately $6.7 million from seven different investors (collectively, the “Historic Investors”) through the issuance of a series of our Convertible Promissory Notes (collectively, the “Historic Investors Pre-Hyla Transaction Promissory Notes”) and, with accrued interest standard rate interest through the Hyla Transaction Closing Date, we owed the Historic Investors approximately $9.445 million. Each of the Historic Promissory Notes accrued interest at a specified rate that increased significantly in the event that we defaulted in our obligations thereunder. As of the Hyla Transaction Closing Date, we may have been in default under the provisions of some or all of the Historic Investors Pre-Hyla Transaction Promissory Notes. In connection with our initial sale and issuance of each Historic Investors Pre-Hyla Transaction Promissory Note, we also granted to each Historic Investor a Common Stock Purchase Warrant that provided to each Historic Investor the right to purchase shares of our Common Stock (collectively, the “Historic Investors Warrants”). The initial aggregate number of shares of our Common Stock underlying the Historic Investors Warrants was approximately 74 million.

 

In connection with, and effective upon, the Hyla Transaction Closing Date, each of the Historic Investors and we entered into Settlement, Lock-Up, and Leak-Out Agreements (each, a “Historic Investors Settlement Agreement”). Pursuant to the provisions of each such Agreement, each Historic Investor agreed to exchange its Historic Investors Pre-Hyla Transaction Promissory Note and its Historic Investors Warrant for a replacement, simple Promissory Note (collectively, the “Historic Investors Replacement Notes”). The initial principal balance of each Historic Investors Replacement Note was equal to the sum of (i) the principal amount owed to each Historic Investor under its Historic Investors Pre-Hyla Transaction Promissory Note and (ii) the accrued and unpaid stated rate of interest thereunder.

 

The term of each Historic Investors Replacement Note is 18 months. Payments of principal thereunder are to commence on the three-month anniversary of the NPA Closing Date – an amount that escalates through and including the 17-month anniversary, with a balloon payment due the following month. Interest accrues during the term of each Historic Investors Replacement Note at a rate of 6.667% per annum and is also due with the balloon payment. We may prepay the Historic Investors Replacement Notes at any time without premium or penalty. Upon an event of default thereunder, the interest rate on the then-unpaid principal increases to 18.0% per annum until that default has been cured or the debt has been paid in full. Upon an event of default of a Historic Investors Replacement Note, the holder thereof has the right to pursue payment of only those amounts that were then due and payable; however, the holder does not have any right to accelerate any future amounts due thereunder. Further, in the event that a Historic Investor obtains a judgment against us resulting from a default under a Historic Investors Replacement Note, the Historic Investor is precluded from attaching any of (i) the Hyla Series H Preferred that we acquired in the Hyla Transaction and (ii) Hyla’s assets.

 

Pursuant to the provisions of the Settlement Agreements, each Historic Investor agreed to (i) waive any default or additional interest, fees, and penalties that otherwise might have been due under its Historic Investors Pre-Hyla Transaction Promissory Note and (ii) waive any Common Stock conversion rights under its Historic Investors Pre-Hyla Transaction Promissory Note. Two of the Historic Investors that owned shares of our Common Stock agreed (i) that, for a period of 12 or 18 months, they would not sell any of those shares and (ii) for the succeeding period of 12 months, they would limit their sales of those shares to a maximum of five percent of the daily trading volume of our Common Stock, as reported by the OTCM. A third Historic Investor that, because it is also an NPA Investor, is not party to such an agreement.

 

Todd Davis Agreements

 

Effective as of the Hyla Transaction Closing Date, we entered into a series of agreements with our president, Todd Davis, as detailed below.

 

Contribution and Exchange Agreement

 

Effective as of the Hyla Transaction Closing Date, Todd Allen Davis, our President (“Mr. Davis”), Rayne Forecast Inc., an Arizona corporation that is wholly owned by Mr. Davis (“Rayne”), CBD Unlimited, Inc., a Nevada corporation that, until then was a wholly-owned subsidiary ours (“CBDU”), and we entered into a Contribution and Exchange Agreement (the “Davis/Rayne Contribution Agreement”). Pursuant to its terms, (i) Rayne surrendered to us for cancellation (y) certain shares of our Common Stock then owned of record and beneficially by Rayne and (z) Mr. Davis surrendered all of the then-issued and outstanding shares of our Series Z Convertible Preferred Stock (“Series Z Preferred”), all of which stock was owned of record and beneficially by Mr. Davis, such that upon such cancellations, Mr. Davis and Rayne collectively remained the record and beneficial owners of 4.99% of the then-issued and outstanding shares of our Common Stock (separate from additional shares of our Common Stock thereafter held in an escrow, which, if released, would increase such percentage to 8.62%, calculated as if that stock had been released to Rayne on the Hyla Transaction Closing Date, which potential post-release percentage is equivalent to the percentage of our capital stock owned of record and beneficially by the Seller (assuming that, as of the Hyla Transaction Closing Date, the Seller had converted all of the shares of Series H Preferred) and (ii) Mr. Davis and Rayne contributed to us certain unpaid compensation and related items in their favor. In exchange therefor, we transferred to Mr. Davis/Rayne that number of shares of CBDU common stock equal to 30% of its then-issued and outstanding capital stock (the “Davis/Rayne Exchange Transaction”). Pursuant to the provisions of the Davis/Rayne Contribution Agreement, we contributed all of our operating assets, wherever situated, and all of our liabilities directly related thereto to CBDU. As a result of the provisions of the Davis/Rayne Contribution Agreement, CBDU became a majority-owned subsidiary of ours that we will continue to consolidate for financial reporting purposes. Subsequent to the Hyla Transaction Closing Date, but in connection with the Davis/Rayne Contribution Agreement and the Davis/Rayne Exchange Transaction, we filed our Certificate of Withdrawal of Certificate of Designation for our Series Z Preferred (the “Series Z Withdrawal”) with the Secretary of State of the State of Nevada.

 

Escrow Agreement

 

Effective as of Hyla Transaction Closing Date and as required pursuant to the provisions of the Davis/Rayne Contribution Agreement, Mr. Davis, Rayne, a third-party escrow agent, and we entered into an Escrow Agreement (the “Davis/Rayne Escrow Agreement”), pursuant to which Rayne delivered a number of shares of our Common Stock (the “Davis/Rayne Escrowed Shares”) to the escrow agent to be held in escrow. Under the terms of the Davis/Rayne Escrow Agreement, the Davis/Rayne Escrowed Shares will be released to Rayne (or Mr. Davis) upon our payment in full of each of the Historic Investors Replacement Notes.

 

4
 

 

Executive Agreement

 

Effective as of Hyla Transaction Closing Date and in connection therewith and with the Davis /Rayne Contribution Agreement and the Davis/Rayne Exchange Transaction, Mr. Davis and we entered into a one-year Executive Agreement (the “Davis Executive Agreement”). Pursuant thereto, Mr. Davis will continue to serve as our President and will continue to provide such services as are customary of such officeholder and will continue to oversee CBDU’s operations, as now consolidated into CBDU. We will provide base compensation to Mr. Davis at a rate of $10,000 per month. He will also be eligible to participate in all other benefits that we offer to our executives, including, but not limited to, health insurance for Mr. Davis and his family members. Either of us may terminate the Davis Executive Agreement upon 30 days’ written notice for any or no reason; provided, that we can terminate Mr. Davis immediately for Cause (as such term is defined in the Davis Executive Agreement). If we terminate the Davis Executive Agreement other than for Cause or if Mr. Davis terminates the Davis Executive Agreement for Good Reason (as such term is defined in the Davis Executive Agreement), then we will continue to pay to Mr. Davis his base compensation for the succeeding six months. We do not have any obligations to Mr. Davis if we terminate the Davis Executive Agreement for Cause or if Mr. Davis terminates the Davis Executive Agreement other than for Good Reason.

 

The foregoing brief summary description of certain terms and provisions of each of the Series Z Withdrawal, the Series H CoD, the NPA Warrants, the Hyla Acquisition Agreement, the Self-financing Note, the Hyla ISA, Hyla’s ISA Note, the NPA, the NPA Promissory Notes, the NPA Warrants, the NPA Registration Rights Agreement, the NPA Security Agreement, the NPA IP Security Agreement, the Historic Investors Settlement Agreements, the Historic Investors Replacement Notes, the Davis/Rayne Contribution Agreement, the Davis/Rayne Escrow Agreement, and the Davis Executive Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of each of such certificates, securities, and agreements, a copy of the form of each of which is attached to this Current Report on Form 8-K, as Exhibits 3.3a, 3.4, 4.11, and 10.35 through 10.48, respectively. Readers are encouraged to read each Exhibit in full for a more comprehensive understanding of the transaction described herein.

 

Section 2 – Financial Information

 

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The information set forth in Item 1.01 above is incorporated by reference into this Item 2.03

 

Section 5 – Corporate Governance and Management

 

Item 5.01 Changes in Control of Registrant.

 

The information set forth in Item 1.01 above is incorporated by reference into this Item 5.01.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Effective as of the Hyla Transaction Closing Date, Daniel Brandwein resigned his position as a member of our board of directors for personal reasons. There were no disagreements between Mr. Brandwein and us on any matter relating to our operations, policies, or practices.

 

Effective as of the Hyla Transaction Closing Date, Nick Mehdi, the chief executive officer of Hyla, was appointed as a member of our board of directors. Mr. Mehdi, 49, has served as Hyla’s CEO since inception in September of 2021. Mr. Mehdi’s annual compensation through March 31, 2023 is $200,000, which will increase to $220,000 for the balance of 2023. He is also eligible for a discretionary annual bonus in the amount of four percent of Hyla’s EBITDA and a one-time discretionary bonus in the event of a sale of Hyla or all or substantially all of its assets or a change of control of Hyla. The foregoing brief summary description of certain terms and provisions of Mr. Mehdi’s employment agreement does not purport to be complete and is qualified in its entirety by reference to the full text of that agreement, a copy of which is attached to this Current Report on Form 8-K, as Exhibit 10.50. Readers are encouraged to read that Exhibit in full for a more comprehensive understanding of his employment relationship with Hyla. Prior to joining Hyla and commencing in May of 2019, he was the Chief Executive Officer of ZT Wireless, LLC, and from October of 2018 to October of 2018, he was the Vice President of Operations for Sun Com Mobile, LLC. Both companies are a Sugarland, Texas-based wireless communications companies. Nick received his bachelor’s degree from University of Houston in May 2001. Based on his experience with Hyla’s products and his position as its CEO, we believe that Mr. Mehdi is well qualified to serve as one of our directors.

 

Effective as of the Hyla Transaction Closing Date, Steven M. Plumb, CPA, 63, was appointed as our Secretary and Treasurer, succeeding Mr. Davis. Mr. Plumb is a seasoned senior executive and financial manager, experienced in operations, finance, and marketing. He is a former auditor with PriceWaterhouseCoopers and KPMG. He also has a background in IT, biotech, oil and gas, real estate, medical, and utility companies. Since 2001, Mr. Plumb has served as the president of Clear Financial Solutions, Inc., a consulting firm that he founded, which provides interim CFO services to small public companies. Between December of 2018 and May of 2021, he served as the Chief Financial Officer of Artella Solutions, Inc., a private medical device company; from May of 2013 through February of 2019, as the Chief Financial Officer of ProBility Media Corp. (PBYA.PK), a Pasadena, Texas-based online training school for skilled trades, and commencing January of 2020, as the Chief Financial Officer of DirectView Holdings, Inc. (DIRV.PK), a Boca Raton, Florida-based security monitoring company. In his career, he has prepared SEC filings, managed investor relations, conducted mergers and acquisition activities, developed successful offering memoranda, registration statements, and investor presentations. Steve received his Bachelor of Business Administration degree from the University of Texas at Austin, Austin, Texas. We do not have a written employment agreement with Mr. Plumb, but will be compensating him at the rate of $5,000 per month. Based on his financial background and he wide variety of experience, we believe that M. Plumb will be well suited to act as our Secretary and Treasurer.

 

There are no family relationships among any of our directors or executive officers. None of our directors or executive officers was selected to serve in their respective roles pursuant to any arrangement or understanding between such director or executive officer and any person.

 

Certain of the information set forth in Item 1.01 above is incorporated by reference into this Item 5.02.

 

5
 

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On August 25, 2022, in preparation for the closing of the Hyla Transaction, we filed our Series H CoD with the Secretary of State of the State of Nevada. Please see the information set forth in Item 1.01 for a summary description of the rights, privileges, preferences, and limitations of the Series H Preferred, which is incorporated by reference into this Item5.03.

 

In connection with the Hyla Transaction, the Davis/Rayne Contribution Agreement, and the Davis/Rayne Exchange Transaction, we effectuated the Series Z Withdrawal on September 6, 2022.

 

The information set forth in Item 1.01 above is incorporated by reference into this Item 5.03.

 

Section 9 – Financial Statements and Exhibits

 

Item 9.01 Financial Statements and Exhibits.

 

  (a) Financial Statements of Business Acquired.

 

The financial statements required by this item will be filed by November 10, 2022, which is the 71st calendar day following the date this Current Report was required to be filed with the SEC.

 

  (b) Pro Forma Financial Information.

 

The pro forma financial information required by this item will be filed by November 10, 2022, which is the 71st calendar day following the date this Current Report was required to be filed with the SEC.

 

  (d) Exhibits.

 

Exhibit No.   Description
     
3.3a   Certificate of Withdrawal of Certificate of Designation for the Series Z Convertible Preferred Stock filed with the Secretary of State for the State of Nevada on September 6, 2022.
     
3.4   Certificate of Designation of Rights, Privileges, Preferences, and Limitations of Series H Convertible Preferred Stock of the registrant filed with the Secretary of State of the State of Nevada on August 25, 2022.
     
4.11   Form of Warrant of the registrant granted to two separate investors, effective as of August 31, 2022.
     
10.35   Form of Control Acquisition Agreement among the registrant, EH Sub Inc., and HYLA UK Holdco Limited, effective as of August 31, 2022.
     
10.36   Form of Self-Financing Promissory Note of the registrant issued to HYLA UK Holdco Limited, effective as of August 31, 2022.
     
10.37   Form of Intercompany Services Agreement between the registrant and Hyla US Holdco Limited, effective as of August 31, 2022.
     
10.38   Form of Promissory Note of HYLA US Holdco Limited issued to the registrant, effective as of August 31, 2022.
     
10.39   Form of Note Purchase Agreement among the registrant and two separate investors, effective as of August 31, 2022.
     
10.40   Form of Convertible Senior Note of the registrant sold and issued to two separate investors, effective as of August 31, 2022.
     
10.41   Form of Registration Rights Agreement between the registrant and two separate investors, effective as of August 31, 2022.
     
10.42   Form of Security Agreement of the registrant in favor of two separate investors, effective as of August 31, 2022.
     
10.43   Form of IP Security Agreement of the registrant in favor of two separate investors, effective as of August 31, 2022.
     
10.44   Form of Settlement, Lock-Up, and Leak-Out Agreement between the registrant and seven separate investors, effective August 31, 2022.
     
10.45   Form of Promissory Note of the registrant issued to seven separate investors, effective August 31, 2022.
     
10.46   Form of Contribution and Exchange Agreement among the registrant, CBD Unlimited, Inc., Todd Allen Davis, and Rayne Forecast Inc., effective August 31.
     
10.47   Form of Escrow Agreement among the registrant, Todd Allen Davis, Rayne Forecast Inc., and the escrow agent, effective August 31, 2022.
     
10.48   Form of Executive Agreement between the registrant and Todd Allen Davis, effective August 31, 2022.
     
10.49*   Form of Stockholders Agreement among the registrant, Todd Allen Davis, Rayne Forecast Inc., and CBD Unlimited, Inc., effective as of August 31, 2022.
     
10.50   Employment Agreement between Hyla US Holdco Limited and Nick Mehdi, dated June 14, 2021.
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* To be filed by amendment.

 

6
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, we have duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Endexx Corporation  
     
By: /s/ Todd Davis  
Name: Todd Davis  
Title: President  
     
Dated: September 7, 2022  

 

7

 

 

Exhibit 3.3a

 

 

 

 

 

Exhibit 3.4

 

 

Endexx Series H Certificate of Designation.4
1
 

 

ENDEXX CORPORATION

 

CERTIFICATE OF DESIGNATION
OF RIGHTS, PRIVILEGES, PREFERENCES, AND LIMITATIONS
OF
SERIES H CONVERTIBLE PREFERRED STOCK

 

The undersigned, Todd Davis, does hereby certify that:

 

1. He is the President and acting Secretary of Endexx Corporation, a Nevada corporation (the “Company”).

 

2. The Company is authorized to issue ten million (10,000,000) shares of preferred stock, par value $0.0001 per share, seven hundred nineteen thousand five hundred seventy-one (719,571) of which have been designated “Series Z Convertible Preferred Stock,” all of which are currently issued and outstanding, and that no other shares of preferred stock are issued and outstanding.

 

3. The following resolutions were adopted by the board of directors (the “Board of Directors”) of the Company:

 

RESOLVED, that pursuant to the authority expressly granted to and vested in the Board of Directors of the Company by provisions of the Articles of Incorporation of the Company as amended and restated (the “Articles of Incorporation”), there hereby is created out of the shares of the Company’s preferred stock, par value $0.0001 per share, of the Company authorized in the Articles of Incorporation, a series of Preferred Stock of the Company, to be named “Series H Convertible Preferred Stock,” consisting of four million nine hundred thousand (4,900,000) shares, which series shall have the following designations, powers, preferences and relative and other special rights and the following qualifications, limitations, and restrictions:

 

Section 1. Definitions. For the purposes hereof, the following terms shall have the following meanings:

 

Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.

 

Alternate Consideration” shall have the meaning set forth in Section 7(c).

 

Bankruptcy Event” means any of the following events: (a) the Company or any Subsidiary (as such term is defined in Rule 1-02(w) of Regulation S-X) thereof commences a case or other proceeding under any bankruptcy, reorganization, arrangement, adjustment of debt, relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction relating to the Companies or any Subsidiary thereof, (b) there is commenced against the Companies or any Subsidiary thereof any such case or proceeding that is not dismissed within sixty (60) calendar days after commencement, (c) the Company or any Subsidiary thereof is adjudicated insolvent or bankrupt or any order of relief or other order approving any such case or proceeding is entered, (d) the Company or any Subsidiary thereof suffers any appointment of any custodian or the like for it or any substantial part of its property that is not discharged or stayed within sixty (60) calendar days after such appointment, (e) the Company or any Subsidiary thereof makes a general assignment for the benefit of creditors, (f) the Company or any Subsidiary thereof calls a meeting of its creditors with a view to arranging a composition, adjustment, or restructuring of its debts or (g) the Company or any Subsidiary thereof, by any act or failure to act, expressly indicates its consent to, approval of, or acquiescence in any of the foregoing or takes any corporate or other action for the purpose of effecting any of the foregoing.

 

Endexx Series H Certificate of Designation.4
2
 

 

Business Day” means any day except any Saturday, any Sunday, any day that is a federal legal holiday in the United States, or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

 

Certificate” means this Certificate of Designation of the Rights, Privileges, Preferences, and Limitations of Series H Convertible Preferred Stock.

 

Change of Control Transaction” means the occurrence after the date hereof of any of (a) an acquisition after the date hereof by an individual or legal entity or “group” (as described in Rule 13d-5(b)(l) promulgated under the Exchange Act), other than a legal entity majority owned by, or a group wholly consisting of, officers and directors of the Company and their Affiliates, of effective control (whether through legal or beneficial ownership of capital stock of the Company, by contract or otherwise) of in excess of two-thirds of the voting securities of the Company (other than by means of conversion of Series H Preferred Stock and the issuance of the Conversion Shares), (b) the Company merges into or consolidates with any other Person, or any Person merges into or consolidates with the Company and, after giving effect to such transaction, the stockholders of the Company immediately prior to such transaction own less than two-thirds of the aggregate voting power of the Company or the successor entity of such transaction, (c) the Company sells or transfers all or substantially all of its assets to another Person and the stockholders of the Company immediately prior to such transaction own less than one-half of the aggregate voting power of the acquiring entity immediately after the transaction, (d) a replacement at one time or within a one-year period of more than one-half of the members of the Board of Directors that is not approved by a majority of those individuals who are members of the Board of Directors on the Original Issue Date (or by those individuals who are serving as members of the Board of Directors on any date whose nomination to the Board of Directors was approved by a majority of the members of the Board of Directors who are members on the Original Issue Date), or (e) the execution by the Company of an agreement to which the Company is a party or by which it is bound, providing for any of the events set forth in clauses (a) through (d), above.

 

Commission” means the United States Securities and Exchange Commission.

 

Common Stock” means the Company’s common stock, par value $0.0001 per share, and stock of any other class of securities into which such securities may hereafter be reclassified or changed.

 

Common Stock Equivalents” means any securities of the Company or the Subsidiaries that would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument, that is at any time convertible into, or otherwise entitles the holder thereof to receive, Common Stock.

 

Conversion Date” shall have the meaning set forth in Section 6(a).

 

Conversion Rate” shall have the meaning set forth in Section 6(a).

 

Endexx Series H Certificate of Designation.4
3
 

 

Conversion Rights” shall mean the rights of conversion as set forth in Section 6.

 

Conversion Shares” means, collectively, the shares of Common Stock issuable upon conversion of the shares of Series H Preferred Stock in accordance with the terms hereof.

 

DTC” means the Depository Trust Company.

 

DWAC” means Deposit and Withdrawal at Custodian, as defined by the DTC.

 

Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

Fundamental Transaction” shall have the meaning set forth in Section 7(c).

 

Holder” shall have the meaning given such term in Section 2.

 

Liquidation” shall have the meaning set forth in Section 5.

 

Nevada courts” shall have the meaning set forth in Section 10(d).

 

Notice of Conversion” shall have the meaning set forth in Section 6(a).

 

Original Issue Date” means the date of the first issuance of any shares of the Series H Preferred Stock regardless of the number of transfers of any particular shares of Series H Preferred Stock and regardless of the number of certificates that may be issued to evidence such Series H Preferred Stock.

 

Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof), or other entity of any kind.

 

Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

Securities” means the Series H Preferred Stock and the Conversion Shares.

 

Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

Series H Preferred Stock” shall have the meaning set forth in Section 2.

 

Share Delivery Date” shall have the meaning set forth in Section 6(b).

 

Stated Value” shall have the meaning set forth in Section 2.

 

Successor Entity” shall have the meaning set forth in Section 7(c).

 

Subsidiaries” shall mean any company owned or controlled by the Company.

 

Transfer Agent” means a transfer agent for the Common Stock and the Securities, and any successor transfer agent of the Company. If the Company does not have a transfer agent for its Common Stock on the date in question, then Transfer Agent shall mean the Company.

 

Endexx Series H Certificate of Designation.4
4
 

 

Section 2. Designation; Amount; Par Value; Stated Value; Restrictive Legend. The series of preferred stock shall be designated as the Company’s Series H Convertible Preferred Stock (the “Series H Preferred Stock”) and the number of shares so designated shall be up to four million nine hundred thousand (4,900,000) shares (which shall not be subject to increase without the written consent of the holders of a majority of the then-issued and outstanding Series H Preferred Stock (each, a “Holder”; and, collectively, the “Holders”)). Each share of Series H Preferred Stock shall have a par value of $0.0001 per share and a stated value of forty-one cents ($0.41) (the “Stated Value”). Each share of Series H Preferred Stock shall initially be convertible into ten (10) shares of Common Stock. The certificate representing shares of Series H Preferred Stock shall bear a restrictive legend in the following form:

 

“NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.”

 

Section 3. Dividends. The Company shall not declare, pay, or set aside any dividends on shares of Common Stock of the Company unless (in addition to the obtaining of any consents required elsewhere in the Articles of Incorporation), from and including the Original Issue Date, the Holders of the Series H Preferred Stock then outstanding shall receive a dividend in an aggregate amount equivalent to the aggregate amount of dividends that the Company is then declaring, paying, or setting aside for the Common Stock. Such dividends shall be payable to the Holders of the Series H Preferred Stock in the same specie as dividends are payable on the shares of Common Stock and shall be made in accordance with applicable corporate law.

 

Section 4. Voting Rights. Except as expressly provided herein, or as provided by applicable law, the Holders of the Series H Preferred Stock shall have the same voting rights as the holders of the Common Stock and shall be entitled to notice of any stockholders’ meeting in accordance with the Bylaws of the Company, and the holders of Common Stock and Series H Preferred Stock shall vote together as a single class on all matters. Each holder of Common Stock shall be entitled to one vote for each share of Common Stock held, and the Holders of Series H Preferred Stock shall be entitled, on a variable basis, to an aggregate vote equivalent to one share in excess of the maximum potential vote of the aggregate of the other classes or series of the then-issued and outstanding equity voting shares at any occasion when the vote of the holders of voting equity of the Company is held (whether at an annual meeting or special meeting of such holders or by the written consent of such holders). Further, so long as any shares of Series H Preferred Stock remain outstanding, the directors of the Company shall be elected as follows: (a) the holders of a majority of the shares of Series H Preferred Stock represented at a duly called special or annual meeting of such stockholders or by an action by written consent for that purpose shall be entitled to elect two (2) directors (the “Series H Directors”) and the holders of the Series H Preferred Stock may waive their rights in full or in part to elect any or all of such two (2) directors at any time and, under such circumstances, may assign such waived rights to the Board of Directors to elect such directors or may fully waive their rights in respect of any such meeting; and (b) the holders of a majority of the shares of Common Stock and the Series H Preferred Stock, in the exercise of their variable basis voting rights, represented at a duly called special or annual meeting of such stockholders or by an action by written consent for that purpose shall be entitled to elect three (3) directors.

 

Endexx Series H Certificate of Designation.4
5
 

 

Section 5. Liquidation Preference. Upon any liquidation, dissolution, or winding-up of the Company, whether voluntary or involuntary (a “Liquidation”), the Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the Stated Value for each share of Series H Preferred Stock out of the proceeds of the Liquidation, plus any accrued and unpaid dividends thereon and any other fees then due and owing thereon under this Certificate. This entitlement to liquidation proceeds shall be junior to any other series of Preferred Stock, that, in accordance with its respective liquidation rights, is superior to the liquidation rights of the Series H Preferred Stock. Except as provided hereinabove, the Holders of the Series H Preferred Stock shall not participate in the Company’s remaining proceeds from a Liquidation. A Fundamental Transaction or Change of Control Transaction shall not be deemed a Liquidation. The Company shall mail written notice of any Liquidation, not less than forty-five (45) days prior to the payment date stated therein, to each Holder.

 

Section 6. Conversion. The Holders of the Series H Preferred Stock shall have the following conversion rights (the “Conversion Rights”):

 

a) Conversions at Option of Holder. At the option of the Holder, each share of Series H Preferred Stock held by a Holder shall be initially convertible into ten (10) shares of the Common Stock (such number of shares of Common Stock into which each share of Series H Preferred Stock is convertible, the initial “Conversion Rate”). Any converting Holder shall effect a conversion by providing the Company with a completed and executed form of conversion notice attached hereto as Annex A (a “Notice of Conversion”). Each Notice of Conversion shall specify the number of shares of Series H Preferred Stock to be converted, the number of shares of Series H Preferred Stock owned prior to the conversion at issue, the number of shares of Series H Preferred Stock owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which date may not be prior to the date the applicable Holder delivers in a manner permitted by Section 10(a), below, such Notice of Conversion to the Company (such date, the “Conversion Date”). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion to the Company is deemed delivered hereunder. The calculations and entries set forth in the Notice of Conversion shall control in the absence of manifest or mathematical error. To effect conversions of shares of Series H Preferred Stock, a Holder shall not be required to surrender the certificate(s) representing the shares of Series H Preferred Stock to the Company unless all of the shares of Series H Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing such shares of Series H Preferred Stock promptly following the Conversion Date at issue. Shares of Series H Preferred Stock converted into Common Stock in accordance with the terms hereof shall be canceled and shall not be reissued.

 

b) Mechanics of Conversion.

 

i. Delivery of Certificate Upon Conversion. Not later than two (2) Business Days after each Conversion Date (the “Share Delivery Date”), the Company shall deliver, or cause to be delivered, to the converting Holder a certificate or certificates representing the Conversion Shares or a book entry notation from the Transfer Agent. The Conversion Shares or book entry notation shall bear a restrictive legend in the following form, as appropriate:

 

Endexx Series H Certificate of Designation.4
6
 

 

“THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATE-MENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.”

 

ii. Valid Issuance. All shares of Common Stock that shall be issued upon conversion of shares of Series H Preferred Stock into shares of Common Stock will, upon issuance by the Company in accordance with this Certificate, be duly and validly issued, fully paid, and non-assessable and free from all taxes, liens, and charges with respect to the issuance thereof. The Company covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid, and nonassessable.

 

iii. Fractional Shares. No fractional shares of Common Stock shall be issued upon conversion of the Series H Preferred Stock. In lieu of any fractional shares to which the holder would otherwise be entitled, the Company shall round the fraction to the next whole number of shares of Common Stock.

 

iv. Transfer Taxes and Expenses. The issuance of certificates for shares of the Common Stock on conversion of this Series H Preferred Stock shall be made without charge to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such certificates, provided that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any such certificate upon conversion in a name other than that of the Holders of such shares of Series H Preferred Stock and the Company shall not be required to issue or deliver such certificates unless or until the Person or Persons requesting the issuance thereof shall have paid to the Company the amount of such tax or shall have established to the satisfaction of the Company that such tax has been paid. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Conversion.

 

Endexx Series H Certificate of Designation.4
7
 

 

Section 7. Certain Adjustments.

 

a) Subsequent Rights Offerings. In addition to any adjustments set forth in this Section 7, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities, or other property pro rata to the record holders of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights that each Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of the Series H Preferred Stock (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance, or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue, or sale of such Purchase Rights (provided, however, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

b) Adjustments for Reclassification, Exchange, and Substitution. If the Common Stock issuable upon conversion of the Series H Preferred Stock at any time or from time to time after the Original Issuance Date shall be changed to the same or different number of shares of any class or classes of stock, whether by reclassification, exchange, substitution, or otherwise, then, and in each event, the Conversion Rate shall be equitably adjusted so that the Holder of each share of Series H Preferred Stock shall have the right thereafter to convert such share of Series H Preferred Stock into the kind and amount of shares of stock and other securities receivable upon reclassification, exchange, substitution, or other change, by holders of shares of Common Stock into which such shares of Series H Preferred Stock might have been converted on the date of such reclassification, exchange, substitution, or other change, all subject to further adjustment as provided herein.

 

Endexx Series H Certificate of Designation.4
8
 

 

c) Fundamental Transaction. If, at any time while this Series H Preferred Stock is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, including a Change of Control Transaction, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash, or property, (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each, a “Fundamental Transaction”), then, upon any subsequent conversion of this Series H Preferred Stock, the Holder shall have the right to receive, for each Conversion Share at the Conversion Rate, the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Series H Preferred Stock is convertible immediately prior to such Fundamental Transaction. For purposes of any such conversion, the determination of the Conversion Rate shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Conversion Rate among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash, or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any conversion of this Series H Preferred Stock following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to the Company or surviving entity in such Fundamental Transaction shall file a new Certificate with the same terms and conditions and issue to the Holders new preferred stock consistent with the foregoing provisions and evidencing the Holders’ right to convert such preferred stock into Alternate Consideration. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Certificate in accordance with the provisions of this Section 7(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the holder of this Series H Preferred Stock, deliver to the Holder in exchange for this Series H Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Series H Preferred Stock that is convertible for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of this Series H Preferred Stock (without regard to any limitations on the conversion of this Series H Preferred Stock) prior to such Fundamental Transaction, and with a Conversion Rate that applies the Conversion Rate hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock being for the purpose of protecting the economic value of this Series H Preferred Stock immediately prior to the consummation of such Fundamental Transaction), and that is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Certificate shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Certificate with the same effect as if such Successor Entity had been named as the Company herein.

 

Endexx Series H Certificate of Designation.4
9
 

 

d) Stock Dividends and Stock Splits. If the Company, at any time while shares of Series H Preferred Stock are outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon conversion of, or payment of dividends on, the Series H Preferred Stock), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Company, then the Stated Value shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Company) outstanding immediately before such event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination, or re-classification.

 

e) Dilution. The Company specifically acknowledges that its obligation to issue the Conversion Shares is binding upon the Company and enforceable regardless of the dilution such issuance may have on the ownership interests of other stockholders of the Company. The Conversion Rate will be subject to a full ratchet adjustment in the event that the Company issues additional equity securities at a purchase price or deemed purchase price less than the applicable Conversion Rate per share of Series H Preferred Stock (the “Share Price”). In the event of an issuance of equity involving tranches or other multiple closings, the antidilution adjustment shall be calculated as if all equity had been issued at the first closing. The Share Price will also be subject to proportional adjustment for stock splits, stock dividends, combinations, recapitalizations, and the like.

 

f) Calculations. All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Company) issued and outstanding.

 

g) Notice to the Holders. If (i) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (ii) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (iii) the Company shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (iv) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property or (v) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be filed at each office or agency maintained for the purpose of conversion of this Series H Preferred Stock, and shall cause to be delivered to each Holder at its last address as it shall appear upon the stock books of the Company, at least twenty (20) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (A) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights, or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (B) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to convert the Conversion Rate of this Series H Preferred Stock (or any part hereof) during the 20-day period commencing on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

Endexx Series H Certificate of Designation.4
10
 

 

Section 8. Negative Covenants. In addition, as long as any shares of Series H Preferred Stock are outstanding, unless the Holders of at least 50% in Stated Value of the then-outstanding shares of Series H Preferred Stock shall have otherwise given prior written consent, the Company shall not, directly or indirectly, amend its charter documents, including, without limitation, its Articles of Incorporation and Bylaws, in any manner that materially and adversely affects any rights of any Holder.

 

Section 9. Holder’s Exercise Limitations. The Company shall not effect any conversion of shares of Series H Preferred Stock, and a Holder shall not have the right to convert any of such shares, pursuant to Section 6 or otherwise, to the extent that after giving effect to such issuance after conversion as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates shall include the number of shares of Common Stock issuable upon conversion of shares of Series H Preferred Stock with respect to which such determination is being made, but shall exclude the number of shares of Common Stock that would be issuable upon (i) conversion of the remaining, unconverted portion of the shares of Series H Preferred Stock beneficially owned by the Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this Section 9, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that neither the Company nor any of its Affiliates is representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 9 applies, the determination of whether any shares of Series H Preferred Stock are exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of how many of such shares are convertible shall be in the sole discretion of the Holder, and the submission of a Notice of Conversion shall be deemed to be the Holder’s determination of whether any shares of Series H Preferred Stock are convertible (in relation to other securities owned by the Holder together with any Affiliates), in each case subject to the Beneficial Ownership Limitation, and neither the Company nor any of its Affiliates shall have any obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 9, in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company, or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including the converted shares of Series H Preferred Stock set forth in the Notice of Conversion, by the Holder or its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of shares of Series H Preferred Stock. The Holder, upon not less than 61 days’ prior notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 9, provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon conversion of shares of Series H Preferred Stock set forth in the Notice of Conversion and the provisions of this Section 9 shall continue to apply. Any such increase or decrease will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 9 to correct this paragraph (or any portion hereof) that may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of shares of Series H Preferred Stock.

 

Endexx Series H Certificate of Designation.4
11
 

 

Section 10. Miscellaneous.

 

a) Notices. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice of Conversion, shall be in writing and delivered personally, by facsimile, electronic mail, or by a nationally recognized overnight courier service addressed to the Company at the physical, facsimile, or electronic mail number or address as the Company may specify for such purposes by notice to the Holders delivered in accordance with this Section 10. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by facsimile, electronic mail, or by a nationally recognized overnight courier service addressed to each Holder at the physical, facsimile, or electronic mail number or address of such Holder appearing on the books of the Company, or if no such number or address appears on the books of the Company, at the principal place of business of such Holder. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth in this Section prior to 5:30 p.m. (New York time) on any date, (ii) the next Business Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth in this Section on a day that is not a Business Day or later than 5:30 p.m. (New York time) on any Business Day, (iii) the second Business Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given.

 

b) Absolute Obligation. Except as expressly provided herein, no provision of this Certificate shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay accrued dividends, as applicable, on the shares of Series H Preferred Stock at the time, place, and rate, and in the coin or currency, herein prescribed.

 

c) Lost or Mutilated Series H Preferred Stock Certificate. If a Holder’s Series H Preferred Stock certificate shall be mutilated, lost, stolen or destroyed, the Company shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated certificate, or in lieu of or in substitution for a lost, stolen, or destroyed certificate, a new certificate for the shares of Series H Preferred Stock so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such certificate, and of the ownership hereof reasonably satisfactory to the Company.

 

Endexx Series H Certificate of Designation.4
12
 

 

d) Governing Law. All questions concerning the construction, validity, enforcement, and interpretation of this Certificate shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated hereby (whether brought against a party hereto or its respective Affiliates, directors, officers, shareholders, employees, or agents) shall be commenced in the state and federal courts sitting in the City of Las Vegas, County of Clark (the “Nevada courts”). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the Nevada courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such Nevada courts, or such Nevada courts are improper or inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action, or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Certificate and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Certificate or the transactions contemplated hereby. If any party shall commence an action or proceeding to enforce any provisions of this Certificate, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses incurred in the investigation, preparation, and prosecution of such action or proceeding.

 

e) Waiver. Any waiver by the Company or a Holder of a breach of any provision of this Certificate shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate or a waiver by any other Holders. The failure of the Company or a Holder to insist upon strict adherence to any term of this Certificate on one or more occasions shall not be considered a waiver or deprive that party (or any other Holder) of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate on any other occasion. Any waiver by the Company or a Holder must be in writing.

 

f) Severability. If any provision of this Certificate is invalid, illegal, or unenforceable, the balance of this Certificate shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law.

 

Endexx Series H Certificate of Designation.4
13
 

 

g) Remedies, Characterizations, Other Obligations, Breaches, and Injunctive Relief. The remedies provided in this Series H Preferred Stock shall be cumulative and in addition to all other remedies available under this Certificate at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the Holder’s right to pursue actual and consequential damages for any failure by the Company to comply with the terms of this Series H Preferred Stock. The Company covenants to the Holder that there shall be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments, conversion, and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, the Holder shall be entitled, in addition to all other available remedies, to an injunction restraining any such breach or any such threatened breach, without the necessity of showing economic loss and without any bond or other security being required. The Company shall provide all information and documentation to the Holder that is requested by the Holder to enable the Holder to confirm the Company’s compliance with the terms and conditions of this Certificate.

 

h) Next Business Day. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment obligation shall be made on the next succeeding Business Day.

 

i) Headings. The headings contained herein are for convenience only, do not constitute a part of this Certificate and shall not be deemed to limit or affect any of the provisions hereof.

 

[Remainder of the page intentionally left blank. Signature page follows.]

 

Endexx Series H Certificate of Designation.4
14
 

 

IN WITNESS WHEREOF, the undersigned has executed and subscribed this Certificate and does affirm the foregoing as true as of the ____ day of August, 2022.

 

  ENDEXX CORPORATION
     
  By:  
    Todd Davis, President and Acting Secretary

 

Endexx Series H Certificate of Designation.4
15
 

 

ANNEX A

 

NOTICE OF CONVERSION

 

(TO BE EXECUTED BY THE REGISTERED HOLDER IN ORDER TO CONVERT SHARES OF SERIES H PREFERRED STOCK)

 

The undersigned hereby elects to convert the number of shares of Series H Convertible Preferred Stock indicated below into shares of common stock, par value $0.0001 per share (the “Common Stock”), of Endexx Corporation, a Nevada corporation (the “Company”), according to the conditions hereof, as of the date written below. If shares of Common Stock are to be issued in the name of a Person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto and is delivering herewith such certificates and opinions as may be required by the Company. No fee will be charged to the Holders for any conversion, except for any such transfer taxes.

 

Conversion calculations:

 

Date to Effect Conversion:

 

Number of shares of Series H Preferred Stock owned prior to Conversion: _________________________________

 

Number of shares of Series H Preferred Stock to be Converted: _________________________________________

 

Stated Value of shares of Series H Preferred Stock to be Converted: _____________________________________

 

Number of shares of Common Stock to be Issued: __________________________________________________

 

Applicable Conversion Price: _________________________________________________________________

 

Number of shares of Series H Preferred Stock subsequent to Conversion: ________________________________

 

Address for Delivery: ________________________________________________________________________

 _________________________________________________________________________________________

 

or

 

  DWAC Instructions:  
       
  Broker no:    
       
  Account no:    

 

  [HOLDER]
     
  By:        
  Name:  
  Title:  

 

Endexx Series H Certificate of Designation.4
Annex A

 

 

 

Exhibit 4.11

 

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON STOCK PURCHASE WARRANT

 

ENDEXX CORPORATION

 

Warrant No: ________  
Warrant Shares: _________ Initial Exercise Date: August 31, 2022

 

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________________, a _____________________, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August 31, 2022 (the “Initial Exercise Date”) and on or prior to the close of business on the five-year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Endexx Corporation, a Nevada corporation (the “Company”), up to __________shares of the Company’s common stock (in any event, as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

 

Section 1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Convertible Note Purchase Agreement, dated August 31, 2022 (collectively, the “Purchase Agreement”), between the Company and the purchaser(s) signatory thereto.

 

1
 

 

Section 2. Exercise.

 

a) Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or from time to time on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed facsimile copy of the Notice of Exercise form annexed hereto and within two (2) Trading Days of the date said Notice of Exercise is delivered to the Company, the Company shall have received payment of the aggregate Exercise Price of the shares thereby purchased by wire transfer or cashier’s check drawn on a United States bank or, if available, pursuant to the cashless exercise procedure specified in Section 2(c). No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation on two (2) Trading Days after (i) the date the final Notice of Exercise was delivered to the Company and (ii) the date on which the Warrant Shares were delivered to the Holder. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise Form within one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

 

b) Exercise Price. The exercise price per share of the Common Stock under this Warrant shall be $0.02695 per share (the “Exercise Price”).

 

c) Cashless Exercise. If at any time there is no effective registration statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

  (A) = the VWAP on the Trading Day immediately preceding the date on which Holder elects to exercise this Warrant by means of a “cashless exercise,” as set forth in the applicable Notice of Exercise;
       
  (B) = the Exercise Price of this Warrant, as adjusted hereunder; and
       
  (X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

 

Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c), subject to the Beneficial Ownership Limitation of 9.99% as set forth in Section 2(e).

 

2
 

 

d) Mechanics of Exercise.

 

i. Delivery of Warrant Shares Upon Exercise. Warrant Shares purchased hereunder shall be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder’s prime broker with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144, and otherwise by physical delivery to the address specified by the Holder in the Notice of Exercise by the date that is two (2) Trading Days after the latest of (A) the delivery to the Company of the Notice of Exercise and (B) surrender of this Warrant (if required) (such date, the “Warrant Share Delivery Date”). The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the Company of the Exercise Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant to Section 2(d)(vi) prior to the issuance of such shares, having been paid. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.

 

ii. Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

 

iii. Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

3
 

 

iv. Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares that the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

 

v. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share that the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

 

vi. Charges, Taxes, and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise.

 

vii. Closing of Books. The Company will not close its stockholder books or records in any manner that prevents the timely exercise of this Warrant, pursuant to the terms hereof.

 

4
 

 

e) Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock that would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon not less than 61 days’ prior notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any such increase or decrease will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) that may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

 

5
 

 

Section 3. Certain Adjustments.

 

a) Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination, or re-classification.

 

b) Subsequent Equity Sales. If the Company or any Subsidiary thereof, as applicable, at any time while this Warrant is outstanding, shall sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents, at an effective price per share less than the Exercise Price then in effect (such lower price, the “Base Share Price” and such issuances collectively, a “Dilutive Issuance”) (it being understood and agreed that if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share that are issued in connection with such issuance, be entitled to receive shares of Common Stock at an effective price per share that is less than the Exercise Price, such issuance shall be deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance at such effective price), then simultaneously with the consummation of each Dilutive Issuance the Exercise Price shall be reduced and only reduced to equal the Base Share Price and the number of Warrant Shares issuable hereunder shall be increased such that the aggregate Exercise Price payable hereunder, after taking into account the decrease in the Exercise Price, shall be equal to the aggregate Exercise Price prior to such adjustment. Such adjustment shall be made whenever such Common Stock or Common Stock Equivalents are issued. Notwithstanding the foregoing, no adjustments shall be made, paid, or issued under this Section 3(b) in respect of an Exempt Issuance. The Company shall notify the Holder, in writing, no later than the Trading Day following the issuance or deemed issuance of any Common Stock or Common Stock Equivalents subject to this Section 3(b), indicating therein the applicable issuance price, or applicable reset price, exchange price, conversion price and other pricing terms (such notice, the “Dilutive Issuance Notice”). For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section 3(b), upon the occurrence of any Dilutive Issuance, the Holder is entitled to receive a number of Warrant Shares based upon the Base Share Price regardless of whether the Holder accurately refers to the Base Share Price in the Notice of Exercise. If the Company enters into a Variable Rate Transaction, despite the prohibition thereon in the Purchase Agreement, the Company shall be deemed to have issued Common Stock or Common Stock Equivalents at the lowest possible conversion or exercise price at which such securities may be converted or exercised.

 

6
 

 

c) Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a), if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights that the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

d) Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

7
 

 

e) Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each, a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash, or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder’s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction, purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction. “Black Scholes Value” means the value of this Warrant based on the Black and Scholes Option Pricing Model obtained from the “OV” function on Bloomberg, L.P. (“Bloomberg”) determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction, and (D) a remaining option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant that is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and that is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.

 

8
 

 

f) Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

g) Notice to Holder.

 

i. Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ii. Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be mailed to the Holder at its last address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer, or share exchange; provided that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

Section 4. Transfer of Warrant.

 

a) Transferability. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within two (2) Trading Days of the date the Holder delivers an assignment form to the Company assigning this Warrant full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

 

9
 

 

b) New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer that may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

c) Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

 

d) Transfer Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of Section 4(d) of the Purchase Agreement.

 

e) Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.

 

Section 5. Reserved.

 

Section 6. Miscellaneous.

 

a) No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends, or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.

 

b) Loss, Theft, Destruction, or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

 

10
 

 

c) Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.

 

d) Authorized Shares. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares that may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid, and nonassessable and free from all taxes, liens, and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant, and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

Before taking any action that would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

 

e) Jurisdiction. All questions concerning the construction, validity, enforcement, and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.

 

11
 

 

f) Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

 

g) Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers, or remedies, notwithstanding the fact that all rights hereunder terminate on the Termination Date. If the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

h) Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.

 

i) Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

 

j) Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

k) Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

 

l) Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

 

m) Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

n) Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

 

o) Derivative Accounting Treatment. Notwithstanding anything to the contrary contained herein, the Holder and the Company will use commercially reasonable efforts to modify the provisions hereof in such a manner that the Company’s financial statements will not be subject to derivative accounting treatment; provided, however, that the Company acknowledges that the maintenance of the various exercise price provisions herein are, to the Holder, a material component of the consideration for the entire transaction of which this Warrant is a component and any modification must be reasonably acceptable to the Holder. Any such agreed upon modification shall be deemed to be effective as of the first day of the Company’s fiscal year in which the Company entered into a transaction with such a “derivative instrument.”

 

********************

 

(Signature Page Follows)

 

12
 

 

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

  ENDEXX CORPORATION
     
  By:

                  

  Name:  
  Title:  

 

13
 

 

NOTICE OF EXERCISE

 

To: ENDEXX cORPORATION

 

(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2) Payment shall take the form of (check applicable box):

 

[  ] in lawful money of the United States; or

 

[  ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).

 

(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

_______________________________

 

The Warrant Shares shall be delivered to the following DWAC Account Number:

 

_______________________________

 

_______________________________

 

_______________________________

 

(4) Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

 

[SIGNATURE OF HOLDER]

 

Name of Investing Entity: ___________________________________________________

Signature of Authorized Signatory of Investing Entity: ___________________________

Name of Authorized Signatory: _______________________________________________

Title of Authorized Signatory: ____________________________________________

Date: ______________________

 

Exhibit A
 

 

EXHIBIT B

 

ASSIGNMENT FORM

 

(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

Name:    
      (Please Print)
       
Address:    
      (Please Print)
       
Dated: _______________ __, ___________    
     
Holder’s Signature: _____________________    
       
Holder’s Address: _____________________    

 

Exhibit B

 

 

Exhibit 10.35

 

CONTROL ACQUISITION AGREEMENT

 

BY AND AMONG

 

ENDEXX CORPORATION,

 

EH SUB, INC.,

 

AND

 

HYLA UK HOLDCO LIMITED

 

DATED AS OF AUGUST 31, 2022

 

Endexx Control Acquisition Agreement (Hyla).3

 

 

TABLE OF CONTENTS

 

ARTICLE 1 DEFINITIONS 1
Section 1.1 Definitions 1
Section 1.2 Interpretive Provisions 9
 
ARTICLE 2 THE CONTROL ACQUISITION 10
Section 2.1 The Control Acquisition 10
Section 2.2 Effective Time 10
Section 2.3 Effect of the Control Acquisition 10
Section 2.4 Directors and Officers 10
Section 2.5 Adjustments 10
Section 2.6 Closing Issuance Schedule 11
 
ARTICLE 3 THE CLOSING 11
Section 3.1 Closing Date 11
Section 3.2 Closing Deliverables 11
 
ARTICLE 4 REPRESENTATIONS AND WARRANTIES OF THE SELLER AND HYLA 13
Section 4.1 Organization and Power 13
Section 4.2 Authority; Binding Obligation; Board Approval 13
Section 4.3 Consents; No Conflict or Violation 14
Section 4.4 Capitalization 14
Section 4.5 No Subsidiaries 14
Section 4.6 Financial Statements; No Undisclosed Liabilities; Inventory 14
Section 4.7 Absence of Certain Developments 15
Section 4.8 Contracts and Commitments 15
Section 4.9 Compliance with Laws; Permits 17
Section 4.10 Litigation 18
Section 4.11 Title to Real Property and Other Assets 18
Section 4.12 Tax Matters 19
Section 4.13 Intellectual Property 21
Section 4.14 Employee Benefit Plans 22
Section 4.15 Insurance Policies 22
Section 4.16 Labor and Employment Matters 23
Section 4.17 Brokers 24
Section 4.18 Affiliate Transactions 24
Section 4.19 Books and Records 24
Section 4.20 Customers and Suppliers 24
Section 4.21 Certain Other Representations or Warranties 24
 
ARTICLE 5 REPRESENTATIONS AND WARRANTIES OF ENDEXX AND ACQUISITION SUB 26
Section 5.1 Organization 26
Section 5.2 Authority; Binding Obligation 26
Section 5.3 No Defaults or Conflicts 26

 

Endexx Control Acquisition Agreement (Hyla).3
i

 

 

Section 5.4 No Authorization or Consents Required 26
Section 5.5 Sufficient Funds 26
Section 5.6 No Prior Acquisition Sub Operations 27
Section 5.7 Brokers 27
Section 5.8 Financial Statements 27
Section 5.9 Litigation 27
Section 5.10 Reliance 28
 
ARTICLE 6 COVENANTS 28
Section 6.1 Conduct of Business of Hyla, Pre-Closing 28
Section 6.2 Access to Information; Confidentiality; Public Announcements 30
Section 6.3 Filings, Authorizations, and Consents 31
Section 6.4 Further Assurances 31
Section 6.5 Waiver of Conflicts; Attorney-Client Privilege 32
Section 6.6 Tax Matters 32
Section 6.7 Supplements to Disclosure Schedules 34
Section 6.8 Financing; Financial Statements 35
Section 6.9 Endexx’s Transaction Expenses; Seller’s and Hyla’s Transaction Expenses 35
Section 6.10 Seller’s Contributions 35
Section 6.11 Conduct of Business of Hyla and its Affiliates, Post-Closing 35
Section 6.12 Covenants Against Competition and Solicitation by Seller’s Equity Holders 36
 
ARTICLE 7 CONDITIONS TO OBLIGATIONS OF ENDEXX AND ACQUISITION SUB 36
Section 7.1 Representations and Warranties Accurate 36
Section 7.2 Performance 36
Section 7.3 No Legal Prohibition or Action 36
Section 7.4 Consents 36
Section 7.5 Financing Shall Have Closed 36
Section 7.6 Closing Deliveries 36
Section 7.7 Frustration of Closing Conditions 37
 
ARTICLE 8 CONDITIONS TO OBLIGATIONS OF THE SELLER AND HYLA 37
Section 8.1 Representations and Warranties Accurate 37
Section 8.2 Performance 37
Section 8.3 Legal Prohibition 37
Section 8.4 Closing Deliveries 37
Section 8.5 Frustration of Closing Conditions 37
 
ARTICLE 9 indemnificATION 38
Section 9.1 Survival 38
Section 9.2 Indemnification by the Seller and Hyla 38
Section 9.3 Indemnification by Endexx and Acquisition Sub 38
Section 9.4 Indemnification Procedures 39
Section 9.5 Payments 40

 

Endexx Control Acquisition Agreement (Hyla).3
ii

 

 

Section 9.6 Tax Treatment of Indemnification Payments 40
Section 9.7 Exclusive Remedies 40
Section 9.8 No Circular Recovery 41
 
ARTICLE 10 TERMINATION 41
Section 10.1 Termination 41
Section 10.2 Effect of Termination 42
 
ARTICLE 11 MISCELLANEOUS 42
Section 11.1 Expenses 42
Section 11.2 Amendment 42
Section 11.3 Entire Agreement 42
Section 11.4 Headings 43
Section 11.5 Notices 43
Section 11.6 Disclosure Schedules 44
Section 11.7 Waiver 44
Section 11.8 Binding Effect; Assignment 44
Section 11.9 No Third-party Beneficiary 44
Section 11.10 Counterparts 44
Section 11.11 Governing Law 44
Section 11.12 Exclusive Jurisdiction; Consent to Service of Process; Attorneys’ Fees 45
Section 11.13 WAIVER OF JURY TRIAL 45
Section 11.14 Severability 45

 

Endexx Control Acquisition Agreement (Hyla).3
iii

 

 

ACQUISITION AGREEMENT

 

This ACQUISITION AGREEMENT (this “Agreement”), is entered into as of August 31, 2022, by and among Endexx Corporation, a Nevada corporation (“Endexx”); EH Sub, Inc., a Nevada corporation and wholly owned subsidiary of Endexx (the “Acquisition Sub”); and Hyla UK Holdco Limited, a United Kingdom limited company (the “Seller”).

 

RECITALS

 

WHEREAS, the parties intend that the Seller sell to Endexx an aggregate of fifty-one percent (51%) (the “Hyla Control Stock”) of the issued and outstanding capital stock of Hyla US Holdco Limited, a Delaware corporation (“Hyla”), on the terms and subject to the conditions set forth herein (the “Control Acquisition”); and

 

WHEREAS, the respective boards of directors of Endexx and Acquisition Sub have unanimously (a) determined that this Agreement and the transactions contemplated hereby, including the Acquisition, are in the best interests of Endexx and its stockholders and Acquisition Sub and its sole stockholder, and (b) approved and declared advisable this Agreement and the transactions contemplated hereby, including the Acquisition; and

 

WHEREAS, the Seller have determined that this Agreement and the transactions contemplated hereby, including the Acquisition, are in the best interests of the Seller and the board of directors of Hyla has determined that this Agreement and the transactions contemplated hereby are in the best interests of Hyla and its stockholders; and

 

WHEREAS, Hyla, the Seller, Endexx, and Acquisition Sub desire to make certain representations, warranties, covenants, and agreements in connection with this Agreement.

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth and for such other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

ARTICLE 1

 

DEFINITIONS

 

Section 1.1 Definitions. The following terms, whenever used herein, shall have the following meanings for all purposes of this Agreement.

 

Accounting Methodology” means GAAP applied on a basis consistent with the methodologies, practices, estimation techniques, assumptions and principles used in the preparation of the Audited Balance Sheet.

 

Action” means any audit, claim, demand, grievance, unfair labor practice charge, investigation, notice of violation, litigation, lawsuit, arbitration, mediation, subpoena, or other legal proceeding, whether civil, criminal, administrative, regulatory, or otherwise, in law or in equity.

 

Endexx Control Acquisition Agreement (Hyla).3
1

 

 

Acquisition Sub” has the meaning set forth in the Preamble.

 

Affiliate” means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, such Person, and the term “control” (including the terms “controlled by” and “under common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through ownership of voting securities, by contract or otherwise.

 

Agreement” has the meaning set forth in the Preamble.

 

Business Day” means any day that is not a Saturday, Sunday, or other day on which banking institutions in the State of Nevada are authorized or required by Law or Order to close.

 

Certificate of Designation” means the Certificate of Designation of Series H Convertible Preferred Stock.

 

Change” has the meaning set forth in the definition of Material Adverse Effect.

 

Closing” has the meaning set forth in Section 3.1.

 

Closing Date” has the meaning set forth in Section 3.1.

 

Code” means the Internal Revenue Code of 1986, as from time to time amended.

 

Closing Issuance Schedule” has the meaning set forth in Section 2.6.

 

Contract” means any contract, indenture, note, bond, lease, deed, mortgage, license, commitment, or other legally binding agreement, whether written or oral.

 

Date hereof” and “Date of this Agreement” means the date first written above.

 

Direct Claim” has the meaning set forth in Section 9.5(c).

 

Disclosure Schedules” has the meaning set forth in Article 4.

 

Effective Time” has the meaning set forth in Section 2.2.

 

Encumbrance” means any and all liens, claims, charges, mortgages, options, pledges, rights of first offer or refusal, security interests, hypothecations, easements, rights-of-way, zoning restrictions, encroachments, defects or irregularities in title, community property interests, or other encumbrances or restrictions of any kind, in respect of any property or asset, including any restriction on use, voting, transfer, receipt of income or exercise of any other attribute of ownership.

 

Endexx” has the meaning set forth in the Preamble.

 

Endexx Closing Stock” means the shares of Endexx Series H Convertible Preferred Stock being delivered to the Seller at the Closing.

 

Endexx Control Acquisition Agreement (Hyla).3
2

 

 

Endexx Common Stock” means the authorized shares of common stock, par value $0.0001 per share, of Endexx.

 

Endexx Documents” means all of the agreements, documents, instruments, or certifications contemplated by this Agreement to be executed by Endexx or Acquisition Sub.

 

Endexx Indemnitees” has the meaning set forth in Section 9.2.

 

Endexx’s Transaction Expenses” means, with respect to Endexx and the Acquisition Sub, the aggregate amount of all fees, costs, and expenses of Endexx and the Acquisition Sub incurred or payable prior to or as of the Effective Time (and not paid prior to the Effective Time) in connection with this Agreement and the transactions contemplated hereby, including all fees (including brokers and finders fees) and expenses payable to attorneys, investment bankers, accountants, and other professional advisors retained by Endexx and the Acquisition Sub or any Affiliate on behalf of Endexx or the Acquisition Sub, including those arising out of or incidental to the discussion, evaluation, negotiation, and documentation of the transactions contemplated hereby, in each case whether or not accrued or invoiced. For the avoidance of doubt, no fees or expenses of the Seller, Hyla, or their Affiliates incurred or accrued prior to the Closing in connection with this Agreement and the transactions contemplated hereby are included in “Endexx’s Transaction Expenses”.

 

Equitable Exceptions” has the meaning set forth in Section 4.2(a).

 

Equity Interests” means (a) any partnership interests, (b) any membership interests or units, (c) any shares of capital stock, (d) any other interest or participation that confers on a Person the right to receive a unit of the profits and losses of, or distribution of assets of, the issuing entity, (e) any rights, subscriptions, calls, warrants, options, or commitments of any kind or character relating to, or entitling any Person or entity to purchase or otherwise acquire membership interests or units, capital stock, or any other equity securities, (f) any securities convertible into or exercisable or exchangeable for partnership interests, membership interests or units, capital stock, or any other equity securities, (g) restricted stock units, profits interests, profit participation, stock appreciation rights, phantom stock, or (h) any other interest classified as an equity security of a Person.

 

ERISA” means the Employee Retirement Income Security Act of 1974, as amended, and the regulations promulgated thereunder.

 

ERISA Affiliate” means any Person that is (or at any relevant time was or will be) (a) a member of a “controlled group of corporations” with, under “common control” with, or a member of an “affiliated service group” with Hyla as such terms are defined in Section 414(b), (c), (m), or (o) of the Code or (b) treated together with Hyla or any of its Affiliates as a “single employer” within the meaning of Section 414 of the Code.

 

Exchange Act” means the Securities Exchange Act of 1934, as amended.

 

Financial Statements” means (a) the unaudited balance sheet of Hyla as at December 31, 2021 (the “Unaudited Balance Sheet”) and the related unaudited statements of income and cash flows of Hyla for the year then ended and (b) the unaudited balance sheet of Hyla as at June 30, 2022 (the “Later Unaudited Balance Sheet”) and the related unaudited statements of income and cash flows of Hyla for the three- and six-month periods then ended and ended June 30, 2022.

 

Endexx Control Acquisition Agreement (Hyla).3
3

 

 

Financing” has the meaning set forth in Section 6.8.

 

GAAP” means, with respect to any date of determination, United States generally accepted accounting principles as in effect on such date of determination, consistently applied throughout the applicable period.

 

Governmental Authority” means any nation or government, any state, province, or other political subdivision thereof, or any government authority, agency, department, board, tribunal, commission or instrumentality of the United States of America, any foreign government, any state of the United States of America, or any municipality or other political subdivision thereof, and any court, tribunal or arbitrator(s) of competent jurisdiction, and any self-regulatory organization.

 

Governmental Authorizations” means any permit, license, franchise, tariff, consent, approval, or authorization by or of, or declaration or notice to or filing with, any Governmental Authority.

 

Hyla Control Stock” has the meaning set forth in the Recitals.

 

Hyla Common Stock” means the authorized shares of common stock, par value $0.001 per share, of Hyla US Holdco Limited.

 

Hyla Organizational Documents” means the articles of incorporation and bylaws (or the equivalent organizational documents) of Hyla as in effect on the date of this Agreement (or as “then in effect” when such language is used herein in respect of Hyla Organizational Documents).

 

Hyla’s Intellectual Property” has the meaning set forth in Section 4.13(a).

 

Hyla’s IT Systems” means all computer software and code, computer hardware, servers, networks, platforms, peripherals, and similar or related items of automated, computerized, or other information technology (IT) networks and systems (including telecommunications networks and systems for voice, data, and video) owned, leased, licensed, or used (including through cloud-based or other third-party service providers) by Hyla.

 

Hyla’s Registered Intellectual Property” means all patents, registered trademarks, registered service marks, registered trade names, registered corporate names, registered domain names and registered copyrights, and all pending applications for any of the foregoing that are owned by Hyla.

 

Endexx Control Acquisition Agreement (Hyla).3
4

 

 

Indebtedness” means, with respect to the Hyla, all (a) indebtedness for borrowed money, whether long- or short-term and whether evidenced by a note, debenture, bond, mortgage or other debt instrument or debt security, (b) obligations under any interest rate, currency or other hedging agreement (in each case, valued at the termination value thereof), (c) obligations under any performance bond or letter of credit, but only to the extent drawn or called, (d) obligations for the deferred purchase price of property or services (other than current liabilities taken into account in the calculation of Net Working Capital) and deferred Tax liabilities, (e) capital lease obligations, (f) guarantees with respect to any indebtedness of any other Person of a type described in clauses (a) through (e) above, and (g) any unpaid interest, prepayment penalties, premiums, costs and fees that would arise or become due as a result of the prepayment of any of the obligations referred to in the foregoing clauses (a) through (f). Notwithstanding the foregoing, “Indebtedness” shall not include (i) any Indebtedness incurred by the Seller and any of their Affiliates (and subsequently assumed by the Hyla) on the Closing Date in connection with the Self-financing Note, (ii) any endorsement of negotiable instruments for collection in the Ordinary Course of Business, (iii) any deferred revenue, and (iv) any amounts taken into account in the determination of the Seller’s and Hyla’s Transaction Expenses (which amounts shall be borne solely by the Seller). For any Indebtedness payable in non-United States dollars, the amount of such Indebtedness will be determined by using the Exchange Rates to denominate the value of such Indebtedness in United States dollars.

 

Indemnified Party” has the meaning set forth in Section 9.4.

 

Indemnifying Party” has the meaning set forth in Section 9.4.

 

Insurance Policies” has the meaning set forth in Section 4.15.

 

Intellectual Property” means any and all rights in or arising out of any of the following in any jurisdiction throughout the world: (i) patents and patent applications; (ii) trademarks, service marks, trade dress, trade names, corporate names and logos, as well as all goodwill related thereto; (iii) copyrights and mask works; (iv) internet domain names, all associated web addresses, URLs, websites and web pages, and all content and data thereon or relating thereto; (v) trade secrets under applicable Law, know-how, inventions, discoveries, improvements, technology, business and technical information, databases, data compilations and collections, tools, methods, processes, techniques, and other confidential and proprietary information and all rights therein; and (vi) registrations, applications for registration, and renewals of, any of the foregoing.

 

IRS” means the United States Internal Revenue Service.

 

Knowledge” means the actual knowledge, after reasonable inquiry, of Nick Mehdi, Chief Executive Officer of Hyla..

 

Later Unaudited Balance Sheet” shall have the meaning as set forth in the definition of Financial Statements.

 

Law” means any federal, state, local or foreign law, statute, code, ordinance, tariff, treaty, directive (to the extent having the force of law), Order, rule, or regulation.

 

Losses” means losses, damages, liabilities, deficiencies, Actions, judgments, interest, awards, penalties, fines, costs or expenses of whatever kind, including reasonable attorneys’ fees and the cost of enforcing any right to indemnification hereunder and the cost of pursuing any insurance providers; provided, however, that “Losses” shall not include consequential, indirect, special, exemplary, punitive or similar damages, except to the extent actually awarded to a Governmental Authority or other third party.

 

Endexx Control Acquisition Agreement (Hyla).3
5

 

 

Material Adverse Effect” means any event, act, change, effect, circumstance, state of facts, or development (a “Change”) that has, or would reasonably be expected to have, individually or in the aggregate with any other Change, a material and adverse effect on the business, financial condition, assets, prospects, or results of operations of Hyla or on the ability of Hyla to consummate the transactions contemplated hereby on a timely basis; provided, however, that none of the following shall be deemed (either alone or in combination) to constitute, and none of the following shall be taken into account in determining whether there has been or may be, a Material Adverse Effect: (a) any Change affecting the United States of America’s or foreign economies’ securities or financial, banking, or credit markets (including changes in interest or exchange rates) or geopolitical conditions in general; (b) any Change that generally affects any industry in which Hyla operates; (c) any Change that results from any action taken (or failure to take any action) by Hyla or any Seller as required by or in compliance with this Agreement or with the prior, written consent of or at the prior, written request of Endexx; (d) any Change that results from a change in applicable Law or accounting rules; (e) the failure of Hyla to meet any of its internal projections (it being understood that the facts or occurrences giving rise to such failure may be taken into account in determining whether there has been a Material Adverse Effect to the extent permitted by this Agreement); (f) any Change that results from natural disasters or acts of nature, hostilities, acts of war, sabotage, terrorism, or military actions, or any escalation or material worsening of any such hostilities, acts of war, sabotage, terrorism, or military actions; (g) any Change resulting from the announcement of this Agreement or the consummation of the transactions contemplated by this Agreement; (h) any breach by Endexx of its obligations under this Agreement, or (i) any epidemic, plague, pandemic, or other outbreak of illness or public health event, including, without limitation, the coronavirus disease known as COVID-19, except, in the case of each of clauses (a), (b), and (i), above, to the extent any such Change has had a disproportionate effect on the business of Hyla compared to other participants in the industries in which Hyla conducts its business.

 

Material Contract” has the meaning set forth in Section 4.8(a).

 

Order” means any order, injunction, judgment, decree, ruling, writ, assessment, or award of a Governmental Authority.

 

Ordinary Course of Business” means, with respect to Hyla, the ordinary and usual course of business of Hyla, consistent with past practice.

 

Owned Real Property” has the meaning set forth in Section 4.11(b).

 

Endexx Control Acquisition Agreement (Hyla).3
6

 

 

Permitted Encumbrances” means, (a) for periods prior to the Closing, Encumbrances securing the obligations of Hyla (which Encumbrances shall be released and removed prior to or as of the Closing), (b) Encumbrances for Taxes, assessments and other government charges not yet due and payable or which are being contested in good faith by appropriate proceedings and, in each case, for which appropriate reserves have been created in accordance with GAAP, (c) mechanics’, workmen’s, repairmen’s, warehousemen’s, carriers’, or other like Encumbrances arising in the Ordinary Course of Business for amounts that are not yet due and payable or that are being contested in good faith by appropriate proceedings and, in each case, for which appropriate reserves have been created in accordance with GAAP that do not result from any breach, violation or default by Hyla of any Contract or applicable Law, (d) Encumbrances securing rental payments under capitalized leases to the extent any such Encumbrance is contained within the applicable lease itself, (e) Encumbrances in favor of the lessors of Real Property leased by Hyla to the extent any such Encumbrance is contained within the applicable lease itself, or encumbering the interests of such lessors in Real Property, (f) non-exclusive licenses of Intellectual Property rights granted in the Ordinary Course of Business that, individually or in the aggregate, do not, and would not reasonably be expected to, materially interfere with the use of the Intellectual Property by Hyla, (g) easements, rights-of-way, covenants, restrictions, and other encumbrances of record as of the date hereof that an accurate survey would show, and (h) the Encumbrances set forth on Section 1.1(c) of the Disclosure Schedules.

 

Person” means any individual, corporation (including any not for profit corporation), general or limited partnership, limited liability partnership, joint venture, estate, trust, firm, company (including any limited liability company or joint stock company), association, organization, entity, or Governmental Authority.

 

Post-Closing Tax Period” means any taxable period beginning after the Closing Date and, with respect to any Straddle Period, the portion of such Straddle Period beginning after the Closing Date.

 

Pre-Closing Tax Period” means any taxable period ending on or before the Closing Date and, with respect to any Straddle Period, the portion of such Straddle Period ending on and including the Closing Date.

 

Pre-Closing Taxes” means Taxes of Hyla for any Pre-Closing Tax Period.

 

Qualified Hyla Plans” has the meaning set forth in Section 4.14(a).

 

Real Property” means the real property owned, leased, or subleased by Hyla, together with all buildings, structures and facilities located thereon.

 

Real Property Leases” has the meaning set forth in Section 4.11(a).

 

Related Persons” has the meaning set forth in Section 4.18.

 

Representatives” means, with respect to any Person, any director, manager, officer, agent, employee, general partner, member, stockholder, advisor, accountant, financing source or other representative of such Person.

 

Schedule Supplement” has the meaning set forth in Section 6.7.

 

Self-financing Note” is the Promissory Note of Acquisition, the form of which is attached to this Agreement as Exhibit SfN.

 

Endexx Control Acquisition Agreement (Hyla).3
7

 

 

Seller’s and Hyla’s Transaction Expenses” means, with respect to the Seller and Hyla, the aggregate amount of all fees, costs, and expenses of the Seller and Hyla incurred or payable prior to or as of the Effective Time (and not paid prior to the Effective Time) in connection with this Agreement and the transactions contemplated hereby (including those that become due and payable at or after the Closing pursuant to Contracts or other arrangements entered into by or on behalf of the Seller of Hyla prior to the Effective Time in connection with this Agreement and the transactions contemplated hereby), including all fees (including brokers and finders fees) and expenses payable to attorneys, investment bankers, accountants, and other professional advisors retained by the Seller or Hyla or any Affiliate on behalf of the Seller or Hyla, including those arising out of or incidental to the discussion, evaluation, negotiation, and documentation of the transactions contemplated hereby, in each case whether or not accrued or invoiced. For the avoidance of doubt, no fees or expenses of Endexx, Acquisition Sub, or their Affiliates or accrued prior to the Closing in connection with this Agreement and the transactions contemplated hereby are included in “Seller’s and Hyla’s Transaction Expenses”.

 

Straddle Period” has the meaning set forth in Section 6.6(c).

 

Tax” or “Taxes” means (a) all federal, state, county, local, municipal, foreign and other net income, gross income, gross receipts, alternative, estimated, sales, use, ad valorem, value added, transfer, conveyance, franchise, profits, registration, license, lease, service, service use, withholding, payroll, employment, excise, severance, social security, welfare, workers’ compensation, unemployment, disability, environmental, stock, stamp, capital production, occupation, premium, real, personal or intangible property, windfall profits, transaction, title, customs, duties, levies, tariffs, imposts, amounts due under any escheat or unclaimed property Law or other taxes, fees, assessments or charges of any kind whatsoever (including any amounts resulting from the failure to file any Tax Return), (b) any interest and penalties, fines or additions to tax or additional amounts imposed in connection with (i) any item described in clause (a) or (ii) the failure to comply with any requirement imposed with respect to any Tax Return; and (c) any liability for payment of amounts described in clauses (a) or (b) whether as a result of transferee or successor liability, of being a member of an affiliated, consolidated, combined, unitary or similar group for any period or otherwise through operation of Law; and (d) any liability for the payment of amounts described in clauses (a), (b), or (c) as a result of any Tax sharing, Tax indemnity or Tax allocation agreement or any similar agreement.

 

Tax Claim” has the meaning set forth in Section 6.6(d).

 

Tax Returns” means any report, filing, form, declaration, return, information return, claim for refund, election, disclosure, estimate, statement, or other document required by a Governmental Authority to be made, prepared, or filed by Law in connection with Taxes, including any schedule or attachment thereto, and including any amendments thereof.

 

Termination Date” has the meaning set forth in Section 10.1(b).

 

Third-party Claim” has the meaning set forth in Section 9.4(a).

 

Transaction Documents” means this Agreement, the Self-financing Note, and _____________.

 

Endexx Control Acquisition Agreement (Hyla).3
8

 

 

Treasury Regulations” means the Treasury regulations promulgated under the Code.

 

Unaudited Balance Sheet” shall have the meaning as set forth in the definition of Financial Statements.

 

Union” has the meaning set forth in Section 4.16(b).

 

Section 1.2 Interpretive Provisions. Unless the express context otherwise requires:

 

(a) the words “hereof,” “herein” and “hereunder” and words of similar import, when used in this Agreement, shall refer to this Agreement as a whole and not to any particular provision of this Agreement;

 

(b) terms defined in the singular shall have a comparable meaning when used in the plural, and vice versa;

 

(c) the terms “Dollars” and “$” mean United States Dollars;

 

(d) references herein to a specific Section, Subsection, Recital, Schedule, or Exhibit shall refer, respectively, to Sections, Subsections, Recitals, Schedules, or Exhibits of this Agreement;

 

(e) wherever the word “include,” “includes,” or “including” is used in this Agreement, it shall be deemed to be followed by the words “without limitation”;

 

(f) references herein to any gender shall include each other gender;

 

(g) references herein to any Person shall include such Person’s heirs, executors, personal representatives, administrators, successors, and assigns; provided, however, that nothing contained in this clause (g) is intended to authorize any assignment or transfer not otherwise permitted by this Agreement;

 

(h) references herein to a Person in a particular capacity or capacities shall exclude such Person in any other capacity;

 

(i) references herein to any Contract (including this Agreement) mean such Contract as amended, supplemented, or modified from time to time in accordance with the terms thereof;

 

(j) with respect to the determination of any period of time, the word “from” means “from and including” and the words “to” and “until” each means “to but excluding”;

 

(k) references herein to any Law or any license mean such Law or license as amended, modified, codified, reenacted, supplemented, or superseded in whole or in part, and in effect from time to time;

 

(l) if the last day for the giving of any notice or the performance of any act required or permitted under this Agreement is a day that is not a Business Day, then the time for the giving of such notice or the performance of such action shall be extended to the next succeeding Business Day;

 

Endexx Control Acquisition Agreement (Hyla).3
9

 

 

(m) the word “or” is not exclusive; and

 

(n) references herein to any Law shall be deemed also to refer to all rules and regulations promulgated thereunder.

 

The parties acknowledge and agree that (i) each party and its counsel reviewed and negotiated the terms and provisions of this Agreement and have contributed to its revision, (ii) the rule of construction to the effect that any ambiguities are resolved against the drafting party shall not be employed in the interpretation of this Agreement, and (iii) the terms and provisions of this Agreement shall be construed fairly as to all parties, regardless of which party was generally responsible for the preparation of this Agreement.

 

ARTICLE 2

 

THE CONTROL ACQUISITION

 

Section 2.1 The Control Acquisition. On the terms and subject to the conditions set forth in this Agreement, at the Closing, Acquisition Sub will acquire the shares of Hyla Control Stock from the Seller.

 

Section 2.2 Effective Time. On the terms and subject to the provisions of this Agreement, at the Closing, (a) Endexx shall issue to the Seller the shares of Endexx Closing Stock in accordance with the information set forth on the Closing Issuance Schedule and (b) Acquisition Sub shall execute and deliver to the Seller the Self-financing Note (the effective time of the Acquisition being hereinafter referred to as the “Effective Time”). If any shares of Endexx Closing Stock are to be issued to a Person other than a Seller, it shall be a condition to such issuance that the Person requesting such issuance shall pay to Endexx any Transfer Tax or other Tax required as a result of such issuance to a Person other than a Seller or establish to the reasonable satisfaction of Endexx that such Tax has been paid or is not payable.

 

Section 2.3 Effect of the Control Acquisition. The Acquisition shall have the effects set forth herein. Without limiting the generality of the foregoing, and subject thereto, from and after the Effective Time, Acquisition Sub shall be the record and beneficial owner of the shares of the Hyla Control Stock.

 

Section 2.4 Directors and Officers. Subject to Section 3.2(a)(vi), the sole director and officer of Hyla, in each case immediately prior to the Effective Time, shall, from and after the Effective Time, be one of the directors and offices, respectively, of Hyla. Such current individual shall serve until the soonest to occur of (i) his death, (ii) disability, (iii) resignation, or (iv) the Self-financing Note has been satisfied in full or otherwise retired.

 

Section 2.5 Adjustments. Without limiting the other provisions of this Agreement, if at any time during the period between the date of this Agreement and the Effective Time, any change in the outstanding shares of capital stock of Hyla shall occur, including by reason of any reclassification, recapitalization, stock split (including reverse stock split), or combination, exchange, or readjustment of shares, or any stock dividend or distribution paid in stock, the issuance of the shares of Endexx Closing Stock pursuant to this Agreement shall be appropriately adjusted to reflect such change.

 

Endexx Control Acquisition Agreement (Hyla).3
10

 

 

Section 2.6 Closing Issuance Schedule. At least two (2) Business Days before the Closing, Hyla shall prepare and deliver to Endexx a schedule (the “Closing Issuance Schedule”), certified by the Chief Executive Officer or the Chief Financial Officer of Hyla, which shall set forth, as of immediately prior to the Effective Time, (a) the names and addresses of all stockholders and the number (and class) of shares of Hyla Common Stock held by each such stockholder and, (b) calculations of the shares of Endexx Closing Stock. The parties agree that Endexx shall be entitled to rely on the Closing Issuance Schedule in issuing the shares of Endexx Closing Stock to the Seller pursuant to this Agreement and that Endexx shall not be responsible for the calculations or the determinations regarding such calculations in such Closing Issuance Schedule.

 

ARTICLE 3

 

THE CLOSING

 

Section 3.1 Closing Date. Subject to the terms and conditions of this Agreement, the consummation of the Acquisition (the Closing”) shall take place at 10:00 A.M. Pacific Time on the second (2nd) Business Day after the date that the conditions set forth in Article 7 and Article 8 (other than those conditions which, by their terms, are to be satisfied or waived at the Closing, but subject to the satisfaction or waiver of such conditions) shall have been satisfied or waived by the party entitled to waive the same, or at such other time and date that Hyla and Endexx may agree in writing, but no earlier than August 31, 2022. The Closing shall be conducted electronically via email. The date upon which the Closing occurs is referred to herein as the “Closing Date.”

 

Section 3.2 Closing Deliverables.

 

(a) At or prior to the Closing, the Seller and Hyla shall deliver, or cause to be delivered, to Endexx:

 

(i) at least two (2) Business Days prior to the Closing, the Closing Issuance Schedule;

 

(ii) at least two (2) Business Days prior to the Closing, payoff letters for all Hyla Indebtedness outstanding as of immediately prior to the Effective Time that is to be paid off by Hyla at the Closing, which payoff letters shall indicate that the lenders of such Indebtedness have agreed to release all Encumbrances in respect of such Indebtedness relating to the assets and properties of Hyla upon receipt of the amounts indicated in such payoff letters, except the promissory note of Hyla in favor of Umais Abubaker;

 

(iii) discharges, UCC termination statements, or other appropriate releases, in form and substance reasonably satisfactory to Endexx, which, when filed, will release and satisfy any and all Encumbrances (other than Permitted Encumbrances) relating to any assets or properties of Hyla;

 

Endexx Control Acquisition Agreement (Hyla).3
11

 

 

(iv) a certificate, dated as of the Closing Date and signed by the Chief Executive Officer of Hyla, certifying that (A) each of the conditions set forth in Section 7.1 and Section 7.2 have been satisfied, (B) attached thereto are true and complete copies of all resolutions adopted by Hyla’s Board authorizing the execution, delivery, and performance of this Agreement and the Transaction Documents and the consummation of the transactions contemplated hereby and thereby, and (C) all such resolutions are in full force and effect and are all the resolutions adopted in connection with the transactions contemplated hereby and thereby;

 

(v) good standing certificate (or the equivalent) for Hyla from the secretary of state or similar Governmental Authority of the State of Delaware; and

 

(vi) such other documents or instruments as Endexx reasonably requests and are reasonably necessary to consummate the transactions contemplated by this Agreement.

 

(b) At the Closing, Endexx and Acquisition Sub shall deliver, or cause to be delivered, the following:

 

(i) The shares of Endexx Closing Stock to the Seller (or such other Person as may be specified, as relevant) in accordance with the Closing Issuance Schedule;

 

(ii) The Self-financing Note to the Seller;

 

(iii) a certificate, dated as of the Closing Date and signed by a duly authorized officer of Endexx, certifying that (A) each of the conditions set forth in Section 8.1 and Section 8.2 have been satisfied, (B) attached thereto are true and complete copies of all resolutions adopted by the board of directors of Endexx and Acquisition Sub authorizing the execution, delivery, and performance of this Agreement and the consummation of the transactions contemplated hereby, and (C) all such resolutions are in full force and effect and are all the resolutions adopted in connection with the transactions contemplated hereby and thereby;

 

(iv) good standing certificates (or the equivalent) for (A) Endexx from the secretary of state or similar Governmental Authority of the State of Nevada and (B) Acquisition Sub from the secretary of state or similar Governmental Authority of the State of Nevada; and

 

(v) such other documents or instruments as the Seller may reasonably request and are reasonably necessary to consummate the transactions contemplated by this Agreement.

 

Endexx Control Acquisition Agreement (Hyla).3
12

 

 

ARTICLE 4

 

REPRESENTATIONS AND WARRANTIES OF THE SELLER AND HYLA

 

Except as set forth in the Disclosure Schedules attached hereto (collectively, the “Disclosure Schedules”), the Seller and Hyla, jointly and severally, represent and warrant to Endexx, as of the date hereof and as of the Closing Date, as follows:

 

Section 4.1 Organization and Power. Hyla is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Delaware. Hyla has all requisite organizational and corporate power and authority necessary to own, lease or operate its properties and other assets that it purports to own, lease, or operate and to carry on its businesses as now conducted and as has been conducted in the past three years. Hyla is qualified to do business and is in good standing in each jurisdiction in which the failure to be so qualified, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. Hyla has made available to Endexx, prior to the execution of this Agreement, true and correct copies of Hyla Organizational Documents.

 

Section 4.2 Authority; Binding Obligation; Board Approval. Each of the Seller and Hyla has all requisite power and authority to execute and deliver this Agreement and the other agreements contemplated hereby and thereby and to perform his and its respective obligations hereunder and thereunder and, subject to, in the case of the consummation of the Acquisition, adoption of this Agreement by the action of the board of directors of Hyla, to consummate the transactions contemplated hereby and thereby. The execution, delivery and performance by the Seller and by Hyla of this Agreement and the other agreements contemplated hereby and the consummation by the Seller and by Hyla of the transactions contemplated hereby and thereby have been duly authorized by all requisite individual action on the Seller’s part and by all corporate action on Hyla’s part and no other corporate proceedings on the Seller’s part and on Hyla’s part are necessary to authorize the execution, delivery or performance of this Agreement or other agreements contemplated hereby and thereby or to consummate the transactions contemplated hereby and thereby. This Agreement has been duly executed and delivered by each of the Seller and by Hyla and, assuming that this Agreement is a valid and binding obligation of the other parties hereto, this Agreement constitutes a legal, valid and binding obligation of each of the Seller and of Hyla, enforceable against each of them in accordance with its terms, except as such enforceability may be limited by (i) applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or similar laws from time to time in effect affecting generally the enforcement of creditors’ rights and remedies; and (ii) general principles of equity (collectively, the “Equitable Exceptions”).

 

(b) The Hyla Board, by resolutions duly adopted by unanimous vote at a meeting of all directors of Hyla duly called and held or by unanimous written consent and, as of the date hereof, not subsequently rescinded or modified in any way and in accordance with the BIC and Hyla Organizational Documents, (i) determined that this Agreement and the transactions contemplated hereby, including the Control Acquisition, are fair to, and in the best interests of, Hyla’s stockholders and (ii) approved and declared advisable this Agreement and the transactions contemplated hereby, including the Control Acquisition.

 

Endexx Control Acquisition Agreement (Hyla).3
13

 

 

Section 4.3 Consents; No Conflict or Violation. The execution, delivery, and performance of this Agreement by the Seller and by Hyla and the Transaction Documents and the consummation by the Seller and by Hyla of the transactions contemplated hereby and thereby, including the Control Acquisition, do not and will not, (a) violate applicable Law, any Governmental Authorization or any Order, (b) require any Governmental Authorizations or declaration or filing with, or notice to, any Governmental Authority, (c) violate Hyla Organizational Documents, or (d) result in the creation or imposition of any Encumbrance other than Permitted Encumbrances on any properties or assets of Hyla.

 

Section 4.4 Capitalization. The authorized capital stock of Hyla consists of 1,000 shares of common stock. Section 4.4 of the Disclosure Schedules sets forth the issued and outstanding shares thereof as of the date of hereof. Such shares constitute the only issued and outstanding Equity Interests of Hyla. All of such Shares (i) have been duly authorized, are validly issued, fully paid, and non-assessable, (ii) are not subject to, and were not issued in violation of, any preemptive right, (iii) are free and clear of all Encumbrances (other than restrictions on transfer arising under federal or state securities Laws), and (iv) were issued in compliance with applicable Law. Except for such Shares, Hyla has no other outstanding Equity Interests. There are no authorized or outstanding rights, subscriptions, warrants, or options to purchase or otherwise acquire any Equity Interests of Hyla or securities or obligations of any kind convertible into or exchangeable for any Equity Interests of Hyla or any outstanding or authorized stock appreciation, dividend equivalent, phantom stock, profit participation, or other similar rights with respect to Hyla or any of its Equity Interests. There is no commitment by Hyla to issue, sell, or grant any Equity Interests or to repurchase or redeem any Equity Interests of Hyla. Any distributions, dividends, repurchases, and redemptions of the Equity Interests of Hyla were undertaken in compliance with Hyla Organizational Documents then in effect, any agreement to which Hyla then was a party, and in compliance with applicable Law. Section 4.4 of the Disclosure Schedules sets forth as of the date hereof the name of each Person that is a registered or beneficial owner of any of such Shares and the number of such Shares owned by such Person. There are no voting trusts, stockholders agreements, proxies, or other agreements or understandings in effect with respect to the voting or transfer of such Shares.

 

Section 4.5 No Subsidiaries. Hyla does not own or have any interest in any Equity Interest or have an ownership interest in any other Person.

 

Section 4.6 Financial Statements; No Undisclosed Liabilities; Inventory.

 

(a) Hyla has furnished Endexx with complete copies of the Financial Statements. The Financial Statements (i) were prepared in accordance with GAAP, subject in the case of the Unaudited Balance Sheet to (A) the absence of footnote disclosures and (B) changes resulting from normal year-end adjustments (each of which would be immaterial individually and in the aggregate to the Unaudited Balance Sheet), and (ii) present fairly in all material respects the financial condition and results of operations of Hyla as of the times and for the periods referred to therein. Hyla maintains a standard system of accounting established and administered in accordance with GAAP, such that the Financial Statements are capable being audited for the fiscal year ended December 31, 2021 and reviewed for the three- and six-month periods ended June 30, 2022 and 2021.

 

Endexx Control Acquisition Agreement (Hyla).3
14

 

 

(b) Hyla has no liabilities, obligations, or commitments of any nature whatsoever, asserted or unasserted, known or unknown, absolute or contingent, accrued or unaccrued, matured or unmatured or otherwise, except (i) those that are adequately reflected or reserved against in the Unaudited Balance Sheet, (ii) those that have been incurred in the Ordinary Course of Business since the date of the Unaudited Balance Sheet and that are not, individually or in the aggregate, material in amount, and (iii) the Seller’s and Hyla’s Transaction Expenses (which shall be solely born by the Seller).

 

(c) The cost of inventory reflected on the books and records of Hyla is calculated in accordance with the historical practices of Hyla that were used in calculating the inventory set forth in the Unaudited Balance Sheet.

 

Section 4.7 Absence of Certain Developments. During the period from the date of the Later Unaudited Balance Sheet to the date of this Agreement, Hyla has conducted its businesses in the Ordinary Course of Business in all material respects. Since the date of the Later Unaudited Balance Sheet, there has been no event, occurrence, or development that has had, or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, nor, except as set forth in Section 4.7 of the Disclosure Schedules, has there been any action taken or failure to act by Hyla that, if taken or failed to be taken during the period from the date of this Agreement through the Effective Time without Endexx’s prior, written consent, would constitute a breach of any of subsection (viii), (x), (xi), or (xiii) of Section 6.1(b).

 

Section 4.8 Contracts and Commitments.

 

(a) Section 4.8(a) of the Disclosure Schedules sets forth a true and complete list of the following Contracts to which Hyla is a party:

 

(i) any collective bargaining, works council, shop, enterprise, or recognition agreement or other Contract with any Union;

 

(ii) any employment agreement with any employee of Hyla;

 

(iii) any Contract relating to (A) Indebtedness or (B) the mortgaging, pledging, or otherwise placing of an Encumbrance (other than Permitted Encumbrances) on any of Hyla’s assets;

 

(iv) any lease or agreement under which it is the lessee of, or holds or operates any personal property owned by any other party, or lease or agreement under which it is the lessor of or permits any third party to hold or operate any Hyla property, real or personal;

 

(v) any Contract, other than purchase orders entered into in the Ordinary Course of Business, (A) with the ten (10) customers and five (5) suppliers/vendors of Hyla that have purchased from or sold to, as applicable, Hyla the most products or services (based upon consideration received/paid by Hyla) during each of (i) the 12-month period ended as of the date of the Unaudited Balance Sheet and (ii) the six-month period ended as of the date of the Unaudited Balance sheet, (B) for the purchase or sale of materials, supplies, merchandise, equipment, parts, or other property or services with other customers or suppliers requiring aggregate future payments in excess of $100,000, or (C) any guaranty of any obligation described in clauses (A) and (B);

 

Endexx Control Acquisition Agreement (Hyla).3
15

 

 

(vi) any Contract for capital expenditures or the acquisition or construction of fixed assets for the benefit and use of Hyla, the performance of which involves unpaid commitments or liabilities in excess of $100,000;

 

(vii) any Contract (A) for the acquisition (by merger or otherwise) of any business or securities of another Person or all or substantially all of the of the assets of another Person or (B) for the disposition of the assets or of any business enterprise of Hyla other than dispositions of inventory and products of Hyla in the Ordinary Course of Business, in each case that is the source of any surviving rights, obligations, or other provisions;

 

(viii) any license, sublicense, consent to use agreement, settlement, coexistence agreement, covenants not to sue, permission, or other Contract pursuant to which Hyla grants rights to any third party or receives a grant of rights from any third party to use any Intellectual Property material to the operation of the business of Hyla, other than agreements relating to off-the-shelf commercially available software available for an annual or one time license fee of less than $25,000 in the aggregate;

 

(ix) any Contract that requires Hyla to purchase its total requirements of any product or service from a third party or that contain “take or pay” provisions;

 

(x) any broker, distributor, dealer, manufacturer’s representative, franchise, agency, sales promotion, market research, marketing consulting, or advertising Contract;

 

(xi) any Contract with any Governmental Authority;

 

(xii) any Contract that limits the ability of Hyla to compete in any line of business or with any Person or in any geographic area or during any period of time;

 

(xiii) any Contract that provides for any joint venture, partnership, or similar arrangement by Hyla; and

 

(xiv) any other Contract involving aggregate consideration in excess of $100,000 and that, in each case, cannot be cancelled by Hyla without penalty or without more than 90 days’ notice.

 

Each Contract of the type described in clauses (i) through (xiv) above (and each Real Property Lease required to be listed in Section 4.11(a) of the Disclosure Schedules) is referred to herein as a “Material Contract”.

 

(b) Hyla has made available to Endexx a true and complete copy (including all amendments or modifications thereto) of each Material Contract (other than purchase orders entered into in the Ordinary Course of Business).

 

Endexx Control Acquisition Agreement (Hyla).3
16

 

 

(c) With respect to each Material Contract, neither Hyla nor, to the Knowledge of Hyla, any other party thereto is (with or without the lapse of time or the giving of notice, or material breach or default under such Material Contract, or has provided or received any notice of any written intention (or to Hyla’s Knowledge, verbal notice) to terminate such Material Contract.

 

(d) Except as set forth on Section 4.8(d) of the Disclosure Schedules, the execution, delivery, and performance by Hyla of this Agreement and the Transaction Documents and the consummation of the transactions contemplated hereby or thereby do not and will not conflict with or result in any material breach of, constitute a material default or an event that, with or without notice or lapse of time or both, would constitute a material default under, or result in the acceleration of or create in any party the right to accelerate, terminate, modify or cancel any, or require any consent, notice or other material action by any Person under, the provisions of any Material Contract. No event has occurred, is pending or, to Hyla’s Knowledge, threatened in writing, which after the giving of notice, lapse of time or otherwise would constitute a material breach or default by Hyla under any Material Contract or, to Hyla’s Knowledge, any other party to any Material Contract or would result in a termination thereof or cause or permit the acceleration or other changes of any material right or obligation or the loss of any material benefit thereunder.

 

(e) Each Material Contract is in full force and effect and constitutes a legal, valid, and binding obligation of Hyla, and, to Hyla’s Knowledge, constitutes a valid and binding obligation of the other parties thereto in each case, except as such enforceability may be limited by the Equitable Exceptions.

 

Section 4.9 Compliance with Laws; Permits.

 

(a) Hyla is, and has always been, in compliance in all material respects with all Laws applicable to Hyla or its business, properties, or assets.

 

(b) (a) Hyla holds all Governmental Authorizations required to conduct its business, (b) all such Governmental Authorizations are valid and in full force and effect, and (c) Hyla is in compliance in all material respects with all such Governmental Authorities.

 

(c) Without limiting the generality of Section 4.9(a), since January 1, 2021, (i) Hyla has complied in all material respects with, satisfied the conditions of, and made all filings and notices and obtained all consents, permissions, approvals and authorizations (and otherwise performed all acts) required under, all tariffs (including trade tariffs) applicable to the business or operation of Hyla, including those issued under Section 232 of the United States Trade Expansion Act of 1962, as amended, and (ii) neither Hyla nor, to Hyla’s Knowledge, any Person acting on its behalf, has (A) violated, or engaged in any activity, practice or conduct that would violate, any applicable anti-corruption Laws; (B) used corporate funds or assets for any unlawful contribution, gift, entertainment or other unlawful expense, or made any bribe, rebate, payoff, influence payment, kickback, or other unlawful payment; or (C) directly, or indirectly through Representatives, offered, promised, paid, given, or authorized the payment or giving of money or anything else of value, to any (1) official of any Governmental Authority or (2) other Person while knowing or having reason to believe that some portion or all of the payment or thing of value will be offered, promised or given, directly or indirectly, to an official of a Governmental Authority or another Person, in each case for the purpose of (x) influencing any act or decision of such official or such other Person in his, her, or its official capacity, including a decision to do or omit to do any act in violation of his, her, or its lawful duties or proper performance of functions or (y) inducing such official or such person or entity to use his, her or its influence or position with any Governmental Authority or other Person to influence any act or decision, in each case in order to obtain or retain business for, direct business to, or secure an improper advantage for, Hyla.

 

Endexx Control Acquisition Agreement (Hyla).3
17

 

 

Section 4.10 Litigation. Except as set forth on Section 4.10 of the Disclosure Schedules, there are no Actions pending or, to Hyla’s Knowledge, threatened in writing against Hyla or any of its assets or properties or officers, directors, or employees in their capacity as an officer, director, or employee, respectively, at Law or in equity, or before or by any Governmental Authority. Hyla is not subject to any material outstanding Order.

 

Section 4.11 Title to Real Property and Other Assets.

 

(a) Section 4.11(a) of the Disclosure Schedules sets forth a true and complete list of all of the Contracts under which Hyla leases or subleases any Real Property (the “Real Property Leases”). With respect to each Real Property Lease:

 

(i) Hyla has made available to Endexx a true and complete copy (including all amendments or modifications thereto) of each Real Property Lease required to be listed on Section 4.11(a) of the Disclosure Schedules.

 

(ii) Each Real Property Lease is in full force and effect, and Hyla holds a valid and existing leasehold interest under each such lease; and neither Hyla nor, to Hyla’s Knowledge, any party thereto is (with or without the lapse of time or giving notice, or both) in material breach or default under such lease. Hyla is not a sublessor or grantor under any sublease or other instrument granting to any other Person any right to the possession, lease, occupancy, or enjoyment of any Real Property leased by Hyla.

 

(b) Section 4.11(b) of the Disclosure Schedules lists the address of any Real Property owned by Hyla (the “Owned Real Property”). With respect to the Owned Real Property:

 

(i) Hyla has good and marketable fee simple title thereto, free and clear of all Encumbrances, other than Permitted Encumbrances;

 

(ii) Hyla has not leased or otherwise granted to any Person the right to use or occupy the Owned Real Property or any portion thereof;

 

(iii) Hyla has made available to Endexx true and complete copies of (A) the deeds and other instruments (as recorded) by which Hyla acquired the Owned Real Property and (B) all title insurance policies, opinions, abstracts, and surveys in the possession of Hyla and relating to the Owned Real Property; and

 

Endexx Control Acquisition Agreement (Hyla).3
18

 

 

(iv) the use and operation of the Owned Real Property in the conduct of Hyla’s business do not violate in any material respect any Law, covenant, condition, restriction, easement, license, permit, or agreement, in each case applicable to Hyla, its business, or the Owned Real Property. There are no Actions pending nor, to Hyla’s Knowledge, threatened against or affecting the Owned Real Property in the nature or in lieu of condemnation or eminent domain proceedings.

 

(c) Hyla has good and valid title to, or a valid leasehold interest in, all personal property and other assets (excluding Real Property) reflected in the Unaudited Balance Sheet or acquired after the date of the Unaudited Balance Sheet, other than properties and assets sold or otherwise disposed of in the Ordinary Course of Business since the date of the Unaudited Balance Sheet. Except as set forth on Section 4.11(c) of the Disclosure Schedules, all such properties and assets (including leasehold interests) are free and clear of Encumbrances except for Permitted Encumbrances.

 

(d) To the actual conscious knowledge (as opposed to constructive knowledge) of the Knowledge Persons, the material assets of Hyla that constitute machinery or equipment used in the operation of the business of Hyla as currently conducted are in good operating condition and repair, except for ordinary, routine maintenance and repairs that are not material in nature or cost, individually or in the aggregate.

 

Section 4.12 Tax Matters.

 

(a) All Tax Returns required to be filed by or with respect to Hyla have been timely (within any applicable extension periods) filed, and all such Tax Returns are true, complete, and correct in all respects and were prepared in accordance with applicable Laws.

 

(b) Hyla has fully and timely paid, or there has been paid on their behalf, all Taxes due and owing by Hyla (whether or not shown to be due on any Tax Return).

 

(c) Hyla has withheld and paid each Tax required to have been withheld and paid in connection with amounts paid or owing to any employee, independent contractor, creditor, customer, stockholder, or other party, and complied with all information reporting and backup withholding provisions of applicable Law.

 

(d) No claim has been made by any Governmental Authority in any jurisdiction where Hyla does not file Tax Returns that it is, or may be, subject to Tax by that jurisdiction.

 

(e) Hyla is not currently the beneficiary of any extension of time within which to file any Tax Return or pay any Taxes.

 

(f) The amount of Hyla’s liability for unpaid Taxes for all periods ending on or before the date of the Unaudited Balance Sheet does not, in the aggregate, exceed the amount of accruals for Taxes (excluding reserves for deferred Taxes) reflected on the Unaudited Balance Sheet. The amount of Hyla’s liability for unpaid Taxes for all periods following the date of the Unaudited Balance Sheet shall not, in the aggregate, exceed the amount of accruals for Taxes (excluding reserves for deferred Taxes) as adjusted for the passage of time in accordance with the past custom and practice of Hyla (and which accruals shall not exceed comparable amounts incurred in similar periods in prior years).

 

Endexx Control Acquisition Agreement (Hyla).3
19

 

 

(g) All deficiencies for Taxes asserted or assessed in writing against Hyla have been fully and timely (within any applicable extension periods) paid, settled, or properly reflected in the Financial Statements.

 

(h) No audit or other Action by any Governmental Authority is pending or, to the Knowledge of Hyla, threatened in writing with respect to any Taxes due from or with respect to Hyla.

 

(i) There are no outstanding agreements extending or waiving the statutory period of limitations applicable to any claim for, or the period for the collection or assessment or reassessment of, Taxes due from Hyla for any taxable period and no request for any such waiver or extension is currently pending.

 

(j) Hyla has made available to Endexx copies of all federal, state, local, and foreign income, franchise, and similar Tax Returns, examination reports, and statements of deficiencies assessed against, or agreed to by, Hyla for all Tax periods ending after December 31, 2015.

 

(k) There are no Encumbrances for Taxes (other than for current Taxes not yet due and payable) upon the assets of Hyla.

 

(l) Hyla is not a party to, or bound by, any Tax indemnity, Tax sharing, Tax allocation agreement, or similar agreement.

 

(m) Hyla has never been a member of an affiliated, combined, consolidated or unitary Tax group for Tax purposes. Hyla has no liability for Taxes of any Person (other than Hyla) under Treasury Regulations Section 1.1502-6 (or any corresponding provision of state, local or foreign Law), as transferee or successor, by contract or otherwise.

 

(n) Hyla will not be required to include any item of income in, or exclude any item or deduction from, taxable income for any taxable period or portion thereof ending after the Closing Date as a result of:

 

(i) any change in a method of accounting under Section 481 of the Code (or any comparable provision of state, local or foreign Tax Laws), or use of an improper method of accounting, for a taxable period ending on or prior to the Closing Date;

 

(ii) an installment sale or open transaction occurring on or prior to the Closing Date;

 

(iii) a prepaid amount received on or before the Closing Date;

 

(iv) any closing agreement under Section 7121 of the Code, or similar provision of state, local, or foreign Law, entered into on or before the Closing Date; or

 

Endexx Control Acquisition Agreement (Hyla).3
20

 

 

(v) any election under Section 108(i) of the Code.

 

(o) Hyla is not, nor has it been, a United States real property holding corporation (as defined in Section 897(c)(2) of the Code) during the applicable period specified in Section 897(c)(1)(a) of the Code.

 

(p) Hyla has not, within the past six years, been a “distributing corporation” or a “controlled corporation” in connection with a distribution described in Section 355 of the Code.

 

(q) Hyla is not, and has not been, a party to, or a promoter of, a “reportable transaction” within the meaning of Section 6707A(c)(1) of the Code and Treasury Regulations Section 1.6011-4(b).

 

(r) No property owned by Hyla is (i) required to be treated as being owned by another person pursuant to the so-called “safe harbor lease” provisions of former Section 168(f)(8) of the Internal Revenue Code of 1954, as amended, (ii) subject to Section 168(g)(1)(A) of the Code, or (iii) subject to a disqualified leaseback or long-term agreement as defined in Section 467 of the Code.’

 

Section 4.13 Intellectual Property.

 

(a) Section 4.13(a)(i) of the Disclosure Schedules sets forth all of Hyla’s Registered Intellectual Property. All of Hyla’s Registered Intellectual Property is subsisting, in full force and effect and, to Hyla’s Knowledge, valid and enforceable. Except as disclosed in Section 4.13(a)(ii) of the Disclosure Schedules, Hyla is the exclusive owner of all right, title, and interest in and to Hyla’s Registered Intellectual Property, free and clear of all Encumbrances, except for Permitted Encumbrances. Hyla is the owner of, or has the valid right to use, all other Intellectual Property necessary for or used in the business of Hyla as currently conducted (collectively with Hyla’s Registered Intellectual Property, “Hyla’s Intellectual Property”), in each case free and clear of Encumbrances other than Permitted Encumbrances.

 

(b) The conduct of Hyla’s business as currently conducted, including the use of Hyla’s Intellectual Property by Hyla in connection therewith, and the products, processes and services of Hyla do not infringe, misappropriate, or violate any Intellectual Property rights of any other Person. There are no Actions that are currently pending, or since Hyla’s inception that have been brought or, to the Knowledge of Hyla, are threatened in writing against Hyla challenging the ownership, use, validity, or enforceability of any of Hyla’s Intellectual Property or alleging any infringement, misappropriation, or other violation by Hyla of the Intellectual Property of any Person. To the Knowledge of Hyla and since Hyla’s inception, no Person has infringed, misappropriated, or otherwise violated or is infringing, misappropriating, or otherwise violating any of Hyla’s Intellectual Property, and no such claims have been made or are pending against any Person by Hyla.

 

(c) Since Hyla’s inception, there has not been any malfunction, failure, continued substandard performance, denial-of-service, or other cyber incident, including any cyberattack, or other impairment of Hyla’s IT Systems that has resulted or is reasonably likely to result in substantial disruption or damage to the business of Hyla and that has not been remedied. Hyla has taken all commercially reasonable steps to safeguard the confidentiality, availability, security, and integrity of Hyla’s IT Systems, including implementing and maintaining appropriate backup, disaster recovery, and software and hardware support arrangements.

 

Endexx Control Acquisition Agreement (Hyla).3
21

 

 

(d) Hyla has complied in all material respects with all applicable Laws and all of its publicly posted policies, notices, and statements concerning the collection, use, processing, storage, transfer, and security of personal information in the conduct of Hyla’s business. Since Hyla’s inception, Hyla has not (i) experienced any data breach or other security incident involving personal information in its possession or control or (ii) received any written notice of any audit, investigation, complaint, or other Action by any Governmental Authority or other Person concerning Hyla’s collection, use, processing, storage, transfer, or protection of personal information or actual, alleged, or suspected violation of any applicable Law concerning privacy, data security or data breach notification.

 

Section 4.14 Employee Benefit Plans.

 

(a) Section 4.14(a) of the Disclosure Schedules lists each “employee benefit plan” (as defined under Section 3(3) of ERISA), employment, severance, termination, retirement, profit sharing, cash or equity-based incentive, bonus, performance award, phantom equity, deferred compensation, retention, change in control, pension, vacation, paid time off (PTO), medical, vision, dental, disability, welfare, Code Section 125, cafeteria, fringe-benefit or other employee compensation or benefit plan, program, policy, arrangement, agreement, fund or commitment, sponsored, maintained or required to be contributed to by Hyla or any ERISA Affiliate or with respect to which Hyla has any liability (the “Hyla Plans”). Hyla has made available to Endexx accurate, current and complete copies of (i) each of the Hyla Plans and (ii) with respect to each of the Hyla Plans, the most recent summary plan description, the two most recently filed IRS Form 5500 annual reports, the IRS determination letter or opinion letter issued by the IRS, any trust agreement or other funding arrangement, custodial agreement, insurance policy and contract, administration agreement and similar agreement, and investment management or investment advisory agreement, now in effect, actuarial valuations and reports with respect to the two most recently completed plan years, the most recent nondiscrimination tests performed under the Code, and copies of material notices, letters or other correspondence from the IRS, Department of Labor, Department of Health and Human Services, Pension Benefit Guaranty Corporation or other Governmental Authority relating to Hyla Plan.

 

(b) With respect to each of the Hyla Plans: (i) such Hyla Plan and any related trust has been established, operated and administered in material compliance with its terms and all applicable Laws (including ERISA and the Code); and (ii) all benefits, contributions, premiums and expenses to or in respect of such Hyla Plan have been timely paid in full or, to the extent not yet due, have been adequately accrued and reserved for on Hyla’s Financial Statements, in each case in accordance with the terms of such Hyla Plan, all applicable Laws and, as applicable, GAAP.

 

Section 4.15 Insurance Policies. All of the insurance policies maintained as of the date hereof by Hyla for the benefit of Hyla or any of its assets, businesses, operations, employees, officers, or directors (collectively, the “Insurance Policies”) are listed in Section 4.15 of the Disclosure Schedules. The Insurance Policies are in full force and effect and are valid, binding, and enforceable. True and complete copies of the Insurance Policies have been made available to Endexx. Hyla is not in breach or default in any material respect of its obligations under any of such Insurance Policies and all premiums due thereon have been timely paid. Except as set forth on Section 4.15 of the Disclosure Schedules, Hyla has never with respect to any of the Insurance Policies (a) had a claim disputed or rejected or a payment denied by any insurance provider, (b) had a claim in which there is an outstanding reservation of rights, (c) had the policy limit under any Insurance Policy exhausted or materially reduced, or (d) received any notice of cancellation of, premium increase with respect to, or alteration of coverage under, any of the Insurance Policies.

 

Endexx Control Acquisition Agreement (Hyla).3
22

 

 

Section 4.16 Labor and Employment Matters.

 

(a) There are no Actions against Hyla pending, or to the Knowledge of Hyla, threatened in writing, relating to the employment, termination of employment of or failure to employ any individual.

 

(b) Hyla is not a party to, bound by, or negotiating any collective bargaining agreement or other Contract with a union, works council or labor organization (collectively, “Union”), and there is not any Union representing or purporting to represent any employee of Hyla, and, to Hyla’s Knowledge, no Union or group of employees is seeking or has sought to organize employees for the purpose of collective bargaining. There has never been, nor, to Hyla’s Knowledge, has there been any threat of, any strike, slowdown, work stoppage, lockout, concerted refusal to work overtime or other similar labor disruption or dispute affecting Hyla or any of its employees. Since Hyla’s inception, Hyla has been in compliance in all material respects with the terms of the collective bargaining agreements and other Contracts required to be listed on Section 4.16(b) of the Disclosure Schedules.

 

(c) Hyla has complied in all material respects with all applicable labor and employment Laws, including the National Labor Relations Act and other applicable Laws relating to wages, hours, benefits, classification, collective bargaining, equal employment opportunities, fair employment practices, employment discrimination, harassment, retaliation, reasonable accommodation, disability rights or benefits, immigration, hiring, promotion and termination of employees, working conditions, meal and break periods, privacy, health and safety, workers’ compensation, leaves of absence, paid sick leave, unemployment insurance and all other applicable occupational safety and health acts and Laws.

 

(d) Section 4.16(d) of the Disclosure Schedules contains a list of all persons who are employees, independent contractors or consultants of Hyla as of the date hereof, including any employee who is on a leave of absence of any nature, paid or unpaid, authorized or unauthorized, and sets forth for each such individual the following: (i) name; (ii) title or position (including whether full-time or part-time); (iii) hire or retention date; (iv) current annual base compensation rate or contract fee; (v) commission, bonus or other incentive-based compensation; (v) work location; (vi) employment status (i.e., active, disabled or on authorized leave and the reason therefor); and (vii) whether covered by a collective bargaining agreement. All compensation, including wages, commissions, bonuses, fees, and other compensation, payable to all employees, independent contractors, or consultants of Hyla for services performed prior to the date hereof have been paid in full (or accrued in full on the audited balance sheet contained in the Closing Working Capital Statement) and there are no outstanding agreements, understandings, or commitments of Hyla with respect to any compensation, commissions, bonuses, or fees.

 

Endexx Control Acquisition Agreement (Hyla).3
23

 

 

Section 4.17 Brokers. No broker, finder, or investment banker is entitled to any brokerage commissions, finders’ fees, or other fee, commission, or remuneration in connection with the transactions contemplated by this Agreement based on any arrangement or agreement made by or on behalf of the Seller or Hyla.

 

Section 4.18 Affiliate Transactions. Except for employment agreements entered into in the Ordinary Course of Business, no executive officer or director of Hyla, any member of such executive officer’s or director’s immediate family, any 5% or greater holder of Equity Interests of Hyla or any Affiliate of any of the foregoing (collectively, “Related Persons”) (a) is indebted to Hyla, nor does Hyla owe any amount to, or has committed to make any loan or extend or guarantee credit to or for the benefit of, any Related Person, (b) is involved in any material business arrangement or other relationship with Hyla or otherwise is a party to any Contract with or binding upon Hyla, or (c) has any interest in any property owned by Hyla.

 

Section 4.19 Books and Records. The minute books and stock record books of Hyla have been made available to Endexx, are complete and correct in all material respects, and have been maintained in accordance with applicable Laws. At the Closing, all of those books and records will be in the possession of Acquisition Sub.

 

Section 4.20 Customers and Suppliers. Section 4.20(a) of the Disclosure Schedules sets forth a list of the ten (10) largest customers and the five (5) largest suppliers/vendors of Hyla, as measured by the dollar amount of purchases therefrom or thereby, during and for each of (a) the fiscal year ended December 31, 2021 and (b) the six-month period ended June 30, 2022, and, in each case, the amount of consideration paid by or to each such customer or supplier during such period. Except as set forth in Section 4.20(b) of the Disclosure Schedules, since January 1, 2021, no such customer or supplier has (i) terminated its relationship with Hyla or materially reduced or changed in any materially adverse manner the terms on which such customer or supplier conducts business with Hyla or (ii) notified Hyla in writing that it intends to terminate or materially reduce its business with Hyla.

 

Section 4.21 Certain Other Representations or Warranties. Except for the representations and warranties contained in this Article 4 (including the related portions of the Disclosure Schedules), none of the Seller, Hyla, or any of their Representatives has made or makes any other express or implied representation or warranty, whether written or oral, on behalf of the Seller, Hyla, or any of their Affiliates, or Representatives, including with respect to (a) any estimates, projections, forecasts, plans, budget or prospect information relating to the business of Hyla (including the reasonableness of the assumptions underlying such estimates, projections, forecasts, plans, budgets or prospect information) or (b) except for the representations and warranties contained in this Article 4 (including the related portions of the Disclosure Schedules), any oral or written information presented to Endexx or any of its Affiliates or Representatives in the course of their due diligence of Hyla, the business of Hyla, the negotiation of this Agreement, or in the course of the transactions contemplated hereby.

 

Endexx Control Acquisition Agreement (Hyla).3
24

 

 

(a) Accredited Investor. Each Seller is an “accredited investor” as defined in Rule 501(a) in Regulation D promulgated under the Securities Act of 1933, as amended. Each Seller is not a registered broker or a dealer under Section 15 of the Exchange Act. Each Seller has such experience in business and financial matters that he, she, or it is capable of evaluating the merits and risks of the acquisition of the shares of Endexx Closing Stock. Each Seller acknowledges that an investment in the shares of Endexx Closing Stock is speculative and involves a high degree of risk.

 

(b) General Solicitation. Each Seller is not purchasing the shares of Endexx Closing Stock as a result of any advertisement, article, notice, or other communication regarding such shares published in any newspaper, magazine, or similar media or broadcast over television or radio or presented at any seminar or any other general solicitation or general advertisement.

 

(c) Access to Information. Each Seller acknowledges that her, she, or it has reviewed Endexx’s most recent Annual Report on From 10-K and Quarterly Report on 10-Q, each as filed with the Securities and Exchange Commission during the 2022 calendar year and has been afforded (i) the opportunity to ask such questions as he, she, or it has deemed necessary of, and to receive answers from, representatives of Endexx concerning the terms and conditions of the offering of the shares of Endexx Closing Stock and the merits and risks of investing in the shares of Endexx Closing; (ii) access to information about Endexx and its financial condition, results of operations, business, properties, management, and prospects sufficient to enable it to evaluate his, her, or its investment; and (iii) the opportunity to obtain such additional information that Endexx possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment in the shares of Endexx Closing Stock. Each Seller has knowledge and experience in financial and business matters and is capable of evaluating the merits and risks of an investment in the shares of Endexx Closing and has the ability to protect his, her, or its own interest in connection with such investment.

 

(d) Proportionality of Investment. Each Seller’s overall commitment to investments that are not readily marketable is not disproportionate to its individual net worth, and each Seller’s investment in the shares of Endexx Closing Stock will not cause such overall commitment to become excessive.

 

(e) Protection of Financial Requirements. Each Seller has adequate means of providing for his financial requirements, both current and anticipated, and has no need for liquidity in the shares of Endexx Closing Stock and can bear and is willing to accept the economic risk of losing his, her, or its entire investment in the shares of Endexx Closing Stock.

 

(f) Acquisition for Own Account. Each Seller is acquiring the shares of Endexx Closing Stock for his, her, or its own account and for investment purposes only and has no present intention, agreement or arrangement for the distribution, transfer, assignment, resale, or subdivision of the shares of Endexx Closing Stock.

 

Endexx Control Acquisition Agreement (Hyla).3
25

 

 

ARTICLE 5

 

REPRESENTATIONS AND WARRANTIES OF ENDEXX AND ACQUISITION SUB

 

Endexx and Acquisition Sub represent and warrant to Hyla, as of the date hereof and as of the Closing Date, as follows:

 

Section 5.1 Organization. Endexx is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Nevada. Acquisition Sub is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Nevada.

 

Section 5.2 Authority; Binding Obligation. Each of Endexx and Acquisition Sub has all requisite power and authority to execute and deliver this Agreement and the other agreements contemplated hereby and to perform its respective obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby and no corporate proceedings on its respective part, other than as expressly contemplated by this Agreement, are necessary to authorize the execution, delivery, or performance of this Agreement and the Transaction Documents and to consummate the transactions contemplated hereby and thereby. This Agreement has been duly executed and delivered by Endexx and Acquisition Sub and (assuming due authorization, execution, and delivery by each other party hereto) this Agreement constitutes a valid and binding obligation of Endexx and Acquisition Sub, enforceable against Endexx and Acquisition Sub in accordance with its terms, except as such enforceability may be limited by the Equitable Exceptions.

 

Section 5.3 No Defaults or Conflicts. The execution and delivery of this Agreement and the other agreements contemplated hereby and the consummation of the transactions contemplated hereby and thereby by Endexx and Acquisition Sub, and performance by Endexx and Acquisition Sub of their respective obligations hereunder or thereunder do not and will not (a) violate the organizational documents of Endexx or Acquisition Sub, (b) materially contravene or conflict with, or result in any material violation or breach of, any of the terms or provisions of, or constitute a material default (with or without notice or lapse of time or both) under, any indenture, mortgage, or loan or any other material agreement or instrument to which Endexx or Acquisition Sub is a party or by which Endexx or Acquisition Sub is bound or to which the properties of Endexx or Acquisition Sub may be subject, or (c) assuming that all Governmental Authorizations in Section 5.4 have been obtained or made, result in any violation of any existing applicable Law or Order of any Governmental Authority having jurisdiction over Endexx or Acquisition Sub or any of its respective properties.

 

Section 5.4 No Authorization or Consents Required. Except for such filings by Endexx with the Securities and Exchange Commission under the Exchange Act or otherwise as Endexx reasonably determines to be necessary, appropriate or desirable, no Governmental Authorizations will be required to be obtained or made by Endexx or Acquisition Sub in connection with the execution, delivery, and performance by Endexx and Acquisition Sub of this Agreement and the other agreements contemplated hereby and the consummation by Endexx and Acquisition Sub of the transactions contemplated hereby or thereby.

 

Section 5.5 Sufficient Funds.

 

(a) The obligations of Endexx and Acquisition Sub hereunder are subject to the closing of the Financing.

 

Endexx Control Acquisition Agreement (Hyla).3
26

 

 

(b) Assuming the closing of the Financing, Endexx and the Acquisition Sub will have as of the Closing sufficient cash, available lines of credit, or other sources of immediately available funds to pay all amounts required to be paid by Endexx the Acquisition Sub in connection with this Agreement and the transactions contemplated hereby.

 

Section 5.6 No Prior Acquisition Sub Operations. Acquisition Sub was formed solely for the purpose of effecting the Control Acquisition and has not engaged in any business activities or conducted any operations other than in connection with the transactions contemplated hereby.

 

Section 5.7 Brokers. No broker, finder, or similar intermediary is entitled to any broker’s, finder’s, or similar fee or other commission in connection with this Agreement or the transactions contemplated hereby based on any agreement or arrangement made by or on behalf Endexx or Acquisition Sub.

 

Section 5.8 Financial Statements. The financial statements of Endexx and its consolidated subsidiaries for the fiscal years ended September 30, 2021 and 2019 and the three- and six-month periods ended March 31, 2022 and 2021 are included in the reports filed by Endexx with the Securities and Exchange Commission pursuant to the Exchange Act and were true and correct in all material respects when filed.

 

Section 5.9 Litigation. As of the date hereof, there is no Action pending or, to the actual knowledge of Endexx, threatened against Endexx, Acquisition Sub, or any of their respective Affiliates, or any material portion of its properties or assets that would reasonably be expected, individually or in the aggregate, to materially impair the ability of Endexx or Acquisition Sub to effect the transactions contemplated hereby. As of the date hereof, neither Endexx nor Acquisition Sub is subject to any unsatisfied Order that, individually or in the aggregate, would reasonably be expected to materially impair the ability of Endexx or Acquisition Sub to effect the transactions contemplated hereby.

 

Endexx Control Acquisition Agreement (Hyla).3
27

 

 

Section 5.10 Reliance. Each of Endexx and Acquisition Sub acknowledges that it and its Representatives have been permitted full and complete access to the books and records, facilities, equipment, Tax Returns, contracts, insurance policies (or summaries thereof) and other properties and assets of Hyla that they and their respective Representatives have desired or requested to see or review, and that they and their respective Representatives have had a full opportunity to meet with the officers and employees of Hyla to discuss the business of Hyla. Each of Endexx and Acquisition Sub acknowledges that neither the Seller, Hyla, nor any other Person has made any representation or warranty, express or implied, as to the accuracy or completeness of any information that the Seller or Hyla furnished or made available to Endexx or Acquisition Sub and their respective Representatives, except for representations and warranties by the Seller and Hyla expressly set forth in Article 4 (including the related portions of the Disclosure Schedules). Neither the Seller nor Hyla nor any other Person (including any Affiliate of the Seller or Hyla or their respective Representatives) shall have or be subject to any liability to Endexx, Acquisition Sub, or any other Person (including in contract or tort, at law, or in equity, under federal or state securities Laws or otherwise) resulting from the use of any information, documents, or material made available to Endexx or Acquisition Sub (or any omissions therefrom) in any “data rooms,” management presentations, due diligence, or in any other form in expectation of the transactions contemplated hereby, except that the foregoing shall not apply to any claim arising from actual fraud on the part of the Seller or Hyla or limit any of the express representations and warranties of the Seller or Hyla set forth in this Agreement (or any liability of the Seller for any breach thereof pursuant to ‎Article 9). Each of Endexx and Acquisition Sub acknowledges that, should the Closing occur, Acquisition Sub shall acquire the Hyla Control Stock without any representation or warranty as to merchantability or fitness for any particular purpose of Hyla’s assets, in an “as is” condition and on a “where is” basis, except that the foregoing shall not apply to any claim arising from actual fraud on the part of the Seller or Hyla or limit any of the express representations and warranties of the Seller and Hyla set forth in this Agreement. Each of Endexx and Acquisition Sub acknowledges that, except for the representations and warranties of the Seller and Hyla contained in Article 4 (including the related portions of the Disclosure Schedules), neither the Seller nor Hyla nor any other Person has made, and neither Endexx nor Acquisition Sub has relied on, any other express or implied representation or warranty by or on behalf of, or with respect to, Hyla. Each of Endexx and Acquisition Sub acknowledges that neither Hyla nor any other Person, directly or indirectly, has made, and neither Endexx nor Acquisition Sub has relied on, any representation or warranty regarding the pro-forma financial information, financial projections, or other forward-looking statements of the Seller and Hyla (except as expressly set forth herein), and neither Endexx nor Acquisition Sub will make any claim with respect thereto.

 

ARTICLE 6

 

COVENANTS

 

Section 6.1 Conduct of Business of Hyla, Pre-Closing.

 

(a) During the period from the date of this Agreement to the earlier of the Closing and the termination of this Agreement in accordance with Article 10, except (i) as set forth on Section 6.1(a) of the Disclosure Schedules, (ii) as required by applicable Law, (iii) as otherwise contemplated by this Agreement, or (iv) with the prior, written consent of Endexx (such consent not to be unreasonably withheld, delayed, denied, or conditioned), Hyla shall (A) conduct its business in the Ordinary Course of Business and (B) use commercially reasonable efforts to (i) maintain and preserve intact its current organization, business, and franchise and (ii) preserve the rights, franchises, goodwill, and relationships of its employees, customers, lenders, suppliers, regulators, and others having business relationships with Hyla.

 

(b) During the period from the date of this Agreement to the earlier of the Closing and the termination of this Agreement in accordance with Article 10 and without limiting the generality of Section 6.1(a), except (i) as set forth on Section 6.1(b) of the Disclosure Schedules, (ii) as required by applicable Law, (iii) as otherwise contemplated by this Agreement or any of the Transaction Documents, or (iv) with the prior written consent of Endexx (such consent not to be unreasonably withheld, conditioned, delayed or denied), Hyla shall not:

 

(i) transfer, issue, sell, purchase, redeem, retire, or grant any Equity Interests of Hyla or grant any options, warrants, calls, or other rights to purchase or otherwise acquire Equity Interests of Hyla;

 

Endexx Control Acquisition Agreement (Hyla).3
28

 

 

(ii) reclassify, combine, split, subdivide, or amend the terms of any of its capital stock or issue or authorize the issuance of other securities in respect of, in lieu of, or in substitution for, shares of its capital stock;

 

(iii) amend any of its Organizational Documents;

 

(iv) except as required by the terms of any existing Hyla Plan as of the date hereof, grant any bonuses or materially increase the amount of any salary, wages, or cash incentive compensation to any employee, or enter into any employment or severance agreement with any employee, except (A) in the case of any bonus, any bonus granted in the Ordinary Course of Business that is not, individually or in the aggregate, material in amount and (B) in the case of any increase in compensation, increases made in the Ordinary Course of Business that do not exceed more than 2% per annum;

 

(v) increase or accelerate the payments to or benefits under any employment Contract or Hyla Plan except as required by the terms of any such employment Contract or Hyla Plan as of the date hereof, or as required by applicable Law, or adopt, modify in any material respect, or terminate any Hyla Plan, except as required by applicable Law;

 

(vi) not voluntarily recognize, or collectively bargain without the participation by and approval of Endexx with, any Unions as the collective bargaining representative of any employee of Hyla;

 

(vii) make, or enter into any commitment for, any capital expenditures of Hyla except for those contemplated in the budget of Hyla made available to Endexx prior to the date hereof and in any event not in excess of the aggregate amount set forth in the budget of Hyla for such portion of the applicable fiscal year attributable to the pre-Closing period;

 

(viii) (A) without duplication of subsection (vii), acquire or lease any material properties or assets or (B) sell, assign, license (or sublicense), transfer, convey, or otherwise dispose of any of the rights, properties, or assets of Hyla other than dispositions of inventory made in the Ordinary Course of Business;

 

(ix) make any capital investment in, or any loan to, any other Person;

 

(x) change its present Accounting Methodologies or principles in any material respect, except as required by GAAP or by Hyla’s auditors;

 

(xi) make, change, or rescind any material Tax election, amend any Tax Return, settle any material Tax claim relating to Hyla or take any position on any Tax Return, take any action, omit to take any action or enter into any other transaction other than in the Ordinary Course of Business that would have the effect of increasing the Tax liability or reducing any Tax asset of Endexx in respect of any Post-Closing Tax Period;

 

Endexx Control Acquisition Agreement (Hyla).3
29

 

 

(xii) other than in the Ordinary Course of Business, incur any Indebtedness other than unsecured current liabilities and obligations incurred in the Ordinary Course of Business, permit the imposition of any Encumbrance upon any of Hyla’s properties or assets, or cancel any indebtedness owed to Hyla;

 

(xiii) enter into or agree to enter into any merger or consolidation with any corporation or other entity, acquire the securities of any other Person, or adopt any plan of merger, consolidation, reorganization, liquidation, or dissolution;

 

(xiv) (A) enter into any Contract that would constitute a Material Contract unless such Contract (1) is entered into in the Ordinary Course of Business, (2) does not involve payments by Hyla of greater than $225,000 over the term of such Contract, and (3) is not of a type described in clauses (ii), (vii), (viii), (ix), (xii), or (xiii) of Section 4.8(a); (B) accelerate any Material Contract; (C) terminate any Material Contract (excluding the expiration of any Material Contract in accordance with its terms); or (D) knowingly make any material modification to any Material Contract that is adverse to Hyla;

 

(xv) enter into any Contract or transaction with a Related Person; or

 

(xvi) agree to take any of the foregoing actions.

 

(c) Nothing contained in this Agreement shall give Endexx or Acquisition Sub, directly or indirectly, rights to control or direct the operations of Hyla before the Closing Date. Before the Closing Date, Hyla shall, consistent with the terms and conditions of this Agreement and subject to the rights and obligations of the parties under this Agreement, exercise complete control and supervision over its operations.

 

Section 6.2 Access to Information; Confidentiality; Public Announcements.

 

(a) During the period from the date of this Agreement to the earlier of the Closing Date and the termination of this Agreement in accordance with Article 10, Hyla shall (i) give Endexx and its Representatives reasonable access during normal business hours to (and the right to inspect) all books, records, Contracts, offices and other facilities, properties, and data of Hyla as Endexx or its Representatives may from time to time reasonably request; provided, however, that any such access and inspection shall be conducted in a manner not to interfere with the business or operations of Hyla unreasonably; and (ii) furnish Endexx and its Representatives with such financial, operating, and other data and information relating to Hyla that Endexx may reasonably request (including monthly financial statements for periods following the date of the Later Unaudited Balance Sheet). Notwithstanding anything to the contrary in this Agreement, Hyla shall not be required to provide such access or disclose any information to Endexx or its Representatives, if doing so would, based on the advice of Hyla’s outside counsel, (A) result in a waiver of attorney-client privilege, work product doctrine or similar privilege or (B) violate any agreement or Law to which Hyla is a party or to which Hyla is subject (provided that, in either such case, Hyla and Endexx shall cooperate in seeking alternative means whereby such information may be disclosed to Endexx without jeopardizing any such privilege or violating any such agreement or Law).

 

Endexx Control Acquisition Agreement (Hyla).3
30

 

 

(b) No party will issue or cause the publication of any press release or other public announcement with respect to this Agreement or the transactions contemplated hereby without the prior written consent of the other parties hereto (which consent shall not be unreasonably withheld, delayed, denied, or conditioned); provided, however, that nothing herein will prohibit any party from issuing or causing publication of any such press release or public announcement to the extent that such disclosure is upon advice of counsel (including in-house counsel) required by Law or stock exchange requirements, in which case the party making such determination will, if practicable in the circumstances, use reasonable commercial efforts to allow the other party reasonable time to comment on such release or announcement in advance of its issuance.

 

Section 6.3 Filings, Authorizations, and Consents.

 

(a) Subject to the terms and conditions herein, each party hereto agrees to use commercially reasonable efforts to take, or cause to be taken, all action, and to do, or cause to be done as promptly as practicable, all things necessary, proper, and advisable under applicable Law to consummate and make effective as promptly as practicable the transactions contemplated under this Agreement and the Transaction Documents. Subject to appropriate confidentiality protections, each party hereto shall furnish to the other parties such necessary information and reasonable assistance as such other party may reasonably request in connection with the foregoing.

 

(b) Each of the parties shall cooperate with one another in good faith to prepare all necessary documentation to effect promptly all necessary filings, to give all notices and to obtain all consents, waivers, and approvals necessary to consummate the transactions contemplated by this Agreement. Each such party shall promptly inform the other parties hereto of any oral communication with, and provide copies of written communications with any Governmental Authority regarding any such filings or any such transaction.

 

(c) Notwithstanding the foregoing, nothing in this Section 6.3 shall require, or be construed to require, the Seller, Hyla, or any of their Affiliates to agree to (i) sell, hold, divest, discontinue or limit, before or after the Closing Date, any assets, businesses, or interests of Hyla or any of its Affiliates; (ii) any conditions relating to, or changes or restrictions in, the operations of any such assets, businesses, or interests that, in either case, could reasonably be expected to result in a Material Adverse Effect or materially and adversely impact the economic or business benefits to Hyla of the transactions contemplated by this Agreement; (iii) any material modification or waiver of the terms and conditions of this Agreement; (iv) expend any money to obtain any consent of any counterparty to any Contract of Hyla, or (v) commence or defend any Action.

 

Section 6.4 Further Assurances. From the date hereof until the earlier of the Closing Date and the termination of this Agreement in accordance with Article 10, each of the parties hereto shall execute such documents and perform such further acts as may be reasonably required to carry out the provisions hereof and the actions contemplated hereby. Each party shall, on or prior to the Closing Date, use its reasonable best efforts to fulfill or obtain the fulfillment of the conditions precedent to the consummation of the transactions contemplated hereby, including the execution and delivery of any documents, certificates, instruments, or other papers that are reasonably required for the consummation of the transactions contemplated by this Agreement and the Transaction Documents.

 

Endexx Control Acquisition Agreement (Hyla).3
31

 

 

Section 6.5 Waiver of Conflicts; Attorney-Client Privilege. Notwithstanding anything to the contrary in any other agreement, recognizing that Clark Hill PLC has acted as legal counsel to Endexx and its respective Affiliates in connection with this Agreement, the Acquisition and the other transactions contemplated hereby, and that Clark Hill PLC intends to continue to act as legal counsel to Endexx, but will also act as legal counsel for Hyla and its respective Affiliates (other than the Seller) after the Closing, the Seller and Hyla hereby waive, on their own behalf and on behalf of their respective Affiliates, any conflicts that have arisen or may arise in connection with Clark Hill PLC representing Hyla and its Affiliates at or after the Closing other than in contesting and settling any claims on behalf of Endexx and Acquisition Sub arising out of this Agreement or resolving any other disputes hereunder, against Hyla and/or its Affiliates in litigation, arbitration, or mediation in connection therewith. Endexx, Acquisition Sub, and Hyla each consents, on its own behalf and on behalf of its Affiliates, to the continued representation of Endexx and Acquisition Sub, and the initiation of representation of Hyla and its Affiliates by Clark Hill PLC other than in connection with this Agreement, the Acquisition and the other transactions contemplated hereby, notwithstanding the fact that Clark Hill PLC may have represented, and may currently or in the future represent, Endexx, Acquisition Sub, and Hyla and/or any of their respective Affiliates with respect to unrelated matters and notwithstanding anything to the contrary in any other agreement. In addition, Endexx and Hyla each hereby acknowledges that its consent and waiver under this Section 6.6 is voluntary and informed, and that Endexx, Acquisition Sub, the Seller, and Hyla have each obtained independent legal advice with respect to this consent and waiver. Endexx, Acquisition Sub, the Seller, and Hyla each agree that Clark Hill PLC is an express third-party beneficiary of this Section 6.5.

 

Section 6.6 Tax Matters.

 

(a) Filing of Tax Returns by the Seller and Hyla. The Seller and Hyla shall timely prepare and file (or cause to be timely prepared and filed) all Tax Returns that are required to be filed by or with respect to Hyla that are due on or before the Closing Date (taking into account any extensions), and shall timely pay all Taxes that are due and payable on or before the Closing Date (taking into account any extensions). Any such Tax Return shall be prepared in a manner consistent with past practice (unless otherwise required by Law).

 

(b) Filing of Certain Tax Returns by Hyla and Acquisition Sub After the Closing Date. Hyla and Acquisition Sub (or Endexx if such tax returns of Hyla may be filed on a consolidated basis) shall prepare and timely file, or cause to be prepared and timely filed, all Tax Returns required to be filed by Hyla after the Closing Date with respect to any Pre-Closing Tax Period or any Straddle Period. Any such Tax Return shall be prepared in a manner consistent with past practice (unless otherwise required by Law or change in fact). Acquisition Sub shall provide a draft of any such material Tax Return to the Seller for their review and comment at least thirty (30) days prior to the due date for the filing thereof; provided, that, if any such material Tax Return is required to be filed within sixty (60) days of the ending date of the applicable Tax period, Acquisition Sub shall provide a draft of any such material Tax Return to the Seller for review and comment within such period of time prior to the due date for filing such material Tax Return as is reasonable under the circumstances to provide Seller an adequate opportunity to review and comment. Not later than ten (10) days (for material Tax Returns provided to Seller at least thirty (30) days prior to the due date for the filing thereof) or, within such reasonable time as may be applicable under the circumstances (for all other material Tax Returns), Seller shall notify Acquisition Sub in writing of any proposed changes that Seller may have to any item set forth on such material Tax Returns and the basis for any such changes and Acquisition Sub shall consider in good faith all such changes. If Seller do not provide a notice of proposed changes to Acquisition Sub for any such material Tax Returns within the time period specified in the preceding sentence, Acquisition Sub is permitted to assume that Seller have no proposed changes to any such material Tax Return.

 

Endexx Control Acquisition Agreement (Hyla).3
32

 

 

(c) Straddle Period. In the case of Taxes that are payable with respect to a taxable period that includes but does not end on the Closing Date (each such period, a “Straddle Period”), the portion of any such Taxes that are treated as Pre-Closing Taxes for purposes of this Agreement shall be:

 

(i) in the case of Taxes (A) based upon, or related to, income, receipts, profits, wages, capital, or net worth, (B) imposed in connection with the sale, transfer, or assignment of property, or (C) required to be withheld, deemed equal to the amount that would be payable if the taxable year ended with and included the Closing Date and

 

(ii) in the case of other Taxes, deemed to be the amount of such Taxes for the entire period multiplied by a fraction the numerator of which is the number of days in the period ending on and including the Closing Date and the denominator of which is the number of days in the entire period.

 

(d) Tax Proceedings. Endexx shall promptly notify the Seller in writing upon receipt by Endexx or any of its Affiliates (including, following the Closing, and for the avoidance of doubt, the Acquisition Sub) of any written communication from a Governmental Authority concerning any pending or threatened audit, claim, demand or administrative or judicial proceeding relating to Tax matters of Hyla for any Pre-Closing Tax Periods in respect of which an indemnity may be sought by Endexx pursuant to Article 9 (a “Tax Claim”) describing such Tax Claim in reasonable detail; provided, that failure to comply with this provision shall not affect Endexx’s right to indemnification hereunder, except and only to the extent that the Seller forfeit rights or defenses or is otherwise materially prejudiced by reason of such failure. Endexx shall control the contest or resolution of any Tax Claim; provided, however, that Endexx shall obtain the prior written consent of the Seller (which consent shall not be unreasonably withheld, delayed, denied, or conditioned) before entering into any settlement of a Tax Claim or ceasing to defend a Tax Claim. The Seller shall be entitled to participate, at their sole cost, in the defense of a Tax Claim and to employ counsel of their choice for such purpose, the fees and expenses of which separate counsel shall be borne solely by the Seller.

 

(e) Post-Closing Actions Relating to Taxes. Except as required by applicable Law or otherwise provided in this Section 6.6, Endexx shall not, and shall not permit any of its Affiliates (including, after the Closing, for the avoidance of doubt, the Acquisition Sub) to, without the prior written consent of the Seller (which consent shall not be unreasonably withheld, delayed, denied, or conditioned), (i) amend, refile or otherwise modify (or grant an extension of any statute of limitations with respect to) any Tax Return of Hyla for any Pre-Closing Tax Periods, (ii) voluntarily approach any Governmental Authority regarding any Tax matters of Hyla for any Pre-Closing Tax Period the result of which would reasonably be expected to have a material adverse effect on the Taxes of Hyla for any Pre-Closing Tax Period, (iii) take any action after the Closing that is outside the Ordinary Course of Business that would reasonably be expected to have material adverse effect on the Taxes of Hyla for any Pre-Closing Tax Period, or (iv) make or amend any Tax election with respect to Hyla with retroactive effect for a Pre-Closing Tax Period.

 

Endexx Control Acquisition Agreement (Hyla).3
33

 

 

(f) Cooperation on Tax Matters. Each party shall cooperate fully, as and to the extent reasonably requested by any other party, in connection with the preparation and filing of any Tax Return and any Action with respect to Taxes. Such cooperation shall include the retention and, upon request, the provision of records and information that are reasonably relevant to any such Tax Return or Action or any Tax planning and shall also include making employees available on a mutually convenient basis to provide additional information and explanation of any material provided hereunder. Each party further agrees, upon request, to use its commercially reasonable efforts to obtain any certificate or other document from any Governmental Authority or any other Person as may be necessary to mitigate, reduce or eliminate any Tax that could be imposed (including any Transfer Taxes).

 

(g) Conflicts. To the extent that any provision of Article 9 conflicts with any provision of this Section 6.6, the provisions of this Section 6.6 shall govern.

 

Section 6.7 Supplements to Disclosure Schedules. During the period from the date of this Agreement to the earlier of the Closing Date and the termination of this Agreement in accordance with Article 10, Hyla shall have the right to supplement or amend the applicable section(s) of the Disclosure Schedules with respect to any matter first arising after the date hereof that, if existing or occurring as of the date of this Agreement, would have been required to be set forth or described in such section(s) of the Disclosure Schedules (each, a “Schedule Supplement”). Any disclosure in any such Schedule Supplement shall not be deemed to have cured any inaccuracy in or breach of any representation or warranty contained in this Agreement, including for purposes of the indemnification or termination rights contained in this Agreement or of determining whether or not the conditions set forth in Article 7 have been satisfied, and if such matter results in a material inaccuracy or breach of any representation or warranty of Hyla contained in this Agreement, as reasonably determined by Endexx in good faith, then Endexx shall have the right to terminate this Agreement within five (5) Business Days of its receipt of such Schedule Supplement, by written notice to Hyla.

 

Endexx Control Acquisition Agreement (Hyla).3
34

 

 

Section 6.8 Financing; Financial Statements.

 

(a) The Financing (as that term is defined hereinbelow) shall consist of the sale by Endexx of one or more of its debentures, convertible into shares of Endexx Common Stock, and one or more warrants for the purchase of shares of Endexx Common Stock. The net proceeds to Endexx shall be approximately two million dollars ($2 million), of which approximately one and one-half million dollars ($1.5 million) shall be directed through the Acquisition Sub to Hyla for the purchase of additional inventory, working capital, marketing, and standard corporate purposes in connection with operating the business of Hyla and the remaining funds shall remain at Endexx for standard corporate purposes in connection with, inter alia, the costs associated with Endexx public filings under the Exchange Act. During the period from the date of this Agreement to the earlier of the Closing Date and the termination of this Agreement in accordance with Article 10, the Seller and Hyla shall use their commercially reasonable efforts to provide, and will use commercially reasonable efforts to cause their Representatives to provide, such cooperation (provided that such requested cooperation does not unreasonably interfere with the ongoing operations of Hyla) reasonably requested by Endexx in connection with the contemplated financing for the transactions contemplated by this Agreement (the “Financing”), including using commercially reasonable efforts to (a) facilitate the pledging of collateral and granting of security interests in connection with the Financing (subject to the occurrence of the Closing), (b) provide the documentation and other information about Hyla as is reasonably requested in connection with the Financing, (c) cause the taking of corporate actions (subject to the occurrence of the Closing) by Hyla reasonably necessary to permit the completion of the Financing, and (d) execute and deliver at the Closing definitive documents (if required in connection with the Financing), in form and substance reasonably acceptable to the Seller, related to the Financing; provided that Hyla shall not be required to incur any liability in connection with the Financing prior to the Closing.

 

(b) Following the Closing, the Seller, on a timely basis and at Seller’s sole cost and expense, shall provide such cooperation and assistance as Endexx may reasonably request in connection with the preparation of financial statements for Hyla for its 2021 fiscal year, the three- and six-months ended June 30, 2022 and 2021, and any fiscal period from and after July 1, 2022, which would include any (i) quarterly financial statements that may be subject to review by Endexx’s PCAOB registered public accounting firm and (ii) pro forma financial statements relating to the Closing, all as required by the Exchange Act, the rules and regulations of the Securities and Exchange Commission, or any rule or regulation of any securities exchange upon which the securities of Endexx are listed, quoted, or traded, which cooperation and assistance shall include access to, and compiling and organization of, the financial, accounting, and other information and records reasonably requested by Endexx in connection with the preparation of such financial statements (including copies of the books and records of Hyla).

 

Section 6.9 Endexx’s Transaction Expenses; Seller’s and Hyla’s Transaction Expenses. Endexx shall bear and be fully responsible for Endexx’s Transaction Expenses, whether or not the transactions contemplated by this Agreement shall close. The Seller shall bear and be fully responsible for the Seller’s and Hyla’s Transaction Expenses, whether or not the transactions contemplated by this Agreement shall close.

 

Section 6.10 Seller’s Contributions. Prior to the Closing, Seller shall contribute to Hyla all of Seller’s intellectual property, contracts, and all other items related to the conduct of its business other than its ownership of the capital stock of Hyla.

 

Section 6.11 Conduct of Business of Hyla and its Affiliates, Post-Closing. Endexx and EH Sub agree that the current management and officers of Hyla shall continue in their respective roles following the Closing. Endexx and EH Sub further agree that, until the Self-financing Note has been satisfied in full or otherwise retired, the Board of Directors of Hyla shall continue to be appointed by Seller.

 

Endexx Control Acquisition Agreement (Hyla).3
35

 

 

Section 6.12 Covenants Against Competition and Solicitation by Seller’s Equity Holders. Each of the Seller’s equity holders understands and agrees that for Endexx a material term and condition of the transactions contemplated hereby is the acknowledgement and agreement by each equity holder of the Seller of their respective covenants against competition and solicitation as set forth on Exhibit Cov, the form of which each such equity holder shall execute in connection with the Closing.

 

ARTICLE 7

 

CONDITIONS TO OBLIGATIONS OF ENDEXX AND ACQUISITION SUB

 

The obligations of Endexx and Acquisition Sub under this Agreement to effect the Closing shall be subject to the satisfaction, at or prior to the Closing, of all of the following conditions, any one or more of which may be waived by Endexx:

 

Section 7.1 Representations and Warranties Accurate. On and as of the date hereof and on and as of the Closing Date as though made on and as of the Closing Date (except for such representations and warranties expressly stated to relate to an earlier date, in which case, as of such earlier date), each of (a) the representations and warranties set forth in Section 4.1 (Organization and Power), Section 4.2 (Authority; Binding Obligation; Board Approval), Section 4.4 (Capitalization), and Section 4.17 (Brokers) shall be true and correct in all respects, and (b) the representations and warranties contained in Article 4 (other than those contained in the Sections listed in clause (a) of this Section 7.1) shall be true and correct in all material respects; provided, that clause (b) shall be deemed satisfied unless the failure of such representations and warranties to be so true and correct, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect.

 

Section 7.2 Performance. The Seller and Hyla shall have performed and complied in all material respects with all agreements and covenants required by this Agreement prior to or on the Closing Date.

 

Section 7.3 No Legal Prohibition or Action. On the Closing Date, there shall exist no (a) Order issued by any Governmental Authority or court of competent jurisdiction that prohibits the consummation of the transactions contemplated under this Agreement or the Transaction Documents or (b) pending Action against Endexx, Acquisition Sub, or Hyla that attempts to enjoin the consummation of the transactions contemplated under this Agreement or the Transaction Documents.

 

Section 7.4 Consents. All approvals, consents and waivers that are listed on Section 7.4 of the Disclosure Schedules shall have been received, and executed counterparts thereof shall have been delivered to Endexx at or prior to the Closing.

 

Section 7.5 Financing Shall Have Closed. The Financing shall have closed on terms acceptable to Endexx.

 

Section 7.6 Closing Deliveries. Hyla shall have delivered each of the deliverables set forth in Section 3.2(a).

 

Endexx Control Acquisition Agreement (Hyla).3
36

 

 

Section 7.7 Frustration of Closing Conditions. Endexx may not rely on the failure of any condition set forth in this Article 7 to be satisfied if such failure was materially contributed to by the failure of Endexx or Acquisition Sub to use commercially reasonable efforts to cause the Closing to occur, as required by and subject to Section 6.3.

 

ARTICLE 8

 

CONDITIONS TO OBLIGATIONS OF THE SELLER AND HYLA

 

The obligation of Hyla to effect the Closing shall be subject to the satisfaction, at or prior to the Closing, of all of the following conditions, any one or more of which may be waived by Hyla:

 

Section 8.1 Representations and Warranties Accurate. The representations and warranties of Endexx and Acquisition Sub contained in Article 5 (without giving effect to any materiality qualification therein) shall be true and correct in all respects on and as of the date hereof and on and as of the Closing Date as though made on and as of the Closing Date (except for representations and warranties expressly stated to relate to a specific date, in which case such representations and warranties shall be true and correct in all material respects on such earlier date), except for any failure or failures of such representations and warranties to be true and correct that do not, individually or in the aggregate, have a material adverse effect on the ability of Endexx to perform its obligations under this Agreement or consummate the transactions contemplated hereby on a timely basis.

 

Section 8.2 Performance. Endexx and Acquisition Sub shall have performed and complied in all material respects with all agreements and covenants required by this Agreement or Endexx Documents to be performed and complied with by them prior to or on the Closing Date.

 

Section 8.3 Legal Prohibition. On the Closing Date, there shall exist no (a) Order issued by any Governmental Authority or court of competent jurisdiction that prohibits the consummation of the transactions contemplated under this Agreement or the Transaction Documents or (b) pending Action against Endexx, Acquisition Sub or Hyla that attempts to enjoin the consummation of the transactions contemplated under this Agreement or the Transaction Documents.

 

Section 8.4 Closing Deliveries. Endexx shall have delivered each of the closing deliverables set forth in Section 3.2(b).

 

Section 8.5 Frustration of Closing Conditions. Hyla may not rely on the failure of any condition set forth in this Article 8 to be satisfied if such failure was materially contributed to by the failure of Hyla to use commercially reasonable efforts to cause the Closing to occur, as required by and subject to Section 6.4.

 

Endexx Control Acquisition Agreement (Hyla).3
37

 

 

ARTICLE 9

 

indemnificATION

 

Section 9.1 Survival. Subject to the other provisions of this Article 9, (a) the representations and warranties contained herein and claims for indemnification under Section 9.2(c) shall survive the Closing and shall remain in full force and effect until August 31, 2024; provided, that (i) the representations and warranties in Section 4.1 (Organization and Power), Section 4.2 (Authority; Binding Obligation; Board Approval), Section 4.4 (Capitalization), Section 4.17 (Brokers), Section 5.1 (Organization), Section 5.2 (Authority; Binding Obligation) and Section 5.7 (Brokers) shall survive for a period of six (6) years, and (ii) the representations and warranties in Section 4.12 (Taxes) shall survive for the full period of the applicable statute of limitations (giving effect to any waiver, mitigation or extension thereof) plus 60 days; (b) the covenants and agreements of the parties contained in this Agreement that are to be performed in their entirety prior to the Closing shall survive the Closing until the date that is twelve (12) months after the Closing Date; (c) the covenants and agreements of the parties contained in this Agreement that are to be performed in whole or in part after the Closing shall survive the Closing in accordance with their respective terms; and (d) claims for indemnification under Section 9.2(e) and Section 9.2(f) shall survive indefinitely. Notwithstanding the foregoing, any claims asserted in good faith with reasonable specificity (to the extent known at such time) and in writing by notice from the Indemnified Party to the Indemnifying Party prior to the expiration date of the applicable survival period set forth above shall not thereafter be barred by the expiration of the relevant survival period and such claims shall survive until finally resolved.

 

Section 9.2 Indemnification by the Seller and Hyla. Subject to the other terms and conditions of this Article 9, the Seller and Hyla, jointly and severally, shall indemnify and defend each of Endexx, Acquisition Sub, and their Affiliates and their respective Representatives (collectively, the “Endexx Indemnitees”) against, and shall hold each of them harmless from and against, and shall pay and reimburse each of them for, any and all Losses incurred or sustained by, or imposed upon, Endexx Indemnitees arising out of:

 

(a) any inaccuracy in or breach of any of the representations or warranties of the Seller or Hyla contained in this Agreement or the Transaction Documents;

 

(b) any breach or non-fulfillment of any covenant, agreement, or obligation to be performed by the Seller or Hyla pursuant to this Agreement or the Transaction Documents; or

 

(c) any and all Indemnified Taxes.

 

Section 9.3 Indemnification by Endexx and Acquisition Sub. Subject to the other terms and conditions of this Article 9, Endexx and Acquisition Sub shall, jointly and severally, indemnify and defend each of the Seller and their Affiliates and their respective Representatives (collectively, the “Seller Indemnitees”) against, and shall hold each of them harmless from and against, and shall pay and reimburse each of them for, any and all Losses incurred or sustained by, or imposed upon, the Seller Indemnitees arising out of:

 

(a) any inaccuracy in or breach of any of the representations or warranties of Endexx and Acquisition Sub contained in this Agreement or the Transaction Documents; or

 

Endexx Control Acquisition Agreement (Hyla).3
38

 

 

(b) any breach or non-fulfillment of any covenant, agreement, or obligation to be performed by Endexx or Acquisition Sub pursuant to this Agreement or the Transaction Documents.

 

Section 9.4 Indemnification Procedures. The Person making a claim under this Article 9 is referred to as the “Indemnified Party”, and the Person against whom such claims are asserted under this Article 9 is referred to as the “Indemnifying Party”. For purposes of this Article 9, (i) if Endexx (or any other Endexx Indemnitee) is the Indemnified Party, any references to Indemnifying Party (except provisions relating to an obligation to make payments) shall be deemed to refer to Endexx and (ii) if Endexx is the Indemnifying Party, any references to the Indemnified Party shall be deemed to refer to the Seller.

 

(a) Third-party Claims. If any Indemnified Party receives notice of the assertion or commencement of any Action made or brought by any Person who is not a party to this Agreement or an Affiliate of a party to this Agreement or a Representative of the foregoing (a “Third-party Claim”) against such Indemnified Party with respect to which the Indemnifying Party is obligated to provide indemnification under this Agreement, the Indemnified Party shall give the Indemnifying Party reasonably prompt written notice thereof, but in any event not later than 30 calendar days after receipt of such notice of such Third-party Claim. The failure to give such prompt written notice shall not, however, relieve the Indemnifying Party of its indemnification obligations, except and only to the extent that the Indemnifying Party forfeits rights or defenses by reason of such failure or is otherwise materially prejudiced by such delay. Such notice by the Indemnified Party shall describe the Third-party Claim in reasonable detail, shall include copies of all material written evidence thereof and shall indicate the estimated amount, if reasonably practicable, of the Loss that has been or may be sustained by the Indemnified Party. The Indemnified Party shall have the right to direct and control the defense of any Third-party Claim with counsel selected by it and reasonably acceptable to the Seller. The Indemnifying Party shall have the right to participate in the defense of any Third-party Claim at the Indemnifying Party’s expense and by the Indemnifying Party’s own counsel, and the Indemnified Party shall cooperate in good faith in such defense. The Seller and Endexx shall cooperate with each other in all reasonable respects in connection with the defense of any Third-party Claim.

 

(b) Settlement of Third-party Claims. The Indemnified Party shall not agree to any settlement of any Third-party Claim without the written consent of the Indemnifying Party (which consent shall not be unreasonably withheld, delayed, denied, or conditioned).

 

(c) Direct Claims. Any Action by an Indemnified Party on account of a Loss that does not result from a Third-party Claim (a “Direct Claim”) shall be asserted by the Indemnified Party giving the Indemnifying Party reasonably prompt written notice thereof, but in any event not later than 30 days after the Indemnified Party becomes aware of such Direct Claim. The failure to give such prompt written notice shall not, however, relieve the Indemnifying Party of its indemnification obligations, except and only to the extent that the Indemnifying Party forfeits rights or defenses by reason of such failure or is otherwise materially prejudiced by such delay. Such notice by the Indemnified Party shall describe the Direct Claim in reasonable detail, shall include copies of all material written evidence thereof and shall indicate the estimated amount, if reasonably practicable, of the Loss that has been or may be sustained by the Indemnified Party. The Indemnifying Party shall have 30 days after its receipt of such notice to respond in writing to such Direct Claim. The Indemnified Party shall allow the Indemnifying Party and its professional advisors to investigate the matter or circumstance alleged to give rise to the Direct Claim, and whether and to what extent any amount is payable in respect of the Direct Claim and the Indemnified Party shall assist the Indemnifying Party’s investigation by giving such information and assistance as the Indemnifying Party or any of its professional advisors may reasonably request. If the Indemnifying Party does not so respond within such 30-day period, the Indemnifying Party shall be deemed to have rejected such claim, in which case the Indemnified Party shall be free to pursue such remedies as may be available to the Indemnified Party on the terms and subject to the provisions of this Agreement.

 

Endexx Control Acquisition Agreement (Hyla).3
39

 

 

(d) Disputes. Nothing in this Section 9.4 shall prohibit an Indemnifying Party from disputing its indemnification, defense and hold harmless obligations with respect to any Third-party Claim or Direct Claim, and all such disputes shall be governed by Section 11.12 hereof.

 

Section 9.5 Payments. Once a Loss is agreed to by the Indemnifying Party or finally adjudicated to be payable pursuant to this Article 9, in the case of a Loss for a claim made by (a) an Endexx Indemnitee, any Loss may be satisfied from the Seller or Hyla, jointly and severally or (b) a Seller Indemnitee, any Loss may be satisfied from Endexx or Acquisition Sub, jointly and severally.

 

Section 9.6 Tax Treatment of Indemnification Payments. All indemnification payments made under this Agreement shall be treated by the parties as an adjustment to the Acquisition Consideration for Tax purposes, unless otherwise required by Law.

 

Section 9.7 Exclusive Remedies. Except as provided in Section 11.14, each party acknowledges and agrees that, following the Closing, its sole and exclusive remedy with respect to any and all claims relating to the subject matter of this Agreement and the transactions contemplated hereby shall be pursuant to the indemnification provisions set forth in this Article 9, the post-Closing adjustment provisions set forth in Section 3.3 or the Tax payment and dispute provisions set forth in Section 6.9, as applicable. In furtherance of the foregoing, but without limiting or otherwise affecting in any respect the rights of indemnification expressly provided for under this Article 9, the post-Closing adjustment provisions set forth in Section 3.3 or the Tax payment and dispute provisions set forth in Section 6.9, as applicable, each party hereby waives, to the fullest extent permitted under Law and except as provided in Section 11.14, any and all rights, claims and causes of action for any breach of any representation, warranty, covenant, agreement or obligation set forth herein or otherwise relating to the subject matter of this Agreement it may have against the other parties hereto and their Affiliates and each of their respective Representatives arising under or based upon any Law and following the Closing. Notwithstanding anything to the contrary in this Article 9 or elsewhere in this Agreement, nothing in this Article 9 or elsewhere in this Agreement shall limit any Person’s right to seek and obtain any equitable relief to which any Person shall be entitled or to seek and obtain any remedy for actual fraud. For the avoidance of doubt and without liming the generality of the preceding sentence, none of the limitations set forth in Section 9.4, Section 9.6, this Section 9.8 or elsewhere in this Agreement (including in Section 11.3) shall apply to any claim or remedy for actual fraud.

 

Endexx Control Acquisition Agreement (Hyla).3
40

 

 

Section 9.8 No Circular Recovery. Notwithstanding anything to the contrary in this Agreement, the Seller hereby agree that they will not make any claim for indemnification against any Endexx Indemnitor by reason of the fact that any Seller was a controlling person, director, employee, or representative of Hyla or any of its Affiliates or was serving as such for another Person at the request of Hyla or any of its Affiliates (whether such claim is for Losses of any kind or otherwise) with respect to any claim brought by an Endexx Indemnitee against the Seller under this Agreement.

 

ARTICLE 10

 

TERMINATION

 

Section 10.1 Termination. This Agreement may be terminated prior to the Closing as follows:

 

(a) by the mutual consent of Endexx and the Seller;

 

(b) at the election of Endexx or the Seller if the Closing Date shall not have occurred on or before September 30, 2022 (such date, the “Termination Date”); provided, however, that the right to terminate this Agreement under this Section 10.1(b) shall not be available to any party whose breach of this Agreement has materially contributed to, or resulted in, the failure to consummate the transactions contemplated hereby by the Termination Date;

 

(c) by Endexx if the Seller or Hyla shall have breached or failed to perform any of their representations, warranties, covenants, or agreements set forth in this Agreement, or if any representation or warranty of the Seller or Hyla shall have become untrue, which breach or failure to perform or to be true, either individually or in the aggregate, if occurring or continuing at the Closing, (i) would result in the failure of any of the conditions set forth in Section 7.1 or 7.2 and (ii) cannot be or has not been cured or waived by Endexx by the earlier of (A) one (1) Business Day prior to the Termination Date and (B) ten (10) Business Days after the giving of written notice to the Seller or Hyla of such breach or failure; provided, that Endexx shall not have the right to terminate this Agreement pursuant to this Section 10.1(c) if Endexx is then in breach of any of its covenants or agreements set forth in this Agreement, which breach would result in the failure of any of the conditions set forth in Section 8.1 or 8.2;

 

(d) by the Seller if Endexx or Acquisition Sub shall have breached or failed to perform any of its representations, warranties, covenants or agreements set forth in this Agreement, or if any representation or warranty of Endexx or Acquisition Sub shall have become untrue, which breach or failure to perform or to be true, either individually or in the aggregate, if occurring or continuing at the Closing, (i) would result in the failure of any of the conditions set forth in Section 8.1 or 8.2 and (ii) cannot be or has not been cured or waived by the Seller by the earlier of (A) one (1) Business Day prior to the Termination Date and (B) ten (10) Business Days after the giving of written notice to Endexx of such breach or failure; provided, that the Seller shall not have the right to terminate this Agreement pursuant to this Section 10.1(d) if the Seller or Hyla are then in breach of any of their respective covenants or agreements set forth in this Agreement, which breach would result in the failure of any of the conditions set forth in Section 7.1 or 7.2; or

 

Endexx Control Acquisition Agreement (Hyla).3
41

 

 

(e) there shall be any Law that makes consummation of the transactions contemplated by this Agreement illegal or otherwise prohibited or, subject to Section 6.4, if a court of competent jurisdiction or other Governmental Authority shall have issued an Order permanently restraining, enjoining, or otherwise prohibiting the transactions contemplated under this Agreement or the Transaction Documents and such Order shall have become final and non-appealable.

 

The party desiring to terminate this Agreement pursuant to this Section 10.1 (other than Section 10.1(a)) shall give written notice of such termination to the other party.

 

Section 10.2 Effect of Termination. If this Agreement is terminated in accordance with Section 10.1, this Agreement shall become void and of no further force and effect and none of the parties hereto shall have any liability in respect of a termination of this Agreement; provided, however, that no party hereto shall be relieved from liability or damages (which the parties acknowledge and agree shall not be limited to reimbursement of expenses or out-of-pocket costs) for (a) any breach of any of its representations, covenants, or agreements contained in this Agreement prior to termination or (b) a failure of any party to consummate the transactions contemplated by this Agreement on the date the Closing should have occurred pursuant to Section 3.1 herein; and provided, further, that the provisions of Section 6.2(b) (Confidentiality), 10.2 (Effect of Termination), 11.11 (Governing Law), 11.12 (Exclusive Jurisdiction; Consent to Service of Process; Attorneys’ Fees) and 11.13 (Waiver of Jury Trial), and the Confidentiality Agreement shall each survive the termination of this Agreement.

 

ARTICLE 11

 

MISCELLANEOUS

 

Section 11.1 Expenses. Except as otherwise expressly provided herein, all costs and expenses, including fees and disbursements of counsel, financial advisors, and accountants, incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses, whether or not the Closing shall have occurred.

 

Section 11.2 Amendment. This Agreement may not be amended except by an instrument in writing signed on behalf of Endexx, Acquisition Sub, Hyla, and the Seller.

 

Section 11.3 Entire Agreement. This Agreement, including the Disclosure Schedules and Exhibits attached hereto and which are deemed for all purposes to be part of this Agreement, contains all of the terms, conditions, and representations and warranties agreed upon or made by the parties relating to the subject matter of this Agreement and the business and operations of Hyla and supersedes all prior and contemporaneous agreements, negotiations, correspondence, undertakings, and communications of the parties or their Representatives, oral or written, respecting such subject matter. No representation, warranty, inducement, promise, understanding, or condition not set forth in this Agreement has been made or relied upon by any of the parties. The parties have voluntarily agreed to define their rights, liabilities, and obligations respecting the subject matter hereof exclusively in contract pursuant to the express terms and provisions of this Agreement and the parties expressly disclaim that they are owed any duties or are entitled to any remedies not expressly set forth in this Agreement. Furthermore, the parties each hereby acknowledge that this Agreement embodies the justifiable expectations of sophisticated parties derived from arm’s-length negotiations; the parties specifically acknowledge that no party has any special relationship with another party that would justify any expectation beyond that of ordinary parties in an arm’s-length transaction.

 

Endexx Control Acquisition Agreement (Hyla).3
42

 

 

Section 11.4 Headings. The headings contained in this Agreement are intended solely for convenience and shall not affect the rights of the parties to this Agreement.

 

Section 11.5 Notices. Any notice or other communication required or permitted under this Agreement shall be deemed to have been duly given and made if (a) in writing and served by personal delivery upon the party for whom it is intended, (b) if delivered by facsimile or email with receipt confirmed, or (c) if delivered by courier service, return-receipt received to the party at the address set forth below, with copies sent to the Persons indicated:

 

If to the Seller or to Hyla (prior to the Closing or in respect of post-Closing indemnification issues):

 

Hyla UK Holdco Limited

60 Cannon Street

London EC4N 6NP, England

Attention: Nick Mehdi

Email: nick@hyladistribution.com

 

With a mandatory copy to (which shall not constitute notice):

 

Gallinger Law PC

4252 Atlantic Ave., Suite B

Long Beach, California 90807

Attention: Todd Gallinger

Email: todd@gallingerlaw.com

 

If to Endexx or the Acquisition Sub or to Hyla (subsequent to the Closing but not in respect of post-Closing indemnification issues):

 

Endexx Corporation

38246 North Hazelwood Circle

Cave Creek, Arizona 85331

Attention: Todd Davis, Chief Executive Officer

Email: endexx@endexx.com

 

With a mandatory copy to (which shall not constitute notice):

 

Randolf W. Katz, Esq.

555 South Flower Street, 24th Floor

Los Angeles, California 90071

Email: rkatz@clarkhill.com

 

Such addresses may be changed, from time to time, by means of a notice given in the manner provided in this Section 11.5.

 

Endexx Control Acquisition Agreement (Hyla).3
43

 

 

Section 11.6 Disclosure Schedules. Any matter, information or item disclosed in any section or subsection of the Disclosure Schedules shall be deemed to have been disclosed for the corresponding section or subsection of this Agreement and any other section or subsection of this Agreement, if and only to the extent that it is readily apparent, based on the face of such disclosure, that it applies to such other section or subsection of this Agreement. The inclusion of any matter, information or item in the Disclosure Schedules shall not be deemed to constitute an admission of any liability by the Seller, Hyla, or Endexx, respectively, to any third party or otherwise imply that any such matter, information or item is material or creates a measure for materiality for the purposes of this Agreement.

 

Section 11.7 Waiver. Waiver of any term or condition of this Agreement by any party shall only be effective if in writing and shall not be construed as a waiver of any subsequent breach or failure of the same term or condition, or a waiver of any other term or condition of this Agreement. The failure of any party hereto to assert any of its rights under this Agreement or otherwise shall not constitute a waiver of such rights, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any right, power, or privilege under this Agreement.

 

Section 11.8 Binding Effect; Assignment. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. No party to this Agreement may assign or delegate all or any portion of its rights, obligations, or liabilities under this Agreement without the prior written consent of the other parties to this Agreement (which consent shall not be unreasonably withheld, delayed, denied, or conditioned).

 

Section 11.9 No Third-party Beneficiary. Nothing in this Agreement shall confer any rights, remedies, or claims upon any Person or entity not a party or a permitted assignee of a party to this Agreement, except for (a) Clark Hill PLC as set forth in Section 6.8 or (b) the Indemnified Parties as set forth in Article 9.

 

Section 11.10 Counterparts. This Agreement may be signed in any number of counterparts with the same effect as if the signatures to each counterpart were upon a single instrument, and all such counterparts together shall be deemed an original of this Agreement. Facsimile signatures or signatures received as a pdf attachment to electronic mail shall be treated as original signatures for all purposes of this Agreement.

 

Section 11.11 Governing Law. This Agreement and all claims or causes of action (whether in contract or tort) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance of this Agreement (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Agreement), shall be governed by and construed in accordance with the internal Laws of the State of Nevada, without giving effect to the conflict of laws principles thereof that might require the application of the Laws of another jurisdiction.

 

Endexx Control Acquisition Agreement (Hyla).3
44

 

 

Section 11.12 Exclusive Jurisdiction; Consent to Service of Process; Attorneys’ Fees. All claims, actions, and proceedings (whether in contract or tort) based upon, arising out of or relating to this Agreement or the negotiation, execution, or performance of this Agreement (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Agreement) shall be heard and determined exclusively in the in the Courts of the State of Nevada located in the City of Las Vegas, County of Clark, and the U.S. District Court for the District of Nevada (and, in the case of appeals, appropriate appellate courts therefrom).

 

The parties hereto irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action, or proceeding in connection with this Agreement by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. The consents to jurisdiction set forth in this Section 11.12 shall not constitute general consents to service of process in the State of Nevada and shall have no effect for any purpose except as provided in this Section 11.12 and shall not be deemed to confer rights on any Person other than the parties hereto. The parties hereto agree that a final judgment in any such action or proceeding shall be conclusive and may be enforced in any other jurisdiction by suit on the judgment or in any other manner provided by applicable Law.

 

The prevailing party shall be entitled to recover from the other party its reasonable attorney’s fees and costs.

 

Section 11.13 WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT TO ANY PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT, THE TRANSACTION DOCUMENTS, OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY, WHETHER ARISING IN CONTRACT OR IN TORT OR OTHERWISE. EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HERETO HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY PROCEEDING, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 11.13.

 

Section 11.14 Severability. If any term, provision, agreement, covenant, or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, void, or unenforceable, the remainder of the terms, provisions, agreements, covenants, and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected, impaired, or invalidated so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party hereto. Upon such a determination, the parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a reasonably acceptable manner so that the transactions contemplated hereby may be consummated as originally contemplated to the fullest extent possible.

 

[Remainder of page intentionally left blank]

 

Endexx Control Acquisition Agreement (Hyla).3
45

 

 

IN WITNESS WHEREOF, the parties hereto have executed and delivered this Agreement as of the date first above written.

 

  ENDEXX CORPORATION
   
  By:  
  Name: Todd Davis
  Title: Chief Executive Officer
   
  EH SUB, INC.
   
  By:  
  Name: Todd Davis
  Title: Chief Executive Officer
   
  HYLA UK HOLDCO LIMITED
   
  By:  
  Name: Nick Mehdi
  Title: Chief Executive Officer

 

Signature Page to Control Acquisition Agreement 

 

Endexx Control Acquisition Agreement (Hyla).3

 

 

Exhibit 10.36

 

SELF-FINANCING PROMISSORY NOTE

 

$8,000,000.00 Issue Date: August 31, 2022

 

FOR VALUE RECEIVED, Endexx Corporation, a Nevada corporation with an address of 38246 North Hazelwood Circle Cave Creek, Arizona 85331 (the “Maker”), hereby promises to pay to Hyla UK Holdco Limited, a United Kingdom limited company with an address of 60 Cannon Street, London, EC4N 6NP, England (the “Holder”), or at such other place as the Holder may from time to time designate in writing to the Maker, the principal sum of up to Eight Million and 00/100 Dollars (US$8,000,000.00) (the “Principal”). Principal and interest (as defined in Section 2, below) shall be payable in lawful money of the United States as hereinafter provided.

 

Maker Covenants and Agrees with the Holder as follows:

 

1. The Maker will pay the indebtedness (the “Indebtedness”) evidenced by this Self-financing Promissory Note (the “Note”) as provided herein. This Note or any portion thereof may be prepaid in whole or in part at any time or from time to time without premium or penalty.

 

2. As of the Issue Date and based upon certain representations made to the Maker by the Holder in connection with the transactions pursuant to which this Note is being sold and issued, the Maker expects that the Principal shall be paid to the Holder in full during a period known as “Mid-term.”1 Accordingly, interest on the unpaid Principal (the “Interest”) shall accrue on the unpaid Principal at the Applicable Federal Rate as of the Issue Date: three and 15/100ths percent (3.15%) per annum, compounded annually. Absent the occurrence and continuation of an Event of Default (as that term is defined in Section 4, below) hereinafter defined), the Maker shall tender to the Holder a payment of Principal and Interest accrued thereon (each, a “Payment”) on a calendar quarterly basis, in arrears, commencing on the fifteenth (15th) calendar day of the month following the end of each relevant calendar quarter (i.e., March 31, June 30, September 30, and December 31). By way of example, the Maker shall tender a Payment to the Holder on October 15, 2022, in respect of the calendar quarter ended on September 30, 2022. The amount of each Payment shall be paid in cash in amounts to be calculated in accordance with the formula, the static version of which is attached hereto as Attachment “Section 2”, and the dynamic version of which has been provided by the Maker to the Holder, which payments are related to the quarterly gross revenues and cost of goods sold (gross profit margin) generated by the operations of Hyla US Holdco Limited (“Hyla”) during such calendar quarter. At the option of the Seller, each of the Payments may be made in whole or in part in cash or through the sale and issuance of restricted shares of common stock (the “Payment Stock”) of the Maker. The shares of Payment Stock shall be issued at the volume-weighted average price (“VWAP”) of the shares of Endexx’s common stock as of the last business day of the relevant calendar quarter. If the Holder want the Payment to be made in shares of Payment Stock, then, not later than the tenth (10th) calendar day of the month following the end of the relevant calendar, the Holder shall send a written notice therefor (the “Payment Stock Issuance Notice”) to the Maker. Notwithstanding anything to the contrary contained herein, no shares of Payment Stock shall be issued in excess of the Beneficial Ownership Limitation.2 Further, by sending the Payment Stock Issuance Notice to the Maker, the Holder acknowledge that (i) each of the Holder is an “accredited investor”, as that term is defined in Rule 501(a) of Regulation D, as promulgated by the Securities and Exchange Commission, (ii) the issuance of the shares of Payment Stock has not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or qualified under the “blue sky” laws of any state, (iii) the resale of the shares of Payment Stock will not be registered under the Securities Act or qualified under the “blue sky” laws of any state and must be held indefinitely unless an exemption from such registration is available, and (iv) during the 12-month period from and after the sale and issuance of any shares of Payment Stock, any resale thereof shall not be in an amount that exceeds five percent of the daily trading volume of Endexx’s Common Stock during any trading day, as reported by the OTC Markets Group Inc.

 

3. If, as of the Maturity Date, but absent any then-current Event of Default that has not been cured, payment in full of the Indebtedness has not been made by the Maker to the Holders, then, notwithstanding the Payment schedule set forth in this Note, the Holders shall promptly forgive in full any such then-outstanding Indebtedness.

 

 

1The Mid-term is a period that is more than three years and less than nine years for maturity of this Note (the “Maturity Date”), which definition is in accordance with the Internal Revenue Code of 1986, as amended.
2The Beneficial Ownership Limitation shall be 4.99% of the number of shares of common stock of Endexx outstanding immediately after giving effect to the issuance of the shares of Payment Stock.

 

Endexx and Hyla Self financing Note.31
 

 

4. Upon the occurrence and during the continuance of a default upon Maker’s obligations to make Payments of the Principal and Interest of this Note, when and as of the time the same shall become due and payable (an “Event of Default”), any Indebtedness then due and owing to the Holder pursuant to this Note shall bear Interest at the rate of six and 30/100ths percent (6.3%) per annum from and after the date of such Event of Default until the date upon which such Event of Default is cured or the Indebtedness in paid in full, which even occurs first.

 

5. Upon the occurrence and during the continuance of an Event of Default, the Holder shall have the right, upon five (5) days’ written notice to the Maker and without further demand or notice, to pursue the payment and collection of such due and payable amounts. For clarity, upon an Event of Default, or otherwise, the Holder may not accelerate any unpaid Principal balance or accrued and unpaid Interest and any action by the Holder against the Maker for non-payment of any of the Maker’s obligations hereunder shall only include such past-due periodic Payments for Principal and Interest and shall not include any request or demand for payment of Principal or Interest that, as of five (5) days subsequent to the Event of Default, had not yet become due and payable hereunder.

 

6. Notwithstanding any rights that an obligee may have generally against an obligor in connection with the obligee’s exercise of any and all of its rights in respect of an obligor’s breach or default under a promissory obligation to an obligee (whether such rights are available before or after any judgment is obtained by the obligee against the obligor), the Holder specifically waive any and all of such rights and covenants such that, at no time, will the Holder levy against (i) any equity owned by the Maker in Hyla (or any successor entity thereto) or (ii) any direct or indirect assets of Hyla.

 

7. Neither the failure of the Holder to exercise its right to accelerate this Note when such right shall become available, nor any delay or omission on the part of the Holder in exercising any other right hereunder shall operate as a waiver of such right or of any other right hereunder. By accepting payment of any sum payable hereunder after its due date, the Holder shall not waive their rights either to require prompt payment when due of all other sums payable hereunder or to declare an Event of Default hereunder for failure to make prompt payment of such other sums.

 

8. The Maker hereby waives diligence, presentment, protest and demand, notice of protest, dishonor and non-payment of this Note, and any other notice of any other kind (other than such notice as is expressly required by applicable law and with respect to which waiver is prohibited under the terms of this Note) and expressly agrees that, without in any way affecting liability for timely payment of amounts due hereunder, the Holder may extend the Maturity Date or the time for payment of any installment due hereunder.

 

9. Any Interest computation under this Note (or under any other instrument executed in connection with or as security for the payment hereof) shall be at not more than the current maximum legal rate permitted by state law and in the event it should be held that Interest payable under this Note (or under any other instrument executed in connection with or as security for the payment hereof) is in excess of the current maximum permitted by law, the Interest chargeable hereunder (or under any other instrument executed in connection with or as security for the payment hereof) shall be reduced to the current maximum amount permitted by state law. If the Holder shall collect Interest which is in excess of the current maximum amount permitted by law, all such sums deemed to constitute Interest in excess of the current maximum amount permitted by state law shall, at the option of the Holder, be refunded to Maker or credited to the payment of the Principal of this Note.

 

Endexx and Hyla Self financing Note.32
 

 

10. This Note shall be governed by and construed in accordance with the laws of the State of Nevada without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by this Note shall be brought only in the Courts of the State of Nevada located in the City of Las Vegas, County of Clark, and the U.S. District Court for the District of Nevada. The parties to this Note hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. To the maximum amount permitted, each of the Company and the Holder waives trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney’s fees and costs. In the event that any provision of this Note or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of this Note. Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action, or proceeding in connection with this Note by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Note and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

 

11. If any provision of this Note or any application of such provision shall be declared by a court of competent jurisdiction to be invalid or unenforceable, such invalidity or unenforceability shall not affect any other application of such provision or any other provisions hereof which shall, to the fullest extent possible, remain in full force and effect.

 

12. Any notice or demand required or permitted to be made or given hereunder shall be deemed sufficiently made and given by personal service or by the mailing of such notice or demand by certified or registered mail, return receipt requested, addressed, if to Maker, at Maker’s address first above written and, if to the Holder, to the address for Payments hereunder first written above. Any party may change its address by like notice to the other parties.

 

[Signature on following page]

 

Endexx and Hyla Self financing Note.33
 

 

IN WITNESS WHEREOF, Maker has duly executed this Self-financing Promissory Note as of the Issue Date.

 

  ENDEXX CORPORATION
   
  By:  
    Todd Davis, CEO

 

Endexx and Hyla Self financing Note.34

 

 

Exhibit 10.37

 

Intercompany Services Agreement

 

This Intercompany Services Agreement (this “Agreement”) effective as of August 31, 2022 (the “Effective Date”), is entered into by and between HYLA US Holdco Limited, a corporation organized under the laws of the State of Delaware (“HYLA”), and Endexx Corporation, a corporation organized under the laws of the State of Nevada (“ENDEXX”).

 

The above parties shall be individually referred to as a “Party” and collectively as the “Parties”.

 

WHEREAS, HYLA desires that ENDEXX provide to HYLA certain Services (as defined below), as more fully set forth herein in consideration of the fees set forth herein; and

 

WHEREAS, the Parties are interested in determining their rights and obligations with respect to the Services to be rendered by ENDEXX;

 

NOW, THEREFORE, in consideration of the mutual covenants, conditions and premises set forth herein, and for such other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Parties agree as follows:

 

1. Definitions

 

1.1. “Affiliate” means any corporation, firm, partnership, limited liability company or other entity, whether de jure or de facto, that directly or indirectly owns, is owned by, or is under common ownership with a Party to the extent of at least fifty percent (50%) of the equity having the power to vote on or direct the affairs of the entity and any person, firm, partnership, corporation, limited liability company or other entity actually controlled by, controlling, or under common control with a Party; provided, however, that the term “Affiliate” shall not include either Party.

 

1.2. “Confidential Information” has the meaning ascribed to in that certain Non-Disclosure Agreement of even date herewith (the “NDA”) between the Parties, substantially in the form attached hereto as Exhibit B.

 

1.3. “Payment Date” means the due date for payment of the payments.

 

1.4. “Payments” shall have the meaning set forth in Section ‎5.1 of this Agreement.

 

1.5. “Services” means the services described in Exhibit A to this Agreement, as amended from time to time.

 

1.6. “Third Party” or “Third Parties” means any person(s) or entity(ies) other than a Party or an Affiliate.

 

2. Services

 

ENDEXX shall render to HYLA such services as detailed in Exhibit A attached hereto, which may be updated and amended from time to time by the mutual consent of the Parties (collectively, the “Services”).

 

3. Obligations of ENDEXX

 

3.1. Appointment. HYLA hereby appoints ENDEXX as a provider of Services, and ENDEXX hereby accepts such appointment on the terms and conditions of this Agreement.

 

3.2. Facilities and Personnel. ENDEXX hereby represents that it has adequate facilities and personnel to perform its obligations under this Agreement.

 

Endexx-Hyla Intercompany-services-agreement.21
 

 

3.3. Best Interests of HYLA. ENDEXX agrees to act in the best interests of HYLA and at no time to do, cause or permit to be done any act, or publish or bring into the public domain any information that is or may be detrimental to the best interests or business reputation of HYLA.

 

3.4. Use of Affiliates and Third Parties. Nothing herein shall be deemed to restrict ENDEXX from utilizing Affiliates or Third Parties to assist ENDEXX in performing the Services, provided, however, that such Affiliates or Third Parties shall be subject to the same restrictions as are imposed on ENDEXX hereunder; provided; further; that HYLA shall retain the right to monitor the activities of such Affiliates or Third Parties to the extent necessary to protect its reputation.

 

4. Obligations of HYLA

 

4.1. Additional Support. As deemed appropriate by the Parties, HYLA will provide additional support to ENDEXX to facilitate ENDEXX’s performance under this Agreement.

 

4.2. No Limitation. Nothing in this Agreement shall be construed as limiting in any manner HYLA’s direct or indirect marketing, sales support, other support, or distribution activities, including, without limitation, HYLA’s right to appoint distributors, value added resellers or other dealers or agents, during the term of this Agreement or thereafter.

 

5. Payments

 

5.1. Payments for Services. In exchange for performing the Services and all other obligations under the terms of this Agreement, HYLA shall tender payments (the “Payments”) to ENDEXX in accordance with the amounts invoiced by ENDEXX to HYLA on a monthly basis.

 

6. Payment Terms

 

6.1. Payment Terms. Payments and any other amounts payable hereunder shall be paid to ENDEXX no later than the Due Date on the Invoice. In the event ENDEXX is not paid by the Payment Date, the Payments will bear a late fee of 1% per month that ENDEXX is not paid.

 

6.2. Currency and Interest. Payments and any other amounts payable hereunder shall be made in the currency of US Dollars or such other currency as may be agreed by the Parties.

 

7. Independent Contractors

 

Each Party is acting in performance of this Agreement as an independent contractor and shall be solely responsible for the payment of compensation of personnel assigned to perform the Services.

 

8. Quality Control

 

The Services provided by ENDEXX shall be of high professional quality and workmanship. If HYLA notifies ENDEXX that any of the Services provided hereunder falls below the established quality standards, ENDEXX shall, at its expense and as soon as practicable but in any event within 30 days, take such corrective action as is necessary to restore its quality and usage to the required standard.

 

9. Confidential Information

 

The exchange of Confidential Information between the Parties and the treatment of such Confidential Information shall be governed by the terms of the NDA.

 

Endexx-Hyla Intercompany-services-agreement.22
 

 

10. Term and Termination

 

10.1. Unless earlier terminated by HYLA, this Agreement shall continue and remain in effect for a period of 108 months from the Effective Date and shall be automatically renewed thereafter for successive additional 12-month periods, unless either Party shall give the other Party notice of non-renewal not less than 90 days prior to the end of the original term or of any such renewal period.

 

10.2. Termination Upon Notice. Notwithstanding any provision of this Agreement to the contrary, to the extent not prohibited by applicable law, ENDEXX may, in its sole dissolution, which may be exercised for any reason or for no reason whatsoever, terminate this Agreement or any one or more provisions thereof effective as of a date specified by ENDEXX in a written notice given to the HYLA at least 30 days prior to such specified termination date.

 

10.3. No Damages or indemnification for Termination. IN THE EVENT OF TERMINATION OF THIS AGREEMENT FOR ANY REASON, TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW, EACH OF THE PARTIES HEREBY AGREES THAT IT SHALL HAVE NO RIGHTS TO DAMAGES OR INDEMNIFICATION OF ANY NATURE, SPECIFICALLY INCLUDING COMMERCIAL SEVERANCE PAY, WHETHER BY WAY OF LOSS OF FUTURE PROFITS, EXPENDITURES FOR PROMOTION OF PRODUCTS OR OTHER COMMITMENTS IN CONNECTION WITH ITS BUSINESS AND GOODWILL. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW, EACH OF THE PARTIES HEREBY EXPRESSLY WAIVES AND RENOUNCES ANY CLAIM TO COMPENSATION OR INDEMNITIES FOR ANY TERMINATION OF A BUSINESS RELATIONSHIP WHICH MAY EXIST UNDER THE LAWS OF ANY STATE OF THE UNITED STATES, THE STATE OF DELAWARE OR OTHERWISE. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW, EACH OF THE PARTIES SHALL BE DEEMED TO HAVE BEEN COMPENSATED FOR ALL ACTIVITIES AND RISKS UNDERTAKEN HEREUNDER BY THE PAYMENTS PAID OR PAYABLE BY THE OTHER PARTY PURSUANT TO THE PROVISIONS OF SECTIONS 5 AND 6 OF THIS AGREEMENT.

 

11. Limitation of Liability

 

EACH OF THE PARTIES HEREBY AGREES THAT IN NO EVENT SHALL THE OTHER PARTY BE LIABLE UNDER OR IN RELATION TO THIS AGREEMENT OR ARISING OUT OF THE TRANSACTIONS CONTEMPLATED HEREBY TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES (AND WHETHER IN RELATION TO TORT, INCLUDING NEGLIGENCE), BREACH OF CONTRACT, STRICT LIABILITY OR OTHERWISE, OR ANY OTHER LIABILITY FOR ANY OF THE FOLLOWING: (I) LOSS OF PROFITS, REVENUES OR SALES; (II) LOSS OF BARGAIN; (III) LOSS OF OPPORTUNITY; (IV) LOSS OF USE OF ANY SERVICE OR ANY COMPUTER EQUIPMENT; (V) LOSS OF TIME ON THE PART OF MANAGEMENT OR OTHER STAFF; (VI) PROFESSIONAL FEES OR EXPENSES; (VII) BUSINESS INTERRUPTION, RELATED TO THIS AGREEMENT OR THE SERVICES PROVIDED HEREUNDER, (VIII) DAMAGE TO OR LOSS OF DATA; OR (VIII) ANY INDIRECT, SPECIAL, INCIDENTAL, EXEMPLARY, EXTRAORDINARY, PUNITIVE OR CONSEQUENTIAL DAMAGES OF ANY KIND HOWSOEVER.

 

EACH PARTY UNDERSTANDS AND AGREES THAT, WITH RESPECT TO THE SERVICES: (A) NEITHER PARTY WILL BE LIABLE, WHETHER IN CONTRACT, TORT, OR STRICT LIABILITY, TO CUSTOMERS OR SUBSIDIARIES OF THE OTHER PARTY FOR ANY SERVICE NOT DELIVERED, REGARDLESS OF THE REASON FOR NON-DELIVERY; AND (B) NEITHER PARTY WILL BE LIABLE TO CUSTOMERS OR SUBSIDIARIES FOR ACTS OR OMISSIONS OR FOR INFORMATION PROVIDED THROUGH THE SERVICE, OR FOR CAUSES BEYOND THEIR REASONABLE CONTROL.

 

Endexx-Hyla Intercompany-services-agreement.23
 

 

12. Assignment

 

Neither Party may assign or delegate its rights or obligations hereunder, in whole or in part, to any third party without the prior written consent of the other Party in each instance, which consent may not be unreasonably withheld or delayed. Any unauthorized assignment or delegation shall be null and void.

 

13. Governing Law

 

This Agreement shall be governed by and construed in accordance with the laws of the State of Nevada without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by this Agreement shall be brought only in the Courts of the State of Nevada located in the City of Las Vegas, County of Clark, and the U.S. District Court for the District of Nevada. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. To the maximum amount permitted, each of the Company and the Securities Holder waives trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney’s fees and costs. In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of this Agreement. Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action, or proceeding in connection with this Agreement by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

 

14. Notices

 

Any notice required or permitted hereunder shall be given in writing (unless otherwise specified herein) and shall be deemed effectively given on the earliest of (a) the date delivered, if delivered by personal delivery as against written receipt therefor or by confirmed or acknowledged facsimile or e-mail transmission, (b) the tenth calendar day (provided such day is a business day in the country or state of the receiving party or, if it is not, the next such calendar day which is a business day there) after deposit, postage prepaid, in the postal service of the United States by registered or certified mail (or equivalent service), or (c) the fifth calendar day (provided such day is a business day in the country or state of the receiving party or, if it is not, the next such calendar day which is a business day there) after mailing by domestic or international express courier, with delivery costs and fees prepaid, in each case addressed to the Chief Executive Officer of the recipient. Each of the Parties shall separately keep the other Party informed of the current mailing address and other contact information of such officer, which information may be changed from time to time by notice similarly given.

 

15. Miscellaneous

 

15.1. No failure, delay of forbearance of either party in exercising any power or right hereunder shall in any way restrict or diminish such party’s rights and powers under this Agreement, or operate as a waiver of any breach or nonperformance by either party of any terms of conditions hereof.

 

15.2. In the event it shall be determined under any applicable law that a certain provision set forth in this Agreement is invalid or unenforceable, such determination shall not affect the remaining provisions of this Agreement.

 

15.3. The preamble and schedules to this Agreement constitute an integral and indivisible part hereof.

 

Endexx-Hyla Intercompany-services-agreement.24
 

 

15.4. This Agreement constitutes the entire understanding and agreement between the Parties hereto with respect to, and supersedes any and all prior discussions, agreements, and correspondence with regard to, the subject matter hereof, and may not be amended, modified, or supplemented in any respect, except by a subsequent writing executed by both Parties hereto.

 

15.5. This Agreement shall inure to the benefit of and be binding upon each of the Parties and their respective successors and assigns.

 

15.6. All pronouns and any variations thereof refer to the masculine, feminine or neuter, singular or plural, as the context may require.

 

15.7. This Agreement may be signed in one or more counterparts, each of which shall be deemed an original. A facsimile or other electronic transmission of this signed Agreement shall be legal and binding on all Parties hereto.

 

15.8. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this Agreement.

 

IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be executed by their duly authorized representatives effective as of the date first above written.

 

ENDEXX CORPORATION   HYLA US HOLDCO LIMITED
         
By:                   By:  
         
Name:     Name:  
         
Title:     Title:  

 

Endexx-Hyla Intercompany-services-agreement.25
 

 

EXHIBIT A

 

SERVICES

 

Within the framework of the Agreement to which this Exhibit is attached, ENDEXX shall provide HYLA with the following services:

 

  1. Back Office Functions, including, but not limited to, accounting, finance, controlling, human resources, and other related services that pertain to the back office needed to support HYLA;
     
  2. Technology Services, including, but not limited to, project management, CRM, time tracking, and other related technologies to support HYLA’s business;
     
  3. Benefits Management, including, but not limited to, health insurance, dental, vision, 401k, and other benefits that may be offered by ENDEXX to HYLA from time to time;
     
  4. Business Development Services, including, but not limited to, introductions to key retailers, sales strategy, and other business development related efforts provided by the ENDEXX sales team;
     
  5. Marketing services, including, but not limited to, SEO, digital marketing, conference attendance, and other related services;
     
  6. Administrative services including, but not limited to, sales support, project management, client service support, and other related services;
     
  7. Other additional services ENDEXX and HYLA may agree to from time to time, but only if agreed to in writing.

 

Endexx-Hyla Intercompany-services-agreement.26
 

 


EXHIBIT B

 

NON-DISCLOSURE AGREEMENT

 

This Agreement (the “Agreement”) is entered into effective as of August 31, 2022, by and between HYLA US Holdco Limited, a corporation organized under the laws of the State of Delaware (“HYLA”), and Endexx Corporation, a corporation organized under the laws of the State of Nevada (“ENDEXX”) (each a “Party” and collectively, the “Parties”).

 

WHEREAS, Each Party may have access to or receive Confidential Information (as defined below) of the other Party for the following purpose: services provided by ENDEXX to HYLA, all in accordance with that Intercompany Services Agreement signed by and between the Parties (the “Purpose”).

 

NOW, THEREFORE, in consideration of the foregoing, the Parties hereby mutually agree as follows:

 

1.(a) For the purposes of this Agreement, “Confidential Information” shall mean (i) all information in any and all medium that has been disclosed or will be disclosed by or made available by one Party (“Disclosing Party”) to the other Party (“Receiving Party”) or otherwise acquired by the Receiving Party as a result of or in connection with this Agreement or the Parties’ discussions (whether prior to the execution hereof or thereafter), including, without limitation, data, data structure, data format, technology, source code, know-how, inventions, discoveries, designs, processes, techniques, methods, performance characteristics, testing strategies, formulations, models, equipment, algorithms, software programs, documents, plans, specifications, information concerning research and development work, or trade and business secrets. Confidential Information will also include information disclosed by Disclosing Party, which relates to current, planned or proposed products, licensing or sales activities, policies, practices, finances, revenue, pricing, cost or profits, marketing and business plans, forecasts, projections and analyses, financial information, customer information and third party confidential information and (ii) any and all techniques, processes, programs, schematics, unreleased products, technical data, product plans, product designs, marketing plans, research and development activities, customer preferences and data, business opportunities, financial data, and particularly the source code and related unpublished documentation of proprietary computer programs, integrated circuit topography designs, industrial designs and documentation.Disclosing Party shall determine in its sole discretion what information and materials it shall disclose to Receiving Party.

 

(b) For the purposes of this Agreement, Confidential Information shall not include any information which, Receiving Party can document: (i) is already known to the Receiving Party can document at the time of disclosure, (ii) is publicly available at the time of disclosure; (iii) becomes public domain after disclosure through no act of the Receiving Party or any of the its Related Persons (as defined below) in breach of this Agreement; (iv) is disclosed to the Receiving Party by a third party who is not, to the best knowledge of the Receiving Party, in breach of an obligation of confidentiality; or (v) was or is independently developed by the personnel of the Receiving Party without access to or use of the Confidential Information.

 

(c) All Confidential Information of Disclosing Party shall remain the sole property of the Disclosing Party, and that no patent, copyright, trademark or other proprietary or other right or license is granted by this Agreement.

 

2.During the term of this Agreement through the tenth anniversary of the termination date of that certain Intercompany Services Agreement of even date to which HYLA and ENDEXX are parties (the “ISA”), each Party shall hold all Confidential Information in strict confidence and take all steps to safeguard the Confidential Information with reasonable care, including, without limitation, those steps it takes to protect its own confidential information, if any, of a similar nature or which a reasonable party would take to protect its own confidential information of a similar nature.

 

Endexx-Hyla Intercompany-services-agreement.27
 

 

3.Except as otherwise expressly agreed in writing by the Disclosing Party, the Receiving Party shall not (a) use, copy or reproduce the Confidential Information, except for the Purpose; (b) disclose or otherwise provide any Confidential Information to any third party without the prior written consent of Disclosing Party (but in all events any such consented to disclosure shall be made only with a written and signed confidentiality agreement, substantially similar to this Agreement, from the recipient,); (c) alter, reverse engineer, decompile, disassemble or otherwise modify the Confidential Information. Notwithstanding the foregoing, the Receiving Party may disclose such Confidential Information to the extent required or requested by any court of competent jurisdiction or by any government or government agency having jurisdiction over the Receiving Party, but only after giving written notice to Disclosing Party of such request and requirement sufficiently in advance to allow Disclosing Party to determine whether to contest or limit such disclosure and, if so, to take steps to prevent or limit such disclosure.
   
4.The Receiving Party agrees to limit its internal disclosure of Confidential Information only to those of its employees, officers, directors, consultants, and advisors (collectively, “Related Persons”) who need to know such information and who have signed a written agreement with the Receiving Party binding them to terms and conditions substantially similar to those of this Agreement. In any event the Receiving Party shall be fully responsible for any acts and omissions of its Related Persons in breach of this Agreement.
   
5.Upon the expiration or termination of this Agreement or at the earlier written request of Disclosing Party, the Receiving Party shall return to Disclosing Party, retaining only one copy for its legal files in order to be able to identify at any time the Confidential Information protected by secrecy obligations (or, subject to Disclosing Party’s written instructions, destroy and certify such destruction, all Confidential Information in tangible form in its possession, it being agreed, however that the Receiving Party shall not be required to destroy any computer files created during automatic system back up which are subsequently stored securely by the Receiving Party).
   
6.The Confidential Information disclosed under this Agreement is delivered “as is” and Disclosing Party makes no representation of any kind with respect to the accuracy of such Confidential Information or its suitability for any particular use.
   
7.The Receiving Party undertakes that all of the Receiving Party’s employees and other Related Persons shall execute a non-disclosure agreement with assignment of inventions obligations which are same or similar to the provisions of this Agreementor the ISA, as may be relevant.
   
8.This Agreement shall remain in effect from the date hereof until the fifth anniversary of the later of (a) the expiration or termination of the ISA or (b) the last date of disclosure of any Confidential Information. Upon expiration or termination of this Agreement, the Receiving Party shall act in accordance with Section 5 above. The Receiving Party’s obligations with respect to Disclosing Party’s Confidential Information shall survive any expiration or termination of this Agreement.

 

Endexx-Hyla Intercompany-services-agreement.28
 

 

9.This Agreement shall be governed by and construed in accordance with the laws of the State of Nevada without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by this Agreement shall be brought only in the Courts of the State of Nevada located in the City of Las Vegas, County of Clark, and the U.S. District Court for the District of Nevada. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. To the maximum amount permitted, each of the Company and the Securities Holder waives trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney’s fees and costs. In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of this Agreement. Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action, or proceeding in connection with this Agreement by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.
   
10.Since unauthorized disclosure or use of Confidential Information will diminish the value of the proprietary interests that are the subject of this Agreement, if the Receiving Party breaches any of its obligations hereunder, Disclosing Party may be entitled to equitable relief to protect its interest therein, including but not limited to injunctive relief, as well as money damages.
   
11.The relationship of the parties is that of independent contractors. This Agreement does not create an agency, partnership, or similar relationship between the parties. Neither party hereby acquires any rights to use in advertising, publicity, or other marketing activities any name, trade name, trademark, or other designation of the other party. Any such rights may be provided in a separate agreement of the parties, each of which, if any, shall be subject to the provisions of this Agreement.
   
12.The notice provisions of the ISA are incorporated herein by reference as if set forth herein in full.
   
13.In the event of invalidity of any provision of this Agreement, the parties agree that such invalidity shall not affect the validity of the remaining portions of this Agreement, and further agree to substitute for such invalid provision a valid provision, which most closely approximates the intent and economic effect of the invalid provision.
   
14.Neither Party may assign this Agreement without the prior written consent of the other Party.
   
15.Any failure by either Party to enforce strict performance by the other Party of any provision herein shall not constitute a waiver of the right to subsequently enforce such provision or any other provision of this Agreement.
   
16.This Agreement shall inure to the benefit of and be binding upon each of the Parties and their respective successors and assigns, and, to the extent not included in the foregoing, all Related Persons who have been provided with Confidential Information.
   
17.All pronouns and any variations thereof refer to the masculine, feminine or neuter, singular or plural, as the context may require.
   
18.This Agreement may be signed in one or more counterparts, each of which shall be deemed an original. A facsimile or other electronic transmission of this signed Agreement shall be legal and binding on all parties hereto.
   
19.Headings used in this Agreement are provided for convenience only and shall not be used to construe meaning or intent.
   
20.This Agreement is the complete and exclusive statement of the agreement between the Parties, and supersedes all prior written and oral communications and agreements relating to the subject matter hereof. This Agreement may only be modified by a written agreement signed by persons duly authorized to sign agreements on behalf of the Parties.

 

Endexx-Hyla Intercompany-services-agreement.29
 

 

IN WITNESS WHEREOF, each party hereto has executed this Non-Disclosure Agreement by a representative duly authorized as of the date first above written.

 

ENDEXX CORPORATION   HYLA US HOLDCO LIMITED
         
By:                  By:     
         
Name:     Name:  
         
Title:     Title:  

 

Endexx-Hyla Intercompany-services-agreement.210

 

 

 

 

Exhibit 10.38

 

PROMISSORY NOTE

 

$1,500,000.00 August 31, 2022

 

FOR VALUE RECEIVED, Hyla US Holdco Limited, a Delaware corporation, with an address of 1535 West Loop S, Suite 410, Houston, Texas 77027 (the “Maker”), hereby promises to pay to the order of Endexx Corporation, a Nevada corporation (the “Holder”), at 38246 North Hazelwood Circle, Cave Creek, Arizona 85331 or at such other place as the Holder may from time to time designate in writing to the Maker, the principal sum of One Million Five Hundred Thousand and 00/100 Dollars ($1,500,000.00). Principal and interest shall be payable in lawful money of the United States as hereinafter provided.

 

Maker Covenants and Agrees with the Holder as follows:

 

1. The Maker will pay the indebtedness (the “Indebtedness”) evidenced by this Note as provided herein. This Note or any portion thereof may be prepaid in whole or in part at any time or from time to time without premium or penalty.

 

2. Interest shall accrue at the rate of ten percent (10%) per annum. Absent the occurrence and continuation of an Event of Default (as hereinafter defined), interest will be paid monthly on the first day of the month, and principal balance shall be due and payable on or by August 31, 2024 (the “Maturity Date”).

 

3. Upon the occurrence and during the continuance of a default upon Maker’s obligations to make payments of the principal and interest of this Note, when and as of the time the same shall become due and payable (an “Event of Default”), any Indebtedness then due and owing to the Holder pursuant to this Note shall bear interest at the rate of eighteen percent (18.0%) per annum from and after the date of such Event of Default until the date upon which such Event of Default is cured or the Indebtedness in paid in full, which even occurs first.

 

4. Upon the occurrence and during the continuance of an Event of Default, the Holder shall have the right, upon five (5) days’ written notice to the Maker and without further demand or notice, to pursue the payment and collection of such due and payable amounts. For clarity, upon an Event of Default, or otherwise, the Holder may not accelerate any unpaid principal balance or accrued and unpaid interest and any action by the Holder against the Maker for non-payment of any of the Maker’s obligations hereunder shall only include such past-due periodic payments for principal and interest and shall not include any request or demand for payment of principal or interest that, as of five (5) days subsequent to the Event of Default, had not yet become due and payable hereunder.

 

5. Neither the failure of the Holder to exercise its right to accelerate this Note when such right shall become available, nor any delay or omission on the part of the Holder in exercising any other right hereunder shall operate as a waiver of such right or of any other right hereunder. By accepting payment of any sum payable hereunder after its due date, the Holder shall not waive its rights either to require prompt payment when due of all other sums payable hereunder or to declare an Event of Default hereunder for failure to make prompt payment of such other sums.

 

6. The Maker hereby waives diligence, presentment, protest and demand, notice of protest, dishonor and nonpayment of this Note, and any other notice of any other kind (other than such notice as is expressly required by applicable law and with respect to which waiver is prohibited under the terms of this Note) and expressly agrees that, without in any way affecting liability for timely payment of amounts due hereunder, the Holder may extend the Maturity Date or the time for payment of any installment due hereunder.

 

7. Any interest computation under this Note (or under any other instrument executed in connection with or as security for the payment hereof) shall be at not more than the current maximum legal rate permitted by state law and in the event it should be held that interest payable under this Note (or under any other instrument executed in connection with or as security for the payment hereof) is in excess of the current maximum permitted by law, the interest chargeable hereunder (or under any other instrument executed in connection with or as security for the payment hereof) shall be reduced to the current maximum amount permitted by state law. If the Holder shall collect interest which is in excess of the current maximum amount permitted by law, all such sums deemed to constitute interest in excess of the current maximum amount permitted by state law shall, at the option of the Holder, be refunded to Maker or credited to the payment of the principal of this Note.

 

Endexx Promissory Note-HYLA US.fina1
 

 

8. This Note shall be governed by and construed in accordance with the laws of the State of Nevada without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by this Note shall be brought only in the Courts of the State of Nevada located in the City of Las Vegas, County of Clark, and the U.S. District Court for the District of Nevada. The parties to this Note hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. To the maximum amount permitted, each of the Company and the Holder waives trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney’s fees and costs. In the event that any provision of this Note or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of this Note. Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action, or proceeding in connection with this Note by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Note and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

 

9. If any provision of this Note or any application of such provision shall be declared by a court of competent jurisdiction to be invalid or unenforceable, such invalidity or unenforceability shall not affect any other application of such provision or any other provisions hereof which shall, to the fullest extent possible, remain in full force and effect.

 

10. Any notice or demand required or permitted to be made or given hereunder shall be deemed sufficiently made and given by personal service or by the mailing of such notice or demand by certified or registered mail, return receipt requested, addressed, if to Maker, at Maker’s address first above written. Either party may change its address by like notice to the other party.

 

[Signature on following page]

 

Endexx Promissory Note-HYLA US.fina2
 

 

IN WITNESS WHEREOF, Maker has duly executed this Promissory Note as of the date first above written.

 

  HYLA US HOLDCO LIMITED
     
  By:  
    Nick Mehdi, CEO

 

Endexx Promissory Note-HYLA US.fina3

 

 

Exhibit 10.39 

 

CONVERTIBLE NOTE PURCHASE AGREEMENT

 

This Convertible Note Purchase Agreement (this “Agreement”) is dated as of August 31, 2022, by and among M2B Funding Corp., a Florida corporation with offices located at 20801 Biscayne Blvd., Suite 307, Aventura, Florida 33180 (the “Lead Investor”), 3A Capital Establishment, a company registered in Liechtenstein with offices at Austrasse 40 Vaduz N2 9490, Liechtenstein (the “Co-Investor”), and Endexx Corporation, a Nevada corporation with offices located at 38246 North Hazelwood Circle, Cave Creek, Arizona 85331 (“Endexx” or the “Company”).

 

WHEREAS, Endexx is desirous of borrowing the aggregate sum of Two Million Dollars ($2,000,000.00) severally from the Lead Investor and the Co-Investor (the “Investment Amount”);

 

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or Rule 506 promulgated thereunder, Endexx desires to issue and sell severally to each Purchaser (as defined below), and each Purchaser desires severally to purchase from Company, securities of the Company as more fully described in this Agreement;

 

WHEREAS, each Purchaser desires that the Company grant it a Warrant (the “Warrant”) for the purchase of a calculable number of shares of common stock at a calculable price per share on terms and conditions that such Purchaser and the Company are willing to accept.

 

NOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and the Purchaser agree as follows:

 

ARTICLE I.

DEFINITIONS

 

1.1 Definitions. In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Notes (as defined herein), and (b) the following terms have the meanings set forth in this Section 1.1:

 

Acquiring Person” shall have the meaning ascribed to such term in Section 4.6.

 

Action” shall have the meaning ascribed to such term in Section 3.1(j).

 

Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

Board of Directors” means the board of directors of Endexx.

 

Business Day” means any day except any Saturday, any Sunday, any day that is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

 

Closing Date” means the Business Day(s) on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto in connection with the Closing, and all conditions precedent to (i) the Purchasers’ obligations to pay the Subscription Amount as to the Closing and (ii) the Company’s obligations to deliver the Securities as to the Closing, in each case, have been satisfied or waived.

 

1

 

 

Closing” means the closing of the purchase and sale of the Securities pursuant to Section 2.2.

 

Closing Statement” means the Closing Statement provided by Endexx to the Purchasers.

 

Commission” means the United States Securities and Exchange Commission.

 

Common Stock” means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.

 

Company Counsel” means Clark Hill PLC.

 

Disclosure Schedules” shall have the meaning ascribed to such term in Section 3.1.

 

Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

FCPA” means the Foreign Corrupt Practices Act of 1977, as amended.

 

GAAP” shall have the meaning ascribed to such term in Section 3.1(h).

 

Indebtedness” means (x) any liabilities for borrowed money or amounts owed in excess of $100,000.00 (other than trade accounts payable or for services provided incurred in the ordinary course of business and other than the transaction referenced in Section 2.4(b)(iv)) and (y) the present value of any lease payments in excess of 110% of those due under leases required to be capitalized in accordance with GAAP that are extant as of the date of this Agreement.

 

Intellectual Property Rights” shall have the meaning ascribed to such term in Section 3.1(o).

 

Intellectual Property Security Agreement” means that certain intellectual property security agreement of the Company in favor of the Purchasers of even date herewith.

 

Liens” means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right, or other restriction.

 

Material Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).

 

Material Permits” shall have the meaning ascribed to such term in Section 3.1(m).

 

Maximum Rate” shall have the meaning ascribed to such term in Section 5.17.

 

Note(s)” means the 12% Senior Secured Convertible Promissory Note(s) due, subject to the terms therein, twelve (12) months from date of issuance, issued by Endexx to each Purchaser hereunder, in the form of Exhibit A attached hereto.

 

Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

2

 

 

Principal Amount” means, as to each Purchaser, the amounts set forth below such Purchaser’s signature block on the signature pages hereto next to the heading “Principal Amount,” in United States Dollars, which shall equal such Purchaser’s Subscription Amount as to the applicable Closing.

 

Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.

 

Purchaser” means each of the Lead Investor and the Co-Investor, as applicable.

 

Purchasers” means, collectively, the Lead Investor and the Co-Investor.

 

Purchaser Party” shall have the meaning ascribed to such term in Section 4.9.

 

Registration Rights Agreement” means that certain Registration Rights Agreement of the Company in favor of the Purchasers of even date herewith.

 

Required Approvals” shall have the meaning ascribed to such term in Section 3.1(e).

 

Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

Securities” means the Notes and the Warrants.

 

Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

Security Agreement” means that certain security agreement of the Company in favor of the Purchasers of even date herewith.

 

Security Agreements” means the Security Agreement and Intellectual Property Security Agreement.

 

Short Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act.

 

Transaction Documents” means all of the following agreements: this Agreement, the 12% Senior Secured Convertible Promissory Note, the Warrant, the Registration Rights Agreement, the Security Agreement, and the IP Security Agreement.

 

Warrant” means those certain Common Stock Purchase Warrants of the Company granted to each Purchaser of even date herewith.

 

3

 

 

ARTICLE II.

PURCHASE AND SALE

 

2.1 Purchase. The Company shall severally sell to the Lead Investor, and the Lead Investor will purchase from the Company, a Senior Secured Convertible Note in the principal amount of One Million Four Hundred Fifty-one Thousand Eighty-six and 95/100ths Dollars ($1,451,086.95) for a purchase price of One Million Three Hundred Thirty-five Thousand and 95/100ths Dollars ($1,335,000.00). The Company shall sell to the Co-Investor, and the Co-Investor will purchase from the Company, a Senior Secured Convertible Note in the principal amount of Seven Hundred Twenty-two Thousand Eight Hundred and Twenty-six and 09/100ths Dollars ($722,826.09) for a purchase price of Six Hundred Sixty-five Thousand and 09/100ths Dollars ($665,000.00). Each Purchaser shall pay the applicable purchase price to the Company by electronic bank transfer promptly after execution of this Agreement in immediately available funds.

 

2.2 Closing. The Closing of the sale and purchase of the Notes shall occur effective as of the date hereof (the “Closing Date”) and shall take place through the electronic exchange of documents as permitted by applicable law, or at such place and at such time as mutually agreed to by the parties (the “Closing”). At the Closing, upon terms and subject to conditions set forth herein, the Company agrees to sell, and the Purchasers, severally, and not jointly, agree to purchase the aggregate Investment Amount of Notes.

 

2.3 Deliveries. On the Closing Date (except as noted or amended by mutual agreement),

 

(a) Endexx shall deliver or cause to be delivered to each Purchaser the following:

 

(i) this Agreement duly executed by Endexx;

 

(ii) the applicable Note duly executed by Endexx;

 

(iii) the applicable Warrant duly executed by Endexx;

 

(iv) the Registration Rights Agreement duly executed by Endexx;

 

(v) the Security Agreements duly executed by Endexx; and

 

(vi) such other documents, certificates, instruments, and other writings as Purchaser’s counsel may reasonably request.

 

(b) Each Purchaser shall deliver or cause to be delivered to Endexx the following:

 

(i) this Agreement duly counter-executed by each Purchaser;

 

(ii) the Registration Rights Agreement duly counter-executed by each Purchaser;

 

(iii) the Security Agreements duly counter-executed by each Purchaser; and

 

(iv) such other documents, certificates, instruments, and other writings as Endexx’s counsel may reasonably request.

 

2.4 Closing Conditions.

 

(a) The obligations of Endexx hereunder in connection with the Closings are subject to the following conditions being satisfied:

 

(i) the accuracy in all material respects on the Closing Date of the several and not joint representations and warranties of each Purchaser contained herein (unless, as of a specific date therein, in which case they shall be accurate as of such date);

 

4

 

 

(ii) all several and not joint obligations, covenants, and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;

 

(iii) the delivery by each Purchaser of the items set forth in Section 2.3(b) of this Agreement; and

 

(iv) there shall have been no Material Adverse Effects with respect to the Company since the date hereof.

 

(b) The several and not joint obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being satisfied:

 

(i) the accuracy in all material respects on the Closing Date of the representations and warranties of Endexx contained herein (unless, as of a specific date therein, in which case they shall be accurate as of such date);

 

(ii) all obligations, covenants, and agreements of Endexx required to be performed at or prior to the Closing Date shall have been performed;

 

(iii) the delivery by Endexx of the items set forth in Section 2.3(a) of this Agreement;

 

(iv) the transaction pursuant to which Endexx acquires 51% of the capital stock of Hyla US Holdco Limited shall have closed immediately prior to or concurrently with the closing of the transactions contemplated hereby; and

 

(v) there shall have been no Material Adverse Effects with respect to the Company since the date hereof.

 

ARTICLE III.

REPRESENTATIONS AND WARRANTIES

 

3.1 Representations and Warranties of the Company. Except as set forth in the “Disclosure Schedules,” which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to the Purchaser as of the date hereof.

 

(a) Subsidiaries. The Company’s subsidiaries are as set forth on Schedule 3.1(a).

 

(b) Organization and Qualification. Endexx is an entity duly incorporated, validly existing, and in good standing under the laws of Nevada, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. The Company is not in violation or default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. The Company is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document; (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company; or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii), or (iii), a “Material Adverse Effect”) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.

 

5

 

 

(c) Authorization; Enforcement. Endexx has the requisite power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of such Company and no further action is required by such Company, its Board of Directors, stockholders, or members, as applicable, in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by such Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of such Company enforceable against that Company in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally; (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies; and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

(d) No Conflicts. The execution, delivery and performance of Endexx of this Agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not: (i) conflict with or violate any provision of the Company’s certificate or articles of incorporation, bylaws or other organizational or charter documents; (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien (except Liens in favor of the Purchaser) upon any of the properties or assets of the Company, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company debt or otherwise) or other understanding to which such Company is a party or by which any property or asset of the Company is bound or affected; or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.

 

(e) Filings, Consents, and Approvals. Endexx is not required to obtain any consent, waiver, authorization, or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local, or other governmental authority or other Person in connection with the execution, delivery, and performance by the Company of the Transaction Documents.

 

6

 

 

(f) Issuance of the Securities. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid, and non-assessable, free, and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents.

 

(g) Capitalization. The capitalization of Endexx is as set forth on Schedule 3.1(g), which Schedule 3.1(g) also includes the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof. Endexx has not issued any capital stock other than as listed on Schedule 3.1(g), other than pursuant to the exercise of employee stock options, the issuance of shares of Common Stock to employees pursuant to the Company’s employee stock purchase plans, and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of Closing. Other than with regard to Exempt Issuances (as that term is defined in Section 5(c) of the Note), no Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities and securities issued to employees, officers, or directors or former employees, officers, or directors and other service providers or former service providers of the Company, there are no outstanding options, warrants, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire any shares of Common Stock, or contracts, commitments, understandings or arrangements by which the Company is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents. The issuance and sale of the Securities will not obligate any Company to issue shares of Common Stock or other securities to any Person (other than the Purchaser) and will not result in a right of any holder of that Company’s securities to adjust the exercise, conversion, exchange or reset price under any of such securities. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and non-assessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder or other equity holder, as applicable, the Board of Directors or others is required for the issuance and sale of the Securities. Other than as set forth on Schedule 3.1(g), there are no stockholders’ agreements, voting agreements or other similar agreements with respect to the Company’s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company’s stockholders.

 

(h) [Reserved.]

 

(i) Material Changes. (i) there has been no event, occurrence, or development that has had or that could reasonably be expected to result in a Material Adverse Effect; (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company’s financial statements pursuant to GAAP; (iii) the Company has not altered its method of accounting; (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock; and (v) the Company has not issued any equity securities to any officer, director or Affiliate except for the issuance of the Securities contemplated by this Agreement, or the Exempt Issuances. No event, liability, fact, circumstance, occurrence, or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its business, properties, operations, assets, or financial condition that would be required to be disclosed by the Company.

 

7

 

 

(j) Litigation. There is no action, suit, inquiry, notice of violation, proceeding, or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, or any of its respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an “Action”), which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect, and neither the Company, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty.

 

(k) Labor Relations. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company’s employees is a member of a union that relates to such employee’s relationship with the Company, and the Company is not a party to a collective bargaining agreement, and the Company believes that its relationships with its employees are good. To the knowledge of the Company, no executive officer of the Company is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company to any liability with respect to any of the foregoing matters. The Company is in compliance with all U.S. federal, state, local, and foreign laws, and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

(l) Compliance. Except as set forth in Schedule 3.1(l), the Company: (i) is not in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company under), nor has the Company received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is not in violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is not and has not been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.

 

(m) Regulatory Permits. The Company possesses all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses, as applicable or on Schedule 3.1(m), except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (“Material Permits”), and neither the Company has received any notice of proceedings relating to the revocation or modification of any Material Permit.

 

8

 

 

(n) Title to Assets. The Company has good and marketable title in fee simple to all real property owned by it and good and marketable title in all personal property owned by it that is material to the business of the Company, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company are held by it under valid, subsisting, and enforceable leases with which the Company is in compliance.

 

(o) Intellectual Property. The Company has rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights as described on Schedule 3.1(o) as necessary or required for use in connection with their business as presently conducted and which the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual Property Rights”). The Company has not received a notice (written or otherwise) that any of the Intellectual Property Rights has expired, terminated, or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. The Company has not received a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company has taken reasonable security measures to protect the secrecy, confidentiality, and value of all of its intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

(p) Transactions with Affiliates and Employees. Except as set forth in Schedule 3.1(p) and for the Exempt Issuances, none of the officers or directors of the Company and, to the knowledge of the Company, none of the employees of the Company is presently a party to any transaction with the Company (other than for services as employees, officers, and directors), including any contract, agreement or other arrangement, providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for: (i) payment of salary or consulting fees for services rendered; (ii) reimbursement for expenses incurred on behalf of the Company; and (iii) other employee benefits, including stock option or stock award agreements.

 

(q) [Reserved.]

 

(r) Certain Fees. No brokerage or finder’s fees or commissions are or will be payable by the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank, or other Person with respect to the transactions contemplated by the Transaction Documents. Neither Purchaser will have any obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.

 

9

 

 

(s) Private Placement. Assuming the accuracy of each Purchaser’s several and not joint representations and warranties set forth in Section 3.2, no registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchaser as contemplated hereby.

 

(t) Investment Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an “investment company” subject to registration under the Investment Company Act of 1940, as amended.

 

(u) Registration Rights. Other than with regard to the Exempt Issuances, no Person has any right to cause any Company to affect the registration under the Securities Act of any securities of the Company.

 

(v) [Reserved.]

 

(w) [Reserved.]

 

(x) Disclosure. The Company understands and confirms that the Purchasers will rely on the representations herein in effecting transactions in any securities of the Company. All of the disclosures furnished by or on behalf of the Company to the Purchasers regarding the Company, and their business and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, are true and correct and do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. The Company acknowledges and agrees that neither Purchaser has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.

 

(y) No Integrated Offering. Assuming the accuracy of each Purchaser’s representations and warranties set forth in Section 3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of the Securities Act which would require the registration of any such securities under the Securities Act.

 

(z) No General Solicitation. Neither the Company nor any person acting on behalf of the Company has offered or sold any of the Securities by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchaser within the meaning of Rule 501 under the Securities Act.

 

(aa) Foreign Corrupt Practices. The Company has not to its knowledge, nor any agent or other person acting on behalf of the Company: (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity; (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds; (iii) failed to disclose fully any contribution made by the Company (or made by any person acting on its behalf of which the Company is aware) which is in violation of law; or (iv) violated in any material respect any provision of FCPA.

 

10

 

 

(bb) Accountants. The Company’s accounting firm is set forth on Schedule 3.1(bb) of the Disclosure Schedules. To the knowledge and belief of the Company, such accounting firm is registered with the Public Company Accounting Oversight Board.

 

(cc) No Disagreements with Accountants and Lawyers. There are no disagreements of any kind presently existing, or reasonably anticipated by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company.

 

(dd) Acknowledgment Regarding Purchasers’ Several Purchase of Securities. The Company acknowledges and agrees that each Purchaser is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that neither Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental to such Purchaser’s purchase of the Securities. The Company further represents to each Purchaser that the Company’s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.

 

(ee) [Reserved.]

 

(gg) Office of Foreign Assets Control. Neither the Company, and to the Company’s knowledge, no director, officer, agent, employee, or affiliate of the Company is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).

 

(hh) U.S. Real Property Holding Corporation. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon the Purchaser’s request.

 

(ii) Bank Holding Company Act. Neither the Company nor any of Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the “Federal Reserve”). Neither the Company nor any of its Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.

 

11

 

 

(jj) Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company (i) has made or filed all United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company know of no basis for any such claim.

 

(kk) Seniority. No Indebtedness or other claim against the Company is senior to the Notes in right of payment, whether with respect to interest or upon liquidation or dissolution, or otherwise, other than indebtedness secured by purchase money security interests (which is senior only as to underlying assets covered thereby) and capital lease obligations (which is senior only as to the property covered thereby).

 

(ll) [Reserved.]

 

(mm) Money Laundering. The operations of the Company are and have been conducted at all times in compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the “Money Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.

 

(nn) Related Party Transactions. All related party transactions have been consummated in accordance with all applicable laws and governing agreements, including, without limitation, those laws applicable to the diversion of a corporate opportunity of each Company or any of Affiliate of such Company or any Affiliate of any principal of that Company. In each instance, the particular related party transaction has been approved by a majority of the disinterested directors of the Company, after full disclosure has been made to each board member of the pertinent facts of the proposed transaction. Each such related party transaction has been consummated on terms and conditions that are equal or more favorable to the Company than a transaction with an unaffiliated third party knowing all the facts and under no compulsion to consummate such transaction.

 

Each Purchaser severally and not jointly acknowledges and agrees that the representations contained in Section 3.1 shall not modify, amend, or affect the Company’s rights to indemnification or to rely on such Purchaser’s representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated hereby.

 

12

 

 

3.2 Representations and Warranties of the Purchasers. Each Purchaser hereby represents and warrants, severally and not jointly, as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein):

 

(a) Organization; Authority. Purchaser is an entity duly formed, validly existing, and in good standing under the laws of the state and/or country of its formation, with full limited corporate power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by the Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability company, or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by the Purchaser, and when delivered by the Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of the Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally; (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies; and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

(b) Own Account. Purchaser understands that the Securities are “restricted securities” and have not been registered under the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and not with a view to or for distributing or reselling the Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of the Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of the Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser’s right to sell the Securities in compliance with applicable federal and state securities laws). Purchaser is acquiring the Securities hereunder in the ordinary course of its business.

 

(c) Purchaser Status. At the time Purchaser was offered the Securities, it was, and as of the date hereof it is, an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), or (a)(8) under the Securities Act.

 

(d) Experience of Such Purchaser. Purchaser, either alone or together with its representatives, has such knowledge, sophistication, and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.

 

(e) General Solicitation. Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine, or similar media or broadcast over television or radio or presented at any seminar or any other general solicitation or general advertisement.

 

13

 

 

(f) Certain Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, Purchaser has not directly or indirectly, nor has any Person acting on behalf of or pursuant to any understanding with Purchaser, executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated hereunder and ending immediately Upon the repayment in full (whether by cash or conversion) of all of the Notes sold by the Company in connection with this Agreement. Notwithstanding the foregoing, in the case of Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of Purchaser’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of Purchaser’s assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement, Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to the identification of the availability of, or securing of, available shares to borrow in order to effect Short Sales or similar transactions in the future.

 

The Company acknowledges and agrees that the representations contained in Section 3.2 shall not modify, amend, or affect either Purchaser’s rights to indemnification or to rely on the Company’s representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated hereby.

 

ARTICLE IV.

OTHER AGREEMENTS OF THE PARTIES

 

4.1 Transfer Restrictions.

 

(a) The Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities other than pursuant to an effective registration statement or Rule 144, to the Company by Purchaser, or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities Act. The Company shall bear the costs of each such opinion. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and shall have the rights and obligations of a Purchaser under this Agreement.

 

(b) Each Purchaser severally agrees to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following form:

 

THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

14

 

 

The Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an “accredited investor” as defined in Rule 501(a) under the Securities Act and who agrees to be bound by the provisions of this Agreement and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party, or pledgor shall be required in connection therewith. Further, no notice shall be required of such pledge. At the Purchaser’s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities.

 

4.2 Grant of Options.

 

(a) The Company hereby grants to Lead Investor the option to purchase up to Twenty Million (20,000,000) shares of Common Stock (the “Lead Investor’s Option”) at an aggregate purchase price of Two-hundred Thousand Dollars ($200,000.00). The Lead Investor’s Option may be exercised by the Lead Investor in whole or in part at any time or from time to time prior to the one-year anniversary of the date hereof (such period, the “Term”).

 

(b) The Company hereby grants to Co-Investor the option to purchase up to Two Million Five Hundred Thousand (2,500,000) shares of Common Stock (the “Co-Investor’s Option”) at an aggregate purchase price of Twenty-five Thousand Dollars ($25,000.00). The Co-Investor’s Option may be exercised by the Co-Investor in whole or in part at any time or from time to time prior to the expiration of the Term.

 

(c) Any Option may be exercised in whole or in part at any time or from time to time prior to the expiration of the Term; provided that an Option shall not be exercised for any fractional shares. In the event an Option is exercised for a number of shares Common Stock that is less than the aggregate number of shares of Common Stock issuable upon the exercise thereof, the exercise price with respect to such partial exercise shall be equal to the applicable aggregate exercise price as set forth above in Section 4.2(a) and (b), multiplied by a fraction, the numerator of which is the total number of shares of Common Stock as to which the applicable Option is then being exercised and the denominator of which is the total number of shares of Common Stock underlying the applicable Option as set forth above.

 

15

 

 

(d) An Option shall be exercisable by execution and delivery of the exercise notice attached as Annex B hereto, which shall state such Purchaser’s election to exercise its Option and the number of shares of Common Stock in respect of which such Option is being exercised (an “Exercise Notice”). Such Exercise Notice shall be delivered to the Company by any means (including electronic means) reasonably calculated to provide notice of the exercise of the Option by such Purchaser. The Exercise Notice shall be accompanied by payment of the Exercise Price. This Option shall be deemed to be exercised upon receipt by the Company of the Exercise Notice accompanied by the aggregate Exercise Price (or fraction thereof if a partial exercise of the Option as provided above) for the purchased shares of Common Stock.

 

(e) Promptly upon receipt of the Exercise Notice, together with payment of the Exercise Price (or fraction thereof if a partial exercise of such Option as provided above), but in no event more than three (3) calendar days following receipt thereof, the Company shall issue to the applicable Purchaser the shares of Common Stock described in the Exercise Notice, which shares of Common Stock shall be fully paid and non-assessable and delivered to the applicable Purchaser free and clear of any liens, encumbrances, or restrictions on transfer (other than restrictions imposed by applicable federal and state securities laws).

 

(f) The Company shall not affect any exercise on an Option, and a Purchaser shall not have the right to exercise an Option, to the extent that, after giving effect to the exercise of such Option set forth in the applicable Exercise Notice, such Purchaser (together with such Purchaser’s Affiliates, and any Persons acting as a group together with such Purchaser or any of such Purchaser’s Affiliates) would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of this Section 4.2, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent that the limitation contained in this Section 4.2 applies, the determination of whether such Option is exercisable (in relation to other securities owned by such Purchaser together with any Affiliates) shall be in the sole discretion of such Purchaser. The “Beneficial Ownership Limitation” shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of an Option by the applicable Purchaser. A Purchaser, upon not less than sixty-one (61) days’ prior notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 4.2, provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise on an Option by the Purchaser and the Beneficial Ownership Limitation provisions of this Section 4.2 shall continue to apply. Any such increase or decrease will not be effective until the sixty-first (61st) calendar day after such notice is delivered to the Company. The Beneficial Ownership Limitation provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 4.2 to correct this paragraph (or any portion hereof) that may be defective or inconsistent with the intended Beneficial Ownership Limitation contained herein or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of an Option.

 

4.3 Acknowledgment of Dilution. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its obligations under the Transaction Documents, including, without limitation, its obligation to issue the shares of Common Stock underlying the Notes and the Warrants pursuant thereto, are unconditional and absolute and not subject to any right of set off, counterclaim, delay, or reduction, regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect that any such issuance may have on the ownership of the other stockholders of the Company.

 

16

 

 

4.4 Integration. The Company shall not sell, offer for sale, or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the sale of the Securities.

 

4.5 Furnishing of Information; Public Information.

 

(a) Until the later of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired, the Company covenants to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the mandatory reporting requirements of the Exchange Act.

 

(b) At any time during the period commencing from the six (6)-month anniversary of this Agreement and ending at such time that all of the Securities may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes such an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a “Public Information Failure”), then, in addition to such Purchaser’s other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of the Purchaser’s ability to sell the shares of Common Stock underlying the Securities in accordance with the exemption from the registration requirements of the Securities Act as provided by Rule 144, an amount in cash equal to two percent (2.0%) of the aggregate Subscription Amount of any of such Purchaser’s Securities (or the shares of Common Stock underlying such Securities) then owned of record or beneficially by such Purchaser on the day of a Public Information Failure and on every thirtieth (30th) day thereafter (prorated for periods totaling less than thirty (30) days) until the earlier of (y) the date on which such Public Information Failure is cured and (b) such other date on which such public information is no longer required for such Purchaser to transfer those shares of Common Stock pursuant to Rule 144. The payments to which a Purchaser shall be entitled pursuant to this Section 4.3(b) are referred to herein as “Public Information Failure Payments.” Public Information Failure Payments shall be paid on the earlier of (1) the last day of the calendar month during which such Public Information Failure Payments are incurred and (2) the third (3rd) Business Day after the event or failure giving rise to the Public Information Failure Payments is cured. In the event that the Company fails to make Public Information Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit such Purchaser’s right to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief.

 

4.6 Stockholder Rights Plan. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that either Purchaser is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the Company and any Purchaser.

 

17

 

 

4.7 Non-Public Information. Except with respect to the material terms and conditions of the transactions contemplated by this Agreement, which shall be disclosed pursuant to this Agreement, the Company covenants and agrees that neither it, nor any other Person acting on its behalf, will provide either Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes could constitute, material, non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information and agreed with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in any securities of the Company. To the extent that the Company, any of its subsidiaries, or any of their respective officers, directors, agents, employees, or Affiliates delivers any material, non-public information to a Purchaser without such Purchaser’s consent to hold such information in a confidential manner, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its subsidiaries, or any of their respective officers, directors, agents, employees, or Affiliates, or a duty to the Company, any of its subsidiaries, or any of their respective officers, directors, agents, employees, or Affiliates not to effectuate any trades on the basis of, such material, non-public information, provided, that such Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company, or any of its subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in any securities of the Company.

 

4.8 Use of Proceeds. The Company shall use the net proceeds hereunder solely in the manner specified in Section 8(k) of the Notes.

 

4.9 Indemnification of Purchaser. Subject to the provisions of this Section 4.9, the Company, will indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a “Purchaser Party”) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants, or agreements made by each Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is based upon a breach of such Purchaser Party’s representations, warranties, or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which constitutes fraud, gross negligence, willful misconduct or malfeasance). If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to such Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the Companies shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company’s prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party’s breach of any of the representations, warranties, covenants, or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.9 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.

 

18

 

 

4.10 Securities Laws Disclosure; Publicity. The Company shall file a Current Report on Form 8-K in respect of the transactions contemplated hereby, which filing shall include, inter alia, the forms of the Transaction Documents as exhibits thereto, with the Commission within the time required by the Exchange Act. The Company represents to the Purchasers that, from and after the date of filing of such Current Report, the Company shall have publicly disclosed all material, non-public information delivered to each of the Purchasers by the Company, or any of its Subsidiaries, or any of their respective officers, directors, agents, employees, or Affiliates in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the filing of such Current Report, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees, or Affiliates, on the one hand, and any of the Purchasers or any of their Affiliates, on the other hand, shall terminate. The Company and each Purchaser shall consult with each other in issuing any press releases with respect to the transactions contemplated hereby, if any such press release is issued prior to the filing of the above-referenced Current Report and neither the Company nor any Purchaser shall issue any such “pre-Current Report” press release without the prior consent of the other party, which consent shall not unreasonably be withheld, delayed, denied, or conditioned, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such press release or public statement. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required by federal securities law in connection with (i) any registration statement contemplated by the Registration Rights Agreement and (ii) the filing of final forms of the Transaction Documents with the Commission and (b) if such disclosure is required by law or regulations of the OTC Markets group Inc., or any other market on which the Company’s securities are listed or quoted for trading, in which case the Company shall provide each Purchaser with prior notice of such disclosure that is permitted under this clause (b). If any notice provided pursuant to any Transaction Document constitutes or contains material, non-public information regarding the Company, or any of its subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in any securities of the Company.

 

19

 

 

4.11 Exercise Procedures. Each Notice of Conversion included in each Note and Notice of Exercise included in each Warrant sets forth the totality of the procedures required of each Purchaser in order to convert its Note or exercise its Warrants, respectively. Without limiting the preceding sentences, except as may be required by the Company’s transfer agent, no ink-original Notice of Conversion or Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion or Notice of Exercise form be required in order for a Purchaser to convert its Note or exercise its Warrants. Except as may be required by the Company’s transfer agent, no additional legal opinion, other information, or instructions shall be required of each Purchaser to convert its Note or exercise its Warrants. The Company shall honor conversions of the Notes and exercises of the Warrants and shall deliver the shares of Common Stock underlying such Note or Warrants in accordance with the terms, conditions, and time periods set forth in the Note and Warrant.

 

4.12 Preservation of Corporate Existence. For as long as a Note or the Warrants remain outstanding, the Company shall preserve and maintain its corporate existence, rights, privileges, and franchises in the jurisdictions of its incorporation, and shall qualify and remain qualified, as a foreign corporation in each jurisdiction in which such qualification is necessary in view of its business or operations and where the failure so to qualify or remain qualified might reasonably have a Material Adverse Effect upon the financial condition, business, or operations of the Company taken as a whole.

 

4.13 Reservation and Listing of Securities.

 

(a) The Company shall maintain a reserve from its duly authorized shares of Common Stock for issuance pursuant to the Transaction Documents in such amount as may then be required to fulfill its obligations in full under the Transaction Documents, but not less than the Reserve Amount.

 

(b) If, on any date, the number of authorized but unissued (and otherwise unreserved) shares of Common Stock is less than the Reserve Amount on such date, then the Board of Directors shall initiate such action (and, thereafter, use its commercially reasonable best efforts) to amend the Company’s Articles of Incorporation to increase the number of authorized but unissued shares of Common Stock to at least the Reserve Amount at such time, as soon as possible, and in any event not later than the ninetieth (90th) day after such date.

 

(c) The Company shall, if applicable: (i) in the time and manner required by the OTC Markets Group Inc., or any other market on which the Company’s securities are listed or quoted, prepare and file with such market an additional shares listing application covering the number of shares of Common Stock at least equal to the Reserve Amount on the date of such application, (ii) take all steps necessary to cause such shares of Common Stock to be approved for listing or quotation thereon as soon as possible thereafter, (iii) provide to each Purchaser evidence of such listing or quotation approval, and (iv) maintain the listing or quotation of such Common Stock on any date at least equal to the Reserve Amount on such date thereon or another market on which the Company’s securities are then listed or quoted for trading. The Company will then take all action necessary to continue the listing or quotation for trading of its Common Stock on such a market for so long as the Company has not fulfilled its obligations under the Notes or the Warrants are outstanding, and will comply in all respects with the Company’s reporting, filing, and other obligations under the bylaws or rules of such a market at least until one year after the later of the Company having fulfilled all of its obligations under the Notes and the Warrants being no longer outstanding (the “Compliance Period”). In the event the afore-described listing or quotation requirement is not continuously maintained during the Compliance Period (a “Compliance Period Default”), then, in addition to any other rights a Purchaser may have hereunder or under applicable law, on the first day of a Compliance Period Default and on each monthly anniversary thereafter (if the applicable Compliance Period Default shall not have been cured by such date) until the applicable Compliance Period Default has been cured, the Company shall pay to the Purchaser an amount in cash, as partial liquidated damages and not as a penalty, equal to one percent (1.0%) of the aggregate Subscription Amount of such Purchaser’s Securities (or the shares of Common Stock underlying such Securities) then owned of record or beneficially by such Purchaser on the day of a Compliance Period Default and on every thirtieth (30th) day thereafter (prorated for periods totaling less than thirty (30) days) until the date such Compliance Period Default is cured. If the Company fails to pay any liquidated damages pursuant to this Section in a timely manner, the Company will pay to the Purchaser interest thereon at a rate of 1.5% per month (prorated for partial months) until paid in full.

 

20

 

 

Section 4.14 Proportionate Treatment of the Purchasers. No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of any of this Agreement unless the same consideration is also offered on a ratable basis to each of the Purchasers. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat each Purchaser as a class and shall not in any way be construed as any Purchaser acting in concert or as a group with respect to the purchase, disposition, or voting of the Securities or otherwise. Notwithstanding any provision contained in this Section 4.14 or otherwise, none of the rights in favor of the holder of a Majority-In-Interest (as that term is referenced in the Notes and as defined in the Security Agreement) set forth herein, in each of the Transaction Documents, and in each of the other documents entered into in connection with the transactions contemplated herein shall be denigrated in favor of any other Purchaser and this Section 14.4 shall not be deemed to provide any other Purchaser with rights equivalent to the right accorded to the holder of a Majority-In-Interest.

 

ARTICLE V.

MISCELLANEOUS

 

5.1 Fees and Expenses. The Company shall deliver to each Purchaser, prior to the Closing, a completed and executed copy of the Closing Statement, attached hereto as Annex A. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants, and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery, and performance of this Agreement; provided that, at the Closing, the Company shall pay: (i) a non-accountable structuring and diligence fee of $35,000 to the Lead Investor, (ii) legal fees of $25,000 to the Lead Investor’s legal counsel, and (iii) the Company shall pay its legal fees out of its proceeds from the Closing. The Company shall pay all stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.

 

5.2 Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits, and schedules.

 

21

 

 

5.3 Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (i) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth on the signature pages attached hereto at or prior to 12:00 noon (New York City time) on a Business Day; (ii) the next Business Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth on the signature pages attached hereto on a day that is not a Business Day or later than 12:00 noon (New York City time) on any Business Day; (iii) the second (2nd) Business Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service; or (iv) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.

 

5.4 Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented, or amended except in a written instrument signed by the Company and a majority-in-interest of the Principal Amount of Notes outstanding as of the date of such waiver, modification, supplement, or amendment. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition, or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.

 

5.5 Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.

 

5.6 Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may assign this Agreement or any rights or obligations hereunder without the prior written consent of the Purchaser (other than by merger). Each Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to such “Purchaser.”

 

5.7 No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

5.8 Governing Law. All questions concerning the construction, validity, enforcement, and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement, and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees, or agents) shall be commenced exclusively in the state and federal courts sitting in the City of Las Vegas. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of Las Vegas, Clark County, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an action, suit, or proceeding to enforce any provisions of the Transaction Documents, then the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation, and prosecution of such action or proceeding.

 

22

 

 

5.9 Survival. The representations and warranties contained herein shall survive each of the Closings and the delivery of the Securities.

 

5.10 Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page was an original thereof.

 

5.11 Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants, and restrictions without including any of such that may be hereafter declared invalid, illegal, void, or unenforceable.

 

5.12 Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand, or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights.

 

5.13 Replacement of Securities. If any certificate or instrument evidencing any of the Securities is mutilated, lost, stolen, or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft, or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.

 

5.14 Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, Purchaser and Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation the defense that a remedy at law would be adequate.

 

23

 

 

5.15 Payment Set Aside. To the extent that Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or any Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then, to the extent of any such restoration, the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

 

5.16 Usury. To the extent it may lawfully do so, Company hereby agrees not to insist upon or plead or in any manner whatsoever claim, and will resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at any time hereafter in force, in connection with any claim, action or proceeding that may be brought by Purchaser in order to enforce any right or remedy under any Transaction Document. Notwithstanding any provision to the contrary contained in any Transaction Document, it is expressly agreed and provided that the total liability of the Company under the Transaction Documents for payments in the nature of interest shall not exceed the maximum lawful rate authorized under applicable law (the “Maximum Rate”), and, without limiting the foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated with any other sums in the nature of interest that the Company may be obligated to pay under the Transaction Documents exceed such Maximum Rate. It is agreed that if the maximum contract rate of interest allowed by law and applicable to the Transaction Documents is increased or decreased by statute or any official governmental action subsequent to the date hereof, the new maximum contract rate of interest allowed by law will be the Maximum Rate applicable to the Transaction Documents from the effective date thereof forward, unless such application is precluded by applicable law. If under any circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Company to any Purchaser with respect to indebtedness evidenced by the Transaction Documents, such excess shall be applied by the Purchaser to the unpaid principal balance of any such indebtedness or be refunded to the Company, the manner of handling such excess to be at the Purchaser’s election.

 

5.17 [Reserved.]

 

5.18 Liquidated Damages. Company’s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been canceled.

 

5.19 Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

 

5.20 Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto.

 

5.21 WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.

 

(Signature Pages Follow)

 

24

 


 

IN WITNESS WHEREOF, the Company has caused this Convertible Note Purchase Agreement to be duly executed by its authorized signatories as of the date first indicated above.

 

ENDEXX CORPORATION

 

By:    
Name:    
Title:    

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGES FOR EACH PURCHASER FOLLOWS]

 

25

 

 

[PURCHASER SIGNATURE PAGES TO

CONVERTIBLE NOTE PURCHASE AGREEMENT]

 

IN WITNESS WHEREOF, the undersigned has caused this Convertible Note Purchase Agreement to be duly executed by its authorized signatory as of the date first indicated above.

 

Name of Purchaser: M2B Funding Corp.

 

Signature of Authorized Signatory of Purchaser: __________________________________________________________

 

Name of Authorized Signatory: _______________________________________________________________________

 

Title of Authorized Signatory: __________________________________

 

E-mail Address of Authorized Signatory: __________________________

 

Facsimile Number of Authorized Signatory: ________________________

 

Address for Notice to Purchaser: ________________________________

 

 _________________________________________________________

 

Address for Delivery of Securities to Purchaser (if not same as address for notice):

 _________________________________________________________ 

 

 _________________________________________________________

 

Closing Principal Amount: $1,451,086.95

 

Closing Subscription Amount: $1,335,000.00

 

EIN Number: ______________________________________

 

26

 

 

[PURCHASER SIGNATURE PAGES TO

 

CONVERTIBLE NOTE PURCHASE AGREEMENT]

 

IN WITNESS WHEREOF, the undersigned has caused this Convertible Note Purchase Agreement to be duly executed by its authorized signatory as of the date first indicated above.

 

Name of Purchaser: 3A Capital Establishment

 

Signature of Authorized Signatory of Purchaser: __________________________________________________________

 

Name of Authorized Signatory: _______________________________________________________________________

 

Title of Authorized Signatory: _______________________________________

 

E-mail Address of Authorized Signatory: _______________________________

 

Facsimile Number of Authorized Signatory: _____________________________

 

Address for Notice to Purchaser: _____________________________________

 

_______________________________________________________________ 

 

Address for Delivery of Securities to Purchaser (if not same as address for notice):

_______________________________________________________________ 

 

_______________________________________________________________ 

 

Closing Principal Amount: $722,826.09

 

Closing Subscription Amount: $665,000.00

 

EIN Number: _____________________________________

 

27

 

 

Annex A

 

CLOSING STATEMENT

 

Pursuant to the attached Purchase Agreement, dated as of the date hereto, the Purchaser shall purchase Note(s) from Endexx Corporation, a Nevada corporation (the “Company”). All funds will be wired into an account maintained by the Company. All funds will be disbursed in accordance with this Closing Statement.

 

Disbursement Date: August 31, 2022

 

I. PURCHASE PRICE

 

 
Gross Proceeds to be Received $2,000,000.00
   

II. DISBURSEMENTS

 

 
M2B Funding Corp. $35,000.00
Clark Hill PLC $25,000.00
Endexx Corporation $1,940,000.00
  $
   
Total Amount Disbursed: $2,000,000.00

 

WIRE INSTRUCTIONS:  
   
As provided.  
   
Duly executed as of the 31st day of August, 2022:  

 

ENDEXX CORPORATION  
   
By:    
Name: Todd Davis  
Title: President  

 

ANNEX A

 

 

Annex B

 

EXERCISE FORM

 

To: ENDEXX CORPORATION Dated:_______________

 

The undersigned, pursuant to the provisions set forth in that certain Convertible Note Purchase Agreement among Endexx Corporation (the “Company”), M2B Funding Corp., and 3A Capital Establishment, dated August 31, 2022 (the “Agreement”), hereby irrevocably elects to purchase ____________________ shares of Common Stock of the Company and covered by the Option described in the Agreement and herewith makes payment of $____________________, representing the Exercise Price for such shares of Common Stock as provided in the Agreement.

 

Defined terms contained herein shall have the meanings assigned to them in the Agreement.

 

Acknowledged and agreed to by the Purchaser:  
   
[Name of Purchaser]  
   
By:    
(Signature)  
Name:    
Title:    

 

ANNEX B

 

 

SECTION 3.1(A)

 

CBD Unlimited, a wholly-owned subsidiary

Global Solaris Group, LLC, a wholly-owned subsidiary

Greenleaf Consulting LLC, a wholly-owned subsidiary

Cann Can LLC, a wholly owned-subsidiary

Together One Step Closer, LLC, a wholly-owned subsidiary

PhytoLabs LLC, a wholly-owned subsidiary

Go Green Global Enterprises, Inc., a wholly-owned subsidiary

CBD Health Solutions, a wholly-owned subsidiary

Kush, Inc., a wholly-owned subsidiary

CBD Life Brands, Inc., a wholly-owned subsidiary

 

Section 3.1(a)

 

 

Exhibit 10.40

 

NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANIES. THIS SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

Original Issue Date: August 31, 2022 Principal Amount: $________

 

12% SENIOR SECURED

 

CONVERTIBLE PROMISSORY NOTE

 

DUE August 31, 2023

 

THIS IS A 12% SENIOR SECURED CONVERTIBLE PROMISSORY NOTE of Endexx Corporation, a Nevada corporation (the “Company”), having its principal place of business at 38246 North Hazelwood Circle, Cave Creek, Arizona 85331 (this “Note”), which represents a duly authorized and validly issued debt of the Company.

 

FOR VALUE RECEIVED, the Company hereby promises to pay to the order of_______ (the “Holder”), or its registered assigns, the principal sum of $_____________ (the “Principal Amount”) and “Guaranteed Interest” thereon at the rate of twelve percent (12.00%), all twelve (12) months of which Guaranteed Interest shall be deemed earned as of the date hereof. The Principal Amount and all accrued, but unpaid, interest shall be due and payable on August 31, 2023 (the “Maturity Date”), or such earlier date as this Note is required or permitted to be repaid as provided hereunder, and to pay such other interest to the Holder on the aggregate unconverted and then outstanding Principal Amount of this Note in accordance with the provisions hereof.

 

Guaranteed Interest:

 

Notwithstanding anything contained herein, this Note shall bear interest on the aggregate unpaid Principal Amount and Guaranteed Interest from and after the occurrence and during the continuance of an Event of Default pursuant to Section 7(a) at the rate (the “Default Rate”) equal to the lesser of two percent (2%) per month (twenty-four percent (24%) per annum) or the maximum rate permitted by law. Unless otherwise agreed or required by applicable law, payments will be applied first to any unpaid collection costs, then to any unpaid Default Rate interest and fees; any remaining amount shall be applied first to any unpaid Guaranteed Interest and then to any unpaid Principal Amount. Notwithstanding the dates for payment of Guaranteed Interest, Default Rate interest shall be due and payable by the Company to the Holder on the tenth (10th) day of each calendar month during which Default Rate interest accrued.

 

1

 

 

This Note is subject to the following additional provisions:

 

Upon the execution and delivery of this Note, the sum of $__________ (reflecting an 8% OID on the Principal Amount) shall be remitted and delivered to, or on behalf of, the Company.

 

Section 1. Definitions. For the purposes hereof, in addition to the terms defined elsewhere in this Note, (a) capitalized terms not otherwise defined herein shall have the meanings set forth in the Purchase Agreement and (b) the following terms shall have the following meanings:

 

Alternate Consideration” shall have the meaning set forth in Section 6(e).

 

Bankruptcy Event” means any of the following events: (a) the Company (as such term is defined in Rule 1-02(w) of Regulation S-X thereof) commences a case or other proceeding under any bankruptcy, reorganization, arrangement, adjustment of debt, relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction relating to the Company , (b) there is commenced against the Company any such case or proceeding that is not dismissed within 60 days after commencement, (c) the Company is adjudicated insolvent or bankrupt or any order of relief or other order approving any such case or proceeding is entered, (d) the Company suffers any appointment of any custodian or the like for it or any substantial part of its property that is not discharged or stayed within 60 calendar days after such appointment, (e) the Company makes a general assignment for the benefit of creditors, (f) the Company calls a meeting of its creditors with a view to arranging a composition, adjustment or restructuring of its debts or (g) the Company, by any act or failure to act, expressly indicates its consent to, approval of or acquiescence in any of the foregoing or takes any corporate or other action for the purpose of effecting any of the foregoing.

 

Base Conversion Price” shall have the meaning set forth in Section 6(b).

 

Beneficial Ownership Limitation” shall have the meaning set forth in Section 5(d).

 

Buy-In” shall have the meaning set forth in Section 5(b)(v).

 

Change of Control Transaction” means the occurrence after the date hereof of any of (a) an acquisition after the date hereof by an individual or legal entity or “group” (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act) of effective control (whether through legal or beneficial ownership of capital stock of the Company, by contract or otherwise) of in excess of fifty percent (50%) of the voting securities of the Company (other than by means of conversion or exercise of this Notes and the Securities issued together with this Notes); (b) the Company merges into or consolidates with any other Person, or any Person merges into or consolidates with the Company and, after giving effect to such transaction, the stockholders of the Company immediately prior to such transaction own less than fifty percent (50%) of the aggregate voting power of the Company or the successor entity of such transaction; (c) the Company sells or transfers all or substantially all of its assets to another Person and the stockholders of the Company immediately prior to such transaction own less than fifty percent (50%) of the aggregate voting power of the acquiring entity immediately after the transaction; (d) a replacement at one time or within a three year period of more than one-half of the members of the Board of Directors which is not approved by a majority of those individuals who are members of the Board of Directors on the Original Issue Date (or by those individuals who are serving as members of the Board of Directors on any date whose nomination to the Board of Directors was approved by a majority of the members of the Board of Directors who are members on the date hereof); or (e) the execution by the Company of an agreement to which the Company is a party or by which it is bound, providing for any of the events set forth in clauses (a) through (d) above.

 

2

 

 

Common Stock” means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.

 

Common Stock Equivalents” means any securities of the Company that would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

 

Conversion” shall have the meaning ascribed to such term in Section 5.

 

Conversion Date” shall have the meaning set forth in Section 5(a).

 

Conversion Schedule” means the Conversion Schedule in the form of Schedule 1 attached hereto.

 

Conversion Shares” means, collectively, the shares of Common Stock issuable upon conversion of this Note in accordance with the terms hereof.

 

Default Rate” shall have the meaning ascribed thereto in the preamble of this Note.

 

Dilutive Issuance” shall have the meaning set forth in Section 6(b).

 

Dilutive Issuance Notice” shall have the meaning set forth in Section 6(b).

 

DTC” means the Depository Trust Company.

 

DTC/FAST Program” means the DTC’s Fast Automated Securities Transfer Program.

 

DWAC Eligible” means that (a) the Common Stock is eligible at DTC for full services pursuant to DTC’s Operational Arrangements, including without limitation transfer through DTC’s DWAC system, (b) the Company has been approved (without revocation) by the DTC’s underwriting department, (c) the Transfer Agent is approved as an agent in the DTC/FAST Program, (d) the Conversion Shares are otherwise eligible for delivery via DWAC, and (e) the Transfer Agent does not have a policy prohibiting or limiting delivery of the Conversion Shares via DWAC.

 

Event of Default” shall have the meaning set forth in Section 7(a).

 

Exchange Act” means, the Securities Exchange Act of 1934, as amended.

 

Exempt Issuance” shall have the meaning set forth in Section 6(c).

 

Fixed Conversion Price” shall have the meaning set forth in Section 5(b).

 

Fundamental Transaction” shall have the meaning set forth in Section 6(e).

 

3

 

 

Guaranteed Interest” shall have the meaning ascribed thereto in the preamble of this Note.

 

Late Fees” shall have the meaning set forth in Section 2(c).

 

Mandatory Default Amount” means the payment of 120% of the outstanding Principal Amount of this Note and accrued and unpaid interest hereon, in addition to the payment of all other amounts, costs, expenses, and liquidated damages due in respect of this Note.

 

Nevada Courts” shall have the meaning set forth in Section 8(d).

 

Note Register” shall have the meaning set forth in Section 2(b).

 

Notice of Conversion” shall have the meaning set forth in Section 5(a).

 

Original Issue Date” means the date of the first issuance of this Note, regardless of any transfers of any Note and regardless of the number of instruments that may be issued to evidence such Notes.

 

Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

Purchase Agreement” means the Convertible Note Purchase Agreement, dated as of August 23, 2022, between the Company and the original Holder, as amended, modified, or supplemented from time to time in accordance with its terms.

 

Required Minimum” means, as of any date, the maximum aggregate number of shares of Common Stock then issued or potentially issuable in the future pursuant to this Note, including any Conversion Shares issuable upon conversion in full of this Note (including Conversion Shares issuable as payment of interest on this Note), ignoring any conversion limits set forth therein, and assuming that the Fixed Conversion Price is at all times on and after the date of determination 100% of the then Fixed Conversion Price on the Trading Day immediately prior to the date of determination.

 

Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

Share Delivery Date” shall have the meaning set forth in Section 5(c)(ii).

 

Successor Entity” shall have the meaning set forth in Section 6(e).

 

Trading Price” shall mean the average of the VWAP for the ten (10) Trading Days following the Clearing Date.

 

4

 

 

Variable Rate Transaction” means, collectively, an “Equity Line of Credit” or similar agreement, or a Variable Priced Equity Linked Instrument. For purposes hereof, (i) “Equity Line of Credit” means any transaction involving a written agreement between the Company and an investor or underwriter, whereby the Company has the right to “put” its securities to the investor or underwriter over an agreed period of time and at future determined price or price formula (other than customary “preemptive” or “participation” rights or “weighted average” or “full-ratchet” anti-dilution provisions or in connection with fixed-price rights offerings and similar transactions that are not Variable Priced Equity Linked Instruments) and (ii) “Variable Priced Equity Linked Instruments” means: (A) any debt or equity securities which are convertible into, exercisable or exchangeable for, or carry the right to receive additional shares of Common Stock either (1) at any conversion, exercise, or exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for Common Stock at any time after the initial issuance of such debt or equity security or (2) with a conversion, exercise, or exchange price that is subject to being reset at some future date at any time after the initial issuance of such debt or equity security due to a change in the market price of the Company’s Common Stock since date of initial issuance (other than customary “preemptive” or “participation” rights or “weighted average” or “full-ratchet” anti-dilution provisions or in connection with fixed-price rights offerings and similar transactions) and (B) any amortizing convertible security that amortizes prior to its maturity date, in which the Company is required or has the option to (or any investor in such transaction has the option to require the Company to) make such amortization payments in shares of Common Stock that are valued at a price that is based upon and/or varies with the trading prices of or quotations for Common Stock at any time after the initial issuance of such debt or equity security (whether or not such payments in shares of Common Stock are subject to certain equity conditions).

 

VWAP” means, for or as of any date, the dollar volume-weighted average price for such security on the Trading Market (or, if the Trading Market is not the principal trading market for such security, then on the principal securities exchange or securities market on which such security is then traded) during the period beginning at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg through its “HP” function (set to weighted average) or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the OTC Markets Group Inc. marketplace for such security during the period beginning at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported by OTC Markets Group Inc. If the VWAP cannot be calculated for such security on such date on any of the foregoing bases, the VWAP of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination, recapitalization, or other similar transaction during such period.

 

Section 2. Interest.

 

Payment of Interest in Cash or Kind. All payments of Guaranteed Interest and interest at the Default Rate hereunder will be payable in cash or Common Stock or a combination thereof, all in the Holder’s sole and absolute discretion.

 

a) Interest Calculations. Default Rate interest shall be calculated on the basis of a 360-day year, consisting of twelve (12) thirty (30)-calendar day periods, and shall accrue daily commencing on the Original Issue Date until payment in full of the outstanding principal, together with all accrued and unpaid Guaranteed Interest, Default Rate interest, liquidated damages and other amounts that may become due hereunder, has been made. Interest hereunder will be paid to the Person in whose name this Note is registered on the records of the Company regarding registration and transfers of this Note (the “Note Register”).

 

5

 

 

b) Late Fees. All overdue accrued and unpaid interest to be paid hereunder shall entail a late fee at the Default Rate (the “Late Fee”), which shall accrue daily from the date such interest is due hereunder through and including the date of actual payment in full.

 

c) Prepayment. At any time upon five calendar days’ written notice to the Holder, but subject to the Holder’s conversion rights set forth herein, the Company may prepay all, but not less than all, of the Principal Amount of this Note and any accrued and unpaid interest, including the Guaranteed Interest thereon. If the Company exercises its right to prepay this Note, the Company shall make payment to the Holder of an amount in cash equal to the sum of the then-outstanding Principal Amount of this Note and all accrued and unpaid interest, including the Guaranteed Interest thereon, multiplied by 125%.

 

Section 3. Reserved.

 

Section 4. Registration of Transfers and Exchanges.

 

a) Investment Representations. This Note has been issued subject to certain investment representations of the original Holder and may be transferred or exchanged only in compliance with applicable federal and state securities laws and regulations.

 

b) Reliance on Note Register. Prior to due presentment for transfer to the Company of this Note, the Company and any agent of the Company may treat the Person in whose name this Note is duly registered on this Note Register as the owner hereof for the purpose of receiving payment as herein provided and for all other purposes, whether or not this Note is overdue, and neither the Company nor any such agent shall be affected by notice to the contrary.

 

Section 5. Conversion.

 

a) Voluntary Conversion. At any time after the Original Issue Date until this Note is no longer outstanding, this Note shall be convertible, in whole or in part, into shares of Common Stock at the option of the Holder, at any time and from time to time (subject to the conversion limitations set forth in Section 5(d) hereof); provided, however, that this Note shall not be convertible through and including the six (6)-month anniversary of the Original Issue Date unless an Event of Default has occurred that has not been cured during the relevant cure period, if any, in which event this six (6)-month prohibition against conversion shall not be operative. The Holder shall effect conversions by delivering to the Company a Notice of Conversion, the form of which is attached hereto as Annex A (each, a “Notice of Conversion”), specifying therein the Principal Amount of this Note and accrued and unpaid Interest thereon to be converted and the date on which such conversion shall be effected (such date, the “Conversion Date”). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion is deemed delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion form be required. To effect conversions hereunder, the Holder shall not be required to physically surrender this Note to the Company unless the entire Principal Amount of this Note, plus all accrued and unpaid interest thereon, has been so converted and the Conversion Shares have been delivered. Conversions hereunder shall have the effect of lowering the outstanding principal amount of this Note in an amount equal to the applicable conversion. The Holder and the Company shall maintain a Conversion Schedule showing the Principal Amount(s) converted and the date of such conversion(s). The Company may deliver an objection to any Notice of Conversion within one (1) Business Day of delivery of such Notice of Conversion. In the event of any dispute or discrepancy, the records of the Holder shall be controlling and determinative in the absence of manifest error. The Holder, and any assignee by acceptance of this Note, acknowledge and agree that, by reason of the provisions of this paragraph, following conversion of a portion of this Note, the unpaid and unconverted Principal Amount of this Note may be less than the amount stated on the face hereof.

 

6

 

 

b) Fixed Conversion Price; Reduced Value Price. The “Fixed Conversion Price” of this Note is $0.0245 per share. In the event that the Company consummates (in whole or in part) any financing (whether such financing is equity, equity-equivalent, or debt or any combination thereof and whether any portion of such financing is a derivative security) at a price less than the Fixed Conversion Price (the “Reduced Valuation Price”), then, from and after the consummation of such Reduced Valuation transaction, the Fixed Conversion Price shall be reduced to an amount equal to the Reduced Valuation Price.

 

c) Reserved.

 

d) Mechanics of Conversion.

 

i. Conversion Shares Issuable Upon Conversion of Principal Amount. The number of Conversion Shares issuable upon a conversion hereunder shall be determined by the quotient obtained by dividing (x) the outstanding Principal Amount of this Note and all interest of any nature to be converted and any accrued and unpaid interest to be converted by (y) the Fixed Conversion Price.

 

ii. Delivery of Certificate Upon Conversion. Not later than two (2) Trading Days after each Conversion Date (the “Share Delivery Date”), the Company shall deliver, or cause to be delivered, to the Holder a certificate or certificates representing the Conversion Shares that, on or after the date on which such Conversion Shares are (A) eligible to be sold under Rule 144 without the need for current public information and the Company has received an opinion of counsel to such effect reasonably acceptable to the Company (which opinion the Company will be responsible for obtaining at the cost of the Company) or (B) subject to a registration statement that has been declared effective by the Securities and Exchange Commission and which registration statement is then neither stale nor subject to any stop order, shall be free of restrictive legends and trading restrictions, representing the number of Conversion Shares being acquired upon the conversion of this Note. All certificate or certificates required to be delivered by the Company under this Section 5(d) shall be delivered electronically through the DTC or another established clearing corporation performing similar functions. If the Conversion Date is prior to the date on which such Conversion Shares are eligible to be sold under Rule 144 without the need for current public information the Conversion Shares shall bear a restrictive legend in the following form, as appropriate:

 

“NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”

 

7

 

 

Notwithstanding the foregoing, commencing on such date that the Conversion Shares are eligible for sale under Rule 144 subject to current public information requirements, the Company, upon request and at the expense of the Company, shall obtain a legal opinion to allow for such sales under Rule 144.

 

iii. Failure to Deliver Certificates. If, in the case of any Notice of Conversion, such certificate or certificates are not delivered to or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Company at any time on or before its receipt of such certificate or certificates, to rescind such Conversion, in which event the Company shall promptly return to the Holder any original Note delivered to the Company and the Holder shall promptly return to the Company the Common Stock certificates issued to such Holder pursuant to the rescinded Conversion Notice.

 

iv. Obligation Absolute; Partial Liquidated Damages. The Company’s obligations to issue and deliver the Conversion Shares upon conversion of this Note in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation, or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to the Company or any violation or alleged violation of law by the Holder or any other Person, and irrespective of any other circumstance which might otherwise limit such obligation of the Company to the Holder in connection with the issuance of such Conversion Shares; provided, however, that such delivery shall not operate as a waiver by the Company of any such action the Company may have against the Holder. In the event the Holder of this Note shall elect to convert any or all of the outstanding principal or interest amount hereof, the Company may not refuse conversion based on any claim that the Holder or anyone associated or affiliated with the Holder has been engaged in any violation of law, agreement or for any other reason, unless an injunction from a court, on notice to Holder, restraining and or enjoining conversion of all or part of this Note shall have been sought. If the injunction is not granted, the Company shall promptly comply with all conversion obligations herein. If the injunction is obtained, the Company must post a surety bond for the benefit of the Holder in the amount of 150% of the outstanding Principal Amount of this Note, which is subject to the injunction, which bond shall remain in effect until the completion of arbitration/litigation of the underlying dispute and the proceeds of which shall be payable to the Holder to the extent it obtains judgment. In the absence of seeking such injunction, the Company shall issue Conversion Shares or, if applicable, cash, upon a properly noticed conversion. If the Company fails for any reason to deliver to the Holder such certificate or certificates pursuant to Section 5(c)(ii) by the Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, $1,000 per Trading Day for each Trading Day after such Share Delivery Date until such certificates are delivered or Holder rescinds such conversion. Nothing herein shall limit a Holder’s right to pursue actual damages or declare an Event of Default pursuant to Section 7 hereof for the Company’s failure to deliver Conversion Shares within the period specified herein and the Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of any such rights shall not prohibit the Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law.

 

8

 

 

v. Compensation for Buy-In on Failure to Timely Deliver Certificates Upon Conversion. In addition to any other rights available to the Holder, if the Company fails for any reason to deliver to the Holder such certificate or certificates by the Share Delivery Date pursuant to Section 5(c)(ii), and if after such Share Delivery Date the Holder is required by its brokerage firm to purchase (in an open market transaction or otherwise), or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Conversion Shares that the Holder was entitled to receive upon the conversion relating to such Share Delivery Date (a “Buy-In”), then the Company shall (A) pay in cash to the Holder (in addition to any other remedies available to or elected by the Holder) the amount, if any, by which (x) the Holder’s total purchase price (including any brokerage commissions) for the Common Stock so purchased exceeds (y) the product of (1) the aggregate number of shares of Common Stock that the Holder was entitled to receive from the conversion at issue multiplied by (2) the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and (B) at the option of the Holder, either reissue (if surrendered) this Note in a principal amount equal to the principal amount of the attempted conversion (in which case such conversion shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued if the Company had timely complied with its delivery requirements under Section 5(c)(ii). For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted conversion of this Note with respect to which the actual sale price of the Conversion Shares (including any brokerage commissions) giving rise to such purchase obligation was a total of $10,000 under clause (A) of the immediately preceding sentence, the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver certificates representing shares of Common Stock upon conversion of this Note as required pursuant to the terms hereof.

 

vi. Reservation of Shares Issuable Upon Conversion. The Company covenants that it will at all times reserve and keep available out of its authorized and unissued shares of Common Stock a number of shares of Common Stock at least equal to 200% of the Required Minimum (the “Reserve Amount”) for the sole purpose of issuance upon conversion of this Note and payment of interest on this Note, each as herein provided, free from preemptive rights or any other actual contingent purchase rights of Persons other than the Holder (and the other holders of this Notes). The Company covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable.

 

vii. Fractional Shares. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of this Note. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Company shall at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Fixed Conversion Price or round up to the next whole share.

 

viii. Transfer Taxes and Expenses. The issuance of certificates for shares of the Common Stock on conversion of this Note shall be made without charge to the Holder hereof for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such certificates, provided that, the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any such certificate upon conversion in a name other than that of the Holder of this Note so converted and the Company shall not be required to issue or deliver such certificates unless or until the Person or Persons requesting the issuance thereof shall have paid to the Company the amount of such tax or shall have established to the satisfaction of the Company that such tax has been paid. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Conversion.

 

9

 

 

e) Holder’s Conversion Limitations. The Company shall not effect any conversion of principal and/or interest of this Note, and a Holder shall not have the right to convert any principal and/or interest of this Note, to the extent that after giving effect to the conversion set forth on the applicable Notice of Conversion, the Holder (together with the Holder’s Affiliates, and any Persons acting as a group together with the Holder or any of the Holder’s Affiliates) would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates shall include the number of shares of Common Stock issuable upon conversion of this Note with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which are issuable upon (i) conversion of the remaining, unconverted Principal Amount of this Note beneficially owned by the Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company subject to a limitation on conversion or exercise analogous to the limitation contained herein (including, without limitation, any other Notes) beneficially owned by the Holder or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this Section 5(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent that the limitation contained in this Section 5(d) applies, the determination of whether this Note is convertible (in relation to other securities owned by the Holder together with any Affiliates) and of which Principal Amount of this Note is convertible shall be in the sole discretion of the Holder, and the submission of a Notice of Conversion shall be deemed to be the Holder’s determination of whether this Note may be converted (in relation to other securities owned by the Holder together with any Affiliates) and which Principal Amount of this Note is convertible, in each case subject to the Beneficial Ownership Limitation. To ensure compliance with this restriction, the Holder will be deemed to represent to the Company each time it delivers a Notice of Conversion that such Notice of Conversion has not violated the restrictions set forth in this paragraph and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 5(e), in determining the number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding shares of Common Stock as stated in the most recent of the following: (i) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (ii) a more recent public announcement by the Company, or (iii) a more recent written notice by the Company or the Company’s transfer agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Note, by the Holder or its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of this Note held by the Holder. The Holder, upon not less than sixty-one (61) days’ prior notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 5(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon conversion of this Note held by the Holder and the Beneficial Ownership Limitation provisions of this Section 5(e) shall continue to apply. Any such increase or decrease will not be effective until the sixty-first (61st) calendar day after such notice is delivered to the Company. The Beneficial Ownership Limitation provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 5(d) to correct this paragraph (or any portion hereof) that may be defective or inconsistent with the intended Beneficial Ownership Limitation contained herein or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Note.

 

Section 6. Certain Adjustments.

 

a) Stock Dividends and Stock Splits. If the Company, at any time while this Note is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon conversion of, or payment of interest on, this Notes), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Company, then the Fixed Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Company) outstanding immediately before such event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination, or re-classification.

 

10

 

 

b) Dilution. The Company specifically acknowledges that its obligation to issue the Common Stock is binding upon the Company and enforceable regardless of the dilution such issuance may have on the ownership interests of other shareholders of the Company.

 

c) Subsequent Equity Sales. If, at any time while this Note is outstanding, the Company enters into (without the prior written consent of the Holder) a Variable Rate Transaction involving the sale or grant of any option to purchase or sells or grants any right to reprice, or otherwise disposes of or issues (or announces any sale, grant or any option to purchase or other disposition), any Common Stock or Common Stock Equivalents entitling any Person to acquire shares of Common Stock at a determinable effective price per share that is lower than the then Fixed Conversion Price (such lower price, the “Base Conversion Price” and such issuances, collectively, a “Dilutive Issuance”) (if the holder of the Common Stock or Common Stock Equivalents so issued as part of such Variable Rate Transaction shall at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share that are issued in connection with such issuance, be entitled to receive shares of Common Stock at a determinable effective price per share that is lower than the Fixed Conversion Price, such issuance shall be deemed to have occurred for less than the Fixed Conversion Price on such date of the Dilutive Issuance), then immediately upon the Company’s entry into such Variable Rate Transaction, the Fixed Conversion Price shall be reduced to an amount equal to the lower of (i) the Variable Rate Transaction on the Conversion Date or (ii) actual price at which shares of Common Stock are issued pursuant to such Variable Rate Transaction (the “New Issuance Price”). Such adjustment for the New Issuance Price shall be made whenever such Common Stock or Common Stock Equivalents are issued and the Base Conversion Price is determinable. Notwithstanding the foregoing, no adjustment will be made under this Section 6(b) in respect of an “Exempt Issuance.” For the purposes hereof, an Exempt Issuance shall consist of any issuance of Common Stock (i) for consideration other than cash pursuant to a merger, consolidation, acquisition, or similar business combination approved by the Board of Directors, (ii) issued pursuant to any equipment loan or leasing arrangement, real property leasing arrangement, or debt financing from a bank or similar financial institution approved by the Board of Directors, and (iii) with respect to which the holders of a majority of the outstanding principal of other notes, if any, of the same series as this Note waive their rights contained in respect of a Dilutive Issuance. The Company shall notify the Holder in writing, no later than the Trading Day following the issuance of any Common Stock or Common Stock Equivalents subject to this Section 6(b), indicating therein the applicable issuance price, or applicable reset price, exchange price, conversion price and other pricing terms (such notice, the “Dilutive Issuance Notice”). For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section 6(b), upon the occurrence of any Dilutive Issuance, the Holder is entitled to receive a number of Conversion Shares based upon the Base Conversion Price on or after the date of such Dilutive Issuance, regardless of whether the Holder accurately refers to the Base Conversion Price in the Notice of Conversion.

 

d) Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 6(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights that the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Note (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

11

 

 

e) Pro Rata Distributions. During such time as this Note is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Note, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Note (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

f) Fundamental Transaction. If, at any time while this Note is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of fifty percent (50%) or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than fifty percent (50%) of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent conversion of this Note, the Holder shall have the right to receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation in Section 5(e) on the conversion of this Note), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Note is convertible immediately prior to such Fundamental Transaction (without regard to any limitation in Section 5(d) on the conversion of this Note). For purposes of any such conversion, the determination of the Fixed Conversion Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one (1) share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Fixed Conversion Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash, or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any conversion of this Note following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Note and any document ancillary hereto, in accordance with the provisions of this Section 6(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the holder of this Note, deliver to the Holder in exchange for this Note a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Note that is convertible for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of this Note (without regard to any limitations on the conversion of this Note) prior to such Fundamental Transaction, and with a conversion price that applies the conversion price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of this Note immediately prior to the consummation of such Fundamental Transaction), and that is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Note and the other Transaction Documents referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Note and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.

 

12

 

 

g) Calculations. All calculations under this Section 6 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 6, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Company) issued and outstanding.

 

h) Notice to the Holder.

 

i. Adjustment to Fixed Conversion Price. Whenever the Fixed Conversion Price is adjusted pursuant to any provision of this Section 6, the Company shall promptly deliver to the Holder a notice setting forth the Fixed Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.

 

ii. Notice to Allow Conversion by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be filed at each office or agency maintained for the purpose of conversion of this Note, and shall cause to be delivered to the Holder at its last address as it shall appear upon this Note Register, at least twenty (20) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to convert this Note during the 20-day period commencing on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

Section 7. Events of Default.

 

a) “Event of Default” means, wherever used herein, any of the following events (whatever the reason for such event and whether such event shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court, or any order, rule, or regulation of any administrative or governmental body):

 

i. (A) Any default in the payment of principal due hereunder, or (B) any default in the payment of interest or other amounts (not including principal) due hereunder, which failure is not cured within three (3) Trading Days after such failure;

 

ii. the Company shall fail to observe or perform any other covenant, provision, or agreement contained in this Note (and other than a breach by the Company of its obligations to deliver shares of Common Stock to the Holder upon conversion, which breach is addressed in clause (x) below) and is not cured, if possible to cure, within the earlier to occur of (A) three (3) Trading Days after notice of such failure sent by the Holder or by any other Holder to the Company and (B) three (3) Trading Days after the Company has become or should have become aware of such failure;

 

13

 

 

iii. a default or event of default of any other material agreement, lease, document, or instrument to which the Company is obligated (and not covered by clause (vi) below);

 

iv. any representation or warranty made in this Note, any other Transaction Documents, any written statement pursuant hereto or thereto or any other report, financial statement or certificate made or delivered to the Holder or any other Holder shall be untrue or incorrect in any material respect as of the date when made or deemed made; provided, however, if any representation or warranty made in the disclosure schedules of the Transaction Document set forth a matter that constitutes an event of default, the Company shall have one hundred twenty (120) days from the Original Issue Date to (i) obtain a waiver of such disclosed default or (ii) cure such disclosed default;

 

v. the Company (as such term is defined in Rule 1-02(w) of Regulation S-X) shall be subject to a Bankruptcy Event;

 

vi. the Company shall default on any of its obligations under any mortgage, credit agreement or other facility, indenture agreement, factoring agreement or other instrument under which there may be issued, or by which there may be secured or evidenced, any indebtedness for borrowed money or money due under any long term leasing or factoring arrangement that (a) involves an obligation greater than $100,000 whether such indebtedness now exists or shall hereafter be created, and (b) results in such indebtedness becoming or being declared due and payable prior to the date on which it would otherwise become due and payable;

 

vii. the Common Stock shall not be eligible for listing or quotation for trading on a Trading Market and shall not be eligible to resume listing or quotation for trading thereon within three (3) Trading Days or the transfer of shares of Common Stock through the DTC’s DWAC System is no longer available or “chilled”;

 

viii. the Company shall be a party to any Change of Control Transaction or Fundamental Transaction (A) without first giving the Holder ten (10) days’ prior written notice of the closing of such Change of Control Transaction or Fundamental Transaction and (B) prior to or simultaneous with the closing of such Change of Control Transaction or Fundamental Transaction, the Holder is not repaid in accordance with Section 2(d) herein;

 

ix. From and after the six-month anniversary of the Original Issuance Date, the Company does not meet the current public information requirements under Rule 144;

 

x. the Company shall fail for any reason to deliver certificates to a Holder prior to the third (3rd) Trading Day after a Conversion Date pursuant to Section 5(c) or the Company shall provide at any time notice to the Holder, including by way of public announcement, of the Company’s intention to not honor requests for conversions of this Note in accordance with the terms hereof;

 

xi. From and after the six-month anniversary of the Original Issuance Date, the Company fails to file with the Commission any required reports under Section 13 or 15(d) of the Exchange Act such that it is not in compliance with Rule 144(c)(1) (or Rule 144(i)(2), if applicable);

 

xii. the Company shall: (i) apply for or consent to the appointment of a receiver, trustee, custodian or liquidator of it or any of its properties; (ii) admit in writing its inability to pay its debts as they mature; (iii) make a general assignment for the benefit of creditors; (iv) be adjudicated a bankrupt or insolvent or be the subject of an order for relief under Title 11 of the United States Code or any bankruptcy, reorganization, insolvency, readjustment of debt, dissolution or liquidation law or statute of any other jurisdiction or foreign country; or (v) file a voluntary petition in bankruptcy, or a petition or an answer seeking reorganization or an arrangement with creditors or to take advantage or any bankruptcy, reorganization, insolvency, readjustment of debt, dissolution or liquidation law or statute, or an answer admitting the material allegations of a petition filed against it in any proceeding under any such law, or (vi) take or permit to be taken any action in furtherance of or for the purpose of effecting any of the foregoing;

 

14

 

 

xiii. if any order, judgment, or decree shall be entered, without the application, approval, or consent of the Company , by any court of competent jurisdiction, approving a petition seeking liquidation or reorganization of the Company, or appointing a receiver, trustee, custodian, or liquidator of the Company , or of all or any substantial part of its assets, and such order, judgment or decree shall continue unstayed and in effect for any period of sixty (60) calendar days;

 

xiv. the occurrence of any levy upon or seizure or attachment of, or any uninsured loss of or damage to, any property of the Company having an aggregate fair value or repair cost (as the case may be) in excess of $100,000 individually or in the aggregate, and any such levy, seizure or attachment shall not be set aside, bonded, or discharged within thirty (30) days after the date thereof;

 

xv. the Company shall fail to maintain the Reserve Amount;

 

xvi. any monetary judgment, writ or similar final process shall be entered or filed against the Company, or any of their respective property or other assets for more than $100,000, and such judgment, writ or similar final process shall remain unvacated, unbonded, or unstayed for a period of forty-five (45) calendar days;

 

xvii. The Company shall fail to comply with the “use of proceeds” of this Note as set forth in Section 8(k); or

 

xviii. The Company fails to become subject to Section 13 or 15(d) of the Exchange Act within 180 days of the Original Issue Date of this Note.

 

b) Remedies upon Event of Default. Subject to the Beneficial Ownership Limitation as set forth in Section 5(d), if any Event of Default occurs, then the outstanding Principal Amount of this Note, plus accrued but unpaid interest, liquidated damages and other amounts owing in respect thereof through the date of acceleration, shall become, at the Holder’s election, immediately due and payable at the Holder’s option, in cash or in shares of Common Stock, at the Mandatory Default Amount. After the occurrence of any Event of Default that results in the eventual acceleration of this Note, the interest rate on this Note shall accrue at the lesser of the Default Rate or the maximum rate permitted under applicable law. Upon the payment in full of the Mandatory Default Amount in cash or in shares of Common, the Holder shall promptly surrender this Note to or as directed by the Company. In connection with such acceleration described herein, the Holder need not provide, and the Company hereby waives, any presentment, demand, protest, or other notice of any kind (other than the Holder’s election to declare such acceleration), and the Holder may immediately and without expiration of any grace period enforce any and all of its rights and remedies hereunder and all other remedies available to it under applicable law. Such acceleration may be rescinded and annulled by Holder at any time prior to payment hereunder and the Holder shall have all rights as a holder of this Note until such time, if any, as the Holder receives full payment pursuant to this Section 7(b). No such rescission or annulment shall affect any subsequent Event of Default or impair any right consequent thereon.

 

Section 8. Miscellaneous.

 

a) Notices. Any and all notices or other communications or deliveries to be provided by the Holder hereunder, including, without limitation, any Notice of Conversion, shall be in writing and delivered personally, by email or facsimile, or sent by a nationally recognized overnight courier service, addressed to the Company, at 38246 North Hazelwood Circle, Cave Creek, Arizona 85331, or such other email address, facsimile number, or address as the Company may specify for such purposes by notice to the Holder delivered in accordance with this Section 8(a). Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by email or facsimile, or sent by a nationally recognized overnight courier service addressed to each Holder at the email address, facsimile number, or address of the Holder appearing on the books of the Company, or if no such email address, facsimile number, or address appears on the books of the Company, at the principal place of business of such Holder. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth on the signature pages attached hereto prior to 12:00 noon (New York City time) on any date, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 12:00 noon (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (iv) upon actual receipt by the party to whom such notice is required to be given.

 

15

 

 

b) Absolute Obligation. Except as expressly provided herein, no provision of this Note shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of, liquidated damages and accrued interest, as applicable, on this Note at the time, place, and rate, and in the coin or currency, herein prescribed. This Note is a direct debt obligation of the Company. This Note ranks pari passu with all other Notes now or hereafter issued under the terms set forth herein.

 

c) Lost or Mutilated Note. If this Note shall be mutilated, lost, stolen, or destroyed, the Company shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated Note, or in lieu of or in substitution for a lost, stolen or destroyed Note, a new Note for the Principal Amount of this Note so mutilated, lost, stolen, or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such Note, and of the ownership hereof, reasonably satisfactory to the Company.

 

d) Governing Law. All questions concerning the construction, validity, enforcement, and interpretation of this Note shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by any of the Transaction Documents (whether brought against a party hereto or its respective Affiliates, directors, officers, shareholders, employees, or agents) shall be commenced in the state and federal courts sitting in the City of Las Vegas, County of Clark (the “Nevada Courts”). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the Nevada Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such Nevada Courts, or such Nevada Courts are improper or inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Note and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Note or the transactions contemplated hereby. If any party shall commence an action or proceeding to enforce any provisions of this Note, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses incurred in the investigation, preparation, and prosecution of such action or proceeding.

 

e) Waiver. Any waiver by the Company or the Holder of a breach of any provision of this Note shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Note. The failure of the Company or the Holder to insist upon strict adherence to any term of this Note on one or more occasions shall not be considered a waiver or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term of this Note on any other occasion. Any waiver by the Company or the Holder must be in writing.

 

f) Severability. If any provision of this Note is invalid, illegal, or unenforceable, the balance of this Note shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law. The Company covenants (to the extent that it may lawfully do so) that it shall not at any time insist upon, plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension, or usury law or other law that would prohibit or forgive the Company from paying all or any portion of the principal of or interest on this Note as contemplated herein, wherever enacted, now or at any time hereafter in force, or that may affect the covenants or the performance of this Note, and the Company (to the extent it may lawfully do so) hereby expressly waives all benefits or advantage of any such law, and covenants that it will not, by resort to any such law, hinder, delay or impede the execution of any power herein granted to the Holder, but will suffer and permit the execution of every such as though no such law has been enacted.

 

16

 

 

g) Remedies, Characterizations, Other Obligations, Breaches, and Injunctive Relief. The remedies provided in this Note shall be cumulative and in addition to all other remedies available under this Note and any of the other Transaction Documents at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the Holder’s right to pursue actual and consequential damages for any failure by the Company to comply with the terms of this Note. The Company covenants to the Holder that there shall be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments, conversion, and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, the Holder shall be entitled, in addition to all other available remedies, to an injunction restraining any such breach or any such threatened breach, without the necessity of showing economic loss and without any bond or other security being required. The Company shall provide all information and documentation to the Holder that is requested by the Holder to enable the Holder to confirm the Company’s compliance with the terms and conditions of this Note.

 

h) Next Business Day. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall be made on the next succeeding Business Day.

 

i) Headings. The headings contained herein are for convenience only, do not constitute a part of this Note and shall not be deemed to limit or affect any of the provisions hereof.

 

j) Security Interest. The obligations of the Company under this Note shall be secured by that certain Security Agreement and Intellectual Property Security Agreement, each dated August 23, 2022, between the Company and the Holder.

 

Notwithstanding anything to the contrary contained in any of the Transaction Documents or any other transaction document between any Company and the Holder or any Affiliate of the Holder, to the extent there be an allocation of cash flow to pay off any obligation any Company, such cash flow shall be first allocated to pay off the Company’s obligations under this Note.

 

k) Use of Proceeds. The gross proceeds of the funding to the Company related to this Note shall be used as set forth on Exhibit 8(k).

 

(Signature Page follows)

 

17

 

 

IN WITNESS WHEREOF, the Company has caused this Note to be duly executed by a duly authorized officer as of the date first above indicated.

 

  ENDEXX CORPORATION
                                 
  By:  
  Name:  
  Title:  
  Facsimile No. for delivery of Notices: ________________

 

18

 

 

ANNEX A

 

NOTICE OF CONVERSION

 

The undersigned hereby elects to convert principal under the 12% Senior Secured Convertible Promissory Note, due August 23, 2023 of Endexx Corporation (the “Company”) into shares of common stock (the “Common Stock”) of the Company according to the conditions hereof, as of the date written below. If shares of Common Stock are to be issued in the name of a person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto and is delivering herewith such certificates and opinions as reasonably requested by the Companies in accordance therewith. No fee will be charged to the holder for any conversion, except for such transfer taxes, if any.

 

By the delivery of this Notice of Conversion the undersigned represents and warrants to the Companies that its ownership of the Common Stock does not exceed the amounts specified under Section 5 of this Note, as determined in accordance with Section 13(d) of the Exchange Act.

 

The undersigned agrees to comply with the prospectus delivery requirements under the applicable securities laws in connection with any transfer of the aforesaid shares of Common Stock.

 

Conversion calculations:

 

Date to Effect Conversion:

 

Principal Amount of Note to be Converted:

 

Payment of Interest in Common Stock __ yes __ no

 

If yes, $_____ of Interest Accrued on Account of Conversion at Issue.

 

Number of shares of Common Stock to be issued:

 

Signature:

 

Name:

 

Delivery Instructions:

 

ANNEX A

 

 

Schedule 1

CONVERSION SCHEDULE

 

This 12% Senior Secured Convertible Promissory Note, due on August 23, 2023, in the original principal amount of $__________ is issued by Endexx Corporation (the “Company”). This Conversion Schedule with respect to the Common Stock of the Company reflects conversions made under Section 5 of the above-referenced Note.

 

Dated: August 23, 2022

 

Date of Conversion (or for first entry, Original Issue Date)   Amount of Conversion  

Aggregate Principal Amount Remaining Subsequent to Conversion

(or original Principal Amount)

  Company’s Attest
             
             
             
             
             
             
             
             
             

 

SCHEDULE 1

 

 

EXHIBIT 8(K)

 

EXHIBIT 8(K)

 

Exhibit 10.41

 

REGISTRATION RIGHTS AGREEMENT

 

This Registration Rights Agreement (this “Agreement”) is made and entered into as of August 31, 2022, among Endexx Corporation, a Nevada corporation (the “Company”), M2B Funding Corp., a Florida corporation, and 3A Capital Establishment, a company registered in Liechtenstein (together the “Purchasers”, and each a “Purchaser”).

 

This Agreement is made pursuant to the Convertible Note Purchase Agreement, dated as of the date hereof, among the Company and the Purchasers (the “Purchase Agreement”).

 

The Company and the Purchasers hereby agrees as follows:

 

1. Definitions.

 

Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:

 

Advice” shall have the meaning set forth in Section 6(d).

 

Effectiveness Date” means, with respect to the Initial Registration Statement required to be filed hereunder, the 90th calendar day following the filing of the Initial Registration Statement with the Commission; provided, however, that, in the event the Company is notified by the Commission that one or more of the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the Effectiveness Date as to such Registration Statement shall be the fifth (5th) Trading Day following the date on which the Company is so notified if such date precedes the dates otherwise required above, provided, further, if such Effectiveness Date falls on a day that is not a Trading Day, then the Effectiveness Date shall be the next succeeding Trading Day.

 

Effectiveness Period” shall have the meaning set forth in Section 2(a).

 

Event” shall have the meaning set forth in Section 2(g).

 

Event Date” shall have the meaning set forth in Section 2(g).

 

Holder” means the holder, as the case may be, from time to time of Registrable Securities.

 

Indemnified Party” shall have the meaning set forth in Section 5(c).

 

Indemnifying Party” shall have the meaning set forth in Section 5(c).

 

Initial Registration Statement” means the initial Registration Statement filed pursuant to this Agreement.

 

Losses” shall have the meaning set forth in Section 5(a).

 

Plan of Distribution” shall have the meaning set forth in Section 2(a).

 

ENDEXX M2B and 3A Registration Rights Agreement August 2022.4
1
 

 

Prospectus” means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the Commission pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.

 

Registrable Securities” means, as of any date of determination, (a) all of the shares of Common Stock then issued and issuable upon conversion in full of the Notes (assuming on such date the applicable Note is converted in full without regard to any conversion limitations therein), (b) all shares of Common Stock issued and issuable as interest or principal on the Notes assuming all permissible interest and principal payments are made in shares of Common Stock and the Notes are held until maturity, (c) any additional shares of Common Stock issued and issuable in connection with any anti-dilution provisions in the Notes (in each case, without giving effect to any limitations on conversion set forth in such Note), (d) all of the shares of Common Stock then issued and issuable upon exercise in full of each Warrant (assuming on such date the applicable Warrant is exercised in full without regard to any exercise limitations therein), (e) any additional shares of Common Stock issued and issuable in connection with any anti-dilution provisions in a Warrant (in each case, without giving effect to any limitations on exercise set forth in such Warrant), and (f) any securities issued or then issuable upon any stock split, dividend, or other distribution, recapitalization, or similar event with respect to the foregoing; provided, however, that any such Registrable Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect thereto) for so long as (x) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by the Commission under the Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with such effective Registration Statement, (y) such Registrable Securities have been previously sold in accordance with Rule 144, or (z) such securities become eligible for resale without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 as set forth in a written opinion letter to such effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holder (assuming that such securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend upon which, such securities were issued or are issuable, were at no time held by any Affiliate of the Company), as reasonably determined by the Company, upon the advice of counsel to the Company.

 

Registration Statement” means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration statements contemplated by Section 2 or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by reference or deemed to be incorporated by reference in any such registration statement.

 

Rule 415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

 

ENDEXX M2B and 3A Registration Rights Agreement August 2022.4
2
 

 

Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

 

Selling Stockholder Questionnaire” shall have the meaning set forth in Section 3(a).

 

SEC Guidance” means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements, or requests of the Commission staff and (ii) the Securities Act.

 

2. Registration.

 

(a) Without Notice or Demand Registration Rights. Without the requirement of any notice or demand by the Purchasers to the Company, the Company shall effect the registration of Registrable Securities not later than four months following the date of this Agreement. The Registration Statement filed hereunder shall be on Form S-3 and shall contain substantially the “Plan of Distribution” attached hereto as Annex A and shall not contain any Person other than a Holder. If Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the resale of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form S-3 as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the Commission. Subject to the limitations set forth in Sections 2(c), the Company shall use its best efforts to cause a Registration Statement filed under this Agreement (including, without limitation, under Section 3(c)) to be declared effective under the Securities Act within ninety (90) days after the filing thereof, but in any event no later than the applicable Effectiveness Date, and shall use its best efforts to keep such Registration Statement continuously effective under the Securities Act until all Registrable Securities covered by such Registration Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) six (6) months after the Registrable Securities may be sold without volume or manner-of-sale restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under Rule 144, as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the Transfer Agent and the affected Holder (the “Effectiveness Period”). The Company shall telephonically request effectiveness of a Registration Statement as of 5:00 p.m. Eastern Time on a Trading Day. The Company shall immediately notify the Holder via facsimile or by e-mail of the effectiveness of a Registration Statement on the same Trading Day that the Company telephonically confirms effectiveness with the Commission, which shall be the date requested for effectiveness of such Registration Statement. The Company shall, by 9:30 a.m. Eastern Time on the Trading Day after the effective date of such Registration Statement, file a final Prospectus with the Commission as required by Rule 424. Failure to so notify the Holder within one (1) Trading Day of such notification of effectiveness or failure to file a final Prospectus as foresaid shall be deemed an Event under Section 2(g).

 

(b) Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement, the Company agrees to promptly inform the Holder thereof and use its commercially reasonable efforts to file amendments to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted to be registered by the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities as a secondary offering, subject to the provisions of Section 2(g); with respect to filing on Form S-3 or other appropriate form, and subject to the provisions of Section 2(g) with respect to the payment of liquidated damages; provided, however, that prior to filing such amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation 612.09.

 

ENDEXX M2B and 3A Registration Rights Agreement August 2022.4
3
 

 

(c) Reserved.

 

(d) Reserved.

 

(e) Reserved.

 

(f) Reserved.

 

(g) If: (i) the Initial Registration Statement is not filed on or prior to the time periods described in Section 2(a) (if the Company files the Initial Registration Statement without affording the Holder the opportunity to review and comment on the same as required by Section 3(a) herein, the Company shall be deemed to have not satisfied this clause (i)), or (ii) the Company fails to file with the Commission a request for acceleration of a Registration Statement in accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five (5) Trading Days of the date that the Company is notified (orally or in writing, whichever is earlier) by the Commission that such Registration Statement will not be “reviewed” or will not be subject to further review, or (iii) prior to the effective date of a Registration Statement, the Company fails to file a pre-effective amendment and otherwise respond in writing to comments made by the Commission in respect of such Registration Statement within ten (10) calendar days after the receipt of comments by or notice from the Commission that such amendment is required in order for such Registration Statement to be declared effective, or (iv) a Registration Statement registering for resale all of the Registrable Securities is not declared effective by the Commission by the Effectiveness Date of the Initial Registration Statement, or (v) after the effective date of a Registration Statement, such Registration Statement ceases for any reason to remain continuously effective as to all Registrable Securities included in such Registration Statement, or the Holder is otherwise not permitted to utilize the Prospectus therein to resell such Registrable Securities, for more than ten (10) consecutive calendar days or more than an aggregate of fifteen (15) calendar days (which need not be consecutive calendar days) during any twelve (12)-month period (any such failure or breach being referred to as an “Event”, and for purposes of clauses (i) and (iv), the date on which such Event occurs, and for purpose of clause (ii) the date on which such five (5) Trading Day-period is exceeded, and for purpose of clause (iii) the date which such ten (10) calendar-day period is exceeded, and for purpose of clause (v) the date on which such ten (10) or fifteen (15) calendar day period, as applicable, is exceeded being referred to as “Event Date”), then, in addition to any other rights the Holder may have hereunder or under applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in cash, as partial liquidated damages and not as a penalty, equal to the product of 2.0% multiplied by the aggregate Subscription Amount paid by such Holder pursuant to the Purchase Agreement. If the Company fails to pay any partial liquidated damages pursuant to this Section in full within seven days after the date payable, the Company will pay interest thereon at a rate of 18% per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily from the date such partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The partial liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the cure of an Event.

 

ENDEXX M2B and 3A Registration Rights Agreement August 2022.4
4
 

 

3. Registration Procedures. In connection with the Company’s registration obligations hereunder, the Company shall:

 

(a) Not less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed to be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed, which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of the Holder, and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning of the Securities Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto to which the Holder of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company is notified of such objection in writing no later than five (5) Trading Days after the Holder has been so furnished copies of a Registration Statement or one (1) Trading Day after the Holder has been so furnished copies of any related Prospectus or amendments or supplements thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement as Annex B (a “Selling Stockholder Questionnaire”) on a date that is not less than two (2) Trading Days prior to the Filing Date or by the end of the fourth (4th) Trading Day following the date on which such Holder receives draft materials in accordance with this Section.

 

(b) (i) Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration Statement or any amendment thereto and provide as promptly as reasonably possible to the Holder true and complete copies of all correspondence from and to the Commission relating to a Registration Statement (provided that the Company shall excise any information contained therein which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply in all material respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with the intended methods of disposition by the Holder thereof set forth in such Registration Statement as so amended or in such Prospectus as so supplemented.

 

ENDEXX M2B and 3A Registration Rights Agreement August 2022.4
5
 

 

(c) If during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case, within thirty (30) days, an additional Registration Statement covering the resale by the Holder of not less than the number of such Registrable Securities.

 

(d) Notify the Holder of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible (and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a “review” of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional information, (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement, Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company, makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus; provided, however, in no event shall any such notice contain any information which would constitute material, non-public information regarding the Company or any of its Subsidiaries.

 

(e) Use its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction, at the earliest practicable moment.

 

(f) Furnish to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference) promptly after the filing of such documents with the Commission; provided, that any such item which is available on the EDGAR system (or successor thereto) need not be furnished in physical form.

 

ENDEXX M2B and 3A Registration Rights Agreement August 2022.4
6
 

 

(g) Subject to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by each of the selling Holder in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).

 

(h) The Company shall cooperate with any broker-dealer through which a Holder proposes to resell its Registrable Securities in effecting a filing with the FINRA Corporate Finance Department pursuant to FINRA Rule 5110, as requested by any such Holder, and the Company shall pay the filing fee required by such filing within two (2) Business Days of request therefor.

 

(i) Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate with the selling Holder in connection with the registration or qualification (or exemption from the Registration or qualification) of such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of the Registrable Securities covered by each Registration Statement; provided, that, the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction where it is not then so subject or file a general consent to service of process in any such jurisdiction.

 

(j) If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holder may request.

 

(k) Upon the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into account the Company’s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. If the Company notifies the Holder in accordance with clauses (iii) through (vi) of Section 3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holder shall suspend use of such Prospectus. The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company shall be entitled to exercise its right under this Section 3(k) to suspend the availability of a Registration Statement and Prospectus, subject to the payment of partial liquidated damages otherwise required pursuant to Section 2(g), for a period not to exceed sixty (60) calendar days (which need not be consecutive days) in any 12-month period.

 

ENDEXX M2B and 3A Registration Rights Agreement August 2022.4
7
 

 

(l) Comply with all applicable rules and regulations of the Commission.

 

(m) The Company shall use its best efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration of the resale of Registrable Securities.

 

(n) The Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control over the shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of the Registrable Securities solely because any Holder fails to furnish such information within three Trading Days of the Company’s request, any liquidated damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise occur solely because of such delay shall be suspended as to such Holder only, until such information is delivered to the Company.

 

4. Registration Expenses. All fees and expenses incident to the performance of or compliance with this Agreement by the Company shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses of the Company’s counsel and independent registered public accountants) (A) with respect to filings made with the Commission, (B) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for trading, (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities) and (D) if not previously paid by the Company in connection with an Issuer Filing, with respect to any filing that may be required to be made by any broker through which a Holder intends to make sales of Registrable Securities with FINRA pursuant to FINRA Rule 5110, so long as the broker is receiving no more than a customary brokerage commission in connection with such sale, (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities), (iii) messenger, telephone, and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as required hereunder. In no event shall the Company be responsible for any broker or similar commissions of any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other costs of the Holder.

 

ENDEXX M2B and 3A Registration Rights Agreement August 2022.4
8
 

 

5. Indemnification.

 

(a) Indemnification by the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal as a result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees (and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys’ fees) and expenses (collectively, “Losses”), as incurred, arising out of or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement, any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading or (2) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but only to the extent, that (i) such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto (it being understood that the Holder has approved Annex A hereto for this purpose) or (ii) in the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi), the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated in Section 6(d), but only if and to the extent that following the receipt of the Advice the misstatement or omission giving rise to such Loss would have been corrected. The Company shall notify the Holder promptly of the institution, threat or assertion of any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities by any of the Holder in accordance with Section 6(g).

 

(b) Indemnification by Holder. The Holder shall indemnify and hold harmless the Company, its directors, officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: (x) the Holder’s failure to comply with any applicable prospectus delivery requirements of the Securities Act through no fault of the Company or (y) any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained in any information so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such Prospectus or (ii) to the extent, but only to the extent, that such information relates to such Holder’s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex A hereto for this purpose), such Prospectus or in any amendment or supplement thereto or (iii) in the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi), to the extent, but only to the extent, related to the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated, defective, or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated in Section 6(d), but only if and to the extent that following the receipt of the Advice the misstatement or omission giving rise to such Loss would have been corrected. In no event shall the liability of any selling Holder under this Section 5(b) be greater in amount than the dollar amount of the net proceeds received by such Holder upon the sale of the Registrable Securities giving rise to such indemnification obligation.

 

ENDEXX M2B and 3A Registration Rights Agreement August 2022.4
9
 

 

(c) Conduct of Indemnification Proceedings. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder (an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the “Indemnifying Party”) in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection with defense thereof; provided, that, the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have materially and adversely prejudiced the Indemnifying Party.

 

An Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.

 

Subject to the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party; provided, that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) not to be entitled to indemnification hereunder.

 

ENDEXX M2B and 3A Registration Rights Agreement August 2022.4
10
 

 

(d) Contribution. If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys’ or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party in accordance with its terms.

 

The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph. Notwithstanding the provisions of this Section 5(d), no Holder shall be required to contribute pursuant to this Section 5(d), in the aggregate, any amount in excess of the amount by which the net proceeds actually received by such Holder from the sale of the Registrable Securities subject to the Proceeding exceeds the amount of any damages that such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.

 

The indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties.

 

6. Miscellaneous.

 

(a) Remedies. In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement, the Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.

 

(b) No Piggyback on Registrations; Prohibition on Filing Other Registration Statements. Neither the Company nor any of its security holders (other than the Holder in such capacity pursuant hereto) may include securities of the Company in any Registration Statements other than the Registrable Securities. The Company shall not file any other registration statements until all Registrable Securities are registered pursuant to a Registration Statement that is declared effective by the Commission, provided that this Section 6(b) (i) shall not prohibit the Company from filing amendments to registration statements filed prior to the date of this Agreement and (ii) shall not prohibit the Company from filing a shelf registration statement on Form S-3 for a primary offering by the Company, provided that the Company makes no offering of securities pursuant to such shelf registration statement prior to the effective date of the Registration Statement required hereunder that includes all of the Registrable Securities.

 

ENDEXX M2B and 3A Registration Rights Agreement August 2022.4
11
 

 

(c) Compliance. Each Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to it (unless an exemption therefrom is available) in connection with sales of Registrable Securities pursuant to a Registration Statement.

 

(d) Discontinued Disposition. By its acquisition of Registrable Securities, the Holder agrees that, upon receipt of a notice from the Company of the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the “Advice”) by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable.

 

(e) Amendments and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified, or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by the Company and the Holder of 67% or more of the then-outstanding Registrable Securities (for purposes of clarification, this includes any Registrable Securities issuable upon exercise or conversion of any Security). If a Registration Statement does not register all of the Registrable Securities pursuant to a waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for the Holder shall be reduced pro rata the Holder shall have the right to designate which of its Registrable Securities shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of the Holder may be given only by the Holder of all of the Registrable Securities to which such waiver or consent relates; provided, however, that the provisions of this sentence may not be amended, modified, or supplemented except in accordance with the provisions of the first sentence of this Section 6(e). No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered to all of the parties to this Agreement.

 

(f) Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set forth in the Purchase Agreement.

 

(g) Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations hereunder without the prior written consent of the Holder of the then-outstanding Registrable Securities. The Holder may assign its rights hereunder in the manner and to the Persons as permitted under Section 9(g) of the Purchase Agreement.

 

ENDEXX M2B and 3A Registration Rights Agreement August 2022.4
12
 

 

(h) No Inconsistent Agreements. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing the rights granted to the Holder in this Agreement or otherwise conflicts with the provisions hereof. Except as set forth on Schedule 6(h), neither the Company nor any of its Subsidiaries has previously entered into any agreement granting any registration rights with respect to any of its securities to any Person that have not been satisfied in full.

 

(i) Execution and Counterparts. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof.

 

(j) Governing Law. All questions concerning the construction, validity, enforcement, and interpretation of this Agreement shall be determined in accordance with the provisions of the Purchase Agreement.

 

(k) Cumulative Remedies. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.

 

(l) Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants, and restrictions without including any of such that may be hereafter declared invalid, illegal, void, or unenforceable.

 

(m) Headings. The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be deemed to limit or affect any of the provisions hereof.

 

(n) Independent Nature of Holder’s Obligations and Rights. The obligations of each Holder hereunder are several and not joint with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holder as a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that the Holder is in any way acting in concert or as a group or entity with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges that the Holder is not acting in concert or as a group, and the Company shall not asset any such claim, with respect to such obligations or transactions. Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. The use of a single agreement with respect to the obligations of the Company contained was solely in the control of the Company, not the action or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested to do so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and the Holder, solely.

 

********************

 

(Signature Pages Follow)

 

ENDEXX M2B and 3A Registration Rights Agreement August 2022.4
13
 

 

IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.

 

 

ENDEXX CORPORATION

 

 

By:

                 

  Name:
  Title:

 

[SIGNATURE PAGE OF HOLDER FOLLOWS]

 

ENDEXX M2B and 3A Registration Rights Agreement August 2022.4
14
 

 

[SIGNATURE PAGE OF HOLDER TO RRA]

 

Name of Holder: M2B Funding Corp.

 

Signature of Authorized Signatory of Holder: __________________________

 

Name of Authorized Signatory: _________________________

 

Title of Authorized Signatory: __________________________

 

[SIGNATURE PAGES CONTINUE]

 

ENDEXX M2B and 3A Registration Rights Agreement August 2022.4
15
 

 

[SIGNATURE PAGE OF HOLDER TO RRA]

 

Name of Holder: 3A Capital Establishment

 

Signature of Authorized Signatory of Holder: __________________________

 

Name of Authorized Signatory: _________________________

 

Title of Authorized Signatory: __________________________

 

ENDEXX M2B and 3A Registration Rights Agreement August 2022.4
16
 

 

Annex A

 

Plan of Distribution

 

Each Selling Stockholder (the “Selling Stockholders”) of the securities and any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their securities covered hereby on The NASDAQ Capital Market or any other stock exchange, market, or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. A Selling Stockholder may use any one or more of the following methods when selling securities:

 

  ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;
     
  block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;
     
  purchases by a broker-dealer as principal and resale by the broker-dealer for its account;
     
  an exchange distribution in accordance with the rules of the applicable exchange;
     
  privately negotiated transactions;
     
  settlement of short sales;
     
  in transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated price per security;
     
  through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;
     
  a combination of any such methods of sale; or
     
  any other method permitted pursuant to applicable law.

 

The Selling Stockholders may also sell securities under Rule 144 under the Securities Act of 1933, as amended (the “Securities Act”), if available, rather than under this prospectus.

 

Broker-dealers engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in compliance with FINRA Supplemental Materials .01 Mark-Up Policy.

 

In connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling Stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).

 

ANNEX A - 1
 

 

The Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be “underwriters” within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the securities.

 

The Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify the Selling Stockholders against certain losses, claims, damages, and liabilities, including liabilities under the Securities Act.

 

Because Selling Stockholders may be deemed to be “underwriters” within the meaning of the Securities Act, they will be subject to the prospectus delivery requirements of the Securities Act including Rule 172 thereunder. In addition, any securities covered by this prospectus which qualify for sale pursuant to Rule 144 under the Securities Act may be sold under Rule 144 rather than under this prospectus. The Selling Stockholders have advised us that there is no underwriter or coordinating broker acting in connection with the proposed sale of the resale securities by the Selling Stockholders.

 

We agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.

 

Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of securities of the common stock by the Selling Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).

 

ANNEX A - 2
 

 

Annex B

 

ENDEXX CORPORATION

 

Selling Stockholder Notice and Questionnaire

 

The undersigned beneficial owner of common stock (the “Registrable Securities”) of Endexx Corporation, a Nevada corporation (the “Company”), understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Registration Rights Agreement (the “Registration Rights Agreement”) to which this document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.

 

Certain legal consequences arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling stockholder in the Registration Statement and the related prospectus.

 

NOTICE

 

The undersigned beneficial owner (the “Selling Stockholder”) of Registrable Securities hereby elects to include the Registrable Securities owned by it in the Registration Statement.

 

ANNEX B - 1
 

 

The undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:

 

QUESTIONNAIRE

 

1. Name.

 

  (a) Full Legal Name of Selling Stockholder
     
     
  (b) Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities are held:
     
     
  (c) Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by this Questionnaire):
     

 

2. Address for Notices to Selling Stockholder:

 

 
 
 
 
Telephone:
 
Fax:
 
Contact Person:
 

 

3. Broker-Dealer Status:

 

(a)Are you a broker-dealer?

 

Yes ☐No ☐

 

(b)If “yes” to Section 3(a), did you receive your Registrable Securities as compensation for investment banking services to the Company?

 

Yes ☐No ☐

 

Note:If “no” to Section 3(b), the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

ANNEX B - 2
 

 

(c)Are you an affiliate of a broker-dealer?

 

Yes ☐No ☐

 

(d)If you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?

 

Yes ☐No ☐

 

Note:If “no” to Section 3(d), the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

4. Beneficial Ownership of Securities of the Company Owned by the Selling Stockholder.

 

Except as set forth below in this Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than the securities issuable pursuant to the Purchase Agreement.

 

(a)Type and Amount of other securities beneficially owned by the Selling Stockholder:

 

     
     

 

ANNEX B - 3
 

 

5. Relationships with the Company:

 

Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors, or principal equity holders (owners of 5% of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years.

 

State any exceptions here:

 

   
   

 

The undersigned agrees to promptly notify the Company of any inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof at any time while the Registration Statement remains effective.

 

By signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and the inclusion of such information in the Registration Statement and the related prospectus and any amendments or supplements thereto. The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related prospectus and any amendments or supplements thereto.

 

IN WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized agent.

 

Date: _____________________ Beneficial Owner: ___________________
   
  By:  
  Name:                             
  Title:

 

PLEASE FAX A COPY (OR EMAIL A .PDF COPY) OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE, AND RETURN THE ORIGINAL BY OVERNIGHT MAIL, TO:

 

ANNEX B - 4

 

 

Exhibit 10.42

 

SECURITY AGREEMENT

 

This SECURITY AGREEMENT, dated as of August 31, 2022 (this “Agreement”), is by and among Endexx Corporation, a Florida corporation (the “Company”), M2B Funding Corp., a Florida corporation with offices located at 20801 Biscayne Blvd., Suite 307, Aventura, Florida 33180 (the “Lead Investor”), and 3A Capital Establishment, a company registered in Liechtenstein with offices at Austrasse 40 Vaduz N2 9490 (the “Co-Investor”), as the holders of the Company’s 12% Senior Secured Convertible Promissory Notes, in the original aggregate principal amount of $2,173,913.04 (collectively, the “Notes”) and its endorsees, transferees, and assigns (collectively, the Lead Investor and the Co-Investor are the “Secured Parties”, and each is a “Secured Party”).

 

W I T N E S S E T H:

 

WHEREAS, the Secured Parties have agreed to extend the loans to the Company evidenced by the Notes;

 

WHEREAS, in order to induce the Secured Parties to extend the loans evidenced by the Notes, the Company has agreed to execute and deliver to each Secured Party this Agreement and to grant each Secured Party a security interest in certain property of the Company to secure the prompt payment, performance and discharge in full of all of the Company’s obligations under the Notes.

 

NOW, THEREFORE, in consideration of the agreements herein contained and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows:

 

1. Certain Definitions. As used in this Agreement, the following terms shall have the meanings set forth in this Section 1. Terms used but not otherwise defined in this Agreement that are defined in Article 9 of the UCC (such as “account”, “chattel paper”, “commercial tort claim”, “deposit account”, “document”, “equipment”, “fixtures”, “general intangibles”, “goods”, “instruments”, “inventory”, “investment property”, “letter-of-credit rights”, “proceeds” and “supporting obligations”) shall have the respective meanings given such terms in Article 9 of the UCC.

 

(a) “Collateral” means the collateral in which the Secured Parties are granted a security interest by this Agreement and which shall include the following personal property of the Company, whether presently owned or existing or hereafter acquired or coming into existence, wherever situated, and all additions and accessions thereto and all substitutions and replacements thereof, and all proceeds, products and accounts thereof, including, without limitation, all proceeds from the sale or transfer of the Collateral and of insurance covering the same and of any tort claims in connection therewith, and all dividends, interest, cash, notes, securities, equity interest or other property at any time and from time to time acquired, receivable or otherwise distributed in respect of, or in exchange for, any or all of the Pledged Securities (as defined below):

 

(i) All goods, including, without limitation, (A) all machinery, equipment, computers, motor vehicles, trucks, tanks, boats, ships, appliances, furniture, special and general tools, fixtures, test and quality control devices and other equipment of every kind and nature and wherever situated, together with all documents of title and documents representing the same, all additions and accessions thereto, replacements therefor, all parts therefor, and all substitutes for any of the foregoing and all other items used and useful in connection with the Company’s businesses and all improvements thereto; and (B) all inventory;

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean1
 

 

(ii) All contract rights and other general intangibles, including, without limitation, all partnership interests, membership interests, stock or other securities, rights under any of the Organizational Documents, agreements related to the Pledged Securities, licenses, distribution and other agreements, computer software (whether “off-the-shelf”, licensed from any third party or developed by the Company), computer software development rights, leases, franchises, customer lists, quality control procedures, grants and rights, goodwill, Intellectual Property and income tax refunds;

 

(iii) All accounts, together with all instruments, all documents of title representing any of the foregoing, all rights in any merchandising, goods, equipment, motor vehicles and trucks which any of the same may represent, and all right, title, security, and guaranties with respect to each account, including any right of stoppage in transit;

 

(iv) All documents, letter-of-credit rights, instruments, and chattel paper;

 

(v) All commercial tort claims;

 

(vi) All deposit accounts and all cash (whether or not deposited in such deposit accounts);

 

(vii) All investment property;

 

(viii) All supporting obligations;

 

(ix) All assets of and equity interests held by the Company;

 

(ix) All files, records, books of account, business papers, and computer programs; and

 

(x) The products and proceeds of all of the foregoing Collateral set forth in clauses (i)-(ix) above.

 

Without limiting the generality of the foregoing, the “Collateral” shall include all investment property and general intangibles respecting ownership and/or other equity interests in each Guarantor, including, without limitation, the shares of capital stock and the other equity interests listed on Schedule H hereto (as the same may be modified from time to time pursuant to the terms hereof), and any other shares of capital stock and/or other equity interests of any other direct or indirect subsidiary of the Company obtained in the future, and, in each case, all certificates representing such shares and/or equity interests and, in each case, all rights, options, warrants, stock, other securities and/or equity interests that may hereafter be received, receivable or distributed in respect of, or exchanged for, any of the foregoing and all rights arising under or in connection with the Pledged Securities, including, but not limited to, all dividends, interest and cash.

 

Notwithstanding the foregoing, nothing herein shall be deemed to constitute an assignment of any asset which, in the event of an assignment, becomes void by operation of applicable law or the assignment of which is otherwise prohibited by applicable law (in each case to the extent that such applicable law is not overridden by Sections 9-406, 9-407 and/or 9-408 of the UCC or other similar applicable law); provided, however, that to the extent permitted by applicable law, this Agreement shall create a valid security interest in such asset and, to the extent permitted by applicable law, this Agreement shall create a valid security interest in the proceeds of such asset.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean2
 

 

(b) “Intellectual Property” means the collective reference to all rights, priorities and privileges relating to intellectual property, whether arising under United States, multinational or foreign laws or otherwise, including, without limitation, (i) all copyrights arising under the laws of the United States, any other country or any political subdivision thereof, whether registered or unregistered and whether published or unpublished, all registrations and recordings thereof, and all applications in connection therewith, including, without limitation, all registrations, recordings and applications in the United States Copyright Office, (ii) all letters patent of the United States, any other country or any political subdivision thereof, all reissues and extensions thereof, and all applications for letters patent of the United States or any other country and all divisions, continuations and continuations-in-part thereof, (iii) all trademarks, trade names, corporate names, company names, business names, fictitious business names, trade dress, service marks, logos, domain names and other source or business identifiers, and all goodwill associated therewith, now existing or hereafter adopted or acquired, all registrations and recordings thereof, and all applications in connection therewith, whether in the United States Patent and Trademark Office or in any similar office or agency of the United States, any State thereof or any other country or any political subdivision thereof, or otherwise, and all common law rights related thereto, (iv) all trade secrets arising under the laws of the United States, any other country or any political subdivision thereof, (v) all rights to obtain any reissues, renewals or extensions of the foregoing, (vi) all licenses for any of the foregoing, and (vii) all causes of action for infringement of the foregoing.

 

(c) “Liens” means a lien, charge, pledge, security interest, encumbrance, and right of first refusal, preemptive right, or other restriction.

 

(d) “Majority in Interest” means, at any time of determination, the majority in interest (based on then-outstanding principal amounts of the Notes at the time of such determination) of the Secured Parties.

 

(e) “Necessary Endorsement” means undated stock powers endorsed in blank or other proper instruments of assignment duly executed and such other instruments or documents as the Agent (as that term is defined below) may reasonably request.

 

(f) “Obligations” means all of the liabilities and obligations (primary, secondary, direct, contingent, sole, joint or several) due or to become due, or that are now or may be hereafter contracted or acquired, or owing to, of the Company to the Secured Party, including, without limitation, all obligations under this Agreement, the Notes, and any other instruments, agreements or other documents executed and/or delivered in connection herewith or therewith, in each case, whether now or hereafter existing, voluntary or involuntary, direct or indirect, absolute or contingent, liquidated or unliquidated, whether or not jointly owed with others, and whether or not from time to time decreased or extinguished and later increased, created or incurred, and all or any portion of such obligations or liabilities that are paid, to the extent all or any part of such payment is avoided or recovered directly or indirectly from the Secured Party as a preference, fraudulent transfer or otherwise as such obligations may be amended, supplemented, converted, extended or modified from time to time. Without limiting the generality of the foregoing, the term “Obligations” shall include, without limitation: (i) principal of, and interest on the Notes and the loan(s) extended pursuant thereto; (ii) any and all other fees, indemnities, costs, obligations and liabilities of the Company from time to time under or in connection with this Agreement, the Notes, and any other instruments, agreements or other documents executed and/or delivered in connection herewith or therewith; and (iii) all amounts (including but not limited to post-petition interest) in respect of the foregoing that would be payable but for the fact that the obligations to pay such amounts are unenforceable or not allowable due to the existence of a bankruptcy, reorganization or similar proceeding involving the Company.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean3
 

 

(g) “Organizational Documents” means with respect to the Company, the documents by which the Company was organized (such as a certificate of incorporation, certificate of limited partnership or articles of organization, and including, without limitation, any certificates of designation for preferred stock or other forms of preferred equity) and which relate to the internal governance of the Company (such as bylaws, a partnership agreement or an operating, limited liability or members agreement).

 

(h) “Permitted Liens” means the following:

 

(i) Liens imposed by law for taxes that are not yet due or are being contested in good faith, which in each case, have been appropriately reserved for;

 

(ii) carriers’, warehousemen’s, mechanics’, materialmen’s, repairmen’s and other like Liens imposed by law, arising in the ordinary course of business and securing obligations that are not overdue by more than thirty (30) days or are being contested in good faith;

 

(iii) pledges and deposits made in the ordinary course of business in compliance with workers’ compensation, unemployment insurance and other social security laws or regulations;

 

(iv) deposits to secure the performance of bids, trade contracts, leases, statutory obligations, surety and appeal bonds, performance bonds and other obligations of a like nature, in each case in the ordinary course of business;

 

(v) Liens under this Agreement; and

 

(vi) Any other Liens in favor of the Secured Parties.

 

(i) “Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

(j) “Pledged Interests” means the ownership and other equity interests in partnerships and limited liability companies (if any) included in the Collateral.

 

(k) “Pledged Securities” shall have the meaning ascribed to such term in Section 4(i).

 

(l) “UCC” means the Uniform Commercial Code of the State of Florida and or any other applicable law of any state or states that have jurisdiction with respect to all, or any portion of, the Collateral or this Agreement, from time to time. It is the intent of the parties that defined terms in the UCC should be construed in their broadest sense so that the term “Collateral” will be construed in its broadest sense. Accordingly, if there are, from time to time, changes to defined terms in the UCC that broaden the definitions, they are incorporated herein and if existing definitions in the UCC are broader than the amended definitions, the existing ones shall be controlling.

 

2. Grant of Security Interest in Collateral. As an inducement for each Secured Party to extend the loans as evidenced by the Notes and to secure the complete and timely payment, performance and discharge in full, as the case may be, of all of the Obligations, the Company hereby unconditionally and irrevocably pledges, grants and hypothecates to the Secured Parties a perfected, first priority security interest in and to, a lien upon and a right of set-off against all of their respective right, title and interest of whatsoever kind and nature in and to, the Collateral (a “Security Interest” and, collectively, the “Security Interests”).

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean4
 

 

3. Delivery of Certain Collateral. Contemporaneously or prior to the execution of this Agreement, the Company shall deliver or cause to be delivered to the Agent (a) any and all certificates and other instruments representing or evidencing the Pledged Securities, and (b) any and all certificates and other instruments or documents representing any of the other Collateral, in each case, together with all Necessary Endorsements. The Company are, contemporaneously with the execution hereof, delivering to Agent, or have previously delivered to Agent, a true and correct copy of each Organizational Document governing any of the Pledged Securities. Each Guarantor has, pursuant to Section 8-103(c) of the UCC, elected in its Organizational Documents that the Pledged Interests shall be treated as securities governed by Article 8 of the UCC.

 

4. Representations, Warranties, Covenants, and Agreements of the Company. Except as set forth under the corresponding section of the disclosure schedules delivered to the Secured Parties concurrently herewith (the “Disclosure Schedules”), which Disclosure Schedules shall be deemed a part hereof, the Company represents and warrants to, and covenants and agrees with, the Secured Parties as follows:

 

(a) The Company has the requisite corporate, partnership, limited liability company or other power and authority to enter into this Agreement and otherwise to carry out its obligations hereunder. The execution, delivery, and performance by the Company of this Agreement and the filings contemplated therein have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company. This Agreement has been duly executed by the Company. This Agreement constitutes the legal, valid, and binding obligation of the Company, enforceable against the Company in accordance with its terms except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, and similar laws of general application relating to or affecting the rights and remedies of creditors and by general principles of equity.

 

(b) The Company has no place of business or offices where their respective books of account and records are kept (other than temporarily at the offices of its attorneys or accountants) or places where Collateral is stored or located, except as set forth on Schedule A attached hereto. Except as specifically set forth on Schedule A, the Company is the record owner of the real property where such Collateral is located, and there exist no mortgages or other liens on any such real property except for Liens as set forth on Schedule A. Except as disclosed on Schedule A, none of such Collateral is in the possession of any consignee, bailee, warehouseman, agent, or processor.

 

(c) Except as set forth on Schedule B attached hereto, the Company is the sole owner of the Collateral (except for non-exclusive licenses granted by the Company in the ordinary course of business), free and clear of any liens, security interests, encumbrances, rights, or claims, and are fully authorized to grant the Security Interests. Except as set forth on Schedule C attached hereto, there is not on file in any governmental or regulatory authority, agency or recording office an effective financing statement, security agreement, license or transfer or any notice of any of the foregoing (other than those that will be filed in favor of the Secured Party pursuant to this Agreement) covering or affecting any of the Collateral. Except as set forth on Schedule C attached hereto and except pursuant to this Agreement, as long as this Agreement shall be in effect, the Company shall not execute and shall not knowingly permit to be on file in any such office or agency any other financing statement or other document or instrument (except to the extent filed or recorded in favor of the Secured Party pursuant to the terms of this Agreement).

 

(d) No written claim has been received that any Collateral or the Company’s use of any Collateral violates the rights of any third party. There has been no adverse decision to the Company’s claim of ownership rights in or exclusive rights to use the Collateral in any jurisdiction or to the Company’s right to keep and maintain such Collateral in full force and effect, and there is no proceeding involving said rights pending or, to the best knowledge of the Company, threatened before any court, judicial body, administrative or regulatory agency, arbitrator, or other governmental authority.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean5
 

 

(e) The Company shall at all times maintain its books of account and records relating to the Collateral at its principal place of business and its Collateral at the locations set forth on Schedule A attached hereto and may not relocate such books of account and records or tangible Collateral unless it delivers to Agent at least thirty (30) days prior to such relocation (i) written notice of such relocation and the new location thereof (which must be within the United States) and (ii) evidence that appropriate financing statements under the UCC and other necessary documents have been filed and recorded and other steps have been taken to perfect the Security Interests to create in favor of the Secured Party a valid, perfected and continuing perfected first priority lien in the Collateral.

 

(f) This Agreement creates in favor of the Secured Parties a valid security interest in the Collateral, securing the payment and performance of the Obligations. Upon making the filings described in the immediately following paragraph, all security interests created hereunder in any Collateral which may be perfected by filing Uniform Commercial Code financing statements shall have been duly perfected. Except for (i) the filing of the Uniform Commercial Code financing statements referred to in the immediately following paragraph, (ii) the recordation of the Intellectual Property Security Agreement (as defined in Section 4(p) hereof) with respect to copyrights and copyright applications in the United States Copyright Office referred to in Section 4(mm), (iii) the recordation of the Intellectual Property Security Agreement (as defined in Section 4(p) hereof) with respect to patents and trademarks of the Company in the United States Patent and Trademark Office referred to in Section 4(oo), (iv) the execution and delivery of deposit account control agreements satisfying the requirements of Section 9-104(a)(2) of the UCC with respect to each deposit account of the Company, (v) if there is any investment property or deposit account included as Collateral that can be perfected by “control” through an account control agreement, the execution and delivery of securities account control agreements satisfying the requirements of 9-106 of the UCC with respect to each such investment property of the Company, and (vi) the delivery of the certificates and other instruments provided in Section 3, Section 4(aa) and Section 4(cc), no action is necessary to create, perfect or protect the security interests created hereunder. Without limiting the generality of the foregoing, except for the foregoing, no consent of any third parties and no authorization, approval, or other action by, and no notice to or filing with, any governmental authority or regulatory body is required for (x) the execution, delivery, and performance of this Agreement, (y) the creation or perfection of the Security Interests created hereunder in the Collateral or (z) the enforcement of the rights of the Agent and the Secured Parties hereunder.

 

(g) The Company hereby authorizes the Agent to file one or more financing statements under the UCC, with respect to the Security Interests, with the proper filing and recording agencies in any jurisdiction deemed proper by it.

 

(h) The execution, delivery and performance of this Agreement by the Company does not (i) violate any of the provisions of any Organizational Documents of the Company or any judgment, decree, order or award of any court, governmental body or arbitrator or any applicable law, rule or regulation applicable to the Company or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing the Company’s debt or otherwise) or other understanding to which the Company is a party or by which any property or asset of the Company is bound or affected. If any, all required consents (including, without limitation, from stockholders or creditors of the Company) necessary for the Company to enter into and perform its obligations hereunder have been obtained.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean6
 

 

(i) The capital stock and other equity interests listed on Schedule H hereto (the “Pledged Securities”) represent all of the capital stock and other equity interests of the Guarantors, and represent all capital stock and other equity interests owned, directly or indirectly, by the Company. All of the Pledged Securities are validly issued, fully paid and nonassessable, and the Company is the legal and beneficial owner of the Pledged Securities, free and clear of any lien, security interest or other encumbrance except for the security interests created by this Agreement and other Permitted Liens as set forth on Schedule A hereto.

 

(j) [Intentionally Omitted.]

 

(k) The Company shall at all times maintain the liens and Security Interests provided for hereunder as valid and perfected, first priority liens and security interests in the Collateral in favor of the Secured Parties until this Agreement and the Security Interest hereunder shall be terminated pursuant to Section 14 hereof. The Company hereby agrees to defend the same against the claims of any and all persons and entities. The Company shall safeguard and protect all Collateral for the account of the Secured Parties. At the request of the Agent, the Company will sign and deliver to the Agent on behalf of the Secured Parties at any time or from time to time one or more financing statements pursuant to the UCC in form reasonably satisfactory to the Agent and will pay the cost of filing the same in all public offices wherever filing is, or is deemed by the Agent to be, necessary or desirable to effect the rights and obligations provided for herein. Without limiting the generality of the foregoing, the Company shall pay all fees, taxes, and other amounts necessary to maintain the Collateral and the Security Interests hereunder, and the Company shall obtain and furnish to the Agent from time to time, upon demand, such releases and/or subordinations of claims and liens which may be required to maintain the priority of the Security Interests hereunder.

 

(l) The Company will not transfer, pledge, hypothecate, encumber, license, sell or otherwise dispose of any of the Collateral (except for non-exclusive licenses granted by the Company in its ordinary course of business, sales of inventory by the Company in its ordinary course of business and the replacement of worn-out or obsolete equipment by the Company in its ordinary course of business) without the prior written consent of a Majority in Interest.

 

(m) The Company shall keep and preserve its equipment, inventory and other tangible Collateral in good condition, repair and order and shall not operate or locate any such Collateral (or cause to be operated or located) in any area excluded from insurance coverage.

 

(n) The Company shall maintain with financially sound and reputable insurers, insurance with respect to the Collateral, including Collateral hereafter acquired, against loss or damage of the kinds and in the amounts customarily insured against by entities of established reputation having similar properties similarly situated and in such amounts as are customarily carried under similar circumstances by other such entities and otherwise as is prudent for entities engaged in similar businesses but in any event sufficient to cover the full replacement cost thereof. The Company shall cause each insurance policy issued in connection herewith to provide, and the insurer issuing such policy to certify to the Agent, that (a) the Agent will be named as lender loss payee and additional insured under each such insurance policy; (b) if such insurance be proposed to be cancelled or materially changed for any reason whatsoever, such insurer will promptly notify the Agent and such cancellation or change shall not be effective as to the Agent for at least thirty (30) days after receipt by the Agent of such notice, unless the effect of such change is to extend or increase coverage under the policy; and (c) the Agent will have the right (but no obligation) at its election to remedy any default in the payment of premiums within thirty (30) days of notice from the insurer of such default. If no Event of Default (as defined in the Notes) exists and if the proceeds arising out of any claim or series of related claims do not exceed $100,000, loss payments in each instance will be applied by the Company to the repair and/or replacement of property with respect to which the loss was incurred to the extent reasonably feasible, and any loss payments or the balance thereof remaining, to the extent not so applied, shall be payable to the Company; provided, however, that payments received by the Company after an Event of Default occurs and is continuing or in excess of $100,000 for any occurrence or series of related occurrences shall be paid to the Agent on behalf of the Secured Parties and, if received by the Company, shall be held in trust for the Secured Parties and immediately paid over to the Agent unless otherwise directed in writing by the Agent. Copies of such policies or the related certificates, in each case, naming the Agent as lender loss payee and additional insured shall be delivered to the Agent at least annually and at the time any new policy of insurance is issued.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean7
 

 

(o) The Company shall, within ten (10) days of obtaining knowledge thereof, advise the Secured Parties promptly, in sufficient detail, of any material adverse change in the Collateral, and of the occurrence of any event which would have a material adverse effect on the value of the Collateral or on the Secured Parties’ security interest, through the Agent, therein.

 

(p) The Company shall promptly execute and deliver to the Agent such further deeds, mortgages, assignments, security agreements, financing statements or other instruments, documents, certificates and assurances and take such further action as the Agent may from time to time request and may in its sole discretion deem necessary to perfect, protect or enforce the Secured Party’ security interest in the Collateral including, without limitation, if applicable, the execution and delivery of a separate security agreement with respect to the Company’s Intellectual Property (“Intellectual Property Security Agreement”) in which the Secured Parties have been granted a security interest hereunder, substantially in a form reasonably acceptable to the Agent, which Intellectual Property Security Agreement, other than as stated therein, shall be subject to all of the terms and conditions hereof.

 

(q) Upon reasonable prior notice (so long as no Event of Default has occurred or continuing, which in either such event, no prior notice is required), the Company shall permit the Agent and its representatives and agents to inspect the Collateral during normal business hours and to make copies of records pertaining to the Collateral as may be reasonably requested by the Agent from time to time.

 

(r) The Company shall take all steps reasonably necessary to diligently pursue and seek to preserve, enforce, and collect any rights, claims, causes of action and accounts receivable in respect of the Collateral.

 

(s) The Company shall promptly notify the Secured Parties in sufficient detail upon becoming aware of any attachment, garnishment, execution, or other legal process levied against any Collateral and of any other information received by the Company that may materially affect the value of the Collateral, the Security Interest or the rights and remedies of the Secured Parties hereunder.

 

(t) All information heretofore, herein or hereafter supplied to the Secured Parties by or on behalf of the Company with respect to the Collateral is accurate and complete in all material respects as of the date furnished.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean8
 

 

(u) The Company shall at all times preserve and keep in full force and effect their respective valid existence and good standing and any rights and franchises material to its business.

 

(v) The Company will not change its name, type of organization, jurisdiction of organization, organizational identification number (if it has one), legal or corporate structure, or identity, or add any new fictitious name unless it provides at least thirty (30) days prior written notice to the Secured Parties of such change and, at the time of such written notification, the Company provides any financing statements or fixture filings necessary to perfect and continue the perfection of the Security Interests granted and evidenced by this Agreement.

 

(w) Except in the ordinary course of business, the Company may not consign any of its inventory or sell any of its inventory on bill and hold, sale or return, sale on approval, or other conditional terms of sale without the consent of the Agent which shall not be unreasonably withheld.

 

(x) The Company may not relocate its chief executive office to a new location without providing thirty (30) days prior written notification thereof to each Secured Party and so long as, at the time of such written notification, the Company provides any financing statements or fixture filings necessary to perfect and continue the perfection of the Security Interests granted and evidenced by this Agreement.

 

(y) The Company was organized and remains organized solely under the laws of the state set forth next to the Company’s name in Schedule D attached hereto, which Schedule D sets forth the Company’s organizational identification number or, if the Company does not have one, states that one does not exist.

 

(z) (i) The actual name of the Company is the name set forth in Schedule D attached hereto; (ii) the Company has no other trade names except as set forth on Schedule E attached hereto; (iii) the Company has not used any name other than that stated in the preamble hereto or as set forth on Schedule E for the preceding five (5) years; and (iv) no entity has merged into the Company or been acquired by the Company within the past five years except as set forth on Schedule E.

 

(aa) At any time and from time to time that any Collateral consists of instruments, certificated securities or other items that require or permit possession by the secured party to perfect the security interest created hereby, the Company shall deliver such Collateral to the Agent.

 

(bb) The Company, in its capacity as issuer, hereby agrees to comply with any and all orders and instructions of Agent regarding the Pledged Interests consistent with the terms of this Agreement without the further consent of the Company as contemplated by Section 8-106 (or any successor section) of the UCC. Further, the Company agrees that it shall not enter into a similar agreement (or one that would confer “control” within the meaning of Article 8 of the UCC) with any other person or entity.

 

(cc) The Company shall cause all tangible chattel paper constituting Collateral to be delivered to the Agent, or, if such delivery is not possible, then to cause such tangible chattel paper to contain a legend noting that it is subject to the security interest created by this Agreement. To the extent that any Collateral consists of electronic chattel paper, the applicable The Company shall cause the underlying chattel paper to be “marked” within the meaning of Section 9-105 of the UCC (or successor Section thereto).

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean9
 

 

(dd) If there is any investment property or deposit account included as Collateral that can be perfected by “control” through an account control agreement, the applicable The Company shall cause such an account control agreement, in form and substance in each case satisfactory to the Agent, to be entered into and delivered to the Agent for the benefit of the Secured Parties.

 

(ee) To the extent that any Collateral consists of letter-of-credit rights, the Company shall cause the issuer of each underlying letter of credit to consent to an assignment of the proceeds thereof to the Secured Parties.

 

(ff) To the extent that any Collateral is in the possession of any third party, the Company shall join with the Agent in notifying such third party of the Secured Parties’ security interest in such Collateral and shall use its best efforts to obtain an acknowledgement and agreement from such third party with respect to the Collateral, in form and substance reasonably satisfactory to the Agent.

 

(gg) If the Company shall at any time hold or acquire a commercial tort claim, the Company shall promptly notify the Secured Parties in a writing signed by the Company of the particulars thereof and grant to the Secured Parties in such writing a security interest therein and in the proceeds thereof, all upon the terms of this Agreement, with such writing to be in form and substance satisfactory to the Agent.

 

(hh) The Company shall immediately provide written notice to the Secured Parties of any and all accounts which arise out of contracts with any governmental authority and, to the extent necessary to perfect or continue the perfected status of the Security Interests in such accounts and proceeds thereof, shall execute and deliver to the Agent an assignment of claims for such accounts and cooperate with the Agent in taking any other steps required, in its judgment, under the Federal Assignment of Claims Act or any similar federal, state or local statute or rule to perfect or continue the perfected status of the Security Interests in such accounts and proceeds thereof.

 

(ii) [Reserved.]

 

(jj) The Company shall vote the Pledged Securities to comply with the covenants and agreements set forth herein and in the Notes.

 

(kk) The Company shall register the pledge of the applicable Pledged Securities on the books of the Company. The Company shall notify each issuer of Pledged Securities to register the pledge of the applicable Pledged Securities in the name of the Secured Parties on the books of such issuer. Further, except with respect to certificated securities delivered to the Agent, the Company shall deliver to Agent an acknowledgement of pledge (which, where appropriate, shall comply with the requirements of the relevant UCC with respect to perfection by registration) signed by the issuer of the applicable Pledged Securities, which acknowledgement shall confirm that: (a) it has registered the pledge on its books and records; and (b) at any time directed by Agent during the continuation of an Event of Default, such issuer will transfer the record ownership of such Pledged Securities into the name of any designee of Agent, will take such steps as may be necessary to effect the transfer, and will comply with all other instructions of Agent regarding such Pledged Securities without the further consent of the Company.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean10
 

 

(ll) In the event that, upon an occurrence of an Event of Default, Agent shall sell all or any of the Pledged Securities to another party or parties (herein called the “Transferee”) or shall purchase or retain all or any of the Pledged Securities, the Company shall, to the extent applicable: (i) deliver to Agent or the Transferee, as the case may be, the articles of incorporation, bylaws, minute books, stock certificate books, corporate seals, deeds, leases, indentures, agreements, evidences of indebtedness, books of account, financial records and all other Organizational Documents and records of the Company and their direct and indirect subsidiaries (but not including any items subject to the attorney-client privilege related to this Agreement or any of the transactions hereunder); (ii) use its best efforts to obtain resignations of the persons then serving as officers and directors of the Company and their direct and indirect subsidiaries, if so requested; and (iii) use its best efforts to obtain any approvals that are required by any governmental or regulatory body in order to permit the sale of the Pledged Securities to the Transferee or the purchase or retention of the Pledged Securities by Agent and allow the Transferee or Agent to continue the business of the Company and their direct and indirect subsidiaries.

 

(mm) Without limiting the generality of the other obligations of the Company hereunder, the Company shall promptly (i) cause to be registered at the United States Copyright Office all of its material copyrights, (ii) cause the security interest contemplated hereby with respect to all Intellectual Property registered at the United States Copyright Office or United States Patent and Trademark Office to be duly recorded at the applicable office, and (iii) give the Agent notice whenever it acquires (whether absolutely or by license) or creates any additional material Intellectual Property.

 

(nn) The Company will from time to time, at the joint and several expense of the Company, promptly execute and deliver all such further instruments and documents, and take all such further action as may be necessary or desirable, or as the Agent may reasonably request, in order to perfect and protect any security interest granted or purported to be granted hereby or to enable the Secured Party to exercise and enforce their rights and remedies hereunder and with respect to any Collateral or to otherwise carry out the purposes of this Agreement.

 

(oo) Schedule F attached hereto lists all of the patents, patent applications, trademarks, trademark applications, registered copyrights, and domain names owned by any of the Company as of the date hereof. Schedule F lists all material licenses in favor of the Company for the use of any patents, trademarks, copyrights, and domain names as of the date hereof. All material patents and trademarks of the Company have been duly recorded at the United States Patent and Trademark Office and all material copyrights of the Company have been duly recorded at the United States Copyright Office.

 

(pp) Except as set forth on Schedule G attached hereto, none of the Company or other persons or entities obligated on any of the Collateral is a governmental authority covered by the Federal Assignment of Claims Act or any similar federal, state, or local statute or rule in respect of such Collateral.

 

5. Effect of Pledge on Certain Rights. If any of the Collateral subject to this Agreement consists of nonvoting equity or ownership interests (regardless of class, designation, preference or rights) that may be converted into voting equity or ownership interests upon the occurrence of certain events (including, without limitation, upon the transfer of all or any of the other stock or assets of the issuer), it is agreed by the Company that the pledge of such equity or ownership interests pursuant to this Agreement or the enforcement of any of Agent’s rights hereunder shall not be deemed to be the type of event which would trigger such conversion rights notwithstanding any provisions in the Organizational Documents or agreements to which the Company is subject or to which the Company is party.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean11
 

 

6. Defaults. The following events shall be “Events of Default”:

 

(a) The occurrence of an Event of Default (as defined in the Notes) under the Notes;

 

(b) Any representation or warranty of the Company in this Agreement shall prove to have been incorrect in any material respect when made;

 

(c) The failure by the Company to observe or perform any of its obligations hereunder for five (5) days after delivery to the Company of notice of such failure by or on behalf of a Secured Party unless such default is capable of cure but cannot be cured within such time frame and the Company is using best efforts to cure same in a timely fashion; or

 

(d) If any provision of this Agreement shall at any time for any reason be declared to be null and void, or the validity or enforceability thereof shall be contested by the Company, or a proceeding shall be commenced by the Company, or by any governmental authority having jurisdiction over the Company, seeking to establish the invalidity or unenforceability thereof, or the Company shall deny that the Company has any liability or obligation purported to be created under this Agreement.

 

7. Duty to Hold in Trust.

 

(a) Upon the occurrence of any Event of Default and at any time thereafter, the Company shall, upon receipt of any revenue, income, dividend, interest or other sums subject to the Security Interests, whether payable pursuant to the Notes or otherwise, or of any check, draft, note, trade acceptance or other instrument evidencing an obligation to pay any such sum, hold the same in trust for the Secured Parties and shall forthwith endorse and transfer any such sums or instruments, or both, to the Secured Parties, pro-rata in proportion to their respective then-currently outstanding principal amount of the Notes for application to the satisfaction of the Obligations (and if the Notes is not outstanding, pro-rata in proportion to the initial purchases of the Notes).

 

(b) If the Company shall become entitled to receive or shall receive any securities or other property (including, without limitation, shares of Pledged Securities or instruments representing Pledged Securities acquired after the date hereof, or any options, warrants, rights or other similar property or certificates representing a dividend, or any distribution in connection with any recapitalization, reclassification or increase or reduction of capital, or issued in connection with any reorganization of the Company or any of its direct or indirect subsidiaries) in respect of the Pledged Securities (whether as an addition to, in substitution of, or in exchange for, such Pledged Securities or otherwise), the Company agrees to (i) accept the same as the agent of the Secured Parties; (ii) hold the same in trust on behalf of and for the benefit of the Secured Parties; and (iii) to deliver any and all certificates or instruments evidencing the same to Agent on or before the close of business on the fifth (5th) business day following the receipt thereof by the Company, in the exact form received together with the Necessary Endorsements, to be held by Agent subject to the terms of this Agreement as Collateral.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean12
 

 

8. Rights and Remedies Upon Default.

 

(a) Upon the occurrence of any Event of Default and at any time thereafter, the Secured Parties, acting through the Agent, shall have the right to exercise all of the remedies conferred hereunder and under the Notes, and the Secured Parties shall have all the rights and remedies of a secured party under the UCC. Without limitation, the Agent, for the benefit of the Secured Parties, shall have the following rights and powers:

 

(i) The Agent shall have the right to take possession of the Collateral and, for that purpose, enter, with the aid and assistance of any person, any premises where the Collateral, or any part thereof, is or may be placed and remove the same, and the Company shall assemble the Collateral and make it available to the Agent at places which the Agent shall reasonably select, whether at the Company’s premises or elsewhere, and make available to the Agent, without rent, all of the Company’s respective premises and facilities for the purpose of the Agent taking possession of, removing or putting the Collateral in saleable or disposable form.

 

(ii) Upon notice to the Company by Agent, all rights of the Company to exercise the voting and other consensual rights which it would otherwise be entitled to exercise and all rights of the Company to receive the dividends and interest which it would otherwise be authorized to receive and retain, shall cease. Upon such notice, Agent shall have the right to receive, for the benefit of the Secured Parties, any interest, cash dividends or other payments on the Collateral and, at the option of Agent, to exercise in such Agent’s discretion all voting rights pertaining thereto. Without limiting the generality of the foregoing, Agent shall have the right (but not the obligation) to exercise all rights with respect to the Collateral as it were the sole and absolute owner thereof, including, without limitation, to vote and/or to exchange, at its sole discretion, any or all of the Collateral in connection with a merger, reorganization, consolidation, recapitalization or other readjustment concerning or involving the Collateral or the Company or any of its direct or indirect subsidiaries.

 

(iii) The Agent shall have the right to operate the business of the Company using the Collateral and shall have the right to assign, sell, lease or otherwise dispose of and deliver all or any part of the Collateral, at public or private sale or otherwise, either with or without special conditions or stipulations, for cash or on credit or for future delivery, in such parcel or parcels and at such time or times and at such place or places, and upon such terms and conditions as the Agent may deem commercially reasonable, all without (except as shall be required by applicable statute and cannot be waived) advertisement or demand upon or notice to the Company or right of redemption of the Company, which are hereby expressly waived. Upon each such sale, lease, assignment or other transfer of Collateral, the Agent, for the benefit of the Secured Parties, may, unless prohibited by applicable law which cannot be waived, purchase all or any part of the Collateral being sold, free from and discharged of all trusts, claims, right of redemption and equities of the Company, which are hereby waived and released.

 

(iv) The Agent shall have the right (but not the obligation) to notify any account the Company and any obligors under instruments or accounts to make payments directly to the Agent, on behalf of the Secured Parties, and to enforce the Company’ rights against such account the Company and obligors.

 

(v) The Agent, for the benefit of the Secured Parties, may (but is not obligated to) direct any financial intermediary or any other person or entity holding any investment property to transfer the same to the Agent, on behalf of the Secured Parties, or their designee.

 

(vi) The Agent may (but is not obligated to) transfer any or all Intellectual Property registered in the name of the Company at the United States Patent and Trademark Office and/or Copyright Office into the name of the Secured Parties or any designee or any purchaser of any Collateral.

 

(b) The Agent shall comply with any applicable law in connection with a disposition of Collateral and such compliance will not be considered adversely to affect the commercial reasonableness of any sale of the Collateral. The Agent may sell the Collateral without giving any warranties and may specifically disclaim such warranties. If the Agent sells any of the Collateral on credit, the Company will only be credited with payments actually made by the purchaser. In addition, the Company waives (except as shall be required by applicable statute and cannot be waived) any and all rights that it may have to a judicial hearing in advance of the enforcement of any of the Agent’s rights and remedies hereunder, including, without limitation, its right following an Event of Default to take immediate possession of the Collateral and to exercise its rights and remedies with respect thereto.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean13
 

 

(c) For the purpose of enabling the Agent to further exercise rights and remedies under this Section 8 or elsewhere provided by agreement or applicable law, the Company hereby grants to the Agent, for the benefit of the Agent and the Secured Parties, an irrevocable, nonexclusive license (exercisable without payment of royalty or other compensation to the Company) to use, license or sublicense following an Event of Default, any Intellectual Property now owned or hereafter acquired by the Company, and wherever the same may be located, and including in such license access to all media in which any of the licensed items may be recorded or stored and to all computer software and programs used for the compilation or printout thereof.

 

9. Applications of Proceeds. The proceeds of any such sale, lease or other disposition of the Collateral hereunder or from payments made on account of any insurance policy insuring any portion of the Collateral shall be applied first, to the expenses of retaking, holding, storing, processing and preparing for sale, selling, and the like (including, without limitation, any taxes, fees and other costs incurred in connection therewith) of the Collateral, to the reasonable attorneys’ fees and expenses incurred by the Agent in enforcing the Secured Partys’ rights hereunder and in connection with collecting, storing and disposing of the Collateral, and then to satisfaction of the Obligations pro rata among the Secured Parties (based on then-outstanding principal amounts of the Notes at the time of any such determination), and to the payment of any other amounts required by applicable law, after which the Secured Parties shall pay to the Company any surplus proceeds. If, upon the sale, license or other disposition of the Collateral, the proceeds thereof are insufficient to pay all amounts to which the Secured Parties is legally entitled, the Company will be liable for the deficiency, together with interest thereon, at the rate of 2% per month (24% per annum) or the lesser amount permitted by applicable law (the “Default Rate”), and the reasonable fees of any attorneys employed by the Secured Parties to collect such deficiency. To the extent permitted by applicable law, the Company waives all claims, damages, and demands against the Secured Parties arising out of the repossession, removal, retention, or sale of the Collateral, unless due solely to the gross negligence or willful misconduct of the Secured Parties as determined by a final judgment (not subject to further appeal) of a court of competent jurisdiction.

 

10. Securities Law Provision. The Company recognizes that Agent may be limited in its ability to effect a sale to the public of all or part of the Pledged Securities by reason of certain prohibitions in the Securities Act of 1933, as amended, or other federal or state securities laws (collectively, the “Securities Laws”), and may be compelled to resort to one or more sales to a restricted group of purchasers who may be required to agree to acquire the Pledged Securities for their own account, for investment and not with a view to the distribution or resale thereof. The Company agrees that sales so made may be at prices and on terms less favorable than if the Pledged Securities were sold to the public, and that Agent has no obligation to delay the sale of any Pledged Securities for the period of time necessary to register the Pledged Securities for sale to the public under the Securities Laws. The Company shall cooperate with Agent in its attempt to satisfy any requirements under the Securities Laws (including, without limitation, registration thereunder if requested by Agent) applicable to the sale of the Pledged Securities by Agent.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean14
 

 

11. Costs and Expenses. The Company agrees to pay all reasonable out-of-pocket fees, costs and expenses incurred in connection with any filing required hereunder, including without limitation, any financing statements pursuant to the UCC, continuation statements, partial releases and/or termination statements related thereto or any expenses of any searches reasonably required by the Agent. The Company shall also pay all other claims and charges which in the reasonable opinion of the Agent is reasonably likely to prejudice, imperil or otherwise affect the Collateral or the Security Interests therein. The Company will also, upon demand, pay to the Agent the amount of any and all reasonable expenses, including the reasonable fees and expenses of its counsel and of any experts and agents, which the Agent, for the benefit of the Secured Parties, may incur in connection with the creation, perfection, protection, satisfaction, foreclosure, collection or enforcement of the Security Interest and the preparation, administration, continuance, amendment or enforcement of this Agreement and pay to the Agent the amount of any and all reasonable expenses, including the reasonable fees and expenses of its counsel and of any experts and agents, which the Agent, for the benefit of the Secured Parties, and the Secured Parties may incur in connection with (i) the enforcement of this Agreement, (ii) the custody or preservation of, or the sale of, collection from, or other realization upon, any of the Collateral, or (iii) the exercise or enforcement of any of the rights of the Secured Parties under the Notes. Until so paid, any fees payable hereunder shall be added to the principal amount of the Notes and shall bear interest at the Default Rate.

 

12. Responsibility for Collateral. The Company assume all liabilities and responsibility in connection with all Collateral, and the Obligations shall in no way be affected or diminished by reason of the loss, destruction, damage, or theft of any of the Collateral or its unavailability for any reason. Without limiting the generality of the foregoing and except as required by applicable law, (a) neither the Agent nor any Secured Party (i) has any duty (either before or after an Event of Default) to collect any amounts in respect of the Collateral or to preserve any rights relating to the Collateral, or (ii) has any obligation to clean-up or otherwise prepare the Collateral for sale, and (b) the Company shall remain obligated and liable under each contract or agreement included in the Collateral to be observed or performed by the Company thereunder. Neither the Agent nor any Secured Party shall have any obligation or liability under any such contract or agreement by reason of or arising out of this Agreement or the receipt by the Agent or any Secured Party of any payment relating to any of the Collateral, nor shall the Agent or any Secured Party be obligated in any manner to perform any of the obligations of the Company under or pursuant to any such contract or agreement, to make inquiry as to the nature or sufficiency of any payment received by the Agent or any Secured Party in respect of the Collateral or as to the sufficiency of any performance by any party under any such contract or agreement, to present or file any claim, to take any action to enforce any performance or to collect the payment of any amounts which may have been assigned to the Agent or to which the Agent or any Secured Party may be entitled at any time or times.

 

13. Security Interests Absolute. All rights of the Secured Parties and all obligations of the Company hereunder, shall be absolute and unconditional, irrespective of: (a) any lack of validity or enforceability of this Agreement, the Notes or any agreement entered into in connection with the foregoing, or any portion hereof or thereof, against the Company; (b) any change in the time, manner or place of payment or performance of, or in any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to any departure from the Notes or any other agreement entered into in connection with the foregoing; (c) any exchange, release or no perfection of any of the Collateral, or any release or amendment or waiver of or consent to departure from any other collateral for, or any guarantee, or any other security, for all or any of the Obligations; (d) any action by the Secured Parties to obtain, adjust, settle and cancel in its sole discretion any insurance claims or matters made or arising in connection with the Collateral; or (e) any other circumstance which might otherwise constitute any legal or equitable defense available to the Company, or a discharge of all or any part of the Security Interests granted hereby. Until the Obligations shall have been paid and performed in full, the rights of the Secured Parties shall continue even if the Obligations are barred for any reason, including, without limitation, the running of the statute of limitations. The Company expressly waives presentment, protest, notice of protest, demand, notice of nonpayment and demand for performance. In the event that at any time any transfer of any Collateral or any payment received by the Secured Parties hereunder shall be deemed by final order of a court of competent jurisdiction to have been a voidable preference or fraudulent conveyance under the bankruptcy or insolvency laws of the United States, or shall be deemed to be otherwise due to any party other than the Secured Parties, then, in any such event, the Company’s obligations hereunder shall survive cancellation of this Agreement, and shall not be discharged or satisfied by any prior payment thereof and/or cancellation of this Agreement, but shall remain a valid and binding obligation enforceable in accordance with the terms and provisions hereof. The Company waives all right to require the Secured Parties to proceed against any other person or entity or to apply any Collateral which any Secured Party may hold at any time, or to marshal assets, or to pursue any other remedy. The Company waives any defense arising by reason of the application of the statute of limitations to any obligation secured hereby.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean15
 

 

14. Term of Agreement. This Agreement and the Security Interests shall terminate on the date on which all payments under the Notes have been indefeasibly paid in full and all other Obligations have been paid or discharged; provided, however, that all indemnities of the Company contained in this Agreement (including, without limitation, Annex A hereto) shall survive and remain operative and in full force and effect regardless of the termination of this Agreement.

 

15. Power of Attorney; Further Assurances.

 

(a) The Company authorizes the Agent, and does hereby make, constitute and appoint the Agent and its officers, agents, successors or assigns with full power of substitution, as the Company’s true and lawful attorney-in-fact, with power, in the name of the Agent or the Company, to, after the occurrence and during the continuance of an Event of Default, (i) endorse any notes, checks, drafts, money orders or other instruments of payment (including payments payable under or in respect of any policy of insurance) in respect of the Collateral that may come into possession of the Agent; (ii) to sign and endorse any financing statement pursuant to the UCC or any invoice, freight or express bill, bill of lading, storage or warehouse receipts, drafts against the Company, assignments, verifications and notices in connection with accounts, and other documents relating to the Collateral; (iii) to pay or discharge taxes, liens, security interests or other encumbrances at any time levied or placed on or threatened against the Collateral; (iv) to demand, collect, receipt for, compromise, settle and sue for monies due in respect of the Collateral; (v) to transfer any Intellectual Property or provide licenses respecting any Intellectual Property; and (vi) generally, at the option of the Agent, and at the expense of the Company, at any time, or from time to time, to execute and deliver any and all documents and instruments and to do all acts and things which the Agent deems necessary to protect, preserve and realize upon the Collateral and the Security Interests granted therein in order to effect the intent of this Agreement and the Notes all as fully and effectually as the Company might or could do; and the Company hereby ratifies all that said attorney shall lawfully do or cause to be done by virtue hereof. This power of attorney is coupled with an interest and shall be irrevocable for the term of this Agreement and thereafter as long as any of the Obligations shall be outstanding. The designation set forth herein shall be deemed to amend and supersede any inconsistent provision in the Organizational Documents or other documents or agreements to which the Company is subject or to which the Company is a party. Without limiting the generality of the foregoing, after the occurrence and during the continuance of an Event of Default, each Secured Party is specifically authorized to execute and file any applications for or instruments of transfer and assignment of any patents, trademarks, copyrights or other Intellectual Property with the United States Patent and Trademark Office and the United States Copyright Office.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean16
 

 

(b) On a continuing basis, the Company will make, execute, acknowledge, deliver, file and record, as the case may be, with the proper filing and recording agencies in any jurisdiction, including, without limitation, the jurisdictions indicated on Schedule C attached hereto, all such instruments, and take all such action as may reasonably be deemed necessary or advisable, or as reasonably requested by the Agent, to perfect the Security Interests granted hereunder and otherwise to carry out the intent and purposes of this Agreement, or for assuring and confirming to the Agent the grant or perfection of a perfected security interest in all the Collateral under the UCC.

 

(c) The Company hereby irrevocably appoints the Agent as the Company’s attorney-in-fact, with full authority in the place and instead of the Company and in the name of the Company, from time to time in the Agent’s discretion, to take any action and to execute any instrument which the Agent may deem necessary or advisable to accomplish the purposes of this Agreement, including the filing, in its sole discretion, of one or more financing or continuation statements and amendments thereto, relative to any of the Collateral without the signature of the Company where permitted by law, which financing statements may (but need not) describe the Collateral as “all assets” or “all personal property” or words of like import, and ratifies all such actions taken by the Agent. This power of attorney is coupled with an interest and shall be irrevocable for the term of this Agreement and thereafter as long as any of the Obligations shall be outstanding.

 

16. Notices. All notices, requests, demands, and other communications hereunder shall be subject to the notice provision of the Notes.

 

17. Other Security. To the extent that the Obligations are now or hereafter secured by property other than the Collateral or by the guarantee, endorsement or property of any other person, firm, corporation, or other entity, then the Agent shall have the right, in its sole discretion, to pursue, relinquish, subordinate, modify or take any other action with respect thereto, without in any way modifying or affecting any of the Secured Party’ rights and remedies hereunder.

 

18. Appointment of Agent. The Secured Parties hereby appoint the Lead Investor to act as their agent (the “Agent”) for purposes of exercising any and all rights and remedies of the Secured Parties hereunder. Such appointment shall continue until revoked in writing by a Majority-in-Interest, at which time a Majority in Interest shall appoint a new Agent, provided that the Agent may not be removed as Agent unless it consents thereto. The Agent shall have the rights, responsibilities, and immunities set forth in Annex A hereto.

 

19. Miscellaneous.

 

(a) No course of dealing between the Company and any Secured Party, nor any failure to exercise, nor any delay in exercising, on the part of any Secured Party, any right, power, or privilege hereunder or under the Notes shall operate as a waiver thereof; nor shall any single or partial exercise of any right, power or privilege hereunder or thereunder preclude any other or further exercise thereof or the exercise of any other right, power, or privilege.

 

(b) All of the rights and remedies of the Secured Parties with respect to the Collateral, whether established hereby or by the Notes or by any other agreements, instruments, or documents or by law shall be cumulative and may be exercised singly or concurrently.

 

(c) This Agreement, together with the exhibits and schedules hereto, contain the entire understanding of the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into this Agreement and the exhibits and schedules hereto. No provision of this Agreement may be waived, modified, supplemented, or amended except in a written instrument signed, in the case of an amendment, by the Company and each of the Secured Parties or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean17
 

 

(d) If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants, and restrictions without including any of such that may be hereafter declared invalid, illegal, void, or unenforceable.

 

(e) No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition, or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.

 

(f) This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company and the Guarantors may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Secured Party (other than by merger). Any Secured Party may assign any or all of its rights under this Agreement to any Person to whom such Secured Party assigns or transfers any Obligations, provided such transferee agrees in writing to be bound, with respect to the transferred Obligations, by the provisions of this Agreement that apply to the “Secured Party.”

 

(g) Each party shall take such further action and execute and deliver such further documents as may be necessary or appropriate in order to carry out the provisions and purposes of this Agreement.

 

(h) Except to the extent mandatorily governed by the jurisdiction or situs where the Collateral is located, all questions concerning the construction, validity, enforcement, and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles of conflicts of law thereof. Except to the extent mandatorily governed by the jurisdiction or situs where the Collateral is located, the Company agrees that all proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and the Notes (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in Clark County Nevada. Except to the extent mandatorily governed by the jurisdiction or situs where the Collateral is located, the Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting Clark County Nevada for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such proceeding is improper. Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean18
 

 

(i) This Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and, all of which taken together shall constitute one and the same Agreement. In the event that any signature is delivered by facsimile transmission, such signature shall create a valid binding obligation of the party executing (or on whose behalf such signature is executed) the same with the same force and effect as if such facsimile signature were the original thereof.

 

(j) The company shall jointly and severally be liable for the obligations of the Company to the Secured Parties hereunder.

 

(k) The Company shall indemnify, reimburse and hold harmless the Agent and each Secured Party and their respective partners, members, shareholders, officers, directors, employees and agents (and any other persons with other titles that have similar functions) (collectively, “Indemnitees”) from and against any and all losses, claims, liabilities, damages, penalties, suits, costs and expenses, of any kind or nature, (including fees relating to the cost of investigating and defending any of the foregoing) imposed on, incurred by or asserted against such Indemnitee in any way related to or arising from or alleged to arise from this Agreement or the Collateral, except any such losses, claims, liabilities, damages, penalties, suits, costs and expenses which result from the gross negligence or willful misconduct of the Indemnitee as determined by a final, nonappealable decision of a court of competent jurisdiction. This indemnification provision is in addition to, and not in limitation of, any other indemnification provision in the Notes, or any other agreement, instrument or other document executed or delivered in connection herewith or therewith.

 

(l) Nothing in this Agreement shall be construed to subject Agent or any Secured Party to liability as a partner in the Company or any if its direct or indirect subsidiaries that is a partnership or as a member in the Company or any of its direct or indirect subsidiaries that is a limited liability company, nor shall Agent or any Secured Party be deemed to have assumed any obligations under any partnership agreement or limited liability company agreement, as applicable, of any the Company or any of its direct or indirect subsidiaries or otherwise, unless and until any such Secured Party exercises its right to be substituted for the Company as a partner or member, as applicable, pursuant hereto.

 

(m) To the extent that the grant of the security interest in the Collateral and the enforcement of the terms hereof require the consent, approval or action of any partner or member, as applicable, of the Company or any direct or indirect subsidiary of the Company or compliance with any provisions of any of the Organizational Documents, the Company hereby represent that all such consents and approvals have been obtained.

 

[SIGNATURE PAGE OF THE COMPANY FOLLOWS]

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean19
 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed on the day and year first above written.

 

ENDEXX CORPORATION  
     
By:                     
Name:    
Title:    

 

[SIGNATURE PAGE OF SECURED PARTY FOLLOWS]

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean20
 

 

[SIGNATURE PAGE OF SECURED PARTY TO SECURITY AGREEMENT]

 

(LEAD-INVESTOR)

 

Name of Investing Entity: M2B Funding Corp

 

Signature of Authorized Signatory of Investing Entity: _________________________

 

Name of Authorized Signatory: _________________________

 

Title of Authorized Signatory: __________________________

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean21
 

 

[SIGNATURE PAGE OF SECURED PARTY TO SECURITY AGREEMENT]

 

(CO-INVESTOR)

 

Name of Investing Entity: 3A Capital Establishment

 

Signature of Authorized Signatory of Investing Entity: _________________________

 

Name of Authorized Signatory: _________________________

 

Title of Authorized Signatory: __________________________

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean22
 

 

DISCLOSURE SCHEDULES

 

Security Agreement

 

The following are the Disclosure Schedules (the “Disclosure Schedules”) referred to in that certain Security Agreement, dated as of August 23, 2022 (the “Agreement”), by and amoung Endexx Corporation, a Nevada corporation (the “Company”), M2B Funding Corp., a Florida corporation, and Capital Establishment, a company registered in Liechtenstein, each as the holder of the Company’s 12% Senior Secured Convertible Promissory Notes, in the original aggregate principal amount of $2,173,913.04 (the “Notes”) and its endorsees, transferees, and assigns (collectively the “Secured Parties”, and each a “Secured Party”).

 

Schedule A

Principal Place of Business of the Company;

Locations Where Collateral is Located or Stored;

Permitted Liens

 

Schedule B

Ownership Interest in Collateral

 

Schedule C

Filing Jurisdictions

 

Schedule D

Legal Names and Organizational Identification Numbers

 

Schedule E

Names; Mergers and Acquisitions

 

Schedule F

Intellectual Property

 

Schedule G

The Company

 

Schedule H

Pledged Securities

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean23
 

 

ANNEX A

to

SECURITY AGREEMENT

THE AGENT

 

1. Appointment. Each Secured Party (all capitalized terms used herein and not otherwise defined shall have the respective meanings provided in the Security Agreement to which this Annex A is attached (the “Agreement”)), by their acceptance of the benefits of the Agreement, hereby designate M2B Funding Corp., a Florida corporation (the “Agent”) as the Agent to act as specified herein and in the Agreement. Each Secured Party shall be deemed irrevocably to authorize the Agent to take such action on its behalf under the provisions of the Agreement and the Notes and to exercise such powers and to perform such duties hereunder and thereunder as are specifically delegated to or required of the Agent by the terms hereof and thereof and such other powers as are reasonably incidental thereto. The Agent may perform any of its duties hereunder by or through its agents or employees.

 

2. Nature of Duties. The Agent shall have no duties or responsibilities except those expressly set forth in the Agreement. Neither the Agent nor any of its partners, members, shareholders, officers, directors, employees or agents shall be liable for any action taken or omitted by it as such under the Agreement or hereunder or in connection herewith or therewith, be responsible for the consequence of any oversight or error of judgment or answerable for any loss, unless caused solely by its or their gross negligence or willful misconduct as determined by a final judgment (not subject to further appeal) of a court of competent jurisdiction. The duties of the Agent shall be mechanical and administrative in nature; the Agent shall not have by reason of the Agreement or any other Transaction Document a fiduciary relationship in respect of the Company or any Secured Party; and nothing in the Agreement or any other Transaction Document, expressed or implied, is intended to or shall be so construed as to impose upon the Agent any obligations in respect of the Agreement or any other Transaction Document except as expressly set forth herein and therein.

 

3. Lack of Reliance on the Agent. Independently and without reliance upon the Agent, each Secured Party, to the extent it deems appropriate, has made and shall continue to make (i) its own independent investigation of the financial condition and affairs of the Company and its subsidiaries in connection with such Secured Party’s investment in the Company, the creation and continuance of the Obligations, the transactions contemplated by the Transaction Documents, and the taking or not taking of any action in connection therewith, and (ii) its own appraisal of the creditworthiness of the Company and its subsidiaries, and of the value of the Collateral from time to time, and the Agent shall have no duty or responsibility, either initially or on a continuing basis, to provide any Secured Party with any credit, market or other information with respect thereto, whether coming into its possession before any Obligations are incurred or at any time or times thereafter. The Agent shall not be responsible to the Company or any Secured Party for any recitals, statements, information, representations or warranties herein or in any document, certificate or other writing delivered in connection herewith, or for the execution, effectiveness, genuineness, validity, enforceability, perfection, collectability, priority or sufficiency of the Agreement or any other Transaction Document, or for the financial condition of the Company or the value of any of the Collateral, or be required to make any inquiry concerning either the performance or observance of any of the terms, provisions or conditions of the Agreement or any other Transaction Document, or the financial condition of the Company, or the value of any of the Collateral, or the existence or possible existence of any default or Event of Default under the Agreement, the Notes or any of the other Transaction Documents.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean
 

 

4. Certain Rights of the Agent. The Agent shall have the right to take any action with respect to the Collateral, on behalf of all of the Secured Parties. To the extent practical, the Agent may request instructions from the Secured Parties with respect to any material act or action (including failure to act) in connection with the Agreement or any other Transaction Document, and shall be entitled to act or refrain from acting in accordance with the instructions of a Majority in Interest; if such instructions are not provided despite the Agent’s request therefor, the Agent shall be entitled to refrain from such act or taking such action, and if such action is taken, shall be entitled to appropriate indemnification from each Secured Party in respect of actions to be taken by the Agent; and the Agent shall not incur liability to any person or entity by reason of so refraining. Without limiting the foregoing, (a) no Secured Party shall have any right of action whatsoever against the Agent as a result of the Agent acting or refraining from acting hereunder in accordance with the terms of the Agreement or any other Transaction Document, and the Company shall have no right to question or challenge the authority of, or the instructions given to, the Agent pursuant to the foregoing and (b) the Agent shall not be required to take any action which the Agent believes (i) could reasonably be expected to expose it to personal liability or (ii) is contrary to this Agreement, the Transaction Documents or applicable law.

 

5. Reliance. The Agent shall be entitled to rely, and shall be fully protected in relying, upon any writing, resolution, notice, statement, certificate, telex, teletype or facsimile, cablegram, radiogram, order or other document or telephone message signed, sent or made by the proper person or entity, and, with respect to all legal matters pertaining to the Agreement and the other Transaction Documents and its duties thereunder, upon advice of counsel selected by it and upon all other matters pertaining to this Agreement and the other Transaction Documents and its duties thereunder, upon advice of other experts selected by it. Anything to the contrary notwithstanding, the Agent shall have no obligation whatsoever to any Secured Party to assure that the Collateral exists or is owned by the Company or is cared for, protected, or insured or that the liens granted pursuant to the Agreement have been properly or sufficiently or lawfully created, perfected, or enforced or are entitled to any particular priority.

 

6. Indemnification. To the extent that the Agent is not reimbursed and indemnified by the Company, the Secured Parties will jointly and severally reimburse and indemnify the Agent, in proportion to their initially purchased respective principal amounts of Notes, from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever which may be imposed on, incurred by or asserted against the Agent in performing its duties hereunder or under the Agreement or any other Transaction Document, or in any way relating to or arising out of the Agreement or any other Transaction Document except for those determined by a final judgment (not subject to further appeal) of a court of competent jurisdiction to have resulted solely from the Agent’s own gross negligence or willful misconduct. Prior to taking any action hereunder as Agent, the Agent may require each Secured Party to deposit with it sufficient sums as it determines in good faith is necessary to protect the Agent for costs and expenses associated with taking such action.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean
 

 

7. Resignation by the Agent.

 

(a) The Agent may resign from the performance of all its functions and duties under the Agreement and the other Transaction Documents at any time by giving thirty (30) days’ prior written notice (as provided in the Agreement) to the Company and each Secured Party. Such resignation shall take effect upon the appointment of a successor Agent pursuant to clauses (b) and (c) below.

 

(b) Upon any such notice of resignation, the Secured Parties, acting by a Majority in Interest, shall appoint a successor Agent hereunder.

 

(c) If a successor Agent shall not have been so appointed within said 30-day period, the Agent shall then appoint a successor Agent who shall serve as Agent until such time, if any, as the Secured Parties appoint a successor Agent as provided above. If a successor Agent has not been appointed within such 30-day period, the Agent may petition any court of competent jurisdiction or may interplead the Company and the Secured Parties in a proceeding for the appointment of a successor Agent, and all fees, including, but not limited to, extraordinary fees associated with the filing of interpleader and expenses associated therewith, shall be payable by the Company on demand.

 

8. Rights with respect to Collateral. Each Secured Party agrees with all other Secured Parties and the Agent (i) that it shall not, and shall not attempt to, exercise any rights with respect to its security interest in the Collateral, whether pursuant to any other agreement or otherwise (other than pursuant to this Agreement), or take or institute any action against the Agent or any of the other Secured Parties in respect of the Collateral or its rights hereunder (other than any such action arising from the breach of this Agreement) and (ii) that such Secured Party has no other rights with respect to the Collateral other than as set forth in this Agreement and the other Transaction Documents. Upon the acceptance of any appointment as Agent hereunder by a successor Agent, such successor Agent shall thereupon succeed to and become vested with all the rights, powers, privileges, and duties of the retiring Agent and the retiring Agent shall be discharged from its duties and obligations under the Agreement. After any retiring Agent’s resignation or removal hereunder as Agent, the provisions of the Agreement including this Annex A shall inure to its benefit as to any actions taken or omitted to be taken by it while it was Agent.

 

ENDEXX M2B and 3A Security Agreement August 2022.2 clean

 

Exhibit 10.43

 

INTELLECTUAL PROPERTY SECURITY AGREEMENT

 

This Intellectual Property SECURITY AGREEMENT (this “Agreement”), dated as of August 31, 2022, by Endexx Corporation, a Nevada corporation (the “Grantor”), is in favor of M2B Funding Corp., a Florida corporation, and 3A Capital Establishment, a company registered in Liechtenstein (each a “Secured Party”, and collectively, the “Secured Parties”).

 

W I T N E S S E T H:

 

WHEREAS, reference is made to that certain Security Agreement, dated as of the date hereof (as amended, restated, supplemented, or otherwise modified from time to time, the “Security Agreement”), entered into by and among the Grantor, the other “Guarantors” party thereto, and each Secured Party, which secures certain now existing and future arising obligations owing to the Secured Parties as provided in the Security Agreement;

 

WHEREAS, pursuant to the Security Agreement, the Grantor is required to execute and deliver to each Secured Party this Agreement;

 

WHEREAS, pursuant to the terms of the Security Agreement, the Grantor has granted to the Secured Parties, a security interest in substantially all the assets of the Grantor, including all right, title and interest of the Grantor in, to and under all now owned and hereafter acquired (i) trademarks, patents, and copyrights; (ii) trademark applications, patent applications, and copyright applications; and (iii) trademark licenses, patent licenses, and copyright licenses, and all products and proceeds thereof, to secure the payment of the Obligations (as defined in the Security Agreement).

 

NOW, THEREFORE, in consideration of the premises and for such other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Grantor hereby grants to the Secured Parties, to secure the Obligations, a continuing security interest in all of the Grantor’s right, title, and interest in, to and under the following, whether presently existing or hereafter created or acquired:

 

1. Each United States and foreign trademark and trademark application, including, without limitation, each United States federally registered trademark and trademark application referred to in Schedule 1 annexed hereto, together with any reissues, continuations, or extensions thereof and all goodwill associated therewith;

 

2. Each trademark license, including, without limitation, each trademark license listed on Schedule 1 annexed hereto, together with all goodwill associated therewith;

 

3. All products and proceeds of the foregoing items 1 through 2, including, without limitation, any claim by the Grantor against third parties for past, present or future infringement, misappropriation, dilution, violation, or other impairment of any trademark, including, without limitation, any trademark referred to in Schedule 1 annexed hereto, any trademark issued pursuant to a trademark application referred to in Schedule 1 and any trademark licensed under any trademark license listed on Schedule 1 annexed hereto (items 1 through 3 being herein collectively referred to as the “Trademark Collateral”);

 

4. Each United States and foreign patent and patent application, including, without limitation, each United States federally registered patent and patent application referred to in Schedule 2 annexed hereto, together with any reissues, continuations, or extensions thereof and all goodwill associated therewith;

 

ENDEXX M2B and 3A IP Security Agreement August 2022.2

1

 

 

5. Each patent license, including, without limitation, each patent license listed on Schedule 2 annexed hereto, together with all goodwill associated therewith;

 

6. All products and proceeds of the foregoing items 4 and 5, including, without limitation, any claim by the Grantor against third parties for past, present, or future infringement, misappropriation, dilution, violation, or other impairment of any patent, including, without limitation, any patent referred to in Schedule 2 annexed hereto, any trademark issued pursuant to a patent application referred to in Schedule 2 and any patent licensed under any patent license listed on Schedule 2 annexed hereto (items 4 through 6 being herein collectively referred to as the “Patent Collateral”);

 

7. Each United States and foreign copyright and copyright application, including, without limitation, each United States federally registered copyright and copyright application referred to in Schedule 3 annexed hereto, together with any reissues, continuations, or extensions thereof and all goodwill associated therewith;

 

8. Each copyright license, including, without limitation, each copyright license listed on Schedule 3 annexed hereto, together with all goodwill associated therewith; and

 

9. All products and proceeds of the foregoing items 7 and 8, including, without limitation, any claim by the Grantor against third parties for past, present or future infringement, misappropriation, dilution, violation, or other impairment of any copyright, including, without limitation, any copyright referred to in Schedule 3 annexed hereto, any copyright issued pursuant to a copyright application referred to in Schedule 3, and any copyright licensed under any copyright license listed on Schedule 3 annexed hereto (items 7 through 9 being herein collectively referred to as the “Copyright Collateral”; items 1 through 9 being herein (i.e., the Trademark Collateral, the Patent Collateral, and the Copyright Collateral) collectively referred to as the “IP Collateral”).

 

This security interest is granted in conjunction with the security interests granted to the Collateral Agent, for itself and on behalf of the other Secured Party, pursuant to the Security Agreement. The Grantor hereby acknowledges and affirms that the rights and remedies of the Collateral Agent with respect to the security interest in the IP Collateral made and granted hereby are more fully set forth in the Security Agreement, the terms and provisions of which are incorporated by reference herein as if fully set forth herein. Capitalized terms used but not defined herein have the respective meanings ascribed thereto in the Security Agreement.

 

Grantor shall give Collateral Agent prior written notice of no less than five (5) Business Days before filing any additional application for registration of any trademark and prompt notice in writing of any additional trademark registrations, patent registration, or copyright registrations granted therefor after the date hereof. Without limiting Grantor’s obligations under this paragraph, Grantor hereby authorizes Collateral Agent unilaterally to modify this Agreement by amending Schedules 1, 2, or 3 to include any future United States registered trademarks, patents, copyrights, or applications therefor of Grantor. Notwithstanding the foregoing, no failure to so modify this Agreement or amend Schedules 1, 2, or 3 shall in any way affect, invalidate or detract from Collateral Agent’s continuing security interest in all Collateral, whether or not listed on Schedule 1, 2, or 3.

 

Grantor hereby agrees that, anything herein to the contrary notwithstanding, such Grantor shall assume full and complete responsibility for the prosecution, defense, enforcement, or any other necessary or desirable actions in connection with their trademarks subject to the security interest hereunder.

 

ENDEXX M2B and 3A IP Security Agreement August 2022.2

2

 

 

This Agreement may be executed in any number of counterparts and by different parties in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. Signature pages may be detached from multiple separate counterparts and attached to a single counterpart.

 

This Agreement shall be construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation and performance of this Agreement and all disputes arising hereunder shall be governed by, the laws of the State of Nevada, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Nevada or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Nevada. The parties hereto (a) agree that any legal action or proceeding with respect to this Agreement or any other agreement, document, or other instrument executed in connection herewith or therewith, shall be brought in any state or federal court located within the City of Las Vegas, State of Nevada, (b) irrevocably waive any objections that either may now or hereafter have to the venue of any suit, action or proceeding arising out of or relating to this Agreement, or any other agreement, document, or other instrument executed in connection herewith, brought in the aforementioned courts, and (c) further irrevocably waive any claim that any such suit, action, or proceeding brought in any such court has been brought in an inconvenient forum.

 

The Grantor has caused this Intellectual Property Security Agreement to be duly executed by its duly authorized officer thereunto as of the date first set forth above.

 

  ENDEXX CORPORATION
   
  By:  
  Name:                    
  Title:  

 

Acknowledged:

 

M2B Funding Corp.

 

By:    
Name:    
Title:    

 

3A CAPITAL ESTABLISHMENT

 

By:    
Name:    
Title:    

 

ENDEXX M2B and 3A IP Security Agreement August 2022.2

3

 

 

SCHEDULE 1

to

INTELLECTUAL PROPERTY SECURITY AGREEMENT

 

Trademark Collateral

 

FILE NO.   COUNTRY   MARK
         
         
         

 

ENDEXX M2B and 3A IP Security Agreement August 2022.2

4

 

 

SCHEDULE 2

to

INTELLECTUAL PROPERTY SECURITY AGREEMENT

 

Patent Collateral

 

Patent/Application #   Filing Date   Title
         
         
         
         
         
         
         
         

 

ENDEXX M2B and 3A IP Security Agreement August 2022.2

5

 

 

SCHEDULE 3

to

INTELLECTUAL PROPERTY SECURITY AGREEMENT

 

Copyright Collateral

 

ENDEXX M2B and 3A IP Security Agreement August 2022.2

6

 

 

Exhibit 10.44

 

SETTLEMENT, LOCK-UP, AND LEAK-OUT AGREEMENT

 

This SETTLEMENT, LOCK-UP, AND LEAK-OUT AGREEMENT (this “Agreement”) is made and entered into as of August 31, 2022 (the “Effective Date”), by and between Endexx Corporation, a Nevada corporation (the “Company”), and _____________________, a _______________________ (the “Securities Holder”). For all purposes of this Agreement, “Securities Holder” includes any affiliate or controlling person of the Securities Holder and any other agent, representative, or other person with whom the Securities Holder is acting in concert.

 

RECITALS

 

A. WHEREAS, in May 2021, the Company sold and issued one (1) Convertible Promissory Note (collectively, the “Original Note”) in favor of Securities Holder with an aggregate initial principal balance of $____________ (collectively, the “Original Principal Amount”), of which, as of the Effective Date, (i) $____________ is the outstanding aggregate principal balance and (ii) $____________ is the aggregate accrued and unpaid stated-rate interest (collectively, the “Effective Date Owings”);

 

B. WHEREAS, as of the Effective Date, the Securities Holder owns, beneficially and of record, __________ shares (the “Pre-Agreement Equity Ownership”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) as set forth on Schedule “A”;

 

C. WHEREAS, the Company acknowledges that the Securities Holder may have a contractually unfettered right to dispose of any or all of the shares of Pre-agreement Equity Ownership in any manner and at any time or from time to time, all as desired by the Securities Holder, including, but not limited to, the sale thereof into the public markets;

 

D. WHEREAS, the Company has requested of the Securities Holder that, as of the Effective Date, it return to the Company for cancellation ____________ shares of Pre-agreement Equity Ownership and the Securities Holder has agreed to effectuate such return (the “Returned Conversion Stock”), also as set forth on Schedule “A”;

 

E. WHEREAS, the Company has requested of the Securities Holder that it (i) not dispose of any shares of Pre-agreement Conversion Stock into the public markets (the “Lock-up”) for the period that commences on the Deemed Effectiveness (as defined below) date cand continues through and including the 12-month anniversary thereof (the “Lock-up Period”) and (ii) not dispose of any shares of Pre-agreement Conversion Stock into the public markets in an amount that exceeds five percent of the daily trading volume of the Common Stock during any trading day (the “Leak-out”), as reported by the OTC Markets Group Inc. (“OTCM”), for the one-year period that commences on the expiration of the Lock-up Period and continues through and including the 24-month anniversary of the Deemed Effectiveness date (the “Leak-out Period”);

 

F. WHEREAS, the Securities Holder has agreed that it will comply with the terms of (i) the Lock-up during the Lock-up Period and (ii) the Leak-out during the Leak-out Period;

 

G. WHEREAS, the Company has requested of the Securities Holder that it waive (i) any and all defaults by the Company in the performance of its obligations under the Original Note and (ii) all of the Securities Holder’s entitlements to any and all economic or enforcement rights provided to it in the Original Note, including, but not limited to, (w) conversion of any amounts owing thereunder into shares of Common Stock, (x) interest at any rate other than the stated, and non-default, rate, (y) default remedies and penalties, and (z) imposition of additional fees and costs, such that the only rights remaining in the Original Note in favor of the Securities Holder is the right to be repaid the Effective Date Owings (collectively, the “Aggregate Waiver”);

 

H. WHEREAS, the Company is willing to pay to the Securities Holder, as a premium, additional interest in an amount equivalent to ten percent of the Effective Date Owings (the “Premium Interest”);

 

I. WHEREAS, the Company is willing to pay to the Securities Holder the Effective Date Owings and the Premium Interest on the schedule (the “Payment Schedule”) attached hereto as Schedule “B”;

 

J. WHEREAS, in connection with the transactions contemplated hereby, including, but not limited to the Aggregate Waiver and the payment of the Premium Interest in accordance with the Payment Schedule, the Company has requested of the Securities Holder that it tender to the Company each Original Note for cancellation and to accept the Company’s unsecured replacement note (the “Replacement Note”) in favor of the Securities Holder, the initial principal balance of which is the Effective Date Owings, and which Replacement Note includes the Premium Interest and provides for repayment according to the Payment Schedule;

 

1
 

 

K. WHEREAS, the Securities Holder is willing to agree to the Aggregate Waiver, to accept the Premium Interest, to accept payments of the Effective Date Owings and the Premium Interest on the Payment Schedule, to tender the Original Note to the Company for cancellation, and to accept the Replacement Note;

 

L. WHEREAS, as of the Effective Date, the Securities Holder is the holder of warrants for the purchase of up to ____________ shares of Common Stock (collectively, the “Warrants”);

 

M. WHEREAS, the Securities Holder acknowledges that, as of the Effective Date, the Company is not under any obligation to grant to the Securities Holder any additional warrants, options, rights, or other derivative securities;

 

N. WHEREAS, the Company has requested of the Securities Holder that, as of the Effective Date, it surrender all of the Warrants and all of its rights in and to the Warrants and the Securities Holder has agreed;

 

O. WHEREAS, as of the Effective Date, the Company intends to consummate a transaction (the “Acquisition Transaction”), pursuant to which the Company intends to acquire 51% of the equity capital of a business that specializes in the sale and distribution of plant-based Vape products (the “Target”);

 

P. WHEREAS, a condition precedent to the consummation of the Acquisition Transaction is that the Company and the Securities Holder and other entities similarly situated each execute and deliver this Agreement not later than August 31, 2022;

 

Q. WHEREAS, subject to the provisions of Section 7, below, this Agreement is effective upon the consummation of the Acquisition Transaction (the “Deemed Effectiveness”);

 

R. WHEREAS, the Company is a party to transactions with approximately six other entities (the “Other Similarly Situated Entities”) that entered into transactions with the Company that are similar in scope, structure, or magnitude to the transactions referenced herein between the Company and the Securities Holder;

 

S. WHEREAS, certain unspecified disputes (the “Unspecified Disputes”) may have arisen between or among the Company, the Securities Holder, and the Other Similarly Situated Entities in respect of the Original Note, the terms and conditions thereof, the payments that may be due and owing thereon, or the actions of any such Other Similarly Situated Entities in connection therewith; and

 

T. WHEREAS, subject to the Other Similarly Situated Entities entering into agreements substantially similar to this Agreement (the “Other Entities’ Agreements”), the Company and the Securities Holder desire to enter into this Agreement to permit the consummation of the Acquisition Transaction and to settle the Unspecified Disputes in the manner set forth herein.

 

AGREEMENT

 

NOW, THEREFORE, in consideration of these premises and for such other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby, agree as follows:

 

1. Incorporation of Recitals. Each of the Recitals set forth above is incorporated herein by reference and forms a material part of the provisions of this Agreement.

 

2. Aggregate Waiver; Tender of Original Note for cancellation; Acceptance of Replacement Note. The Securities Holder hereby acknowledges and agrees that, as of the Effective Date, it is bound by the Aggregate Waiver and it will tender the Original Note to the Company for cancellation. A true and correct copy of each Original Note is attached hereto as Annex 1. The Company hereby acknowledges and agrees that, as of the Effective Date, it will deliver the Replacement Note to the Securities Holder, in the form attached hereto as Annex 2. Among the provisions included in the Replacement Note, in addition to payment of the Premium Interest and the related Payment Schedule, are (i) the Replacement Note may be prepaid in whole or in part at any time or from time to time without notice or penalty, (ii) default interest at the non-compounding rate of 18% per annum, (iii) no acceleration rights in the event of default thereunder, and (iv) Notwithstanding any rights that the Securities Holder may otherwise generally have against the Company in connection with the Securities Holder’s exercise of any and all of any of its rights in respect of an event of default thereunder (whether such rights are available before or after any judgment is obtained by the Securities Holder against the Company), the Securities Holder specifically waives any and all of such rights and covenants such that, at no time, will the holder levy against (i) any equity owned by the Company in any entity, the financial statements of which are consolidated with the financial statements of the Company in any public filings (e.g., the Company’s periodic reports filed with the Securities and Exchange Commission or any of the Company’s reports provided to OTC Markets Group Inc. in connection with its Alternative Reporting Standards) and (ii) any direct or indirect assets of such entity.

 

 __________________

HOLDER’S INITIALS

 

2
 

 

3. Returned Conversion Stock. Effective as of the Effective Date, the Securities Holder shall take such steps as may be required by the Company’s transfer agent (the “Transfer Agent”), including a letter of instructions and authorization, to return to the Transfer Agent the Returned Conversion Stock, whether by “reverse-DWAC” or such other procedure as the Transfer Agent may request.

 

4. Lock-up and Leak-out. During the Lock-up Period, the Securities Holder agrees to the Lock-up, such that it shall not, directly or indirectly, offer, issue, sell, contract to sell (including, without limitation, any short sale), grant any option for the sale of, pledge, or otherwise dispose of or transfer any shares of Pre-agreement Conversion Stock into the public markets or otherwise. During the Leak-out Period, the Securities Holder agrees to the Leak-out, such that (i) it shall not, directly or indirectly, offer, issue, sell, contract to sell (including, without limitation, any short sale), grant any option for the sale of, pledge, or otherwise dispose of or transfer any shares of Pre-agreement Conversion Stock except into the public markets and (ii) no such disposition shall be in an amount that exceeds five percent of the daily trading volume of the Common Stock during any trading day, as reported by the OTCM. In connection with the Lock-up and Leak-out agreements set forth herein, the Securities Holder hereby agrees promptly to provide such documentation to the Company as it may reasonably request of the Securities Holder from time to time to ensure compliance with these provisions as set forth hereinbelow.

 

4.1 Trading Reports. The Securities Holder shall furnish trading reports (redacted as to price) to the Company, from time to time as reasonably requested by the Company, to confirm that the Securities Holder is acting in accordance with the Lock-up and Leak-out provisions of this Agreement.

 

4.2 Stop Transfer Instructions. The Securities Holder acknowledges and agrees that the Company may place appropriate stop-transfer instructions with the transfer agent of the Common Stock to ensure compliance with the Lock-up provisions of this Agreement.

 

4.3 OTCM Website. For purposes of determining the trading volume of the shares of Common Stock, such volume information shall be derived from data published on the OTCM website.

 

5. Company Waiver. Notwithstanding anything to the contrary contained herein, the Company may, in its sole discretion and in good faith, at any time and from time to time, waive any of the conditions or restrictions in its favor contained herein.

 

6. Warrants. As of the Effective Date, the Securities Holder shall have returned to the Company the Warrant certificate and all other documentation evidencing the Warrants, such that, as of the Effective Date, the Securities Holder shall have surrendered all of its rights in and to the Warrants and the Company shall no longer be obligated thereunder.

 

7. Conditions Precedent and Deemed Effectiveness. As conditions precedent to the effectiveness of the transactions contemplated herein (e.g., the Aggregate Waiver, the Lock-up, and the Leak-out), (i) the Acquisition Transaction with the Target shall have been consummated and (ii) the Company and the Other Similarly Situated Entities shall have executed and delivered the Other Entities’ Agreements. Upon the satisfaction of the later of the two conditions precedent, all of the transactions contemplated herein shall be deemed to be effective and, in preparation for the Deemed Effectiveness, the Company and the Securities Holder shall exchange such documents and take such other actions as may be required to effectuate the terms and provisions hereof. If, as of the Effective Date, any further actions are required of either or both of the Company and the Securities Holder to effectuate the terms and provisions hereof, such party shall promptly undertake such actions to completion.

 

Notwithstanding anything to the contrary contained herein, the Securities Holder and the Company shall act in accordance with their respective rights, duties, and obligations herein as if the conditions precedent to the transactions contemplated herein have been completed and, accordingly, the deemed effectiveness shall have occurred as of the Effective Date; provided, however, that, if the Acquisition Transaction shall not have been consummated effective on or before September 30, 2022, then such condition precedent shall not have been completed and the transactions contemplated herein shall be deemed not to have been consummated. Upon such “non-consummation event,” then the Securities Holder and the Company shall be released from the standstill referenced hereinabove.

 

3
 

 

8. General Acknowledgment. Each of the Company and the Securities Holder, as relevant, acknowledges and agrees to the following:

 

8.1 Accuracy of Recitals. Each of the Company and the Securities Holder hereby acknowledges the accuracy of the Recitals of this Agreement;

 

8.2 No Release; etc. Subject to the terms and conditions contained herein, including, but not limited to, the Aggregate Waiver, the Lock-up, and the Leak-out, the Premium Interest, and the Payment Schedule, which shall supersede the balance of this Section 8.2, neither this Agreement nor any other agreement entered in connection herewith or pursuant to the terms hereof shall be deemed or construed to be a compromise, satisfaction, reinstatement, accord and satisfaction, novation, or release of any of the Original Note or the shares of the Pre-Agreement Conversion Stock, or any rights or obligations thereunder or relating thereto, or a waiver by the Securities Holder of any of its rights thereunder or at law or in equity; and

 

8.3 Reaffirmation and Acknowledgement. Subject to the terms and conditions contained herein, including, but not limited to, the Aggregate Waiver, the Lock-up, and the Leak-out, the Premium Interest, and the Payment Schedule, which shall supersede the balance of this Section 8.3, the Company reaffirms the validity, binding effect, and enforceability of each Original Note, and acknowledges that the Company is liable to the Securities Holder for the sum of the Effective Date Owings and the Premium Interest, payments to be made by the Company to the Securities Holder in accordance with the Payment Schedule.

 

9. Representations and Warranties. To induce the Securities Holder to enter into this Agreement, the Company represents and warrants to the Securities Holder as follows:

 

9.1 Organization. The Company is a corporation duly organized, validly existing, and in good standing under the laws of the State of Nevada.

 

9.2 Authority. The Company has full company power and authority to execute, deliver, and perform this Agreement and has taken all corporate action required by law and its Articles of Incorporation to authorize the execution and delivery of this Agreement. This Agreement is a valid and binding agreement of the Company enforceable against the Company in accordance with its terms.

 

9.3 Consent and Approvals. No consent or approval of any party is required in connection with the execution and delivery of this Agreement and the execution and delivery hereof, subject to the execution and delivery of the Other Entities’ Agreements does not (i) contravene or result in a breach or default under the Articles of Incorporation, Bylaws, or any other governing document, agreement, or instrument to which the Company is a party or by which any of its property is bound or (ii) violate any law, rule, regulation, order, writ, judgment, injunction, decree, determination, or award applicable to the Company.

 

4
 

 

10. Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt requested, postage prepaid, (iii) delivered by reputable express courier service with charges prepaid, or (iv) transmitted by hand delivery or e-mail addressed as set forth below or to such other address as such party shall have specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon hand delivery or delivery by e-mail, with accurate confirmation generated by the transmitting computer, if possible, at the address or number designated below (if delivered on a business day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the second (2nd) business day following the date of mailing or deposit with an express courier service, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be:

 

If to the Company:

 

ENDEXX Corporation

38246 North Hazelwood Circle

Cave Creek, Arizona 85331

Attn: Todd Davis, CEO

E-mail: endexx@endexx.com

 

If to the Securities Holder:

 

 _________________________

 _________________________

Attention: _________________________

E-mail: _________________________

 

11. Federal Securities Laws. Nothing contained in this Agreement shall be deemed to supersede or modify any applicable United States and state securities laws, rules, and regulations.

 

12. Integration. This Agreement is intended by the Company and the Securities Holder to be the final expression of their agreement and, therefore, incorporate all negotiations of them and constitute their entire agreement. The Company acknowledges that it is relying on no written or oral agreement, representation, warranty, or understanding of any kind made by the Securities Holder or any employee or agent of the Securities Holder except for the agreements by the Securities Holder set forth herein or in any of the other Integration Documents.

 

13. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Nevada without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by this Agreement shall be brought only in the Courts of the State of Nevada located in the City of Las Vegas, County of Clark, and the U.S. District Court for the District of Nevada. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. To the maximum amount permitted, each of the Company and the Securities Holder waives trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney’s fees and costs. In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of this Agreement. Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action, or proceeding in connection with this Agreement by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

 

14. Consultation with Counsel. Each party represents that, before executing this Agreement, it had the opportunity to consult with competent legal counsel of its own choosing, carefully read this Agreement and has been fully and fairly advised as to their respective terms.

 

15. Waiver of Drafting Interpretation. The parties hereto agree that any rule of law or decision that would require interpretation of any claimed ambiguities in this Agreement against the party that drafted it has no application and is expressly waived.

 

16. Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original for all purposes and all of which shall be deemed, collectively, one agreement. The parties hereto, and their respective successors and assigns, are hereby authorized to rely upon the signature of each person on this Agreement, which are delivered by electronic signature or scanned electronic e-mail attachment, as constituting a duly authorized, irrevocable, actual, current delivery of this Agreement with original ink signatures of each such person. Signatures of the parties transmitted by scanned e-mail attachment shall be deemed to be their original signatures for all purposes. This Agreement shall become effective when executed and delivered by the parties hereto.

 

[signature page follows]

 

5
 

 

IN WITNESS WHEREOF, the undersigned have duly executed and delivered this Settlement, Lock-Up, and Leak-Out Agreement as of the Effective Date.

 

  ENDEXX CORPORATION
  a Nevada corporation
     
  By:                                                             
    Todd Davis
  Its: Chief Executive Officer

     
  ,  
  a  

     
  By:                                                                                 
   
  Its:

 

6
 

 

SCHEDULE “A”
(the “Equity Ownership”)

 

[attached hereto]

 

7
 

 

SCHEDULE “B”
(the “Payment Schedule”)

 

[attached hereto]

 

8
 

 

ANNEX 1
(copy of each Original Note)

 

[attached hereto]

 

9
 

 

ANNEX 2
(form of Replacement Note)

 

[attached hereto]

 

10

 

Exhibit 10.45

 

PROMISSORY NOTE

 

$_________ August 31, 2022

 

FOR VALUE RECEIVED, Endexx Corporation, a Nevada corporation, with an address of 38246 North Hazelwood Circle Cave Creek, Arizona 85331 (the “Maker”), hereby promises to pay to the order of ______, a _______, or assigns (the “Holder”), at ______________________________ or at such other place as the Holder may from time to time designate in writing to the Maker, the principal sum of _________________ Dollars ($____________). Principal and interest shall be payable in lawful money of the United States as hereinafter provided.

 

Maker Covenants and Agrees with the Holder as follows:

 

1. The Maker will pay the indebtedness (the “Indebtedness”) evidenced by this Note as provided herein. This Note or any portion thereof may be prepaid in whole or in part at any time or from time to time without premium or penalty.

 

2. Interest shall accrue at the rate of six and two-thirds percent (~6.667%) per annum. Absent the occurrence and continuation of an Event of Default (as hereinafter defined), principal will be paid as set forth on Schedule 1 attached hereto, and accrued interest shall be due and payable on the 18th payment set forth on Schedule 1 (the “Maturity Date”).

 

3. Upon the occurrence and during the continuance of a default upon Maker’s obligations to make payments of the principal and interest of this Note, when and as of the time the same shall become due and payable (an “Event of Default”), any Indebtedness then due and owing to the Holder pursuant to this Note shall bear interest at the rate of eighteen percent (18.0%) per annum from and after the date of such Event of Default until the date upon which such Event of Default is cured or the Indebtedness in paid in full, which even occurs first.

 

4. Upon the occurrence and during the continuance of an Event of Default, the Holder shall have the right, upon five (5) days’ written notice to the Maker and without further demand or notice, to pursue the payment and collection of such due and payable amounts. For clarity, upon an Event of Default, or otherwise, the Holder may not accelerate any unpaid principal balance or accrued and unpaid interest and any action by the Holder against the Maker for non-payment of any of the Maker’s obligations hereunder shall only include such past-due periodic payments for principal and interest and shall not include any request or demand for payment of principal or interest that, as of five (5) days subsequent to the Event of Default, had not yet become due and payable hereunder.

 

5. Notwithstanding any rights that an obligee may have generally against an obligor in connection with the obligee’s exercise of any and all of its rights in respect of an obligor’s breach or default under a promissory obligation to an obligee (whether such rights are available before or after any judgment is obtained by the obligee against the obligor), the Holder specifically waives any and all of such rights and covenants such that, at no time, will the holder levy against (i) any equity owned by the Maker in any entity, the financial statements of which are consolidated with the financial statements of the Maker in any public filings (e.g., the Maker’s periodic reports filed with the Securities and Exchange Commission or any of the Maker’s reports provided to OTC Markets Group Inc. in connection with its Alternative Reporting Standards) and (ii) any direct or indirect assets of such entity.

 

6. Neither the failure of the Holder to exercise its right to accelerate this Note when such right shall become available, nor any delay or omission on the part of the Holder in exercising any other right hereunder shall operate as a waiver of such right or of any other right hereunder. By accepting payment of any sum payable hereunder after its due date, the Holder shall not waive its rights either to require prompt payment when due of all other sums payable hereunder or to declare an Event of Default hereunder for failure to make prompt payment of such other sums.

 

7. The Maker hereby waives diligence, presentment, protest and demand, notice of protest, dishonor and nonpayment of this Note, and any other notice of any other kind (other than such notice as is expressly required by applicable law and with respect to which waiver is prohibited under the terms of this Note) and expressly agrees that, without in any way affecting liability for timely payment of amounts due hereunder, the Holder may extend the Maturity Date or the time for payment of any installment due hereunder.

 

1
 

 

8. Any interest computation under this Note (or under any other instrument executed in connection with or as security for the payment hereof) shall be at not more than the current maximum legal rate permitted by state law and in the event it should be held that interest payable under this Note (or under any other instrument executed in connection with or as security for the payment hereof) is in excess of the current maximum permitted by law, the interest chargeable hereunder (or under any other instrument executed in connection with or as security for the payment hereof) shall be reduced to the current maximum amount permitted by state law. If the Holder shall collect interest which is in excess of the current maximum amount permitted by law, all such sums deemed to constitute interest in excess of the current maximum amount permitted by state law shall, at the option of the Holder, be refunded to Maker or credited to the payment of the principal of this Note.

 

9. This Note shall be governed by and construed in accordance with the laws of the State of Nevada without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by this Note shall be brought only in the Courts of the State of Nevada located in the City of Las Vegas, County of Clark, and the U.S. District Court for the District of Nevada. The parties to this Note hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. To the maximum amount permitted, each of the Company and the Holder waives trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney’s fees and costs. In the event that any provision of this Note or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of this Note. Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action, or proceeding in connection with this Note by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Note and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

 

10. If any provision of this Note or any application of such provision shall be declared by a court of competent jurisdiction to be invalid or unenforceable, such invalidity or unenforceability shall not affect any other application of such provision or any other provisions hereof which shall, to the fullest extent possible, remain in full force and effect.

 

11. Any notice or demand required or permitted to be made or given hereunder shall be deemed sufficiently made and given by personal service or by the mailing of such notice or demand by certified or registered mail, return receipt requested, addressed, if to Maker, at Maker’s address first above written. Either party may change its address by like notice to the other party.

 

[Signature on following page]

 

2
 

 

IN WITNESS WHEREOF, Maker has duly executed this Promissory Note as of the date first above written.

 

  ENDEXX CORPORATION
     
  By:                      
    Todd Davis, CEO

 

3
 

 

Exhibit 10.46

 

CONTRIBUTION AND EXCHANGE AGREEMENT

 

This CONTRIBUTION AND EXCHANGE AGREEMENT (this “Agreement”) is entered into as of August 31, 2022, by and among ENDEXX Corporation, a Nevada corporation (“EDXC”), CBD Unlimited, Inc., a Nevada corporation (“CBDU”), Todd Allen Davis, a resident of the State of Arizona (“Mr. Davis”), and Rayne Forecast Inc., an Arizona corporation (“Rayne”). Each of EDXC, CBDU, Mr. Davis, and Rayne may be referred to herein, individually, as a “Party” and, collectively, as the “Parties”.

 

WHEREAS, Mr. Davis is a director, executive officer, and significant stockholder of EDXC;

 

WHEREAS, Rayne is wholly owned by Mr. Davis;

 

WHEREAS, CBDU is a wholly owned subsidiary of EDXC;

 

WHEREAS, immediately prior to the date hereof, EDXC contributed all of its operating assets and all of its liabilities directly related thereto to CBDU (the “EDXC – CBDU Contribution”), pursuant to a unanimous written consent executed by the respective boards of directors of EDXC and CBDU, a copy of each of which consents is attached hereto as Attachment A and Attachment B, respectively;

 

WHEREAS, Mr. Davis owns and Rayne own certain equity and capital interests of EDXC as described and set forth on Exhibit A (the “EDXC Equity”);

 

WHEREAS, Mr. Davis and Rayne will surrender to EDXC for cancellation certain of the EDXC Equity (the “Surrendered EDXC Equity”) as noted on Exhibit A;

 

WHEREAS, Mr. Davis and Rayne will retain that number of shares of the EDXC Equity that does not constitute the Surrendered EDXC Equity (the “Retained EDXC Equity”) as described and set forth on Exhibit A;

 

WHEREAS, Mr. Davis and Rayne will surrender that number of shares of the EDXC Equity that does not constitute the Surrendered EDXC Equity to counsel for the Company (the “Escrowed EDXC Equity”) to be held in escrow (such amount as described and set forth on Exhibit A), which shall be released to Mr. Davis and Rayne in accordance with the Escrow release provisions set forth hereinbelow;

 

WHEREAS, through and including the Effective Date (as defined below), EDXC has accrued certain compensation and related obligations in favor of Mr. Davis and Rayne, as described and set forth on Exhibit B (the “Deferred Payments and Obligations”; and, together with the Surrendered EDXC Equity, the “Contributed Items”); and

 

WHEREAS, each of Mr. Davis and Rayne desires to contribute to EDXC, and EDXC desires to accept from Mr. Davis and Rayne, all of their right, title, and interest in and to the Contributed Items, and, in connection therewith, EDXC desires to assign to Mr. Davis and Rayne, and each of Mr. Davis and Rayne desires to accept from EDXC, certain shares of common stock of CBDU that are owned of record and beneficially by EDXC (the “CBDU Equity”), in the amounts and as described and set forth on Exhibit C (the transactions set forth in this paragraph as detailed below, the “Exchange”).

 

Contribution and Exchange Agreement (Todd Davis) August 2022.51

 

 

NOW, THEREFORE, in consideration of these presents and for such other good and valuable consideration, the receipt and sufficiency of which the Parties hereby acknowledge, the Parties, intending to be legally bound hereby, agree as follows:

 

  1. Closing; Contribution and Exchange.

 

(a)The Closing. The closing (the “Closing”) of the transactions contemplated by this Agreement shall take place immediately prior to the consummation of the transactions contemplated by that certain [Hyla Agreement] (the “Effective Date”).

 

(b)Contribution and Exchange. As of the Closing (as defined below), the Parties shall consummate the Exchange, pursuant to which Mr. Davis and Rayne shall contribute to EDXC all of their respective right, title, and interest in and to the Contributed Items, free and clear of any and all liens and restrictions in exchange for the assignment by EDXC to Mr. Davis and Rayne of the CBDU Equity, free and clear of any and all liens and restrictions, other than those imposed by or arising out of state or federal securities laws.

 

(c)The Surrendered EDXC Equity. In connection with the Exchange, Mr. Davis and Rayne shall promptly take such steps as (i) EDXC’s transfer agent shall require for Mr. Davis and Rayne to tender the Surrendered EDXC Equity to EDXC’s transfer agent for cancellation and (ii) the Secretary of State of the State of Nevada shall require for Mr. Davis and Rayne to cancel the outstanding Series Z Convertible Preferred Stock.

 

(d)The Escrowed EDXC Equity. In connection with the Exchange, Mr. Davis and Rayne shall promptly take such steps as EDXC’s transfer agent shall require to revest the Escrowed EDXC Equity (whether in certificated form or in restricted book entry) as “Randolf W. Katz, as Escrow Agent for Todd Davis and Rayne Forecast Inc.” Randolf W. Katz is appointed as escrow agent for the Escrowed EDXC Equity by each of EDXC, Mr. Davis, and Rayne. As more particularly set forth in the Escrow Agreement (the form of which is attached hereto as Exhibit D), the Escrowed EDXC Equity will be released to Mr. Davis and Rayne if, when, and as EDXC has repaid its obligations in full to the seven holders of EDXC’s promissory notes delivered by EDXC on or about the date of this Agreement, all of which notes are referenced in the Escrow Agreement.

 

(e)Assignment of the CBDU Equity. In connection with the Exchange, EDXC shall assign the shares of the CBDU Equity to Mr. Davis and Rayne and, in connection therewith, CBDU shall (i) record such assignments on its books and records of account and (ii) generate and deliver certificates therefor that represent such shares of CBDU Equity.

 

(f)Tax Treatment. Each of the Parties shall be responsible (i) to file his or its tax returns that, if relevant, reference the transactions contemplated by this Agreement and (ii) to pay taxes, if any, resulting therefrom.

 

2. Representations and Warranties of EDXC and CBDU. EDXC and CBDU represent and warrant to Mr. Davis and Rayne, as follows:

 

(a)Authority. Each of EDXC and CBDU is a corporation duly organized and validly existing and in good standing under the laws of the State of Nevada. Each of EDXC and CBDU has the requisite power and authority to execute and deliver this Agreement, and to perform its obligations under, this Agreement.

 

Contribution and Exchange Agreement (Todd Davis) August 2022.52

 

 

(b)Authorization; Execution and Delivery; Enforceability. Each of EDXC and CBDU has taken all action necessary to authorize the execution and delivery by such entity of this Agreement and the performance by such entity of its respective obligations hereunder. This Agreement has been duly executed and delivered by each of EDXC and CBDU and constitutes a valid and binding obligation of each entity, enforceable against such entity in accordance with its terms, subject to applicable bankruptcy, reorganization, insolvency, moratorium, and similar laws affecting creditors’ rights generally and to general principles of equity. The execution, delivery, and performance of this Agreement and the consummation of the transactions contemplated hereby will not, with or without the giving of notice or the lapse of time or both, (a) violate any provision of law, statute, rule, or regulation to which either EDXC or CBDU is subject, (b) violate any order, judgment, or decree applicable to either EDXC or CBDU, or (c) conflict with or result in a breach or default under any term or condition of such entity’s applicable charter documents or any agreement or other instrument to which such entity is a party or by which such entity is bound. No consent, approval, order, or authorization of, or registration, qualification, designation, declaration, or filing with, any federal, state, or local governmental authority on the part of either EDXC or CBDU is required in connection with the consummation of the transactions contemplated by this Agreement, except for such filings required pursuant to applicable federal and state securities laws.

 

(c)Sufficiency of Assets. The assets and liabilities transferred to CBDU as part of the EDXC – CBDU Contribution collectively (i) constitute all the assets and services used by or in operating the “CBD CBDU” business as it was operated by EDXC immediately prior to the EDXC – CBDU Contribution, and (ii) are sufficient for the continued conduct of the “CBD CBDU” business by CBDU after the effectuation of the EDXC – CBDU Contribution in substantially the same manner as conducted by EDXC immediately prior to the EDXC – CBDU Contribution, will be available for use in substantially the same manner as used by EDXC immediately prior to the EDXC – CBDU Contribution, and constitute all of the rights, property and assets necessary to conduct “CBD CBDU” business following the EDXC – CBDU Contribution in substantially the same manner as it was conducted by EDXC prior thereto.

 

(d)CBDU Equity. The shares of CBDU Equity, when assigned by EDXC pursuant to the terms of the Agreement, will have been validly issued, fully paid, and nonassessable, and will be free of any liens or encumbrances caused or created by EDXC or CBDU.

 

3. Representations and Warranties of Mr. Davis and Rayne. Mr. Davis and Rayne, severally, but not jointly, represents and warrants to each of EDXC and CBDU as follows:

 

(a)Authority. Each of Mr. Davis and Rayne has the requisite power and authority and full legal capacity to execute, deliver, and consummate the transactions contemplated by, and to perform his and its respective obligations under, this Agreement.

 

(b)Enforceability. This Agreement has been duly and validly executed and delivered by each of Mr. Davis and Rayne and constitutes a valid and binding obligation of such person or entity, enforceable against such person or entity in accordance with its terms, subject to applicable bankruptcy, reorganization, insolvency, moratorium, and similar laws affecting creditors’ rights generally and to general principles of equity. The execution, delivery, and performance of this Agreement and the consummation of the transactions contemplated hereby will not with or without the giving of notice or the lapse of time or both (a) violate any provision of law, statute, rule, or regulation to which such person or entity is subject, (b) violate any order, judgment, or decree applicable to such person or entity, or (c) conflict with or result in a breach or default under any term or condition of any agreement or other instrument to which such person or entity is a party or by which such person or entity is bound.

 

Contribution and Exchange Agreement (Todd Davis) August 2022.53

 

 

(c)Contributed Items. Each of Mr. Davis and Rayne owns the Contributed Items, free and clear of all Encumbrances, including the EDXC Equity set forth opposite the name of such person or entity on Exhibit A. Each of Mr. Davis and Rayne has good and marketable title to such EDXC Equity, free and clear of all Encumbrances. “Encumbrance” means any lien, mortgage, pledge, security interest, right of first refusal, preemptive or purchase right, option, equitable or beneficial interest, claim, or encumbrance of any kind.

 

(d)Investment. Each of Mr. Davis and Rayne is acquiring the shares of CBDU Equity for his or its own account for investment purposes only and not with a view to, or for the resale in connection with, any “distribution” thereof for purposes of the Securities Act of 1933, as amended (the “Act”).

 

(e)Accredited Investor. Each of Mr. Davis and Rayne is an accredited investor within the meaning of Regulation D promulgated by the Securities and Exchange Commission pursuant to the Act, and each of Mr. Davis and Rayne is capable of evaluating the merits and risks of the investment in the CBDU Equity and each has the capacity to protect his or its respective interests.

 

(f)Holding Period. Mr. Davis further understands that the CBDU Equity must be held indefinitely unless subsequently registered under the Act or unless an exemption from registration is otherwise available. Moreover, Mr. Davis understands that neither EXEC nor CBDU is under no obligation to register the CBDU Equity. In addition, Mr. Davis understands that the CBDU Equity will be imprinted with a legend that prohibits the transfer of the CBDU Equity unless they are registered, or such registration is not required in the opinion of counsel for EDXC or CBDU.

 

(g)Rule 144. Mr. Davis is aware of the provisions of Rule 144, promulgated under the Act, which, in substance, permit limited public resale of “restricted securities” acquired, directly or indirectly from the issuer thereof (or from an affiliate of such issuer), in a non-public offering subject to the satisfaction of certain conditions, including, in case Mr. Davis has held the securities for at least one year or is an affiliate of CBDU: (1) the resale occurring not less than one year after the party has purchased and paid for the securities to be sold and (2) in the case of an affiliate: (a) the availability of certain public information about CBDU; (b) the sale being made through a broker in an unsolicited “broker’s transaction” or in transactions directly with a market maker (as these terms are defined under the Securities Exchange Act of 1934); (c) the amount of securities being sold during any three-month period not exceeding certain specified limitations and (d) the filing of a Notice of Sale on Form 144, as appropriate

 

(h)No Public Market. Mr. Davis further understands that, as of the Effective Date, there is no public market for the equity securities of CBDU (the “CBDU Stock”), and that, at the time he wishes to sell the CBDU Equity, it is highly unlikely that any public market for the CBDU Stock will have commenced into which the CBDU Equity could be sold, and that, even if such a public market were then to exist, CBDU may not be satisfying the current public information requirements of Rule 144, and that, in such event, Mr. Davis would be precluded from selling the CBDU Equity under Rule 144 unless (1) a one-year minimum holding period had been satisfied and (2) Mr. Davis was not at the time of sale nor at any time during the three-month period prior to such sale an affiliate of CBDU.

 

Contribution and Exchange Agreement (Todd Davis) August 2022.54

 

 

4. Releases.

 

(a)Mr. Davis’ and Rayne’s Releases. Each of Mr. Davis and Rayne, on his or its own respective behalf and on behalf of his or its affiliates and each of their respective past, present, and future equity owners, officers, directors, agents, servants, employees, consultants, attorneys, shareholders, representatives, heirs, successors, and assigns (collectively, the “Mr. Davis and Rayne Release Parties”), hereby releases and discharges EDXC, its predecessors, subsidiaries, officers, directors, consultants, attorneys, accountants, equity holders, and debt holders, and the affiliates thereof (collectively, the “EDXC Release Parties”) from and against any and all claims, actions, causes of action, demands, rights, debts, agreements, promises, tort claims, statutory claims, bad faith claims, contract claims, wage claims, charges, grievances, complaints, controversies, suits, hearings, investigations, inquiry, proceeding (arbitral, administrative, legal, or otherwise), demands, debts, penalties, compensatory damages, liquidated damages, costs, expenses, liabilities, losses, damages, punitive damages, liens, compensation, obligations, guarantees, attorneys’ fees, costs, and expenses, or any similar matter, either known or unknown, foreseen or unforeseen, or suspected and unsuspected, of any kind, nature, or amount whatsoever, without limitation or exception, in law, equity, or otherwise, whether based on theories of contract, breach of contract, subrogation, indemnity, tort, violation of statute or regulation, or any other theory of liability or declaration of rights whatsoever, which any releasing party may now have accrued or may hereafter accrue, arising out of or in connection with any contract, transaction, act, cause, matter, event, action, or thing existing at any time prior to and including the Effective Date (collectively, the “Released Claims”). Notwithstanding anything to the contrary contained herein, none of the Mr. Davis and Rayne Release Parties releases, discharges, or waives any of the Released Claims that any of them has, has ever had, or may hereafter have against any of the EDXC Release Parties arising from or related to their performance under this Agreement, and each of the Mr. Davis and Rayne Release Parties hereby expressly reserves any such Released Claims against each of the EDXC Release Parties.

 

(b)EDXC Release. The EDXC Released Parties hereby release and discharge each of the Mr. Davis and Rayne Releasing Parties from and against any and all of the Released Claims. Notwithstanding anything to the contrary contained herein, none of the EDXC Released Parties releases, discharges, or waives any of the Released Claims that any of them has, has ever had, or may hereafter have against any of the Mr. Davis and Rayne Releasing Parties arising from or related to this Agreement, and each of the EDXC Released Parties hereby expressly reserves any such Released Claims against each of the Mr. Davis and Rayne Releasing Parties.

 

5. No Assignment. Each of the Parties represents and warrants that it has not assigned any or all of the Released Claims or has authorized any other person or entity to assert any or all of the Released Claims on behalf of any such Party.

 

6. Covenants of the Parties. Each of the Parties covenants not to initiate, make, or prosecute any claim arising out of any of their relationships that are included in the Released Claims, or to institute or join any grievance, arbitration, action, lawsuit, or proceeding against any of the Parties in respect thereof.

 

Contribution and Exchange Agreement (Todd Davis) August 2022.55

 

 

7. Binding Effect. This Agreement will be binding upon and will inure to the benefit of the Parties and their heirs, successors, and permitted assigns.

 

8. Governing Law; Jurisdiction; Venue. This Agreement shall be governed by and construed in accordance with the laws of the State of Nevada without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by this Agreement shall be brought only in the Courts of the State of Nevada located in the City of Las Vegas, County of Clark, and the U.S. District Court for the District of Nevada. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. To the maximum amount permitted, each of the Parties waives trial by jury. The prevailing party shall be entitled to recover from the other party his or its reasonable attorney’s fees and costs. In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of this Agreement. Each Party hereby irrevocably waives personal service of process and consents to process being served in any suit, action, or proceeding in connection with this Agreement by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such Party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

 

9. Counterparts. This Agreement may be executed in counterparts (including by means of facsimile or other similar methods of electronic transmission), each of which shall be deemed an original, and all of which taken together shall constitute one and the same agreement.

 

10. Entire Agreement. This Agreement embodies the complete agreement and understanding between the parties hereto with respect to the subject matter hereof and supersedes and preempts any prior understandings, agreements, or representations by or between the parties hereto, written or oral, which may have related to the subject matter hereof in any way.

 

11. Amendment. This Agreement may not be altered, modified, or amended except by a written instrument signed by each of the parties hereto.

 

[signatures on following page]

 

Contribution and Exchange Agreement (Todd Davis) August 2022.56

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above.

 

  ENDEXX CORPORATION
     
  By:  
    Todd Davis, Chief Executive Officer
     
  CBD UNLIMITED, INC.
     
  By:  
    Todd Davis, Chief Executive Officer
     
  RAYNE FORECAST INC.
     
  By:  
    Todd Davis, Chief Executive Officer
     
   
  TODD ALLEN DAVIS
  An individual

 

Contribution and Exchange Agreement (Todd Davis) August 2022.57

 

 

Attachment A

 

Unanimous Written Consent of EDXC

 

Contribution and Exchange Agreement (Todd Davis) August 2022.5ATTACHMENT A 

 

 

Attachment B

 

Unanimous Written Consent of CBDU

 

Contribution and Exchange Agreement (Todd Davis) August 2022.5ATTACHMENT B 

 

 

Exhibit A

 

EDXC Equity

 

Mr. Davis: 3,000,000 shares of EDXC common stock in book entry at AST
   
Mr. Davis: 44,175 shares of EDXC common stock held in IRA account at Charles Schwab
   
Rayne: 59,957,275 shares of EDXC common stock in certificated form
   
Rayne: 6,375,303 shares of EDXC common stock in book entry at AST
   
Rayne: 15,795 shares of EDXC common stock held in account at E*Trade
   
Mr. Davis: 719,571 shares of EDXC Series Z Convertible Preferred Stock (71,957,117 shares of EDXC common stock on an as-converted basis) held in book entry at EDXC

 

Surrendered EDXC Equity

 

Rayne: 20,612,060 shares of EDXC common stock in certificated form
   
Mr. Davis: 719,571 shares of EDXC Series Z Convertible Preferred Stock

 

Retained EDXC Equity

 

Mr. Davis: 3,000,000 shares of EDXC common stock in book entry at AST
   
Mr. Davis: 44,175 shares of EDXC common stock held in IRA account at Charles Schwab
   
Rayne: 18,819,072 shares of EDXC common stock in certificated form
   
Rayne: 6,375,303 shares of EDXC common stock in book entry at AST
   
Rayne: 15,795 shares of EDXC common stock held in account at E*Trade

 

Escrowed EDXC Equity

 

Rayne: 20,526,143 shares of EDXC common stock in certificated form

 

Contribution and Exchange Agreement (Todd Davis) August 2022.5EXHIBIT A 

 

 

Exhibit B

 

Deferred Payments and Obligations

 

Approximately $260,000.00

 

Contribution and Exchange Agreement (Todd Davis) August 2022.5EXHIBIT B 

 

 

Exhibit C

 

CBDU Equity

 

30% of the issued and outstanding capital stock of CBDU

 

Contribution and Exchange Agreement (Todd Davis) August 2022.5EXHIBIT C 

 

 

Exhibit D

 

Form of Escrow Agreement

 

Contribution and Exchange Agreement (Todd Davis) August 2022.5EXHIBIT D 

 

Exhibit 10.47

 

ESCROW AGREEMENT

 

THIS ESCROW AGREEMENT (this “Agreement”) is entered into as of August 31, 2022, by and among Rayne Forecast Inc., an Arizona corporation (“Rayne”), Todd Allen Davis, an individual residing in the State of Arizona (“Mr. Davis”), Endexx Corporation, a Nevada corporation (“EDXC”), and Randolf W. Katz, a member of, and on behalf of, Clark Hill PLC, a Michigan domestic professional limited liability company (the “Escrow Agent”). Each of Rayne and Mr. Katz may be referred to individually as a “Party” or collectively as the “Parties.”

 

A. Rayne is the record holder of certain shares of common stock of EDXC, which includes the 20,526,143 shares of common stock that are the subject of this Escrow Agreement (the “Escrow Stock”).

 

B. Rayne, Mr. Davis, and EDXC entered into a series of agreements of even date herewith (the “August Agreements”).

 

C. Pursuant to the terms and conditions of at least one of the August Agreements, the shares of Escrow Stock are being deposited into the escrow that is created hereby, the release of which shares of Escrow Stock is governed by the provisions of the relevant August Agreements and this Escrow Agreement.

 

D. Rayne and EDXC desire that the Escrow Agent hold and release the shares of Escrow Stock, and the Escrow Agent has agreed to hold the shares of Escrow Stock in escrow and, thereafter, to disburse the shares of Escrow Stock, all in according to the terms and conditions of this Escrow Agreement.

 

NOW, THEREFORE, in consideration of these presents and for such other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto, intending to be legally bound, hereby agree as follows:

 

AGREEMENT

 

1. Appointment of the Escrow Agent; the Escrow Agent Fees; Expenses. Rayne and EDXC hereby appoint the Escrow Agent as the Escrow Agent for the purposes set forth herein, and the Escrow Agent hereby accepts such appointment on the terms set forth herein. The Escrow Agent shall receive as compensation for the services to be rendered by the Escrow Agent hereunder the sum of $985.00 for administration of the escrow described herein, along with reimbursement for all reasonable expenses, disbursements, and advances incurred or made by the Escrow Agent in performance of his duties hereunder (including reasonable fees, expenses, and disbursements of its counsel). All such fees are payable by EDXC.

 

2. Delivery of the Shares of Escrow Stock. On or about the date of execution of this Escrow Agreement, Rayne, Mr. Davis, EDXC, and the Escrow Agent shall promptly take such steps as may be required by the transfer agent for EDXC to cause the shares of Escrow Stock to be registered in the name, “Randolf W. Katz, as Escrow Agent for Rayne Forecast Inc.” The shares of Escrow Stock shall be held by the Escrow Agent pursuant to the terms hereof either in certificated form or in restricted book entry form pursuant to a lock-up agreement with EDXC’s transfer agent to effectuate the provisions of this Escrow Agreement.

 

Endexx and Todd Davis Escrow Agreement August 2022.2

1

 

 

3. Splits, Recapitalizations, Dividends, and the Like. In the event that EDXC shall (a) effectuate a forward split or a reverse split of its common stock, (b) declare a dividend (whether in cash or in kind, in its derivative securities or in other rights, or in the equity or debt securities of another entity, which securities are owned of record or beneficially by EDXC) to the holders of shares of its common stock, (c) undergo a recapitalization, (d) make a pro rata distribution to the holders of its common stock, (e) undergo a fundamental transaction, or (f) “spin-out” to the holders of its common stock any equity of any of EDXC’s wholly-owned, majority-owned, or otherwise consolidated subsidiaries, then the shares of Escrow Stock shall be appropriately and equitably adjusted, as if such shares were held of record by Rayne.

 

4. Release of the Shares of Escrow Stock. All of the shares of Escrow Stock will be released (the “Escrow Release Condition”) to Mr. Davis and Rayne, as relevant, if, when, and as EDXC has repaid or otherwise satisfied its obligations (the “EDXC Repayment”) in full to each of the seven separate holders of EDXC’s promissory notes that were delivered by EDXC to each such holder on or about the date of this Escrow Agreement, all of which promissory notes were executed and delivered by EDXC to their respective holders in connection with the respective Settlement, Lock-up, and Leak-out Agreements between EDXC and each of such entities. The holders of such notes are (i) Apollo Management Group, Inc., a Florida corporation, (ii) Apollo Capital Corp., a Delaware corporation, (iii) Apollo Management SPV LLC, a Florida limited liability company, (iv) 3a Capital Establishment, a Lichtenstein corporation, (v) AJB Capital Investments, LLC, a Delaware limited liability company, (vi) Jefferson Street Capital LLC, a New Jersey limited liability company, and (vii) M2B Funding Corp., a Florida corporation. The Escrow Agent will rely on written confirmation from EDXC for notification of the Escrow Release Condition. EDXC hereby covenants to the Parties that it will deliver to the Escrow Agent written notification of the Escrow Release Condition within ten (10) calendar days of the occurrence of the EDXC Repayment. The Escrow Release Condition and the release by the Escrow Holder of the shares of Escrow Stock as required herein shall not be dependent on either or both of Rayne or Mr. Davis having any relationship with EDXC.

 

5. Termination of Escrow. This escrow described herein shall terminate upon the Escrow Agent providing written instructions to EDXC’s transfer agent with such other documentation as the transfer agent may reasonably require to effectuate the revesting of the shares of Escrow Stock into the name of “Rayne Forecast Inc.”

 

6. Liability of the Escrow Agent. The Escrow Agent undertakes to perform only such duties as are expressly set forth herein and no other duties shall be implied. The Escrow Agent may rely upon and shall not be liable for acting or refraining from acting upon any written notice, instruction, or request furnished to it hereunder and believed by it to be genuine and to have been signed or presented by the proper Party or Parties. The Escrow Agent shall be under no duty to inquire into or investigate the validity, accuracy, or content of any such document. The Escrow Agent shall not be liable for any action taken or omitted by it in good faith except to the extent that a court of competent jurisdiction or arbitrator, as applicable, determines that the Escrow Agent’s gross negligence, willful misconduct, or fraud was the primary cause of any loss to a Party. The Escrow Agent may execute any of its powers and perform any of its duties hereunder directly or through agents or attorneys and may consult with counsel, accountants, and other skilled persons to be selected and retained by it in its sole discretion, provided that any such delegation shall not relieve The Escrow Agent from its obligations, duties, and responsibilities hereunder. The Escrow Agent shall not be liable for anything done, suffered, or omitted in good faith by it in accordance with the advice or opinion of any such counsel, accountants, or other skilled persons. In the event that The Escrow Agent shall be uncertain as to its duties or rights hereunder or shall receive instructions, claims or demands from any Party that, in its opinion, conflict with any of the provisions of this Escrow Agreement, or with any instructions, claims or demands from any other Party, it shall refrain from taking any action and its sole obligation shall be to keep safely all property held in escrow until it shall be directed otherwise in writing by the Investor or by a final arbitration decision or a non-appealable order or judgment of a court of competent jurisdiction. Anything in this Escrow Agreement to the contrary notwithstanding, in no event shall the Escrow Agent be liable for special, indirect, or consequential loss or damage of any kind whatsoever (including but not limited to lost profits), even if the Escrow Agent has been advised of the likelihood of such loss or damage and regardless of the form of action.

 

Endexx and Todd Davis Escrow Agreement August 2022.2

2

 

 

All of the terms and conditions in connection with the Escrow Agent’s duties and responsibilities, and the rights of the Parties or anyone else, are contained solely in this Escrow Agreement, and the Escrow Agent is not expected or required to be familiar with the provisions of any other agreements, and shall not be charged with any responsibility or liability in connection with the observance of the provisions of any such other agreements.

 

Except as herein expressly provided, none of the provisions of this Escrow Agreement shall require the Escrow Agent to expend or risk its own funds or otherwise incur financial liability or expense in the performance of any of its duties hereunder.

 

The Escrow Agent is hereby authorized to comply with and obey all final non-appealable orders, judgments, decrees or writs entered or issued by any court or final decision of any arbitrator, and in the event the Escrow Agent obeys or complies with any such final non-appealable order, judgment, decree or writ of any court or final decision of any arbitrator, in whole or in part, after giving the other Parties seven (7) days’ prior written notice, it shall not be liable to any of the other Parties hereto, nor to any other person or entity, by reason of such compliance, notwithstanding that it shall be determined that any such final non-appealable order, judgment, decree, writ, or final decision of a court or final decision of any arbitrator be entered without jurisdiction or be invalid for any reason or be subsequently reversed, modified, annulled or vacated.

 

7. Resignation or Removal of the Escrow Agent. The Escrow Agent (and any successor escrow agent) may at any time resign as such, after which the Escrow Agent shall promptly deliver the shares of Escrow Stock in its possession to any successor The Escrow Agent then jointly designated by the other Parties hereto in writing, or to any court of competent jurisdiction, whereupon the Escrow Agent shall be discharged of and from any and all further obligations arising in connection with this Escrow Agreement. The Parties shall also have the right at any time upon mutual agreement to substitute a new the Escrow Agent by giving written notice thereof to the Escrow Agent. The resignation or removal of the Escrow Agent shall take effect on the earlier of (i) the appointment of a successor (including a court of competent jurisdiction), or (ii) the day which is five (5) days after the date of delivery of its written notice of resignation to the other Parties hereto or the date on which the Parties hereto deliver written notice of removal to the Escrow Agent, as applicable. If at that time described in clause (ii) of the immediately preceding sentence, the Escrow Agent has not received a designation of a successor the Escrow Agent, the Escrow Agent’s sole responsibility after that time shall be to retain and safeguard the shares of Escrow Stock until receipt of a designation of a successor the Escrow Agent or a joint written disposition instruction by the other Parties hereto or a final non-appealable order of a court of competent jurisdiction.

 

8. Indemnification of the Escrow Agent. EDXC and Rayne shall jointly and severally indemnify, defend, and save harmless the Escrow Agent and its members, managers, officers, agents and employees (the “Indemnified Parties”) from all loss, liability, or expense (including the reasonable fees and expenses of outside counsel) arising out of or in connection with (i) the Escrow Agent’s execution and performance of this Escrow Agreement, except in the case of any Indemnified Party to the extent that such loss, liability, or expense is due to the gross negligence, willful misconduct, or fraud of such Indemnified Party or (ii) its following any instructions or other directions executed by the Parties. Each of EDXC and Rayne acknowledges that the foregoing indemnities shall survive the resignation or removal of the Escrow Agent or the termination of this Escrow Agreement.

 

Endexx and Todd Davis Escrow Agreement August 2022.2

3

 

 

9. Disputes. In the event any dispute shall arise between EDXC and Rayne with respect to the release of the shares of Escrow Stock, the Escrow Agent is permitted to interplead the shares of Escrow Stock into a competent federal or state court within the State of Nevada, and thereafter shall be fully relieved from any and all liability or obligation with respect to the shares of Escrow Stock. Each of EDXC and Rayne further agrees to pursue any redress or recourse in connection with such a dispute without making the Escrow Agent a party to same.

 

10. Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt requested, postage prepaid, (iii) delivered by reputable express courier service with charges prepaid, or (iv) transmitted by hand delivery or e-mail addressed as set forth below or to such other address as such party shall have specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon hand delivery or delivery by e-mail, with accurate confirmation generated by the transmitting computer, if possible, at the address or number designated below (if delivered on a business day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the second (2nd) business day following the date of mailing or deposit with an express courier service, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be:

 

If to EDXC:

 

ENDEXX Corporation

38246 North Hazelwood Circle

Cave Creek, Arizona 85331

Attn: Todd Davis, President

E-mail: endexx@endexx.com

 

If to Rayne:

 

Rayne Forecast Inc.

37043 N. Kohuana Place

Cave Creek, Arizona 85331

Attn: Todd Davis, President

E-mail: todski17@yahoo.com

 

If to the Escrow Agent:

 

Clark Hill PLC

555 South Flower Steet, 24th Floor

Los Angeles, California 90071

Attn: Randolf W. Katz, Member

E-mail: rkatz@clarkhill.com and randy@randykatzlaw.com.

 

Endexx and Todd Davis Escrow Agreement August 2022.2

4

 

 

11. Further Assurances. The Parties agree that, from time to time upon the written request of the Escrow Agent, the Parties shall execute and deliver such further documents and do such other acts and things as the Escrow Agent may reasonably request in order to fully effectuate the purposes of this Escrow Agreement.

 

12. Entire Agreement. This Escrow Agreement constitutes the entire understanding and agreement of the Parties hereto with respect to the general subject matter hereof, supersedes all prior discussions and agreements with respect thereto, and cannot be contradicted by evidence of any alleged oral agreement. This Escrow Agreement may only be amended, modified, or rescinded by written agreement signed by the Parties hereto.

 

13. Authority; Counterparts. The persons signing below each represent and warrant that they have all requisite and necessary authority to bind the Party for which they are signing to all the terms of this Escrow Agreement. This Escrow Agreement may be executed by signatures sent by facsimile or other electronic means and in separate counterparts, each signature page of which shall be an original copy, all of which together, when attached to the body hereof, shall constitute one instrument, binding upon all Parties hereto, notwithstanding that all of the Parties shall not have signed the same counterparts.

 

14. Governing Law. This Escrow Agreement shall be construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation, and performance of this Escrow Agreement shall be governed by, the internal laws of the State of Nevada, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Nevada or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Nevada. The Parties hereto hereby exclusively and irrevocably submit to, and waive any objection against, the exclusive jurisdiction and venue of any state or federal court sitting in Clark County, Nevada, over any proceeding arising out of or relating to this Escrow Agreement.

 

15. Successors and Assigns. This Escrow Agreement shall be binding upon the Parties hereto and each of their successors and assigns.

 

16. Assignment. None of the Parties may assign their respective interests in and to this Escrow Agreement without the prior written consent of each other Party.

 

[Signature Page to Follow.]

 

Endexx and Todd Davis Escrow Agreement August 2022.2

5

 

 

IN WITNESS WHEREOF, the Seller and the Escrow Agent have executed this Escrow Agreement as of the date first above.

 

  RAYNE FORECAST INC.
     
  By:
     
    Todd Davis, President
     
     
    TODD ALLEN DAVIS,
     
    an individual
     
  ENDEXX CORPORATION
     
  By:
    Todd Davis, President

 

Appointment accepted    
as of the first date written above: CLARK HILL PLC
     
  By:
    Randolf W. Katz, Member

 

Endexx and Todd Davis Escrow Agreement August 2022.2

6

 

 

 

Exhibit 10.48 

 

EXECUTIVE AGREEMENT

 

This Executive Agreement (the “Agreement”) is made this 31st day of August 2022, by and between Endexx Corporation, a Nevada corporation, and its affiliates, successors, and assigns (“EDXC”) and Todd Allen Davis (the “Executive”).

 

WHEREAS, the Executive is a director, executive officer, and significant stockholder of EDXC;

 

WHEREAS, immediately prior to the effectiveness hereof, EDXC contributed (the “EDXC – CBDU Contribution”) all of EDXC’s operating assets and all of its liabilities directly related thereto to CBD Unlimited, Inc., a Nevada corporation (“CBDU”), pursuant to a unanimous written consent executed by the respective boards of directors of EDXC and CBDU;

 

WHEREAS, in connection with the EDXC – CBDU Contribution, the Executive, EDXC, and CBDU are also parties to that certain Contribution and Exchange agreement of even date herewith (the “Exchange Agreement”), pursuant to which the Executive agreed to, among other things, exchange a portion of his equity interest in EDXC for certain equity interests in CBDU (the transactions set forth in Exchange Agreement, the “Exchange”);

 

WHEREAS, in connection with the EDXC – CBDU Contribution and with the Exchange, the Executive, EDXC, and CBDU are also parties to that certain Stockholders Agreement of even date herewith (the “Stockholders Agreement”), pursuant to which the parties thereto made certain agreements related to their ownership of CBDU’s equity and the operation and management of CBDU;

 

WHEREAS, EDXC and the Executive are entering into this Agreement in connection with the transactions contemplated by (i) the EDXC – CBDU Contribution, (ii) the Exchange Agreement, and (iii) the Stockholders Agreement;

 

WHEREAS, the Executive currently serves EDXC in the roles of its President, Secretary, and Treasurer; and

 

WHEREAS, EDXC desires to continue to have the Executive provide services to EDXC in his role of its President and the Executive desires to continue to provide services by EDXC in that capacity, pursuant to the terms and conditions set forth herein.

 

NOW, THEREFORE, in consideration of the premises and mutual covenants contained in this Agreement and of other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby, agree as follows:

 

1. EFFECTIVE DATE OF AGREEMENT.

 

This Agreement shall take effect as of August 31, 2022 (the “Effective Date”).

 

2. STATUS; TERM.

 

EDXC shall purchase the services of the Executive and the Executive accepts such arrangement with EDXC for the purposes and on the terms and conditions set forth herein. The relationship set forth under this Agreement shall be “at-will”, commencing on the Effective Date (the “Term”). During the Term, the relationship between EDXC and the Executive hereunder shall be subject to termination as specified in Section 5.

 

Endexx Todd Davis Agreement August 2022.31 
 

 

3. TITLE; DUTIES.

 

During the Term, the Executive shall serve as the President of EDXC, and the Executive shall perform all duties and accept all responsibilities incidental to such position as reasonably specified from time to time by the board of directors of EDXC, including but not limited to: (i) day-to-day oversight of EDXC’s status as a public company, coordination of all of its regulatory filings (e.g., the Securities and Exchange Commission and OTC Markets Group Inc.), and coordinating and directing its investor relations programs and (ii) operating CBDU’s business, subject to oversight by the boards of directors of CBDU and EDXC. In respect of item (i), above, the Executive shall report directly to EDXC’s board of directors. In respect of item (ii), above, the Executive shall report directly to both CBDU’s board of directors and EDXC’s board of directors. During the Term, the Executive shall spend not less than 40 hours a week in the faithful discharge of his duties in a diligent manner. Notwithstanding the above and without a breach of the terms of this Agreement, the Executive intends to engage in any outside business activities that (i) are not competitive with the business of EDXC and its “Subsidiaries” and (ii) do not distract from his discharge of the services that he is rendering pursuant to this Agreement, the lack of objection to the Executive’s provision of which outside business activities is hereby confirmed by EDXC. For the purposes of this Agreement, “Subsidiaries” shall include, but not be limited to, any subsidiary that EDXC lists in any periodic reports that it files with the U.S. Securities and Exchange Commission and, specifically, EH Sub Inc., Hyla US Holdco Limited, a Delaware corporation, and CBDU.

 

4. COMPENSATION.

 

The Executive’s compensation for all services rendered to or on behalf of EDXC shall be as follows:

 

4.1. Base Compensation.

 

During the Term, the Executive shall be paid base compensation on a calendar monthly basis at the rate of Ten Thousand Dollars ($10,000.00) (the “Base Compensation”). By virtue of the Executive’s other professional activities, outside of and not in competition with his duties hereunder, the Executive has confirmed to EDXC that his status as President is as an “independent contractor,” rather than as an employee. The Executive will indemnify and hold EDXC and its Subsidiaries harmless from and against any tax, tax-related, or other issues related to the Executive’s determination of his independent, and not employee status.

 

4.2. Health Insurance.

 

During the Term, the Executive may participate in all standard health insurance as made available by EDXC to its executives, which cost shall be borne by EDXC.

 

4.3. Expense Reimbursement

 

During the Term, EDXC shall reimburse the Executive for his reasonable expenses supported by appropriate documentation incurred by him in connection with his fulfillment of his duties hereunder.

 

5. TERMINATION.

 

5.1. Reserved.

 

Endexx Todd Davis Agreement August 2022.32 
 

 

5.2. Termination Without Cause.

 

Either the Executive or EDXC may terminate the relationship set forth under this Agreement for any reason or no reason upon thirty (30) days’ written notice. In the event of such termination, except as otherwise provided in Section 6.1, the Executive shall have no right to receive any compensation or other benefits under this Agreement after the effective date of termination, provided that EDXC will pay the Executive his then-applicable Base Compensation earned through the date of termination at the conclusion of such 30-day period. The termination will become effective as of the end of such 30-day period.

 

5.3. Termination by EDXC for Cause.

 

Any of the following acts or omissions shall constitute grounds for the Board of Directors of EDXC (the “Board”) to terminate the Executive’s the relationship set forth under this Agreement for “Cause”: (i) intentional misconduct in the performance of the Executive’s duties hereunder that is materially injurious to EDXC or to CBDU; (ii) the Executive’s conviction of, or plea of nolo contendere to, a felony; (iii) the Executive’s material dishonesty relating to the performance of his services hereunder; (iv) the Executive’s breach of a fiduciary duty owed to EDXC or its Subsidiaries; (v) the Executive’s misappropriation of confidential information or material property or assets of EDXC or its Subsidiaries; (vi) CBDU is sold or ceases operations as permitted in the Stockholders Agreement, of even date herewith, between EDXC and the Executive (the “Stockholders Agreement”), or (vii) the Executive’s breach of this Agreement. Notwithstanding anything in this Agreement to the contrary, termination for Cause shall be accomplished and effective immediately upon receipt by the Executive of written notice from the Board. Any such termination shall be without prejudice to any other remedy to that EDXC may be entitled either at law, in equity, or under this Agreement. In the event the Executive’s relationship set forth under this Agreement is terminated for Cause, the Executive shall separate from service with EDXC after the date of termination and shall have no right to receive compensation or other benefits under this Agreement after the date of termination, other than any compensation accrued prior to such termination but unpaid as of such termination and any continuation of group health coverage to which the Executive and his qualified beneficiaries may be entitled, at his sole expense, under Section 4980B of the Internal Revenue Code of 1986, as amended or similar state law.

 

5.4. Termination by the Executive for Good Reason.

 

The Executive’s separation from service under this Agreement may be terminated by the Executive for Good Reason in accordance with this Section 5.4 and shall be treated as an involuntary separation from service. For purposes of this Agreement, any of the following acts or omissions without the Executive’s express written consent shall constitute the only grounds for the Executive to initiate a separation from service with EDXC pursuant to this Agreement for “Good Reason”: (i) the reduction of the Executive’s Base Compensation or the failure to provide the Executive with agreed-upon benefits, in either case without the Executive’s consent; (ii) the Executive’s job title is reduced to a lower job title; (iii) the services that the Executive is providing hereunder, when taken as a whole, are materially diminished (without the Executive’s consent) from those in effect as of the effective date of this Agreement or as subsequently agreed between the Executive and EDXC; or (iv) EDXC materially breaches this Agreement. For clarity and not by way of limitation, the Executive may not use “Termination by EDXC for Cause” to constitute “Termination by the Executive for Good Reason.” Notice of a condition purported to constitute Good Reason must be provided to EDXC in writing by the Executive within thirty (30) days following the Executive’s knowledge of the first occurrence of such purported condition and must state a proposed date of termination by the Executive that is at least thirty (30) days but not more than ninety (90) days after the date of such notice, during which time EDXC shall be given the opportunity to cure any basis for such Good Reason. The Executive’s failure to provide a timely notice of Good Reason shall foreclose the Executive from asserting Good Reason for the purpose of receipt of those benefits provided for in Section 6.1 with respect to such condition at any later date. If no cure is timely effected, then the Executive’s termination with Good Reason shall be effective as of the date of termination specified in the notice of termination. In the event of such termination, except as otherwise provided in Section 6.1, the Executive shall have no right to receive any compensation or other benefits under this Agreement after the effective date of termination, provided that EDXC will pay the Executive his then-applicable Base Compensation earned through the date of termination at date of termination.

 

Endexx Todd Davis Agreement August 2022.33 
 

 

5.5. Termination for Death or Disability.

 

This Agreement and the Executive’s relationship hereunder shall terminate if the Executive dies or suffers a Disability. For purposes of this Agreement, the term “Disability” means any physical or mental impairment or illness that has prevented the Executive from performing the normal duties hereunder for a cumulative period of at least one hundred eighty (180) consecutive days and which is expected to be of permanent duration. A determination of whether such impairment or illness is expected to be of permanent duration shall be made by a licensed physician mutually acceptable to the Executive and EDXC. It is EDXC’s intent to comply with the Family and Medical Leave Act and the Americans with Disabilities Act, if applicable, and nothing in this Section 5.5 should be construed to the contrary. In the event the Executive’s relationship hereunder is terminated due to death or Disability, the Executive’s relationship shall cease after the date of termination and shall have no right to receive compensation or other benefits under this Agreement after the date of termination.

 

6. PAYMENTS UPON TERMINATION.

 

6.1. Post-termination Payments.

 

In the event that, during the Term, (i) the Executive’s relationship hereunder has been terminated without Cause by EDXC in accordance with Section 5.2; or (ii) the Executive voluntarily terminates his relationship hereunder with EDXC during the Term for Good Reason in accordance with Section 5.4, the Executive shall be entitled to his then-current Base Compensation as set forth in Section 4.1 (the “Post-termination Payments”) for a period of six (6) months. The Post-termination Payments are contingent upon the Executive’s executing, and not revoking, a full waiver and release of all claims in a commercially reasonable form prepared by and acceptable to EDXC (the “Release”) and upon the Executive complying with the Executive’s obligations under Section 7 of this Agreement. Provided that the Executive has first executed the Release, and does not revoke such Release, the Post-termination Payments will begin on the first day of the month that occurs after the 60th day following the Executive’s termination date.

 

6.2. Effect of Termination for Reasons Not Covered by Section 6.1.

 

In the event the Executive’s relationship hereunder is terminated: (i) [reserved]; (ii) by the Executive under Section 5.2; (iii) by EDXC for Cause under Section 5.3; (iv) by the Executive for reasons that do not satisfy the criteria set forth in Section 5.4, as applicable; or (v) by reason of death or Disability of the Executive under Section 5.5, then the Executive shall cease to provide services to EDXC after the date of termination, and, except for the Executive’s regular Base Compensation earned through the date of termination, the Executive shall have no right to receive any other compensation or other benefits under this Agreement after the date of termination. EDXC will pay the Executive his then-applicable Base Compensation as of the termination date. The Executive’s obligations under Section 7 of this Agreement shall continue in accordance with their terms.

 

Endexx Todd Davis Agreement August 2022.34 
 

 

6.3. Release and Compliance with Obligations.

 

Notwithstanding any other provision of this Agreement, EDXC shall have no obligation to pay or provide, and the Executive shall have no right to receive, the Post-termination Payments unless the Executive first executes, and does not revoke, the Release and unless the Executive complies with his obligations under Section 7 of this Agreement.

 

7. CONFIDENTIAL INFORMATION.

 

7.1. Access to Confidential Information.

 

The Executive understands and acknowledges that, during the period that he provides services to EDXC, he will have access to and become familiar with confidential information belonging to EDXC and each of its Subsidiaries. Examples of confidential information include, but are not limited to, financial information, non-public information pertaining to the business operations, clients, lists of clients, client records, notes, market studies and plans, policies and procedures, sales aids, marketing methods, and all other types of proprietary data and plans for EDXC and its Subsidiaries (collectively, the “Confidential Information”).

 

7.2. Covenant Not to Use or Disclose.

 

The Executive understands that the Confidential Information is the exclusive property of EDXC and its Subsidiaries. The Executive agrees that, during and after the term of this Agreement, the Executive will not, directly or indirectly, use any of the Confidential Information for his own benefit or in any way that is or could be deemed to be detrimental to EDXC or its Subsidiaries. The Executive also agrees that he will not disclose any Confidential Information to anyone other than authorized officers of EDXC or its Subsidiaries

 

7.3. Return of Property.

 

Upon the cessation of the Executive’s relationship with EDXC hereunder for any reason or no reason or at any other time upon EDXC’s request, the Executive will promptly return to EDXC any and all written information, materials and equipment that constitute, contain, or relate in any way to proprietary or confidential information or trade secrets of EDXC (including, but not limited to, Confidential Information) and any other documents, equipment, and materials of any kind that constitute the property of EDXC or its Subsidiaries, whether confidential or not, including any and all copies or notes thereof that may have been made by or for the Executive. After the cessation of the Executive’s relationship with EDXC hereunder, the Executive shall not retain, in hard copy, computer, electronic, or any other form, any information that constitutes, contains, or relates in any way to proprietary, confidential, or trade secret information of EDXC or its Subsidiaries. Upon request by EDXC, the Executive will provide a certification or declaration that the Executive is in compliance with this Section 7.3 of this Agreement, that the Executive has returned all Company property to EDXC, and that the Executive is not using, and does not possess, any Confidential Information.

 

Endexx Todd Davis Agreement August 2022.35 
 

 

7.4. Specific Performance.

 

In the event of any controversy concerning the rights or obligations under this Section 7, such rights or obligations shall be enforceable in a court of equity by a decree of specific performance. Such equity shall, however, be cumulative and nonexclusive and shall be in addition to any other remedy to which the parties may be entitled. The Executive acknowledges that a breach of the provisions of this Section 7 will cause irreparable damage to EDXC or its Subsidiaries, the exact amount of which will be difficult or impossible to ascertain, and that EDXC’s remedies at law for any such breach will be inadequate. Accordingly, upon a breach of the covenants and agreements contained in this Section 7, in addition to all other rights and remedies existing in its favor, EDXC, its successors, assigns, or affiliates may apply to any court of competent jurisdiction for specific performance and/or injunctive or other relief in order to enforce or prevent any violations of the provisions hereof without the requirement of posting any bond.

 

8. SECTION 409A COMPLIANCE

 

The parties to this Agreement intend that the Agreement complies with Section 409A of the Internal Revenue Code of 1986, as amended (“the Code”), where applicable, and this Agreement will be interpreted in a manner consistent with that intention. If employed, a termination of employment will not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment unless such termination qualifies as a “separation from service” within the meaning of Section 409A of the Code and, for purposes of any such provision of this Agreement, references to a “termination,” “termination of employment,” or like terms will mean a “separation from service.” For purposes of Section 409A of the Code, each payment made in accordance with this Agreement will be designated as a “separate payment” within the meaning of Section 409A of the Code. Notwithstanding anything to the contrary herein, except to the extent any expense, reimbursement or in-kind benefit provided pursuant to this Agreement does not constitute a “deferral of compensation” within the meaning of Section 409A of the Code: (i) the amount of expenses eligible for reimbursement or in-kind benefits provided to the Executive during any calendar year will not affect the amount of expenses eligible for reimbursement or in-kind benefits provided to the Executive in any other calendar year, (ii) the reimbursements for expenses for which the Executive is entitled to be reimbursed will be made on or before the last day of the calendar year following the calendar year in which the applicable expense is incurred, and (iii) the right to reimbursement or in-kind benefits hereunder may not be liquidated or exchanged for any other benefit.

 

9. WAIVER.

 

A waiver by EDXC of a breach by the Executive of any provision or covenant of this Agreement shall not operate or be construed as a waiver of any other breach by the Executive. A waiver by the Executive of a breach by EDXC of any provision or covenant of this Agreement shall not operate or be construed as a waiver of any other breach by EDXC.

 

10. GOVERNING LAW; FORUM SELECTION.

 

This Agreement shall be governed by and construed in accordance with the internal laws of the State of Arizona without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Arizona or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Arizona. The parties hereto agree that any suit or proceeding arising out of this Agreement shall be brought only in the State of Arizona or U.S. Federal District courts located in Maricopa County, Arizona; provided, however, that no party waives his or its right to request removal of such action or proceeding from the state court to a federal court. Each party hereto consents to the personal jurisdiction of such courts and agrees that service of process in any such suit or proceeding such be sufficiently accomplished if accomplished in accordance with the notice provisions set forth in the Agreement.

 

Endexx Todd Davis Agreement August 2022.36 
 

 

11. WAIVER OF JURY TRIAL.

 

EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 

12. AMENDMENTS.

 

No amendment or addition to this Agreement shall be binding unless it is approved by EDXC’s Board of Directors and is in writing and signed by the Executive and an individual specifically authorized by the Board of Directors to execute such amendment or addition to this Agreement.

 

13. SEVERABILITY.

 

If any of the provisions of this Agreement are held to be void, illegal, invalid, or unenforceable by a court of competent jurisdiction, the remaining provisions hereof shall nevertheless continue to be valid and enforceable as though the invalid or unenforceable parts had not been included therewith. In the event that any provision in this Agreement relating to the time period, areas of restriction, and/or the scope of actions precluded shall be declared by a court of competent jurisdiction to exceed the maximum time period, areas of restriction and/or scope of actions precluded as such court deems reasonable and enforceable, then in such event the time period, areas of restriction and/or scope of actions precluded deemed most beneficial to EDXC but reasonable and enforceable by the court shall become and thereafter be the maximum time period, areas of restriction and/or scope of actions precluded hereunder.

 

14. NOTICES.

 

Any and all notices or other communications or deliveries required or permitted to be given or made pursuant to any of the provisions of this Agreement shall be deemed to have been duly given or made for all purposes if made in writing and: (a) hand delivered, (b) sent by a nationally recognized overnight courier, or (c) sent by electronic transmission (with confirmation by the transmitting equipment) as follows:

 

If to EDXC:

 

Endexx Corporation

38246 North Hazelwood Circle

Cave Creek, Arizona 85331

Attention: _____________

Email: ____________________

 

with a mandatory copy (which shall not constitute notice) to:

 

Clark Hill PLC

555 South Flower Street, 24th Floor

Los Angeles, California 90071

Attention: Randolf W. Katz

Email: Rkatz@clarkhill.com

 

Endexx Todd Davis Agreement August 2022.37 
 

 

If to the Executive:

 

Todd Allen Davis

37043 North Kohuana Place

Cave Creek, Arizona 85331

Email: todski17@yahoo.com

 

With a mandatory copy (which shall not constitute notice) to:

 

[Info for Todd’s counsel]

Attention: _________

Email: ____________

 

or at such other address as any party may specify by notice given to the other party in accordance with this Section. The date of giving of any such notice shall be the date of hand delivery, the date sent by telephone facsimile, and the day after delivery to the overnight courier service.

 

15. Intentionally Omitted.

 

16. ASSIGNMENT.

 

This Agreement is not assignable by the Executive or by EDXC. Any purported assignment by the Executive in violation of this Section shall be void ab initio.

 

17. CAPTIONS.

 

The captions of the paragraphs of this Agreement are for convenience only and shall not affect in any way the meaning or interpretation of this Agreement or any of the provisions of this Agreement.

 

18. ATTORNEYS’ FEES.

 

In the event of litigation to enforce or defend enforcement of the terms of this Agreement, the prevailing party shall be entitled to collect from the other party, all of his or its costs, including without limitation, court costs and reasonable attorneys’ fees.

 

19. ENTIRE AGREEMENT.

 

This Agreement, the Exchange Agreement, and the Stockholders Agreement executed in connection with the Exchange contain the entire agreement of the parties relating to the subject matter hereof and supersede all prior agreements and understandings with respect to such subject matter (including any prior agreements between the Executive and EDXC), which prior agreements are hereby null and void and of no further effect. Except for the Exchange Agreement and the Stockholders Agreement, the parties hereto have made no agreements, representations or warranties relating to the subject matter of this Agreement which are not set forth herein. The recitals set forth herein are true and correct and hereby made a representation under this Agreement. Nothing in this Agreement shall supersede or otherwise amend any provisions of the Stockholders Agreement.

 

20. Counterparts and Signatures.

 

This Agreement may be executed in as many counterparts as may be deemed necessary and convenient, each of which when so executed shall be deemed an original, but all such counterparts shall constitute but one and the same instrument. One or more counterparts of this Agreement may be delivered by facsimile or other electronic means, with the intention that delivery by such means shall have the same effect as delivery of an original counterpart.

 

[Signature Page Follows]

 

Endexx Todd Davis Agreement August 2022.38 
 

 

 

IN WITNESS WHEREOF, and intending to be legally bound, the parties have signed this Agreement as of the date first above written. 

 

  ENDEXX CORPORATION
   
  By:                    
  Name:  
  Title:  
     
   
  TODD ALLEN DAVIS

 

Endexx Todd Davis Agreement August 2022.39 

 

 

Exhibit 10.50